ID   KCNA1_HUMAN             Reviewed;         495 AA.
AC   Q09470; A6NM83; Q3MIQ9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   15-FEB-2017, entry version 177.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 1;
DE   AltName: Full=Voltage-gated K(+) channel HuKI {ECO:0000303|PubMed:19912772};
DE   AltName: Full=Voltage-gated potassium channel HBK1 {ECO:0000303|PubMed:2128063};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.1;
GN   Name=KCNA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND ENZYME
RP   REGULATION.
RC   TISSUE=Brain;
RX   PubMed=19912772; DOI=10.1016/1044-7431(90)90004-N;
RA   Ramaswami M., Gautam M., Kamb A., Rudy B., Tanouye M.A., Mathew M.K.;
RT   "Human potassium channel genes: molecular cloning and functional
RT   expression.";
RL   Mol. Cell. Neurosci. 1:214-223(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 263-315.
RX   PubMed=2128063;
RA   Freeman S.N., Conley E.C., Brennand J.C., Russell N.J.W.,
RA   Brammar W.J.;
RT   "Cloning and characterization of a cDNA encoding a human brain
RT   potassium channel.";
RL   Biochem. Soc. Trans. 18:891-892(1990).
RN   [6]
RP   INTERACTION WITH KCNA2 AND KCNAB2, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11086297;
RX   DOI=10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y;
RA   Rasband M.N., Trimmer J.S.;
RT   "Subunit composition and novel localization of K+ channels in spinal
RT   cord.";
RL   J. Comp. Neurol. 429:166-176(2001).
RN   [7]
RP   RNA EDITING OF POSITION 400.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
RN   [8]
RP   PALMITOYLATION AT CYS-243, MUTAGENESIS OF 35-CYS--CYS-36 AND CYS-243,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15837928; DOI=10.1073/pnas.0501999102;
RA   Gubitosi-Klug R.A., Mancuso D.J., Gross R.W.;
RT   "The human Kv1.1 channel is palmitoylated, modulating voltage sensing:
RT   Identification of a palmitoylation consensus sequence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:5964-5968(2005).
RN   [9]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [10]
RP   INTERACTION WITH KCNRG, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19968958; DOI=10.1016/j.bbrc.2009.11.143;
RA   Usman H., Mathew M.K.;
RT   "Potassium channel regulator KCNRG regulates surface expression of
RT   Shaker-type potassium channels.";
RL   Biochem. Biophys. Res. Commun. 391:1301-1305(2010).
RN   [11]
RP   FUNCTION.
RX   PubMed=21106501; DOI=10.1093/brain/awq318;
RA   Tomlinson S.E., Tan S.V., Kullmann D.M., Griggs R.C., Burke D.,
RA   Hanna M.G., Bostock H.;
RT   "Nerve excitability studies characterize Kv1.1 fast potassium channel
RT   dysfunction in patients with episodic ataxia type 1.";
RL   Brain 133:3530-3540(2010).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=21483673; DOI=10.1371/journal.pone.0018213;
RA   Ma Z., Lavebratt C., Almgren M., Portwood N., Forsberg L.E.,
RA   Branstrom R., Berglund E., Falkmer S., Sundler F., Wierup N.,
RA   Bjorklund A.;
RT   "Evidence for presence and functional effects of Kv1.1 channels in
RT   beta-cells: general survey and results from mceph/mceph mice.";
RL   PLoS ONE 6:E18213-E18213(2011).
RN   [13]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-446, AND MUTAGENESIS OF
RP   SER-446.
RX   PubMed=23774215; DOI=10.1158/0008-5472.CAN-12-3690;
RA   Lallet-Daher H., Wiel C., Gitenay D., Navaratnam N., Augert A.,
RA   Le Calve B., Verbeke S., Carling D., Aubert S., Vindrieux D.,
RA   Bernard D.;
RT   "Potassium channel KCNA1 modulates oncogene-induced senescence and
RT   transformation.";
RL   Cancer Res. 73:5253-5265(2013).
RN   [14]
RP   INTERACTION WITH ANK3, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23903368; DOI=10.1038/ki.2013.280;
RA   San-Cristobal P., Lainez S., Dimke H., de Graaf M.J., Hoenderop J.G.,
RA   Bindels R.J.;
RT   "Ankyrin-3 is a novel binding partner of the voltage-gated potassium
RT   channel Kv1.1 implicated in renal magnesium handling.";
RL   Kidney Int. 85:94-102(2014).
RN   [15]
RP   VARIANTS EA1 PHE-174; SER-239; ILE-249 AND ALA-408.
RX   PubMed=7842011; DOI=10.1038/ng1094-136;
RA   Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R.P., Smith E.A.,
RA   Kramer P., Litt M.;
RT   "Episodic ataxia/myokymia syndrome is associated with point mutations
RT   in the human potassium channel gene, KCNA1.";
RL   Nat. Genet. 8:136-140(1994).
RN   [16]
RP   VARIANTS EA1 PHE-174; CYS-184 AND ASP-325.
RX   PubMed=8541859; DOI=10.1093/hmg/4.9.1671;
RA   Browne D.L., Brunt E.R.P., Griggs R.C., Nutt J.G., Gancher S.T.,
RA   Smith E.A., Litt M.;
RT   "Identification of two new KCNA1 mutations in episodic ataxia/myokymia
RT   families.";
RL   Hum. Mol. Genet. 4:1671-1672(1995).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS EA1 CYS-184; ASP-325 AND ALA-408.
RX   PubMed=8845167; DOI=10.1016/0896-6273(95)90022-5;
RA   Adelman J.P., Bond C.T., Pessia M., Maylie J.;
RT   "Episodic ataxia results from voltage-dependent potassium channels
RT   with altered functions.";
RL   Neuron 15:1449-1454(1995).
RN   [18]
RP   VARIANT EA1 MET-226.
RX   PubMed=8871592; DOI=10.1002/ana.410400422;
RA   Comu S., Giuliani M., Narayanan V.;
RT   "Episodic ataxia and myokymia syndrome: a new mutation of potassium
RT   channel gene Kv1.1.";
RL   Ann. Neurol. 40:684-687(1996).
RN   [19]
RP   VARIANTS EA1 ARG-177; ALA-226 AND ILE-404.
RX   PubMed=9600245; DOI=10.1007/s004390050722;
RA   Scheffer H., Brunt E.R.P., Mol G.J.J., van der Vlies P., Stulp R.P.,
RA   Verlind E., Mantel G., Averyanov Y.N., Hofstra R.M.W., Buys C.H.C.M.;
RT   "Three novel KCNA1 mutations in episodic ataxia type I families.";
RL   Hum. Genet. 102:464-466(1998).
RN   [20]
RP   VARIANT EA1 ARG-226, AND CHARACTERIZATION OF VARIANT EA1 ARG-226.
RX   PubMed=10355668; DOI=10.1093/brain/122.5.817;
RA   Zuberi S.M., Eunson L.H., Spauschus A., De Silva R., Tolmie J.,
RA   Wood N.W., McWilliam R.C., Stephenson J.P.B., Kullmann D.M.,
RA   Hanna M.G.;
RT   "A novel mutation in the human voltage-gated potassium channel gene
RT   (Kv1.1) associates with episodic ataxia type 1 and sometimes with
RT   partial epilepsy.";
RL   Brain 122:817-825(1999).
RN   [21]
RP   VARIANTS MK1 PRO-242 AND HIS-244, VARIANT EA1 ILE-404,
RP   CHARACTERIZATION OF VARIANTS MK1 PRO-242 AND HIS-244, CHARACTERIZATION
RP   OF VARIANT EA1 ILE-404, AND FUNCTION.
RX   PubMed=11026449;
RX   DOI=10.1002/1531-8249(200010)48:4<647::AID-ANA12>3.3.CO;2-H;
RA   Eunson L.H., Rea R., Zuberi S.M., Youroukos S., Panayiotopoulos C.P.,
RA   Liguori R., Avoni P., McWilliam R.C., Stephenson J.B.P., Hanna M.G.,
RA   Kullmann D.M., Spauschus A.;
RT   "Clinical, genetic, and expression studies of mutations in the
RT   potassium channel gene KCNA1 reveal new phenotypic variability.";
RL   Ann. Neurol. 48:647-656(2000).
RN   [22]
RP   VARIANT EA1 ILE-329.
RX   PubMed=11013453;
RX   DOI=10.1002/1098-1004(200010)16:4<374::AID-HUMU15>3.3.CO;2-W;
RA   Knight M.A., Storey E., McKinlay Gardner R.J., Hand P., Forrest S.M.;
RT   "Identification of a novel missense mutation L329I in the episodic
RT   ataxia type 1 gene KCNA1 -- a challenging problem.";
RL   Hum. Mutat. 16:374-374(2000).
RN   [23]
RP   CHARACTERIZATION OF VARIANTS EA1 ASP-325 AND ALA-408, FUNCTION,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH KCNAB1.
RX   PubMed=12077175;
RA   Maylie B., Bissonnette E., Virk M., Adelman J.P., Maylie J.G.;
RT   "Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel
RT   alter hKvbeta 1-induced N-type inactivation.";
RL   J. Neurosci. 22:4786-4793(2002).
RN   [24]
RP   VARIANT EA1 ILE-342.
RX   PubMed=15532032; DOI=10.1002/humu.9295;
RA   Lee H., Wang H., Jen J.C., Sabatti C., Baloh R.W., Nelson S.F.;
RT   "A novel mutation in KCNA1 causes episodic ataxia without myokymia.";
RL   Hum. Mutat. 24:536-536(2004).
RN   [25]
RP   CHARACTERIZATION OF VARIANTS EA1 ASP-325; ILE-404 AND ALA-408,
RP   MUTAGENESIS OF ILE-177, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17156368; DOI=10.1111/j.1460-9568.2006.05186.x;
RA   Imbrici P., D'Adamo M.C., Kullmann D.M., Pessia M.;
RT   "Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast
RT   inactivation properties of the human potassium channels Kv1.4-
RT   1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.";
RL   Eur. J. Neurosci. 24:3073-3083(2006).
RN   [26]
RP   VARIANT MK1 LYS-226, CHARACTERIZATION OF VARIANT MK1 LYS-226,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17136396; DOI=10.1007/s10048-006-0071-z;
RA   Chen H., von Hehn C., Kaczmarek L.K., Ment L.R., Pober B.R.,
RA   Hisama F.M.;
RT   "Functional analysis of a novel potassium channel (KCNA1) mutation in
RT   hereditary myokymia.";
RL   Neurogenetics 8:131-135(2007).
RN   [27]
RP   VARIANT MK1 ASP-255, CHARACTERIZATION OF VARIANT MK1 ASP-255,
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=19307729; DOI=10.1172/JCI36948;
RA   Glaudemans B., van der Wijst J., Scola R.H., Lorenzoni P.J.,
RA   Heister A., van der Kemp A.W., Knoers N.V., Hoenderop J.G.,
RA   Bindels R.J.;
RT   "A missense mutation in the Kv1.1 voltage-gated potassium channel-
RT   encoding gene KCNA1 is linked to human autosomal dominant
RT   hypomagnesemia.";
RL   J. Clin. Invest. 119:936-942(2009).
RN   [28]
RP   CHARACTERIZATION OF VARIANT MK1 ASP-255, MUTAGENESIS OF ASN-255,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19903818; DOI=10.1074/jbc.M109.041517;
RA   van der Wijst J., Glaudemans B., Venselaar H., Nair A.V., Forst A.L.,
RA   Hoenderop J.G., Bindels R.J.;
RT   "Functional analysis of the Kv1.1 N255D mutation associated with
RT   autosomal dominant hypomagnesemia.";
RL   J. Biol. Chem. 285:171-178(2010).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain and the central nervous system, but also in
CC       the kidney (PubMed:19903818). Contributes to the regulation of the
CC       membrane potential and nerve signaling, and prevents neuronal
CC       hyperexcitability (PubMed:17156368). Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates
CC       between opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:19912772). Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5,
CC       KCNA6, KCNA7, and possibly other family members as well; channel
CC       properties depend on the type of alpha subunits that are part of
CC       the channel (PubMed:12077175, PubMed:17156368). Channel properties
CC       are modulated by cytoplasmic beta subunits that regulate the
CC       subcellular location of the alpha subunits and promote rapid
CC       inactivation of delayed rectifier potassium channels
CC       (PubMed:12077175, PubMed:17156368). In vivo, membranes probably
CC       contain a mixture of heteromeric potassium channel complexes,
CC       making it difficult to assign currents observed in intact tissues
CC       to any particular potassium channel family member. Homotetrameric
CC       KCNA1 forms a delayed-rectifier potassium channel that opens in
CC       response to membrane depolarization, followed by slow spontaneous
CC       channel closure (PubMed:19912772, PubMed:19968958,
CC       PubMed:19307729, PubMed:19903818). In contrast, a heterotetrameric
CC       channel formed by KCNA1 and KCNA4 shows rapid inactivation
CC       (PubMed:17156368). Regulates neuronal excitability in hippocampus,
CC       especially in mossy fibers and medial perforant path axons,
CC       preventing neuronal hyperexcitability. Response to toxins that are
CC       selective for KCNA1, respectively for KCNA2, suggests that
CC       heteromeric potassium channels composed of both KCNA1 and KCNA2
CC       play a role in pacemaking and regulate the output of deep
CC       cerebellar nuclear neurons (By similarity). May function as down-
CC       stream effector for G protein-coupled receptors and inhibit
CC       GABAergic inputs to basolateral amygdala neurons (By similarity).
CC       May contribute to the regulation of neurotransmitter release, such
CC       as gamma-aminobutyric acid (GABA) release (By similarity). Plays a
CC       role in regulating the generation of action potentials and
CC       preventing hyperexcitability in myelinated axons of the vagus
CC       nerve, and thereby contributes to the regulation of heart
CC       contraction (By similarity). Required for normal neuromuscular
CC       responses (PubMed:11026449, PubMed:17136396). Regulates the
CC       frequency of neuronal action potential firing in response to
CC       mechanical stimuli, and plays a role in the perception of pain
CC       caused by mechanical stimuli, but does not play a role in the
CC       perception of pain due to heat stimuli (By similarity). Required
CC       for normal responses to auditory stimuli and precise location of
CC       sound sources, but not for sound perception (By similarity). The
CC       use of toxins that block specific channels suggest that it
CC       contributes to the regulation of the axonal release of the
CC       neurotransmitter dopamine (By similarity). Required for normal
CC       postnatal brain development and normal proliferation of neuronal
CC       precursor cells in the brain (By similarity). Plays a role in the
CC       reabsorption of Mg(2+) in the distal convoluted tubules in the
CC       kidney and in magnesium ion homeostasis, probably via its effect
CC       on the membrane potential (PubMed:23903368, PubMed:19307729).
CC       {ECO:0000250|UniProtKB:P10499, ECO:0000269|PubMed:11026449,
CC       ECO:0000269|PubMed:12077175, ECO:0000269|PubMed:15837928,
CC       ECO:0000269|PubMed:17136396, ECO:0000269|PubMed:17156368,
CC       ECO:0000269|PubMed:19307729, ECO:0000269|PubMed:19903818,
CC       ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:19968958,
CC       ECO:0000269|PubMed:21106501, ECO:0000269|PubMed:23903368}.
CC   -!- ENZYME REGULATION: Inhibited by 1.1 mM 4-aminopyridine (4-AP) and
CC       by 20 mM tetraethylammonium (TEA), but not by charybdotoxin
CC       (CTX)(PubMed:19912772). Inhibited by dendrotoxin (DTX)
CC       (PubMed:19307729). {ECO:0000269|PubMed:19307729,
CC       ECO:0000269|PubMed:19912772}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-
CC       forming alpha subunits, such as KCNA2, KCNA4, KCNA5, KCNA6 and
CC       KCNA7 (PubMed:12077175, PubMed:17156368). Channel activity is
CC       regulated by interaction with the beta subunits KCNAB1 and KCNAB2
CC       (PubMed:12077175, PubMed:17156368). Identified in a complex with
CC       KCNA2 and KCNAB2 (PubMed:11086297). Interacts (via C-terminus)
CC       with the PDZ domains of DLG1, DLG2 and DLG4 (By similarity).
CC       Interacts with LGI1 within a complex containing LGI1, KCNA4 and
CC       KCNAB1 (By similarity). Interacts (via N-terminus) with STX1A;
CC       this promotes channel inactivation (By similarity). Interacts (via
CC       N-terminus) with the heterodimer formed by GNB1 and GNG2; this
CC       promotes channel inactivation (By similarity). Can interact
CC       simultaneously with STX1A and the heterodimer formed by GNB1 and
CC       GNG2 (By similarity). Interacts (via cytoplasmic N-terminal
CC       domain) with KCNRG; this inhibits channel activity
CC       (PubMed:19968958). Interacts with ANK3; this inhibits channel
CC       activity (PubMed:23903368). {ECO:0000250|UniProtKB:P10499,
CC       ECO:0000269|PubMed:11086297, ECO:0000269|PubMed:17156368,
CC       ECO:0000269|PubMed:19968958, ECO:0000269|PubMed:23903368,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q62936:Dlg3 (xeno); NbExp=2; IntAct=EBI-8286599, EBI-349596;
CC       P78352:DLG4; NbExp=2; IntAct=EBI-8286599, EBI-80389;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12077175,
CC       ECO:0000269|PubMed:15837928, ECO:0000269|PubMed:17136396,
CC       ECO:0000269|PubMed:17156368, ECO:0000269|PubMed:19307729,
CC       ECO:0000269|PubMed:19903818, ECO:0000269|PubMed:19912772,
CC       ECO:0000269|PubMed:19968958, ECO:0000269|PubMed:23903368}; Multi-
CC       pass membrane protein {ECO:0000305}. Membrane
CC       {ECO:0000269|PubMed:11086297}. Cell projection, axon
CC       {ECO:0000269|PubMed:11086297}. Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:23774215}. Perikaryon
CC       {ECO:0000250|UniProtKB:P10499}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P10499}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P16388}. Cell junction
CC       {ECO:0000250|UniProtKB:P16388}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P16388}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:P10499}.
CC       Note=Homotetrameric KCNA1 is primarily located in the endoplasmic
CC       reticulum. Interaction with KCNA2 and KCNAB2 or with KCNA4 and
CC       KCNAB2 promotes expression at the cell membrane (By similarity).
CC       Detected at axon terminals (By similarity).
CC       {ECO:0000250|UniProtKB:P10499, ECO:0000250|UniProtKB:P16388}.
CC   -!- TISSUE SPECIFICITY: Detected adjacent to nodes of Ranvier in
CC       juxtaparanodal zones in spinal cord nerve fibers, but also in
CC       paranodal regions in some myelinated spinal cord axons (at protein
CC       level) (PubMed:11086297). Detected in the islet of Langerhans
CC       (PubMed:21483673). {ECO:0000269|PubMed:11086297,
CC       ECO:0000269|PubMed:21483673}.
CC   -!- DOMAIN: The cytoplasmic N-terminus is important for
CC       tetramerization and for interaction with the beta subunits that
CC       promote rapid channel closure. {ECO:0000250|UniProtKB:P10499}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P10499}.
CC   -!- PTM: Palmitoylated on Cys-243; which may be required for membrane
CC       targeting. {ECO:0000269|PubMed:15837928}.
CC   -!- PTM: Phosphorylated on tyrosine residues. Phosphorylation
CC       increases in response to NRG1; this inhibits channel activity (By
CC       similarity). Phosphorylation at Ser-446 regulates channel activity
CC       by down-regulating expression at the cell membrane
CC       (PubMed:23774215). {ECO:0000250|UniProtKB:P16388,
CC       ECO:0000269|PubMed:23774215}.
CC   -!- RNA EDITING: Modified_positions=400 {ECO:0000269|PubMed:12907802};
CC       Note=Partially edited. RNA editing varies from 17% in the caudate
CC       nucleus to 68% in the spinal cord and to 77% in the medulla.;
CC   -!- DISEASE: Episodic ataxia 1 (EA1) [MIM:160120]: An autosomal
CC       dominant disorder characterized by brief episodes of ataxia and
CC       dysarthria. Neurological examination during and between the
CC       attacks demonstrates spontaneous, repetitive discharges in the
CC       distal musculature (myokymia) that arise from peripheral nerve.
CC       Nystagmus is absent. {ECO:0000269|PubMed:10355668,
CC       ECO:0000269|PubMed:11013453, ECO:0000269|PubMed:11026449,
CC       ECO:0000269|PubMed:12077175, ECO:0000269|PubMed:15532032,
CC       ECO:0000269|PubMed:17156368, ECO:0000269|PubMed:7842011,
CC       ECO:0000269|PubMed:8541859, ECO:0000269|PubMed:8845167,
CC       ECO:0000269|PubMed:8871592, ECO:0000269|PubMed:9600245}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Myokymia isolated 1 (MK1) [MIM:160120]: A condition
CC       characterized by spontaneous involuntary contraction of muscle
CC       fiber groups that can be observed as vermiform movement of the
CC       overlying skin. Electromyography typically shows continuous motor
CC       unit activity with spontaneous oligo- and multiplet-discharges of
CC       high intraburst frequency (myokymic discharges). Isolated
CC       spontaneous muscle twitches occur in many persons and have no
CC       grave significance. {ECO:0000269|PubMed:11026449,
CC       ECO:0000269|PubMed:17136396, ECO:0000269|PubMed:19307729,
CC       ECO:0000269|PubMed:19903818}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The delay or D-type current observed in hippocampus
CC       pyramidal neurons is probably mediated by potassium channels
CC       containing KCNA2 plus KCNA1 or other family members. It is
CC       activated at about -50 mV, i.e. below the action potential
CC       threshold, and is characterized by slow inactivation, extremely
CC       slow recovery from inactivation, sensitivity to dendrotoxin (DTX)
CC       and to 4-aminopyridine (4-AP). {ECO:0000305|PubMed:17917103}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.1/KCNA1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L02750; AAA36139.1; -; mRNA.
DR   EMBL; AC006063; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88833.1; -; Genomic_DNA.
DR   EMBL; BC101733; AAI01734.1; -; mRNA.
DR   EMBL; BC112180; AAI12181.1; -; mRNA.
DR   CCDS; CCDS8535.1; -.
DR   PIR; I57680; I57680.
DR   RefSeq; NP_000208.2; NM_000217.2.
DR   UniGene; Hs.416139; -.
DR   PDB; 2AFL; Model; -; A/B/C/D=326-407.
DR   PDBsum; 2AFL; -.
DR   ProteinModelPortal; Q09470; -.
DR   SMR; Q09470; -.
DR   BioGrid; 109939; 7.
DR   IntAct; Q09470; 9.
DR   MINT; MINT-1900397; -.
DR   STRING; 9606.ENSP00000371985; -.
DR   BindingDB; Q09470; -.
DR   ChEMBL; CHEMBL2309; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB01236; Sevoflurane.
DR   GuidetoPHARMACOLOGY; 538; -.
DR   TCDB; 1.A.1.2.12; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q09470; -.
DR   PhosphoSitePlus; Q09470; -.
DR   SwissPalm; Q09470; -.
DR   BioMuta; KCNA1; -.
DR   DMDM; 223590092; -.
DR   MaxQB; Q09470; -.
DR   PaxDb; Q09470; -.
DR   PeptideAtlas; Q09470; -.
DR   PRIDE; Q09470; -.
DR   Ensembl; ENST00000382545; ENSP00000371985; ENSG00000111262.
DR   GeneID; 3736; -.
DR   KEGG; hsa:3736; -.
DR   UCSC; uc001qnh.4; human.
DR   CTD; 3736; -.
DR   DisGeNET; 3736; -.
DR   GeneCards; KCNA1; -.
DR   GeneReviews; KCNA1; -.
DR   HGNC; HGNC:6218; KCNA1.
DR   HPA; CAB022365; -.
DR   MalaCards; KCNA1; -.
DR   MIM; 160120; phenotype.
DR   MIM; 176260; gene.
DR   neXtProt; NX_Q09470; -.
DR   OpenTargets; ENSG00000111262; -.
DR   Orphanet; 37612; Episodic ataxia type 1.
DR   Orphanet; 972; Hereditary continuous muscle fiber activity.
DR   Orphanet; 199326; Isolated autosomal dominant hypomagnesemia, Glaudemans type.
DR   PharmGKB; PA30019; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q09470; -.
DR   KO; K04874; -.
DR   OMA; IHRIDNT; -.
DR   OrthoDB; EOG090B05AD; -.
DR   PhylomeDB; Q09470; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNA1; human.
DR   GeneWiki; Kv1.1; -.
DR   GenomeRNAi; 3736; -.
DR   PRO; PR:Q09470; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111262; -.
DR   CleanEx; HS_KCNA1; -.
DR   Genevisible; Q09470; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0033270; C:paranode region of axon; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0015079; F:potassium ion transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0010644; P:cell communication by electrical coupling; ISS:UniProtKB.
DR   GO; GO:0034613; P:cellular protein localization; IEA:Ensembl.
DR   GO; GO:0071286; P:cellular response to magnesium ion; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0050976; P:detection of mechanical stimulus involved in sensory perception of touch; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0010960; P:magnesium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0050905; P:neuromuscular process; IMP:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; ISS:UniProtKB.
DR   GO; GO:0023041; P:neuronal signal transduction; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0006937; P:regulation of muscle contraction; ISS:UniProtKB.
DR   GO; GO:0001964; P:startle response; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004048; K_chnl_volt-dep_Kv1.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01508; KV11CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasmic vesicle; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   RNA editing; Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    495       Potassium voltage-gated channel subfamily
FT                                A member 1.
FT                                /FTId=PRO_0000053968.
FT   TOPO_DOM      1    164       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    165    186       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    187    220       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    221    242       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    243    253       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    254    274       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    275    287       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    288    308       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    309    323       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    324    345       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    346    359       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    360    371       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    372    379       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    380    386       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    387    415       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    416    495       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        1    128       Tetramerization domain.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   REGION      310    323       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       372    377       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       493    495       PDZ-binding. {ECO:0000250}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   MOD_RES     322    322       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     437    437       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   MOD_RES     439    439       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   MOD_RES     446    446       Phosphoserine; by PKA.
FT                                {ECO:0000305|PubMed:23774215}.
FT   LIPID       243    243       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:15837928}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT     174    174       V -> F (in EA1; dbSNP:rs104894349).
FT                                {ECO:0000269|PubMed:7842011,
FT                                ECO:0000269|PubMed:8541859}.
FT                                /FTId=VAR_001508.
FT   VARIANT     177    177       I -> R (in EA1).
FT                                {ECO:0000269|PubMed:9600245}.
FT                                /FTId=VAR_001509.
FT   VARIANT     184    184       F -> C (in EA1; alters voltage dependence
FT                                and kinetics of activation though not of
FT                                C-type inactivation; dbSNP:rs104894357).
FT                                {ECO:0000269|PubMed:8541859,
FT                                ECO:0000269|PubMed:8845167}.
FT                                /FTId=VAR_020830.
FT   VARIANT     204    204       R -> H (in dbSNP:rs2229000).
FT                                /FTId=VAR_020051.
FT   VARIANT     226    226       T -> A (in EA1; dbSNP:rs104894354).
FT                                {ECO:0000269|PubMed:9600245}.
FT                                /FTId=VAR_001510.
FT   VARIANT     226    226       T -> K (in MK1; induces a reduced efflux
FT                                of potassium ions during depolarization
FT                                which results in increased muscle cell
FT                                activity; coexpression studies of the
FT                                mutant protein with the wild-type protein
FT                                produces significantly reduced currents
FT                                suggesting a severe effect of the
FT                                mutation; dbSNP:rs28933383).
FT                                {ECO:0000269|PubMed:17136396}.
FT                                /FTId=VAR_037100.
FT   VARIANT     226    226       T -> M (in EA1; dbSNP:rs28933383).
FT                                {ECO:0000269|PubMed:8871592}.
FT                                /FTId=VAR_020831.
FT   VARIANT     226    226       T -> R (in EA1; yields currents with a
FT                                largely reduced amplitude;
FT                                dbSNP:rs28933383).
FT                                {ECO:0000269|PubMed:10355668}.
FT                                /FTId=VAR_037101.
FT   VARIANT     239    239       R -> S (in EA1; dbSNP:rs104894348).
FT                                {ECO:0000269|PubMed:7842011}.
FT                                /FTId=VAR_001511.
FT   VARIANT     242    242       A -> P (in MK1; 10% reduction of mean
FT                                peak current amplitudes compared to wil-
FT                                dtype; mutant and wild-type expression
FT                                together is consistent with a loss-of-
FT                                function effect of the mutation;
FT                                dbSNP:rs28933381).
FT                                {ECO:0000269|PubMed:11026449}.
FT                                /FTId=VAR_037102.
FT   VARIANT     244    244       P -> H (in MK1; does not affect channel
FT                                activity; dbSNP:rs28933382).
FT                                {ECO:0000269|PubMed:11026449}.
FT                                /FTId=VAR_037103.
FT   VARIANT     249    249       F -> I (in EA1; dbSNP:rs104894356).
FT                                {ECO:0000269|PubMed:7842011}.
FT                                /FTId=VAR_001512.
FT   VARIANT     255    255       N -> D (in MK1; strongly reduces the
FT                                activity of homomeric channels with
FT                                dominant negative effects on wild-type
FT                                channels; dbSNP:rs121918067).
FT                                {ECO:0000269|PubMed:19307729}.
FT                                /FTId=VAR_072397.
FT   VARIANT     325    325       E -> D (in EA1; results in non-functional
FT                                homomeric channels; accelerates recovery
FT                                from N-type inactivation due to
FT                                interaction with KCNAB1; slows down N-
FT                                type inactivation of heteromeric channels
FT                                formed by KCNA1 and KCNA4;
FT                                dbSNP:rs104894353).
FT                                {ECO:0000269|PubMed:12077175,
FT                                ECO:0000269|PubMed:17156368,
FT                                ECO:0000269|PubMed:8541859,
FT                                ECO:0000269|PubMed:8845167}.
FT                                /FTId=VAR_020832.
FT   VARIANT     329    329       L -> I (in EA1).
FT                                {ECO:0000269|PubMed:11013453}.
FT                                /FTId=VAR_020833.
FT   VARIANT     342    342       S -> I (in EA1; phenotype without
FT                                myokymia). {ECO:0000269|PubMed:15532032}.
FT                                /FTId=VAR_020834.
FT   VARIANT     400    400       I -> V (in RNA edited version).
FT                                /FTId=VAR_016805.
FT   VARIANT     404    404       V -> I (in EA1; results in slower channel
FT                                activation compared to wild-type; slows
FT                                down N-type inactivation of heteromeric
FT                                channels formed by KCNA1 and KCNA4;
FT                                dbSNP:rs104894355).
FT                                {ECO:0000269|PubMed:11026449,
FT                                ECO:0000269|PubMed:17156368,
FT                                ECO:0000269|PubMed:9600245}.
FT                                /FTId=VAR_001513.
FT   VARIANT     408    408       V -> A (in EA1; channels have voltage
FT                                dependence similar to that of wild-type
FT                                channels but with faster kinetics and
FT                                increased C-type inactivation;
FT                                accelerates recovery from N-type
FT                                inactivation due to interaction with
FT                                KCNAB1; slows down N-type inactivation of
FT                                heteromeric channels formed by KCNA1 and
FT                                KCNA4; dbSNP:rs104894352).
FT                                {ECO:0000269|PubMed:12077175,
FT                                ECO:0000269|PubMed:17156368,
FT                                ECO:0000269|PubMed:7842011,
FT                                ECO:0000269|PubMed:8845167}.
FT                                /FTId=VAR_001514.
FT   MUTAGEN      35     36       CC->AA: No effect on palmitoylation, no
FT                                effect on current kinetics.
FT                                {ECO:0000269|PubMed:15837928}.
FT   MUTAGEN     177    177       I->N: Slows down N-type inactivation of
FT                                heteromeric channels formed by KCNA1 and
FT                                KCNA4. {ECO:0000269|PubMed:17156368}.
FT   MUTAGEN     243    243       C->A: Strongly decreases palmitoylation
FT                                and alters current kinetics.
FT                                {ECO:0000269|PubMed:15837928}.
FT   MUTAGEN     255    255       N->A,H,T: Slightly increases channel
FT                                activity, but does not affect expression
FT                                at the cell membrane.
FT                                {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     255    255       N->E: Abolishes channel activity, but
FT                                does not affect expression at the cell
FT                                membrane. {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     255    255       N->Q: Strongly reduces channel activity,
FT                                but does not affect expression at the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     255    255       N->V: No effect on channel activity.
FT                                {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     446    446       S->A: Impairs phosphorylation by PKA.
FT                                {ECO:0000269|PubMed:23774215}.
FT   MUTAGEN     446    446       S->E: Impairs expression at the cell
FT                                membrane. {ECO:0000269|PubMed:23774215}.
FT   CONFLICT    265    265       Missing (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    315    315       L -> R (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       S -> Y (in Ref. 1; AAA36139).
FT                                {ECO:0000305}.
SQ   SEQUENCE   495 AA;  56466 MW;  0A1B1AB87BCDDEBA CRC64;
     MTVMSGENVD EASAAPGHPQ DGSYPRQADH DDHECCERVV INISGLRFET QLKTLAQFPN
     TLLGNPKKRM RYFDPLRNEY FFDRNRPSFD AILYYYQSGG RLRRPVNVPL DMFSEEIKFY
     ELGEEAMEKF REDEGFIKEE ERPLPEKEYQ RQVWLLFEYP ESSGPARVIA IVSVMVILIS
     IVIFCLETLP ELKDDKDFTG TVHRIDNTTV IYNSNIFTDP FFIVETLCII WFSFELVVRF
     FACPSKTDFF KNIMNFIDIV AIIPYFITLG TEIAEQEGNQ KGEQATSLAI LRVIRLVRVF
     RIFKLSRHSK GLQILGQTLK ASMRELGLLI FFLFIGVILF SSAVYFAEAE EAESHFSSIP
     DAFWWAVVSM TTVGYGDMYP VTIGGKIVGS LCAIAGVLTI ALPVPVIVSN FNYFYHRETE
     GEEQAQLLHV SSPNLASDSD LSRRSSSTMS KSEYMEIEED MNNSIAHYRQ VNIRTANCTT
     ANQNCVNKSK LLTDV
//
ID   KCNA2_HUMAN             Reviewed;         499 AA.
AC   P16389; A0A024R0D3; A8K1Z6; Q86XG6;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   15-FEB-2017, entry version 167.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 2;
DE   AltName: Full=NGK1;
DE   AltName: Full=Voltage-gated K(+) channel HuKIV {ECO:0000303|PubMed:19912772};
DE   AltName: Full=Voltage-gated potassium channel HBK5;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.2;
GN   Name=KCNA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Brain;
RX   PubMed=19912772; DOI=10.1016/1044-7431(90)90004-N;
RA   Ramaswami M., Gautam M., Kamb A., Rudy B., Tanouye M.A., Mathew M.K.;
RT   "Human potassium channel genes: molecular cloning and functional
RT   expression.";
RL   Mol. Cell. Neurosci. 1:214-223(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Substantia nigra {ECO:0000312|EMBL:BAF82750.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH KCNA4.
RX   PubMed=8495559; DOI=10.1161/01.RES.72.6.1326;
RA   Po S., Roberds S., Snyders D.J., Tamkun M.M., Bennett P.B.;
RT   "Heteromultimeric assembly of human potassium channels. Molecular
RT   basis of a transient outward current?";
RL   Circ. Res. 72:1326-1336(1993).
RN   [7]
RP   INTERACTION WITH CNTNAP2.
RX   PubMed=10624965; DOI=10.1016/S0896-6273(00)81049-1;
RA   Poliak S., Gollan L., Martinez R., Custer A., Einheber S.,
RA   Salzer J.L., Trimmer J.S., Shrager P., Peles E.;
RT   "Caspr2, a new member of the neurexin superfamily, is localized at the
RT   juxtaparanodes of myelinated axons and associates with K+ channels.";
RL   Neuron 24:1037-1047(1999).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11211111; DOI=10.1007/s004240000406;
RA   Imbrici P., Tucker S.J., D'Adamo M.C., Pessia M.;
RT   "Role of receptor protein tyrosine phosphatase alpha (RPTPalpha) and
RT   tyrosine phosphorylation in the serotonergic inhibition of voltage-
RT   dependent potassium channels.";
RL   Pflugers Arch. 441:257-262(2000).
RN   [9]
RP   SUBCELLULAR LOCATION, INTERACTION WITH KCNA1 AND KCNAB2, SUBUNIT, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11086297;
RX   DOI=10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y;
RA   Rasband M.N., Trimmer J.S.;
RT   "Subunit composition and novel localization of K+ channels in spinal
RT   cord.";
RL   J. Comp. Neurol. 429:166-176(2001).
RN   [10]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16473933; DOI=10.1073/pnas.0511197103;
RA   Inda M.C., DeFelipe J., Munoz A.;
RT   "Voltage-gated ion channels in the axon initial segment of human
RT   cortical pyramidal cells and their relationship with chandelier
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:2920-2925(2006).
RN   [11]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [12]
RP   INTERACTION WITH KCNAB1.
RX   PubMed=19713757; DOI=10.4161/chan.3.5.9558;
RA   Peters C.J., Vaid M., Horne A.J., Fedida D., Accili E.A.;
RT   "The molecular basis for the actions of Kvbeta1.2 on the opening and
RT   closing of the Kv1.2 delayed rectifier channel.";
RL   Channels 3:314-322(2009).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND ENZYME REGULATION.
RX   PubMed=20220134; DOI=10.1074/jbc.M109.068486;
RA   Chen P., Dendorfer A., Finol-Urdaneta R.K., Terlau H., Olivera B.M.;
RT   "Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel
RT   blocker: evaluation of cardioprotective effects of kappaM-
RT   conotoxins.";
RL   J. Biol. Chem. 285:14882-14889(2010).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=22649228; DOI=10.1523/JNEUROSCI.0719-12.2012;
RA   Zenker J., Poirot O., de Preux Charles A.S., Arnaud E., Medard J.J.,
RA   Lacroix C., Kuntzer T., Chrast R.;
RT   "Altered distribution of juxtaparanodal kv1.2 subunits mediates
RT   peripheral nerve hyperexcitability in type 2 diabetes mellitus.";
RL   J. Neurosci. 32:7493-7498(2012).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23769686; DOI=10.1016/j.neulet.2013.05.048;
RA   Lee J.H., Choi S.H., Lee B.H., Hwang S.H., Kim H.J., Rhee J.,
RA   Chung C., Nah S.Y.;
RT   "Activation of lysophosphatidic acid receptor by gintonin inhibits
RT   Kv1.2 channel activity: involvement of tyrosine kinase and receptor
RT   protein tyrosine phosphatase alpha.";
RL   Neurosci. Lett. 548:143-148(2013).
RN   [16]
RP   INVOLVEMENT IN EIEE32, AND VARIANT EIEE32 GLN-297.
RX   PubMed=25477152; DOI=10.1111/cge.12542;
RA   Pena S.D., Coimbra R.L.;
RT   "Ataxia and myoclonic epilepsy due to a heterozygous new mutation in
RT   KCNA2: proposal for a new channelopathy.";
RL   Clin. Genet. 87:E1-E3(2015).
RN   [17]
RP   INVOLVEMENT IN EIEE32, VARIANTS EIEE32 THR-263; GLN-297; PHE-298 AND
RP   LEU-405, AND CHARACTERIZATION OF VARIANTS EIEE32 THR-263; GLN-297;
RP   PHE-298 AND LEU-405.
RX   PubMed=25751627; DOI=10.1038/ng.3239;
RA   Syrbe S., Hedrich U.B., Riesch E., Djemie T., Mueller S.,
RA   Moeller R.S., Maher B., Hernandez-Hernandez L., Synofzik M.,
RA   Caglayan H.S., Arslan M., Serratosa J.M., Nothnagel M., May P.,
RA   Krause R., Loeffler H., Detert K., Dorn T., Vogt H., Kraemer G.,
RA   Schoels L., Mullis P.E., Linnankivi T., Lehesjoki A.E., Sterbova K.,
RA   Craiu D.C., Hoffman-Zacharska D., Korff C.M., Weber Y.G., Steinlin M.,
RA   Gallati S., Bertsche A., Bernhard M.K., Merkenschlager A., Kiess W.,
RA   Gonzalez M., Zuechner S., Palotie A., Suls A., De Jonghe P.,
RA   Helbig I., Biskup S., Wolff M., Maljevic S., Schuele R.,
RA   Sisodiya S.M., Weckhuysen S., Lerche H., Lemke J.R.;
RT   "De novo loss- or gain-of-function mutations in KCNA2 cause epileptic
RT   encephalopathy.";
RL   Nat. Genet. 47:393-399(2015).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain and the central nervous system, but also in
CC       the cardiovascular system. Prevents aberrant action potential
CC       firing and regulates neuronal output. Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates
CC       between opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:19912772, PubMed:8495559,
CC       PubMed:11211111, PubMed:23769686). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, KCNA6, KCNA7,
CC       and possibly other family members as well; channel properties
CC       depend on the type of alpha subunits that are part of the channel
CC       (PubMed:8495559, PubMed:20220134). Channel properties are
CC       modulated by cytoplasmic beta subunits that regulate the
CC       subcellular location of the alpha subunits and promote rapid
CC       inactivation of delayed rectifier potassium channels. In vivo,
CC       membranes probably contain a mixture of heteromeric potassium
CC       channel complexes, making it difficult to assign currents observed
CC       in intact tissues to any particular potassium channel family
CC       member. Homotetrameric KCNA2 forms a delayed-rectifier potassium
CC       channel that opens in response to membrane depolarization,
CC       followed by slow spontaneous channel closure (PubMed:19912772,
CC       PubMed:23769686). In contrast, a heteromultimer formed by KCNA2
CC       and KCNA4 shows rapid inactivation (PubMed:8495559). Regulates
CC       neuronal excitability and plays a role as pacemaker in the
CC       regulation of neuronal action potentials (By similarity). KCNA2-
CC       containing channels play a presynaptic role and prevent
CC       hyperexcitability and aberrant action potential firing (By
CC       similarity). Response to toxins that are selective for KCNA2-
CC       containing potassium channels suggests that in Purkinje cells,
CC       dendritic subthreshold KCNA2-containing potassium channels prevent
CC       random spontaneous calcium spikes, suppressing dendritic
CC       hyperexcitability without hindering the generation of somatic
CC       action potentials, and thereby play an important role in motor
CC       coordination (By similarity). Plays a role in the induction of
CC       long-term potentiation of neuron excitability in the CA3 layer of
CC       the hippocampus (By similarity). May function as down-stream
CC       effector for G protein-coupled receptors and inhibit GABAergic
CC       inputs to basolateral amygdala neurons (By similarity). May
CC       contribute to the regulation of neurotransmitter release, such as
CC       gamma-aminobutyric acid (GABA) (By similarity). Contributes to the
CC       regulation of the axonal release of the neurotransmitter dopamine
CC       (By similarity). Reduced KCNA2 expression plays a role in the
CC       perception of neuropathic pain after peripheral nerve injury, but
CC       not acute pain (By similarity). Plays a role in the regulation of
CC       the time spent in non-rapid eye movement (NREM) sleep (By
CC       similarity). {ECO:0000250|UniProtKB:P63141,
CC       ECO:0000250|UniProtKB:P63142, ECO:0000269|PubMed:11211111,
CC       ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:20220134,
CC       ECO:0000269|PubMed:23769686, ECO:0000269|PubMed:8495559,
CC       ECO:0000305}.
CC   -!- ENZYME REGULATION: Inhibited by 4-aminopyridine (4-AP) and
CC       charybdotoxin (CTX), but not by tetraethylammonium (TEA)
CC       (PubMed:19912772). Inhibited by dendrotoxin (DTX) (By similarity).
CC       Inhibited by tityustoxin-K alpha (TsTX-Kalpha), a toxin that is
CC       highly specific for KCNA2 (By similarity). Inhibited by maurotoxin
CC       (By similarity). Inhibited by kappaM conotoxins kappaM-RIIIJ and
CC       kappaM-RIIIK; kappaM-RIIIJ has much higher affinity for channels
CC       containing KCNA2 than kappaM-RIIIK, with the exception of
CC       heterodimers formed by KCNA2 and KCNA7 where the opposite is true
CC       (PubMed:20220134). {ECO:0000250|UniProtKB:P63141,
CC       ECO:0000250|UniProtKB:P63142, ECO:0000269|PubMed:19912772,
CC       ECO:0000269|PubMed:20220134}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels activate rapidly, i.e within a few
CC         msec, but inactivation is very slow, with only a marginal
CC         decrease in conductance over several seconds. The voltage-
CC         dependence of activation and inactivation and other channel
CC         characteristics vary depending on the experimental conditions,
CC         the expression system, post-translational modifications and the
CC         presence or absence of ancillary subunits. For the activation of
CC         homotetrameric channels expressed in xenopus oocytes, the
CC         threshold is at about -30 mV and the midpoint at about -5 mV.
CC         {ECO:0000269|PubMed:19912772};
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-
CC       forming alpha subunits, such as KCNA1, KCNA4, KCNA5, KCNA6 and
CC       KCNA7. Channel activity is regulated by interaction with the beta
CC       subunits, including KCNAB1 and KCNAB2. Identified in a complex
CC       with KCNA1 and KCNAB2 (PubMed:11086297). Identified in a complex
CC       with KCNA5 and KCNAB1 (By similarity). Identified in a complex
CC       with KCNA4 and FYN (By similarity). Interacts with the beta
CC       subunit KCNAB1 (PubMed:19713757). Interacts with PTK2B (By
CC       similarity). Interacts (via C-terminus) with CTTN (By similarity).
CC       Interacts (via N-terminal cytoplasmic domain) with RHOA (GTP-bound
CC       form); this regulates channel activity by reducing location at the
CC       cell surface in response to CHRM1 activation (By similarity).
CC       Interacts with DRD2 (By similarity). Interacts with SIGMAR1;
CC       cocaine consumption leads to increased interaction (By
CC       similarity). Interacts with ADAM22 (By similarity). Interacts (via
CC       C-terminus) with the PDZ domains of DLG1, DLG2 and DLG4 (By
CC       similarity). Interacts with CNTNAP2 (PubMed:10624965).
CC       {ECO:0000250|UniProtKB:P63141, ECO:0000250|UniProtKB:P63142,
CC       ECO:0000250|UniProtKB:Q09081, ECO:0000269|PubMed:10624965,
CC       ECO:0000269|PubMed:11086297, ECO:0000269|PubMed:19713757,
CC       ECO:0000269|PubMed:8495559, ECO:0000305}.
CC   -!- INTERACTION:
CC       P49069:CAMLG; NbExp=3; IntAct=EBI-10210559, EBI-1748958;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11211111,
CC       ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:20220134,
CC       ECO:0000269|PubMed:23769686, ECO:0000269|PubMed:8495559}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:P63142, ECO:0000305}.
CC       Membrane {ECO:0000250|UniProtKB:P63142}. Cell projection, axon
CC       {ECO:0000269|PubMed:16473933}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P63142}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P63142}. Cell projection, lamellipodium
CC       membrane {ECO:0000250|UniProtKB:P63142}. Cell junction, synapse,
CC       synaptosome {ECO:0000250|UniProtKB:P63141}. Cell junction,
CC       synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:P63141}.
CC       Cell projection, dendrite {ECO:0000250|UniProtKB:P63141}.
CC       Note=KCNA2 by itself is detected both at the endoplasmic reticulum
CC       and at the cell membrane. Coexpression with KCNA4 or with beta
CC       subunits promotes expression at the cell membrane. Coexpression
CC       with KCNA1 inhibits cell surface expression.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P16389-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P16389-2; Sequence=VSP_043077;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex (PubMed:16473933).
CC       Detected in peroneal nerve in the juxtaparanodal regions of the
CC       node of Ranvier; expression is decreased in patients with diabetes
CC       mellitus that suffer from axonal neuropathy (PubMed:22649228).
CC       Detected in paranodal and juxtanodal zones in myelinated spinal
CC       cord (at protein level) (PubMed:11086297).
CC       {ECO:0000269|PubMed:11086297, ECO:0000269|PubMed:16473933,
CC       ECO:0000269|PubMed:22649228}.
CC   -!- DOMAIN: The cytoplasmic N-terminus is important for
CC       tetramerization. Interactions between the different subunits
CC       modulate the gating characteristics (By similarity). Besides, the
CC       cytoplasmic N-terminal domain mediates interaction with RHOA and
CC       thus is required for RHOA-mediated endocytosis (By similarity).
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Phosphorylated on tyrosine residues; phosphorylation
CC       increases in response to ischemia (By similarity). Phosphorylated
CC       on tyrosine residues by activated PTK2B/PYK2 (By similarity).
CC       Phosphorylation on tyrosine residues suppresses ion channel
CC       activity (By similarity). Phosphorylated on tyrosine residues in
CC       response to CHRM1 activation; this abolishes interaction with
CC       CTTN. This is probably due to endocytosis of the phosphorylated
CC       channel subunits (By similarity). Phosphorylated on serine
CC       residues in response to increased cAMP levels; phosphorylation is
CC       apparently not catalyzed by PKA (By similarity).
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: N-glycosylated, with complex, sialylated N-glycans.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 32 (EIEE32)
CC       [MIM:616366]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent.
CC       {ECO:0000269|PubMed:25477152, ECO:0000269|PubMed:25751627}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: The delay or D-type current observed in hippocampus
CC       pyramidal neurons is probably mediated by potassium channels
CC       containing KCNA2 plus KCNA1 or other family members. It is
CC       activated at about -50 mV, i.e. below the action potential
CC       threshold, and is characterized by slow inactivation, extremely
CC       slow recovery from inactivation, sensitivity to dendrotoxin (DTX)
CC       and to 4-aminopyridine (4-AP). {ECO:0000305|PubMed:17917103}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.2/KCNA2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L02752; AAA36141.1; -; mRNA.
DR   EMBL; AK290061; BAF82750.1; -; mRNA.
DR   EMBL; AL365361; CAH71982.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56455.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56456.1; -; Genomic_DNA.
DR   EMBL; BC043564; AAH43564.1; -; mRNA.
DR   CCDS; CCDS55625.1; -. [P16389-2]
DR   CCDS; CCDS827.1; -. [P16389-1]
DR   PIR; I77466; I77466.
DR   RefSeq; NP_001191198.1; NM_001204269.1. [P16389-2]
DR   RefSeq; NP_004965.1; NM_004974.3. [P16389-1]
DR   RefSeq; XP_011539698.1; XM_011541396.2. [P16389-1]
DR   RefSeq; XP_011539699.1; XM_011541397.2. [P16389-1]
DR   RefSeq; XP_011539700.1; XM_011541398.2. [P16389-1]
DR   RefSeq; XP_011539701.1; XM_011541399.2. [P16389-1]
DR   RefSeq; XP_011539702.1; XM_011541400.2. [P16389-1]
DR   RefSeq; XP_016856702.1; XM_017001213.1. [P16389-1]
DR   UniGene; Hs.248139; -.
DR   UniGene; Hs.657199; -.
DR   UniGene; Hs.731191; -.
DR   ProteinModelPortal; P16389; -.
DR   SMR; P16389; -.
DR   BioGrid; 109940; 17.
DR   IntAct; P16389; 1.
DR   STRING; 9606.ENSP00000314520; -.
DR   BindingDB; P16389; -.
DR   ChEMBL; CHEMBL2086; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 539; -.
DR   TCDB; 1.A.1.2.10; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P16389; -.
DR   PhosphoSitePlus; P16389; -.
DR   BioMuta; KCNA2; -.
DR   DMDM; 1345813; -.
DR   MaxQB; P16389; -.
DR   PaxDb; P16389; -.
DR   PeptideAtlas; P16389; -.
DR   PRIDE; P16389; -.
DR   Ensembl; ENST00000316361; ENSP00000314520; ENSG00000177301. [P16389-1]
DR   Ensembl; ENST00000369770; ENSP00000358785; ENSG00000177301. [P16389-2]
DR   Ensembl; ENST00000485317; ENSP00000433109; ENSG00000177301. [P16389-1]
DR   Ensembl; ENST00000633222; ENSP00000487785; ENSG00000177301. [P16389-1]
DR   GeneID; 3737; -.
DR   KEGG; hsa:3737; -.
DR   UCSC; uc009wfv.2; human. [P16389-1]
DR   CTD; 3737; -.
DR   DisGeNET; 3737; -.
DR   GeneCards; KCNA2; -.
DR   HGNC; HGNC:6220; KCNA2.
DR   HPA; CAB001976; -.
DR   MalaCards; KCNA2; -.
DR   MIM; 176262; gene.
DR   MIM; 616366; phenotype.
DR   neXtProt; NX_P16389; -.
DR   OpenTargets; ENSG00000177301; -.
DR   PharmGKB; PA206; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P16389; -.
DR   KO; K04875; -.
DR   OMA; MTFHTYS; -.
DR   OrthoDB; EOG090B05AD; -.
DR   PhylomeDB; P16389; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA2; -.
DR   GenomeRNAi; 3737; -.
DR   PRO; PR:P16389; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000177301; -.
DR   CleanEx; HS_KCNA2; -.
DR   Genevisible; P16389; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:BHF-UCL.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; ISS:UniProtKB.
DR   GO; GO:0021633; P:optic nerve structural organization; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl.
DR   GO; GO:0014059; P:regulation of dopamine secretion; ISS:UniProtKB.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:UniProtKB.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004049; K_chnl_volt-dep_Kv1.2.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01509; KV12CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Disease mutation; Endoplasmic reticulum; Epilepsy;
KW   Glycoprotein; Ion channel; Ion transport; Lipoprotein; Membrane;
KW   Palmitate; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Synaptosome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    499       Potassium voltage-gated channel subfamily
FT                                A member 2.
FT                                /FTId=PRO_0000053972.
FT   TOPO_DOM      1    160       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    161    182       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    183    221       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    222    243       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    244    254       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    255    275       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    276    289       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    290    310       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    311    325       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    326    347       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    348    361       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    362    373       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    374    381       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    382    388       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    389    417       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    418    499       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        1    125       Tetramerization domain.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      312    325       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       374    379       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       497    499       PDZ-binding.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   SITE        252    252       Important for normal, slow channel
FT                                gating. {ECO:0000250|UniProtKB:P63142}.
FT   SITE        381    381       Important for binding with the scorpion
FT                                mesomartoxin; when the scorpion
FT                                mesomartoxin-rKv1.2/KCNA2 interaction is
FT                                modeled, this residue is close to the 'Y-
FT                                57' residue of the toxin.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOD_RES     429    429       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P63141}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63141}.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63141}.
FT   MOD_RES     441    441       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q09081}.
FT   MOD_RES     449    449       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q09081}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63141}.
FT   LIPID       244    244       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     299    499       VRVFRIFKLSRHSKGLQILGQTLKASMRELGLLIFFLFIGV
FT                                ILFSSAVYFAEADERESQFPSIPDAFWWAVVSMTTVGYGDM
FT                                VPTTIGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRET
FT                                EGEEQAQYLQVTSCPKIPSSPDLKKSRSASTISKSDYMEIQ
FT                                EGVNNSNEDFREENLKTANCTLANTNYVNITKMLTDV ->
FT                                ERRPLQSQKSKRGRQHLNTSHDCTLGINLVAGMTVQWTRAS
FT                                GPDDRQTPAVTTLHRMY (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043077.
FT   VARIANT     263    263       I -> T (in EIEE32; dominant-negative
FT                                mutation; loss of channel function;
FT                                dbSNP:rs786205231).
FT                                {ECO:0000269|PubMed:25751627}.
FT                                /FTId=VAR_073704.
FT   VARIANT     297    297       R -> Q (in EIEE32; causes a gain of
FT                                function; dbSNP:rs786205232).
FT                                {ECO:0000269|PubMed:25477152,
FT                                ECO:0000269|PubMed:25751627}.
FT                                /FTId=VAR_073705.
FT   VARIANT     298    298       L -> F (in EIEE32; causes a gain of
FT                                function). {ECO:0000269|PubMed:25751627}.
FT                                /FTId=VAR_073706.
FT   VARIANT     405    405       P -> L (in EIEE32; loss of channel
FT                                function). {ECO:0000269|PubMed:25751627}.
FT                                /FTId=VAR_073707.
FT   CONFLICT    230    230       I -> V (in Ref. 2; BAF82750).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  56717 MW;  4B03F1B46A826C39 CRC64;
     MTVATGDPAD EAAALPGHPQ DTYDPEADHE CCERVVINIS GLRFETQLKT LAQFPETLLG
     DPKKRMRYFD PLRNEYFFDR NRPSFDAILY YYQSGGRLRR PVNVPLDIFS EEIRFYELGE
     EAMEMFREDE GYIKEEERPL PENEFQRQVW LLFEYPESSG PARIIAIVSV MVILISIVSF
     CLETLPIFRD ENEDMHGSGV TFHTYSNSTI GYQQSTSFTD PFFIVETLCI IWFSFEFLVR
     FFACPSKAGF FTNIMNIIDI VAIIPYFITL GTELAEKPED AQQGQQAMSL AILRVIRLVR
     VFRIFKLSRH SKGLQILGQT LKASMRELGL LIFFLFIGVI LFSSAVYFAE ADERESQFPS
     IPDAFWWAVV SMTTVGYGDM VPTTIGGKIV GSLCAIAGVL TIALPVPVIV SNFNYFYHRE
     TEGEEQAQYL QVTSCPKIPS SPDLKKSRSA STISKSDYME IQEGVNNSNE DFREENLKTA
     NCTLANTNYV NITKMLTDV
//
ID   KCNA3_HUMAN             Reviewed;         575 AA.
AC   P22001; Q5VWN2;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   15-FEB-2017, entry version 175.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 3;
DE   AltName: Full=HGK5;
DE   AltName: Full=HLK3;
DE   AltName: Full=HPCN3;
DE   AltName: Full=Voltage-gated K(+) channel HuKIII;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.3;
GN   Name=KCNA3; Synonyms=HGK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7829094; DOI=10.1006/geno.1994.1500;
RA   Folander K., Douglass J., Swanson R.;
RT   "Confirmation of the assignment of the gene encoding Kv1.3, a voltage-
RT   gated potassium channel (KCNA3) to the proximal short arm of human
RT   chromosome 1.";
RL   Genomics 23:295-296(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 12-575.
RC   TISSUE=Skeletal muscle;
RX   PubMed=1986382; DOI=10.1073/pnas.88.1.53;
RA   Philipson L.H., Hice R.E., Schaefer K., Lamendola J., Bell G.I.,
RA   Nelson D.J., Steiner D.F.;
RT   "Sequence and functional expression in Xenopus oocytes of a human
RT   insulinoma and islet potassium channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:53-57(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-575.
RX   PubMed=1373731;
RA   Attali B., Romey G., Honore E., Schmid-Alliana A., Mattei M.-G.,
RA   Lesage F., Ricard P., Barhanin J., Lazdunski M.;
RT   "Cloning, functional expression, and regulation of two K+ channels in
RT   human T lymphocytes.";
RL   J. Biol. Chem. 267:8650-8657(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 47-575.
RC   TISSUE=Lymphocyte;
RX   PubMed=1547020; DOI=10.1089/dna.1992.11.163;
RA   Cai Y.-C., Osborne P.B., North R.A., Dooley D.C., Douglass J.;
RT   "Characterization and functional expression of genomic DNA encoding
RT   the human lymphocyte type n potassium channel.";
RL   DNA Cell Biol. 11:163-172(1992).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins. Binds PDZ
CC       domains of DLG1, DLG2 and DLG4 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: N-glycosylation promotes the cell surface expression.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.3/KCNA3 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-53 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36425.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA36425.1; Type=Frameshift; Positions=42; Evidence={ECO:0000305};
CC       Sequence=AAA59457.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA59457.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAB88073.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAC31761.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC31761.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L23499; AAC31761.1; ALT_SEQ; mRNA.
DR   EMBL; AL365361; CAH71983.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56457.1; -; Genomic_DNA.
DR   EMBL; BC035059; AAH35059.2; -; mRNA.
DR   EMBL; M55515; AAA36425.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M85217; AAA59457.1; ALT_SEQ; mRNA.
DR   EMBL; M38217; AAB88073.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS828.2; -.
DR   PIR; A38101; A38101.
DR   RefSeq; NP_002223.3; NM_002232.4.
DR   UniGene; Hs.169948; -.
DR   UniGene; Hs.619197; -.
DR   UniGene; Hs.628223; -.
DR   PDB; 4BGC; X-ray; 1.20 A; A=104-204.
DR   PDBsum; 4BGC; -.
DR   ProteinModelPortal; P22001; -.
DR   SMR; P22001; -.
DR   BioGrid; 109941; 16.
DR   DIP; DIP-44822N; -.
DR   MINT; MINT-1528422; -.
DR   STRING; 9606.ENSP00000358784; -.
DR   BindingDB; P22001; -.
DR   ChEMBL; CHEMBL4633; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 540; -.
DR   TCDB; 1.A.1.2.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P22001; -.
DR   PhosphoSitePlus; P22001; -.
DR   DMDM; 215274135; -.
DR   MaxQB; P22001; -.
DR   PaxDb; P22001; -.
DR   PeptideAtlas; P22001; -.
DR   PRIDE; P22001; -.
DR   DNASU; 3738; -.
DR   Ensembl; ENST00000369769; ENSP00000358784; ENSG00000177272.
DR   GeneID; 3738; -.
DR   KEGG; hsa:3738; -.
DR   UCSC; uc001dzv.3; human.
DR   CTD; 3738; -.
DR   DisGeNET; 3738; -.
DR   GeneCards; KCNA3; -.
DR   HGNC; HGNC:6221; KCNA3.
DR   HPA; HPA016625; -.
DR   MIM; 176263; gene.
DR   neXtProt; NX_P22001; -.
DR   OpenTargets; ENSG00000177272; -.
DR   PharmGKB; PA30021; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P22001; -.
DR   KO; K04876; -.
DR   OMA; KRRMRYF; -.
DR   OrthoDB; EOG090B05AD; -.
DR   PhylomeDB; P22001; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   SIGNOR; P22001; -.
DR   GeneWiki; KCNA3; -.
DR   GenomeRNAi; 3738; -.
DR   PRO; PR:P22001; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000177272; -.
DR   CleanEx; HS_KCNA3; -.
DR   Genevisible; P22001; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004050; K_chnl_volt-dep_Kv1.3.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01510; KV13CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    575       Potassium voltage-gated channel subfamily
FT                                A member 3.
FT                                /FTId=PRO_0000053977.
FT   TOPO_DOM      1    234       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    235    253       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    254    294       Extracellular. {ECO:0000255}.
FT   TRANSMEM    295    316       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    317    327       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    349    362       Extracellular. {ECO:0000255}.
FT   TRANSMEM    363    381       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    382    397       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    398    417       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    418    458       Extracellular. {ECO:0000255}.
FT   TRANSMEM    459    481       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    482    575       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       444    449       Selectivity filter. {ECO:0000250}.
FT   MOTIF       573    575       PDZ-binding. {ECO:0000250}.
FT   MOD_RES     520    520       Phosphoserine; by PKA. {ECO:0000255}.
FT   LIPID       317    317       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...). {ECO:0000255}.
FT   CONFLICT     72     72       A -> G (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       L -> V (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    113    113       L -> V (in Ref. 6; AAA59457).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       L -> V (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       E -> K (in Ref. 1; AAC31761).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       T -> S (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       T -> S (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    540    540       S -> T (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   STRAND      105    110       {ECO:0000244|PDB:4BGC}.
FT   STRAND      113    118       {ECO:0000244|PDB:4BGC}.
FT   HELIX       119    122       {ECO:0000244|PDB:4BGC}.
FT   TURN        129    131       {ECO:0000244|PDB:4BGC}.
FT   HELIX       133    136       {ECO:0000244|PDB:4BGC}.
FT   HELIX       137    139       {ECO:0000244|PDB:4BGC}.
FT   TURN        142    145       {ECO:0000244|PDB:4BGC}.
FT   STRAND      146    149       {ECO:0000244|PDB:4BGC}.
FT   HELIX       153    164       {ECO:0000244|PDB:4BGC}.
FT   HELIX       177    186       {ECO:0000244|PDB:4BGC}.
FT   HELIX       191    201       {ECO:0000244|PDB:4BGC}.
SQ   SEQUENCE   575 AA;  63842 MW;  0E98905187A85F48 CRC64;
     MDERLSLLRS PPPPSARHRA HPPQRPASSG GAHTLVNHGY AEPAAGRELP PDMTVVPGDH
     LLEPEVADGG GAPPQGGCGG GGCDRYEPLP PSLPAAGEQD CCGERVVINI SGLRFETQLK
     TLCQFPETLL GDPKRRMRYF DPLRNEYFFD RNRPSFDAIL YYYQSGGRIR RPVNVPIDIF
     SEEIRFYQLG EEAMEKFRED EGFLREEERP LPRRDFQRQV WLLFEYPESS GPARGIAIVS
     VLVILISIVI FCLETLPEFR DEKDYPASTS QDSFEAAGNS TSGSRAGASS FSDPFFVVET
     LCIIWFSFEL LVRFFACPSK ATFSRNIMNL IDIVAIIPYF ITLGTELAER QGNGQQAMSL
     AILRVIRLVR VFRIFKLSRH SKGLQILGQT LKASMRELGL LIFFLFIGVI LFSSAVYFAE
     ADDPTSGFSS IPDAFWWAVV TMTTVGYGDM HPVTIGGKIV GSLCAIAGVL TIALPVPVIV
     SNFNYFYHRE TEGEEQSQYM HVGSCQHLSS SAEELRKARS NSTLSKSEYM VIEEGGMNHS
     AFPQTPFKTG NSTATCTTNN NPNSCVNIKK IFTDV
//
ID   KCNA4_HUMAN             Reviewed;         653 AA.
AC   P22459;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   15-FEB-2017, entry version 160.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 4;
DE   AltName: Full=HPCN2;
DE   AltName: Full=Voltage-gated K(+) channel HuKII {ECO:0000303|PubMed:19912772};
DE   AltName: Full=Voltage-gated potassium channel HBK4;
DE   AltName: Full=Voltage-gated potassium channel HK1 {ECO:0000303|PubMed:2001794};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.4;
GN   Name=KCNA4; Synonyms=KCNA4L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=2263489; DOI=10.1093/nar/18.23.7160;
RA   Philipson L.H., Schaefer K., Lamendola J., Bell G.I., Steiner D.F.;
RT   "Sequence of a human fetal skeletal muscle potassium channel cDNA
RT   related to RCK4.";
RL   Nucleic Acids Res. 18:7160-7160(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=2001794;
RA   Tamkun M.M., Knoth K.M., Walbridge J.A., Kroemer H., Roden D.M.,
RA   Glover D.M.;
RT   "Molecular cloning and characterization of two voltage-gated K+
RT   channel cDNAs from human ventricle.";
RL   FASEB J. 5:331-337(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND ENZYME
RP   REGULATION.
RC   TISSUE=Brain;
RX   PubMed=19912772; DOI=10.1016/1044-7431(90)90004-N;
RA   Ramaswami M., Gautam M., Kamb A., Rudy B., Tanouye M.A., Mathew M.K.;
RT   "Human potassium channel genes: molecular cloning and functional
RT   expression.";
RL   Mol. Cell. Neurosci. 1:214-223(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8495559; DOI=10.1161/01.RES.72.6.1326;
RA   Po S., Roberds S., Snyders D.J., Tamkun M.M., Bennett P.B.;
RT   "Heteromultimeric assembly of human potassium channels. Molecular
RT   basis of a transient outward current?";
RL   Circ. Res. 72:1326-1336(1993).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=17156368; DOI=10.1111/j.1460-9568.2006.05186.x;
RA   Imbrici P., D'Adamo M.C., Kullmann D.M., Pessia M.;
RT   "Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast
RT   inactivation properties of the human potassium channels Kv1.4-
RT   1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.";
RL   Eur. J. Neurosci. 24:3073-3083(2006).
RN   [7]
RP   INTERACTION WITH KCNRG, AND SUBCELLULAR LOCATION.
RX   PubMed=19968958; DOI=10.1016/j.bbrc.2009.11.143;
RA   Usman H., Mathew M.K.;
RT   "Potassium channel regulator KCNRG regulates surface expression of
RT   Shaker-type potassium channels.";
RL   Biochem. Biophys. Res. Commun. 391:1301-1305(2010).
RN   [8]
RP   STRUCTURE BY NMR OF 1-37.
RX   PubMed=9000078; DOI=10.1038/385272a0;
RA   Antz C., Geyer M., Fakler B., Schott M.K., Guy H.R., Frank R.,
RA   Ruppersberg J.P., Kalbitzer H.R.;
RT   "NMR structure of inactivation gates from mammalian voltage-dependent
RT   potassium channels.";
RL   Nature 385:272-275(1997).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient. The
CC       channel alternates between opened and closed conformations in
CC       response to the voltage difference across the membrane
CC       (PubMed:19912772, PubMed:8495559). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, and possibly
CC       other family members as well; channel properties depend on the
CC       type of alpha subunits that are part of the channel
CC       (PubMed:8495559). Channel properties are modulated by cytoplasmic
CC       beta subunits that regulate the subcellular location of the alpha
CC       subunits and promote rapid inactivation. In vivo, membranes
CC       probably contain a mixture of heteromeric potassium channel
CC       complexes, making it difficult to assign currents observed in
CC       intact tissues to any particular potassium channel family member.
CC       Homotetrameric KCNA4 forms a potassium channel that opens in
CC       response to membrane depolarization, followed by rapid spontaneous
CC       channel closure (PubMed:19912772, PubMed:8495559). Likewise, a
CC       heterotetrameric channel formed by KCNA1 and KCNA4 shows rapid
CC       inactivation (PubMed:17156368). {ECO:0000269|PubMed:17156368,
CC       ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:8495559}.
CC   -!- ENZYME REGULATION: Inhibited by 4-aminopyridine (4-AP), but not by
CC       tetraethylammonium (TEA) and charybdotoxin (CTX).
CC       {ECO:0000269|PubMed:19912772}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel
CC       proteins (By similarity). Interacts with KCNAB1 and KCNAB2 (By
CC       similarity). Binds PDZ domains of DLG1, DLG2 and DLG4 (By
CC       similarity). Interacts with SIGMAR1 (By similarity). Detected in a
CC       complex with KCNA1 (By similarity). Interacts with KCNA2 (By
CC       similarity). Part of a complex containing KCNA1, KCNAB1 and LGI1
CC       (By similarity). Interacts (via cytoplasmic N-terminal domain)
CC       with KCNRG (PubMed:19968958). {ECO:0000250|UniProtKB:P15385}.
CC   -!- INTERACTION:
CC       Q62936:Dlg3 (xeno); NbExp=4; IntAct=EBI-631235, EBI-349596;
CC       P78352:DLG4; NbExp=2; IntAct=EBI-631235, EBI-80389;
CC       P31016:Dlg4 (xeno); NbExp=3; IntAct=EBI-631235, EBI-375655;
CC       P21673:SAT1; NbExp=3; IntAct=EBI-631235, EBI-711613;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17156368,
CC       ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:19968958,
CC       ECO:0000269|PubMed:8495559}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:P15385}.
CC   -!- TISSUE SPECIFICITY: Detected in heart ventricle.
CC       {ECO:0000269|PubMed:2001794}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments. {ECO:0000250|UniProtKB:Q28527}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.4/KCNA4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M55514; AAA60034.1; -; mRNA.
DR   EMBL; M60450; AAA61275.1; -; mRNA.
DR   EMBL; L02751; AAA36140.1; -; mRNA.
DR   EMBL; AC124657; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS41629.1; -.
DR   PIR; A39922; A39922.
DR   RefSeq; NP_002224.1; NM_002233.3.
DR   UniGene; Hs.592002; -.
DR   ProteinModelPortal; P22459; -.
DR   SMR; P22459; -.
DR   BioGrid; 109942; 18.
DR   IntAct; P22459; 7.
DR   MINT; MINT-200816; -.
DR   STRING; 9606.ENSP00000328511; -.
DR   BindingDB; P22459; -.
DR   ChEMBL; CHEMBL4205; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   iPTMnet; P22459; -.
DR   PhosphoSitePlus; P22459; -.
DR   BioMuta; KCNA4; -.
DR   DMDM; 313104127; -.
DR   EPD; P22459; -.
DR   PaxDb; P22459; -.
DR   PeptideAtlas; P22459; -.
DR   PRIDE; P22459; -.
DR   DNASU; 3739; -.
DR   Ensembl; ENST00000328224; ENSP00000328511; ENSG00000182255.
DR   GeneID; 3739; -.
DR   KEGG; hsa:3739; -.
DR   UCSC; uc001msk.4; human.
DR   CTD; 3739; -.
DR   DisGeNET; 3739; -.
DR   GeneCards; KCNA4; -.
DR   H-InvDB; HIX0036152; -.
DR   HGNC; HGNC:6222; KCNA4.
DR   HPA; CAB001977; -.
DR   HPA; HPA016422; -.
DR   MIM; 176266; gene.
DR   neXtProt; NX_P22459; -.
DR   OpenTargets; ENSG00000182255; -.
DR   PharmGKB; PA207; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P22459; -.
DR   KO; K04877; -.
DR   OMA; KKAHHRQ; -.
DR   OrthoDB; EOG090B05AD; -.
DR   PhylomeDB; P22459; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA4; -.
DR   GenomeRNAi; 3739; -.
DR   PRO; PR:P22459; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000182255; -.
DR   CleanEx; HS_KCNA4; -.
DR   Genevisible; P22459; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IMP:UniProtKB.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   Gene3D; 1.20.5.600; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR020467; K_chnl_volt-dep_Kv1.4.
DR   InterPro; IPR012897; K_chnl_volt-dep_Kv1.4_TID.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF07941; K_channel_TID; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01511; KV14CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    653       Potassium voltage-gated channel subfamily
FT                                A member 4.
FT                                /FTId=PRO_0000053981.
FT   TOPO_DOM      1    304       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    305    326       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    327    370       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    371    392       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    393    403       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    404    424       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    425    439       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    440    460       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    461    475       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    476    497       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    498    511       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    512    523       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    524    531       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    532    538       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    539    567       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    568    653       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      462    475       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       524    529       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       651    653       PDZ-binding. {ECO:0000250}.
FT   COMPBIAS     62     65       Poly-His.
FT   COMPBIAS    123    137       Poly-Glu.
FT   COMPBIAS    162    165       Poly-Gly.
FT   COMPBIAS    433    436       Poly-Gln.
FT   MOD_RES      90     90       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61423}.
FT   MOD_RES     599    599       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    352    352       N-linked (GlcNAc...). {ECO:0000255}.
FT   CONFLICT     38     38       A -> R (in Ref. 1; AAA60034).
FT                                {ECO:0000305}.
FT   CONFLICT     42     42       A -> R (in Ref. 1; AAA60034).
FT                                {ECO:0000305}.
FT   CONFLICT     84     88       RRRRQ -> EEEAT (in Ref. 1; AAA60034).
FT                                {ECO:0000305}.
FT   CONFLICT    304    304       S -> D (in Ref. 1; AAA60034).
FT                                {ECO:0000305}.
FT   CONFLICT    542    542       S -> V (in Ref. 1; AAA60034).
FT                                {ECO:0000305}.
FT   CONFLICT    631    631       G -> A (in Ref. 1; AAA60034).
FT                                {ECO:0000305}.
SQ   SEQUENCE   653 AA;  73257 MW;  5E511DB704CCA013 CRC64;
     MEVAMVSAES SGCNSHMPYG YAAQARARER ERLAHSRAAA AAAVAAATAA VEGSGGSGGG
     SHHHHQSRGA CTSHDPQSSR GSRRRRRQRS EKKKAHYRQS SFPHCSDLMP SGSEEKILRE
     LSEEEEDEEE EEEEEEEGRF YYSEDDHGDE CSYTDLLPQD EGGGGYSSVR YSDCCERVVI
     NVSGLRFETQ MKTLAQFPET LLGDPEKRTQ YFDPLRNEYF FDRNRPSFDA ILYYYQSGGR
     LKRPVNVPFD IFTEEVKFYQ LGEEALLKFR EDEGFVREEE DRALPENEFK KQIWLLFEYP
     ESSSPARGIA IVSVLVILIS IVIFCLETLP EFRDDRDLVM ALSAGGHGGL LNDTSAPHLE
     NSGHTIFNDP FFIVETVCIV WFSFEFVVRC FACPSQALFF KNIMNIIDIV SILPYFITLG
     TDLAQQQGGG NGQQQQAMSF AILRIIRLVR VFRIFKLSRH SKGLQILGHT LRASMRELGL
     LIFFLFIGVI LFSSAVYFAE ADEPTTHFQS IPDAFWWAVV TMTTVGYGDM KPITVGGKIV
     GSLCAIAGVL TIALPVPVIV SNFNYFYHRE TENEEQTQLT QNAVSCPYLP SNLLKKFRSS
     TSSSLGDKSE YLEMEEGVKE SLCAKEEKCQ GKGDDSETDK NNCSNAKAVE TDV
//
ID   KCNA5_HUMAN             Reviewed;         613 AA.
AC   P22460; Q4KKT8; Q4VAJ1; Q4VAJ2; Q9UDA4;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 4.
DT   15-FEB-2017, entry version 169.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 5;
DE   AltName: Full=HPCN1;
DE   AltName: Full=Voltage-gated potassium channel HK2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.5;
GN   Name=KCNA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=2001794;
RA   Tamkun M.M., Knoth K.M., Walbridge J.A., Kroemer H., Roden D.M.,
RA   Glover D.M.;
RT   "Molecular cloning and characterization of two voltage-gated K+
RT   channel cDNAs from human ventricle.";
RL   FASEB J. 5:331-337(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Insulinoma;
RX   PubMed=1986382; DOI=10.1073/pnas.88.1.53;
RA   Philipson L.H., Hice R.E., Schaefer K., Lamendola J., Bell G.I.,
RA   Nelson D.J., Steiner D.F.;
RT   "Sequence and functional expression in Xenopus oocytes of a human
RT   insulinoma and islet potassium channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:53-57(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=1349297; DOI=10.1016/0888-7543(92)90302-9;
RA   Curran M.E., Landes G.M., Keating M.T.;
RT   "Molecular cloning, characterization, and genomic localization of a
RT   human potassium channel gene.";
RL   Genomics 12:729-737(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8505626; DOI=10.1085/jgp.101.4.513;
RA   Snyders D.J., Tamkun M.M., Bennett P.B.;
RT   "A rapidly activating and slowly inactivating potassium channel cloned
RT   from human heart. Functional analysis after stable mammalian cell
RT   culture expression.";
RL   J. Gen. Physiol. 101:513-543(1993).
RN   [6]
RP   FUNCTION, AND ALTERNATIVE SPLICING (ISOFORMS 1 AND 2).
RX   PubMed=11524461; DOI=10.1085/jgp.118.3.315;
RA   Kurata H.T., Soon G.S., Fedida D.;
RT   "Altered state dependence of c-type inactivation in the long and short
RT   forms of human Kv1.5.";
RL   J. Gen. Physiol. 118:315-332(2001).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNAB1.
RX   PubMed=12130714; DOI=10.1124/jpet.102.033357;
RA   Williams C.P., Hu N., Shen W., Mashburn A.B., Murray K.T.;
RT   "Modulation of the human Kv1.5 channel by protein kinase C activation:
RT   role of the Kvbeta1.2 subunit.";
RL   J. Pharmacol. Exp. Ther. 302:545-550(2002).
RN   [8]
RP   INTERACTION WITH DLG1, AND MUTAGENESIS OF THR-15.
RX   PubMed=16466689; DOI=10.1016/j.bbrc.2006.01.110;
RA   Mathur R., Choi W.S., Eldstrom J., Wang Z., Kim J., Steele D.F.,
RA   Fedida D.;
RT   "A specific N-terminal residue in Kv1.5 is required for upregulation
RT   of the channel by SAP97.";
RL   Biochem. Biophys. Res. Commun. 342:1-8(2006).
RN   [9]
RP   INVOLVEMENT IN ATFB7.
RX   PubMed=16772329; DOI=10.1093/hmg/ddl143;
RA   Olson T.M., Alekseev A.E., Liu X.K., Park S., Zingman L.V.,
RA   Bienengraeber M., Sattiraju S., Ballew J.D., Jahangir A., Terzic A.;
RT   "Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes
RT   human atrial fibrillation.";
RL   Hum. Mol. Genet. 15:2185-2191(2006).
RN   [10]
RP   SUMOYLATION AT LYS-221 AND LYS-536, INTERACTION WITH UBE2I, AND
RP   MUTAGENESIS OF ILE-220; LYS-221; LEU-535 AND LYS-536.
RX   PubMed=17261810; DOI=10.1073/pnas.0606702104;
RA   Benson M.D., Li Q.J., Kieckhafer K., Dudek D., Whorton M.R.,
RA   Sunahara R.K., Iniguez-Lluhi J.A., Martens J.R.;
RT   "SUMO modification regulates inactivation of the voltage-gated
RT   potassium channel Kv1.5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1805-1810(2007).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-300.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient. The
CC       channel alternates between opened and closed conformations in
CC       response to the voltage difference across the membrane. Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5,
CC       and possibly other family members as well; channel properties
CC       depend on the type of alpha subunits that are part of the channel
CC       (PubMed:12130714). Channel properties are modulated by cytoplasmic
CC       beta subunits that regulate the subcellular location of the alpha
CC       subunits and promote rapid inactivation (PubMed:12130714).
CC       Homotetrameric channels display rapid activation and slow
CC       inactivation (PubMed:8505626, PubMed:12130714). May play a role in
CC       regulating the secretion of insulin in normal pancreatic islets.
CC       Isoform 2 exhibits a voltage-dependent recovery from inactivation
CC       and an excessive cumulative inactivation (PubMed:11524461).
CC       {ECO:0000269|PubMed:11524461, ECO:0000269|PubMed:12130714,
CC       ECO:0000269|PubMed:8505626}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel
CC       proteins. Interacts with DLG1, which enhances channel currents.
CC       Forms a ternary complex with DLG1 and CAV3 (By similarity).
CC       Interacts with KCNAB1 (PubMed:12130714). Interacts with UBE2I
CC       (PubMed:17261810). {ECO:0000250|UniProtKB:P19024,
CC       ECO:0000269|PubMed:11524461, ECO:0000269|PubMed:12130714,
CC       ECO:0000269|PubMed:16466689, ECO:0000269|PubMed:17261810,
CC       ECO:0000269|PubMed:8505626}.
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=6; IntAct=EBI-6426121, EBI-77797;
CC       Q14160:SCRIB; NbExp=2; IntAct=EBI-6426121, EBI-357345;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12130714,
CC       ECO:0000269|PubMed:8505626}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P22460-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P22460-2; Sequence=VSP_037110;
CC   -!- TISSUE SPECIFICITY: Pancreatic islets and insulinoma.
CC   -!- DOMAIN: The amino terminus may be important in determining the
CC       rate of inactivation of the channel while the C-terminal PDZ-
CC       binding motif may play a role in modulation of channel activity
CC       and/or targeting of the channel to specific subcellular
CC       compartments.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Sumoylated on Lys-221, and Lys-536, preferentially with
CC       SUMO3. Sumoylation regulates the voltage sensitivity of the
CC       channel. {ECO:0000269|PubMed:17261810}.
CC   -!- DISEASE: Atrial fibrillation, familial, 7 (ATFB7) [MIM:612240]: A
CC       familial form of atrial fibrillation, a common sustained cardiac
CC       rhythm disturbance. Atrial fibrillation is characterized by
CC       disorganized atrial electrical activity and ineffective atrial
CC       contraction promoting blood stasis in the atria and reduces
CC       ventricular filling. It can result in palpitations, syncope,
CC       thromboembolic stroke, and congestive heart failure.
CC       {ECO:0000269|PubMed:16772329}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.5/KCNA5 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60146.1; Type=Frameshift; Positions=579; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60451; AAA61276.1; -; mRNA.
DR   EMBL; M55513; AAA36422.1; -; mRNA.
DR   EMBL; M83254; AAA60146.1; ALT_FRAME; mRNA.
DR   EMBL; BC096357; AAH96357.1; -; mRNA.
DR   EMBL; BC096358; AAH96358.3; -; mRNA.
DR   EMBL; BC099665; AAH99665.3; -; mRNA.
DR   EMBL; BC099666; AAH99666.3; -; mRNA.
DR   CCDS; CCDS8536.1; -. [P22460-1]
DR   PIR; A56031; A56031.
DR   RefSeq; NP_002225.2; NM_002234.3. [P22460-1]
DR   UniGene; Hs.150208; -.
DR   UniGene; Hs.741439; -.
DR   ProteinModelPortal; P22460; -.
DR   SMR; P22460; -.
DR   BioGrid; 109943; 55.
DR   DIP; DIP-42010N; -.
DR   IntAct; P22460; 4.
DR   MINT; MINT-200758; -.
DR   STRING; 9606.ENSP00000252321; -.
DR   BindingDB; P22460; -.
DR   ChEMBL; CHEMBL4306; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 542; -.
DR   TCDB; 1.A.1.2.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P22460; -.
DR   PhosphoSitePlus; P22460; -.
DR   BioMuta; KCNA5; -.
DR   DMDM; 146345443; -.
DR   PaxDb; P22460; -.
DR   PeptideAtlas; P22460; -.
DR   PRIDE; P22460; -.
DR   Ensembl; ENST00000252321; ENSP00000252321; ENSG00000130037. [P22460-1]
DR   GeneID; 3741; -.
DR   KEGG; hsa:3741; -.
DR   UCSC; uc001qni.5; human. [P22460-1]
DR   CTD; 3741; -.
DR   DisGeNET; 3741; -.
DR   GeneCards; KCNA5; -.
DR   HGNC; HGNC:6224; KCNA5.
DR   HPA; CAB022562; -.
DR   HPA; HPA021516; -.
DR   MalaCards; KCNA5; -.
DR   MIM; 176267; gene.
DR   MIM; 612240; phenotype.
DR   neXtProt; NX_P22460; -.
DR   OpenTargets; ENSG00000130037; -.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   PharmGKB; PA208; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P22460; -.
DR   KO; K04878; -.
DR   OMA; GGELQCP; -.
DR   OrthoDB; EOG090B05AD; -.
DR   PhylomeDB; P22460; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA5; -.
DR   GenomeRNAi; 3741; -.
DR   PRO; PR:P22460; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000130037; -.
DR   CleanEx; HS_KCNA5; -.
DR   Genevisible; P22460; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IDA:BHF-UCL.
DR   GO; GO:0046691; C:intracellular canaliculus; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; IEA:Ensembl.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086087; F:voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086090; F:voltage-gated potassium channel activity involved in SA node cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0060081; P:membrane hyperpolarization; IMP:BHF-UCL.
DR   GO; GO:0098914; P:membrane repolarization during atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086050; P:membrane repolarization during bundle of His cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086052; P:membrane repolarization during SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0055075; P:potassium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:MGI.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0043266; P:regulation of potassium ion transport; IMP:BHF-UCL.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0010033; P:response to organic substance; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004052; K_chnl_volt-dep_Kv1.5.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF199; PTHR11537:SF199; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01512; KV15CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Atrial fibrillation; Cell membrane;
KW   Complete proteome; Ion channel; Ion transport; Isopeptide bond;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation; Voltage-gated channel.
FT   CHAIN         1    613       Potassium voltage-gated channel subfamily
FT                                A member 5.
FT                                /FTId=PRO_0000053985.
FT   TOPO_DOM      1    247       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    248    269       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    270    323       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    324    345       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    346    356       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    357    377       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    378    395       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    396    416       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    417    431       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    432    453       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    454    467       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    468    479       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    480    487       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    488    494       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    495    523       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    524    613       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REPEAT       61     71       1.
FT   REPEAT       72     82       2.
FT   REGION       61     82       2 X 11 AA tandem repeat of D-[SP]-G-V-R-
FT                                P-L-P-P-L-P.
FT   REGION      418    431       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       480    485       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       611    613       PDZ-binding. {ECO:0000250}.
FT   COMPBIAS     94     99       Poly-Glu.
FT   COMPBIAS    382    387       Poly-Gly.
FT   MOD_RES     557    557       Phosphoserine; by PKA. {ECO:0000255}.
FT   LIPID       346    346       S-palmitoyl cysteine. {ECO:0000255}.
FT   CROSSLNK    221    221       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17261810}.
FT   CROSSLNK    536    536       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17261810}.
FT   VAR_SEQ       1    209       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_037110.
FT   VARIANT     228    228       P -> S (in dbSNP:rs1056464).
FT                                /FTId=VAR_053856.
FT   VARIANT     300    300       G -> S (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs148708451).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035770.
FT   VARIANT     578    578       R -> K (in dbSNP:rs12720445).
FT                                /FTId=VAR_054786.
FT   MUTAGEN      15     15       T->A: Loss of DLG1 effect on channel
FT                                current. {ECO:0000269|PubMed:16466689}.
FT   MUTAGEN     220    220       I->N: Reduces sumoylation; when
FT                                associated with N-535.
FT                                {ECO:0000269|PubMed:17261810}.
FT   MUTAGEN     221    221       K->R: Abolishes sumoylation; when
FT                                associated with R-536.
FT                                {ECO:0000269|PubMed:17261810}.
FT   MUTAGEN     535    535       L->N: Reduces sumoylation; when
FT                                associated with N-220.
FT                                {ECO:0000269|PubMed:17261810}.
FT   MUTAGEN     536    536       K->R: Abolishes sumoylation; when
FT                                associated with R-221.
FT                                {ECO:0000269|PubMed:17261810}.
FT   CONFLICT     55     55       Missing (in Ref. 1; AAA61276).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       L -> Q (in Ref. 2; AAA36422).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       R -> P (in Ref. 1; AAA61276 and 2;
FT                                AAA36422). {ECO:0000305}.
FT   CONFLICT    187    188       RP -> G (in Ref. 1; AAA61276).
FT                                {ECO:0000305}.
FT   CONFLICT    214    214       R -> G (in Ref. 2; AAA36422).
FT                                {ECO:0000305}.
FT   CONFLICT    228    228       P -> V (in Ref. 2; AAA36422).
FT                                {ECO:0000305}.
FT   CONFLICT    282    282       L -> V (in Ref. 3; AAA60146).
FT                                {ECO:0000305}.
FT   CONFLICT    307    307       P -> A (in Ref. 1; AAA61276).
FT                                {ECO:0000305}.
SQ   SEQUENCE   613 AA;  67228 MW;  A5B02B27F8396E3D CRC64;
     MEIALVPLEN GGAMTVRGGD EARAGCGQAT GGELQCPPTA GLSDGPKEPA PKGRGAQRDA
     DSGVRPLPPL PDPGVRPLPP LPEELPRPRR PPPEDEEEEG DPGLGTVEDQ ALGTASLHHQ
     RVHINISGLR FETQLGTLAQ FPNTLLGDPA KRLRYFDPLR NEYFFDRNRP SFDGILYYYQ
     SGGRLRRPVN VSLDVFADEI RFYQLGDEAM ERFREDEGFI KEEEKPLPRN EFQRQVWLIF
     EYPESSGSAR AIAIVSVLVI LISIITFCLE TLPEFRDERE LLRHPPAPHQ PPAPAPGANG
     SGVMAPPSGP TVAPLLPRTL ADPFFIVETT CVIWFTFELL VRFFACPSKA GFSRNIMNII
     DVVAIFPYFI TLGTELAEQQ PGGGGGGQNG QQAMSLAILR VIRLVRVFRI FKLSRHSKGL
     QILGKTLQAS MRELGLLIFF LFIGVILFSS AVYFAEADNQ GTHFSSIPDA FWWAVVTMTT
     VGYGDMRPIT VGGKIVGSLC AIAGVLTIAL PVPVIVSNFN YFYHRETDHE EPAVLKEEQG
     TQSQGPGLDR GVQRKVSGSR GSFCKAGGTL ENADSARRGS CPLEKCNVKA KSNVDLRRSL
     YALCLDTSRE TDL
//
ID   KCNA6_HUMAN             Reviewed;         529 AA.
AC   P17658;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   15-FEB-2017, entry version 157.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 6;
DE   AltName: Full=Voltage-gated potassium channel HBK2 {ECO:0000303|PubMed:2347305};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.6;
GN   Name=KCNA6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=2347305;
RA   Grupe A., Schroeter K.H., Ruppersberg J.P., Stocker M., Drewes T.,
RA   Beckh S., Pongs O.;
RT   "Cloning and expression of a human voltage-gated potassium channel. A
RT   novel member of the RCK potassium channel family.";
RL   EMBO J. 9:1749-1756(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=14575698; DOI=10.1016/j.bbrc.2003.09.167;
RA   Guihard G., Bellocq C., Grelet E., Escande D.;
RT   "Human Kv1.6 current displays a C-type-like inactivation when re-
RT   expressed in cos-7 cells.";
RL   Biochem. Biophys. Res. Commun. 311:83-89(2003).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient
CC       (PubMed:2347305, PubMed:14575698). The channel alternates between
CC       opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:2347305, PubMed:14575698).
CC       Can form functional homotetrameric channels and heterotetrameric
CC       channels that contain variable proportions of KCNA1, KCNA2, KCNA4,
CC       KCNA6, and possibly other family members as well; channel
CC       properties depend on the type of alpha subunits that are part of
CC       the channel (By similarity). Channel properties are modulated by
CC       cytoplasmic beta subunits that regulate the subcellular location
CC       of the alpha subunits and promote rapid inactivation (By
CC       similarity). Homotetrameric channels display rapid activation and
CC       slow inactivation (PubMed:2347305). {ECO:0000250|UniProtKB:P17659,
CC       ECO:0000269|PubMed:14575698, ECO:0000269|PubMed:2347305}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel
CC       proteins (By similarity). Interacts with KCNAB1 and KCNAB2 (By
CC       similarity). {ECO:0000250|UniProtKB:P17659, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14575698,
CC       ECO:0000269|PubMed:2347305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.6/KCNA6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17622; CAA35623.1; -; mRNA.
DR   EMBL; BC069355; AAH69355.1; -; mRNA.
DR   CCDS; CCDS8534.1; -.
DR   PIR; S12787; S12787.
DR   RefSeq; NP_002226.1; NM_002235.3.
DR   RefSeq; XP_005253743.1; XM_005253686.3.
DR   RefSeq; XP_011519257.1; XM_011520955.2.
DR   RefSeq; XP_016874759.1; XM_017019270.1.
DR   RefSeq; XP_016874760.1; XM_017019271.1.
DR   RefSeq; XP_016874761.1; XM_017019272.1.
DR   UniGene; Hs.306190; -.
DR   ProteinModelPortal; P17658; -.
DR   BioGrid; 109944; 11.
DR   IntAct; P17658; 2.
DR   STRING; 9606.ENSP00000280684; -.
DR   BindingDB; P17658; -.
DR   ChEMBL; CHEMBL5279; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 543; -.
DR   iPTMnet; P17658; -.
DR   PhosphoSitePlus; P17658; -.
DR   BioMuta; KCNA6; -.
DR   DMDM; 116434; -.
DR   PaxDb; P17658; -.
DR   PeptideAtlas; P17658; -.
DR   PRIDE; P17658; -.
DR   DNASU; 3742; -.
DR   Ensembl; ENST00000280684; ENSP00000280684; ENSG00000151079.
DR   GeneID; 3742; -.
DR   KEGG; hsa:3742; -.
DR   UCSC; uc001qng.4; human.
DR   CTD; 3742; -.
DR   DisGeNET; 3742; -.
DR   GeneCards; KCNA6; -.
DR   HGNC; HGNC:6225; KCNA6.
DR   HPA; CAB011539; -.
DR   HPA; HPA014418; -.
DR   MIM; 176257; gene.
DR   neXtProt; NX_P17658; -.
DR   OpenTargets; ENSG00000130035; -.
DR   OpenTargets; ENSG00000151079; -.
DR   PharmGKB; PA30022; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00670000097647; -.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P17658; -.
DR   KO; K04879; -.
DR   OMA; GKPEFSE; -.
DR   OrthoDB; EOG090B05AD; -.
DR   PhylomeDB; P17658; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNA6; human.
DR   GeneWiki; KCNA6; -.
DR   GenomeRNAi; 3742; -.
DR   PRO; PR:P17658; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000151079; -.
DR   CleanEx; HS_KCNA6; -.
DR   ExpressionAtlas; P17658; baseline and differential.
DR   Genevisible; P17658; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0034705; C:potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004053; K_chnl_volt-dep_Kv1.6.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01513; KV16CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    529       Potassium voltage-gated channel subfamily
FT                                A member 6.
FT                                /FTId=PRO_0000053990.
FT   TOPO_DOM      1    171       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    172    193       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    194    262       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    263    284       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    285    295       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    296    316       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    317    337       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    338    358       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    359    373       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    374    395       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    396    409       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    410    421       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    422    429       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    430    436       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    437    465       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    466    529       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      360    373       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       422    427       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       527    529       PDZ-binding. {ECO:0000255}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61923}.
FT   MOD_RES     511    511       Phosphoserine; by PKA. {ECO:0000305}.
FT   LIPID       285    285       S-palmitoyl cysteine. {ECO:0000255}.
SQ   SEQUENCE   529 AA;  58729 MW;  CFF0710A1F9CD69F CRC64;
     MRSEKSLTLA APGEVRGPEG EQQDAGDFPE AGGGGGCCSS ERLVINISGL RFETQLRTLS
     LFPDTLLGDP GRRVRFFDPL RNEYFFDRNR PSFDAILYYY QSGGRLRRPV NVPLDIFLEE
     IRFYQLGDEA LAAFREDEGC LPEGGEDEKP LPSQPFQRQV WLLFEYPESS GPARGIAIVS
     VLVILISIVI FCLETLPQFR VDGRGGNNGG VSRVSPVSRG SQEEEEDEDD SYTFHHGITP
     GEMGTGGSSS LSTLGGSFFT DPFFLVETLC IVWFTFELLV RFSACPSKPA FFRNIMNIID
     LVAIFPYFIT LGTELVQQQE QQPASGGGGQ NGQQAMSLAI LRVIRLVRVF RIFKLSRHSK
     GLQILGKTLQ ASMRELGLLI FFLFIGVILF SSAVYFAEAD DDDSLFPSIP DAFWWAVVTM
     TTVGYGDMYP MTVGGKIVGS LCAIAGVLTI ALPVPVIVSN FNYFYHRETE QEEQGQYTHV
     TCGQPAPDLR ATDNGLGKPD FPEANRERRP SYLPTPHRAY AEKRMLTEV
//
ID   KCNA7_HUMAN             Reviewed;         456 AA.
AC   Q96RP8; A1KYX7; Q9BYS4;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-FEB-2017, entry version 112.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 7;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.7;
GN   Name=KCNA7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT THR-418, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=11368907; DOI=10.1016/S0378-1119(01)00423-1;
RA   Kashuba V.I., Kvasha S.M., Protopopov A.I., Gizatullin R.Z.,
RA   Rynditch A.V., Wahlestedt C., Wasserman W.W., Zabarovsky E.R.;
RT   "Initial isolation and analysis of the human Kv1.7 (KCNA7) gene, a
RT   member of the voltage-gated potassium channel gene family.";
RL   Gene 268:115-122(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ARG-189 AND THR-418, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11896454; DOI=10.1038/sj.ejhg.5200739;
RA   Bardien-Kruger S., Wulff H., Arieff Z., Brink P., Chandy K.G.,
RA   Corfield V.;
RT   "Characterisation of the human voltage-gated potassium channel gene,
RT   KCNA7, a candidate gene for inherited cardiac disorders, and its
RT   exclusion as cause of progressive familial heart block I (PFHBI).";
RL   Eur. J. Hum. Genet. 10:36-43(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-189.
RC   TISSUE=Heart muscle;
RA   Finol-Urdaneta R.K., Struever N., Terlau H.;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle, heart and
CC       kidney. {ECO:0000269|PubMed:11368907,
CC       ECO:0000269|PubMed:11896454}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments. {ECO:0000250}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.7/KCNA7 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ310479; CAC29065.1; -; mRNA.
DR   EMBL; AF315818; AAK63002.1; -; mRNA.
DR   EMBL; AY779768; AAX11186.1; -; mRNA.
DR   CCDS; CCDS12755.1; -.
DR   RefSeq; NP_114092.2; NM_031886.2.
DR   UniGene; Hs.306973; -.
DR   ProteinModelPortal; Q96RP8; -.
DR   SMR; Q96RP8; -.
DR   STRING; 9606.ENSP00000221444; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 544; -.
DR   iPTMnet; Q96RP8; -.
DR   PhosphoSitePlus; Q96RP8; -.
DR   BioMuta; KCNA7; -.
DR   DMDM; 74752109; -.
DR   PaxDb; Q96RP8; -.
DR   PeptideAtlas; Q96RP8; -.
DR   PRIDE; Q96RP8; -.
DR   Ensembl; ENST00000221444; ENSP00000221444; ENSG00000104848.
DR   GeneID; 3743; -.
DR   KEGG; hsa:3743; -.
DR   UCSC; uc002pmg.3; human.
DR   CTD; 3743; -.
DR   DisGeNET; 3743; -.
DR   GeneCards; KCNA7; -.
DR   HGNC; HGNC:6226; KCNA7.
DR   MIM; 176268; gene.
DR   neXtProt; NX_Q96RP8; -.
DR   OpenTargets; ENSG00000104848; -.
DR   PharmGKB; PA30023; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q96RP8; -.
DR   KO; K04880; -.
DR   OMA; AMEPRCP; -.
DR   OrthoDB; EOG090705O2; -.
DR   PhylomeDB; Q96RP8; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA7; -.
DR   GenomeRNAi; 3743; -.
DR   PRO; PR:Q96RP8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104848; -.
DR   CleanEx; HS_KCNA7; -.
DR   Genevisible; Q96RP8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    456       Potassium voltage-gated channel subfamily
FT                                A member 7.
FT                                /FTId=PRO_0000308273.
FT   TRANSMEM    144    164       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    276    295       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    312    332       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    373    393       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       358    363       Selectivity filter. {ECO:0000250}.
FT   LIPID       231    231       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT     189    189       P -> R (in dbSNP:rs1611775).
FT                                {ECO:0000269|PubMed:11896454,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_036776.
FT   VARIANT     418    418       M -> T (in dbSNP:rs1017219).
FT                                {ECO:0000269|PubMed:11368907,
FT                                ECO:0000269|PubMed:11896454}.
FT                                /FTId=VAR_036777.
FT   CONFLICT     71     71       Y -> H (in Ref. 3; AAX11186).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       A -> V (in Ref. 3; AAX11186).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  50559 MW;  EF9980CF54D52FB8 CRC64;
     MEPRCPPPCG CCERLVLNVA GLRFETRART LGRFPDTLLG DPARRGRFYD DARREYFFDR
     HRPSFDAVLY YYQSGGRLRR PAHVPLDVFL EEVAFYGLGA AALARLREDE GCPVPPERPL
     PRRAFARQLW LLFEFPESSQ AARVLAVVSV LVILVSIVVF CLETLPDFRD DRDGTGLAAA
     AAAGPFPAPL NGSSQMPGNP PRLPFNDPFF VVETLCICWF SFELLVRLLV CPSKAIFFKN
     VMNLIDFVAI LPYFVALGTE LARQRGVGQQ AMSLAILRVI RLVRVFRIFK LSRHSKGLQI
     LGQTLRASMR ELGLLIFFLF IGVVLFSSAV YFAEVDRVDS HFTSIPESFW WAVVTMTTVG
     YGDMAPVTVG GKIVGSLCAI AGVLTISLPV PVIVSNFSYF YHRETEGEEA GMFSHVDMQP
     CGPLEGKANG GLVDGEVPEL PPPLWAPPGK HLVTEV
//
ID   KCA10_HUMAN             Reviewed;         511 AA.
AC   Q16322;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 2.
DT   15-FEB-2017, entry version 138.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 10;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.8;
GN   Name=KCNA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9177773; DOI=10.1006/geno.1997.4712;
RA   Orias M., Bray-Ward P., Curran M.E., Keating M.T., Desir G.V.;
RT   "Genomic localization of the human gene for KCNA10, a cGMP-activated K
RT   channel.";
RL   Genomics 42:33-37(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10836990;
RA   Lang R., Lee G., Liu W., Tian S., Rafi H., Orias M., Segal A.S.,
RA   Desir G.V.;
RT   "KCNA10: a novel ion channel functionally related to both voltage-
RT   gated potassium and CNG cation channels.";
RL   Am. J. Physiol. 278:F1013-F1021(2000).
RN   [6]
RP   INTERACTION WITH POMP, AND REGULATION BY CAMP.
RX   PubMed=12060596; DOI=10.1152/ajprenal.00258.2001;
RA   Tian S., Liu W., Wu Y., Rafi H., Segal A.S., Desir G.V.;
RT   "Regulation of the voltage-gated K+ channel KCNA10 by KCNA4B, a novel
RT   beta-subunit.";
RL   Am. J. Physiol. 283:F142-F149(2002).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12444201; DOI=10.1097/01.ASN.0000036866.37886.C5;
RA   Yao X., Tian S., Chan H.-Y., Biemesderfer D., Desir G.V.;
RT   "Expression of KCNA10, a voltage-gated K channel, in glomerular
RT   endothelium and at the apical membrane of the renal proximal tubule.";
RL   J. Am. Soc. Nephrol. 13:2831-2839(2002).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-200.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Mediates voltage-dependent potassium ion permeability of
CC       excitable membranes. Assuming opened or closed conformations in
CC       response to the voltage difference across the membrane, the
CC       protein forms a potassium-selective channel through which
CC       potassium ions may pass in accordance with their electrochemical
CC       gradient. The channel activity is up-regulated by cAMP.
CC       {ECO:0000269|PubMed:10836990}.
CC   -!- SUBUNIT: Homotetramer. Interacts with KCN4B/POMP. Interaction with
CC       KCN4B/POMP is necessary for the modulation of channel activity by
CC       cAMP. {ECO:0000269|PubMed:12060596}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10836990};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:10836990}.
CC   -!- TISSUE SPECIFICITY: Detected in kidney, in proximal tubules,
CC       glomerular endothelium, in vascular endothelium and in smooth
CC       muscle cells. {ECO:0000269|PubMed:12444201}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.8/KCNA10 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U96110; AAC51333.1; -; Genomic_DNA.
DR   EMBL; AL358215; CAH74103.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56454.1; -; Genomic_DNA.
DR   EMBL; BC074990; AAH74990.1; -; mRNA.
DR   CCDS; CCDS826.1; -.
DR   RefSeq; NP_005540.1; NM_005549.2.
DR   UniGene; Hs.248140; -.
DR   UniGene; Hs.622910; -.
DR   ProteinModelPortal; Q16322; -.
DR   SMR; Q16322; -.
DR   BioGrid; 109946; 17.
DR   IntAct; Q16322; 1.
DR   STRING; 9606.ENSP00000358786; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 545; -.
DR   iPTMnet; Q16322; -.
DR   PhosphoSitePlus; Q16322; -.
DR   BioMuta; KCNA10; -.
DR   DMDM; 74739879; -.
DR   EPD; Q16322; -.
DR   MaxQB; Q16322; -.
DR   PaxDb; Q16322; -.
DR   PeptideAtlas; Q16322; -.
DR   PRIDE; Q16322; -.
DR   Ensembl; ENST00000369771; ENSP00000358786; ENSG00000143105.
DR   GeneID; 3744; -.
DR   KEGG; hsa:3744; -.
DR   UCSC; uc001dzt.2; human.
DR   CTD; 3744; -.
DR   DisGeNET; 3744; -.
DR   GeneCards; KCNA10; -.
DR   H-InvDB; HIX0200074; -.
DR   HGNC; HGNC:6219; KCNA10.
DR   HPA; CAB022564; -.
DR   HPA; HPA015061; -.
DR   MIM; 602420; gene.
DR   neXtProt; NX_Q16322; -.
DR   OpenTargets; ENSG00000143105; -.
DR   PharmGKB; PA30020; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q16322; -.
DR   KO; K04881; -.
DR   OMA; QNIPGEI; -.
DR   OrthoDB; EOG090705CY; -.
DR   PhylomeDB; Q16322; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA10; -.
DR   GenomeRNAi; 3744; -.
DR   PRO; PR:Q16322; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   CleanEx; HS_KCNA10; -.
DR   Genevisible; Q16322; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    511       Potassium voltage-gated channel subfamily
FT                                A member 10.
FT                                /FTId=PRO_0000308275.
FT   TRANSMEM    218    238       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    271    292       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    339    358       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    375    395       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    436    456       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       421    426       Selectivity filter. {ECO:0000250}.
FT   LIPID       293    293       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    334    334       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    498    498       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT     200    200       R -> H (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs755748044).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036778.
FT   VARIANT     220    220       V -> M (in dbSNP:rs34970857).
FT                                /FTId=VAR_036779.
FT   VARIANT     258    258       S -> N (in dbSNP:rs3748729).
FT                                /FTId=VAR_036780.
SQ   SEQUENCE   511 AA;  57785 MW;  1B09B1CD68745F29 CRC64;
     MDVCGWKEME VALVNFDNSD EIQEEPGYAT DFDSTSPKGR PGGSSFSNGK ILISESTNHE
     TAFSKLPGDY ADPPGPEPVV LNEGNQRVII NIAGLRFETQ LRTLSQFPET LLGDREKRMQ
     FFDSMRNEYF FDRNRPSFDG ILYYYQSGGK IRRPANVPID IFADEISFYE LGSEAMDQFR
     EDEGFIKDPE TLLPTNDIHR QFWLLFEYPE SSSAARAVAV VSVLVVVISI TIFCLETLPE
     FREDRELKVV RDPNLNMSKT VLSQTMFTDP FFMVESTCIV WFTFELVLRF VVCPSKTDFF
     RNIMNIIDII SIIPYFATLI TELVQETEPS AQQNMSLAIL RIIRLVRVFR IFKLSRHSKG
     LQILGQTLKA SMRELGLLIF FLFIGVILFS SAVYFAEVDE PESHFSSIPD GFWWAVVTMT
     TVGYGDMCPT TPGGKIVGTL CAIAGVLTIA LPVPVIVSNF NYFYHRETEN EEKQNIPGEI
     ERILNSVGSR MGSTDSLNKT NGGCSTEKSR K
//
ID   KCNB1_HUMAN             Reviewed;         858 AA.
AC   Q14721; Q14193;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2002, sequence version 2.
DT   15-FEB-2017, entry version 148.
DE   RecName: Full=Potassium voltage-gated channel subfamily B member 1 {ECO:0000312|HGNC:HGNC:6231};
DE   AltName: Full=Delayed rectifier potassium channel 1 {ECO:0000303|PubMed:8081723};
DE            Short=DRK1 {ECO:0000303|PubMed:8081723};
DE            Short=h-DRK1 {ECO:0000303|PubMed:8081723};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv2.1 {ECO:0000303|PubMed:8081723};
GN   Name=KCNB1 {ECO:0000312|HGNC:HGNC:6231};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBUNIT,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=8081723;
RA   Albrecht B., Lorra C., Stocker K., Pongs O.;
RT   "Cloning and characterization of a human delayed rectifier potassium
RT   channel gene.";
RL   Recept. Channels 1:99-110(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, BIOPHYSICOCHEMICAL
RP   PROPERTIES, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain cortex;
RX   PubMed=1283219; DOI=10.1007/BF00370422;
RA   Ikeda S.R., Soler F., Zuhlke R.D., Joho R.H., Lewis D.L.;
RT   "Heterologous expression of the human potassium channel Kv2.1 in
RT   clonal mammalian cells by direct cytoplasmic microinjection of cRNA.";
RL   Pflugers Arch. 422:201-203(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lens epithelium;
RA   Rae J.L., Shepard A.R.;
RT   "Identification of potassium channels in human lens epithelium.";
RL   (In) Civan M.M. (eds.);
RL   The eye's aqueous humor-from secretion to glaucoma, pp.69-104,
RL   Academic Press, San Diego (1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   FUNCTION, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10484328;
RA   Shepard A.R., Rae J.L.;
RT   "Electrically silent potassium channel subunits from human lens
RT   epithelium.";
RL   Am. J. Physiol. 277:C412-C424(1999).
RN   [6]
RP   REVIEW.
RX   PubMed=10414301; DOI=10.1111/j.1749-6632.1999.tb11293.x;
RA   Coetzee W.A., Amarillo Y., Chiu J., Chow A., Lau D., McCormack T.,
RA   Moreno H., Nadal M.S., Ozaita A., Pountney D., Saganich M.,
RA   Vega-Saenz de Miera E., Rudy B.;
RT   "Molecular diversity of K+ channels.";
RL   Ann. N. Y. Acad. Sci. 868:233-285(1999).
RN   [7]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNG3, SELF-ASSOCIATION, DOMAIN,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION.
RX   PubMed=11852086; DOI=10.1016/S0014-5793(02)02267-6;
RA   Sano Y., Mochizuki S., Miyake A., Kitada C., Inamura K., Yokoi H.,
RA   Nozawa K., Matsushime H., Furuichi K.;
RT   "Molecular cloning and characterization of Kv6.3, a novel modulatory
RT   subunit for voltage-gated K(+) channel Kv2.1.";
RL   FEBS Lett. 512:230-234(2002).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=12403834; DOI=10.1210/me.2002-0058;
RA   MacDonald P.E., Wang G., Tsuk S., Dodo C., Kang Y., Tang L.,
RA   Wheeler M.B., Cattral M.S., Lakey J.R., Salapatek A.M., Lotan I.,
RA   Gaisano H.Y.;
RT   "Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1
RT   voltage-dependent K(+) channels in neuroendocrine islet beta-cells
RT   through an interaction with the channel N terminus.";
RL   Mol. Endocrinol. 16:2452-2461(2002).
RN   [9]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNG3; KCNH1 AND KCNH2,
RP   SELF-ASSOCIATION, DOMAIN, AND SUBCELLULAR LOCATION.
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [10]
RP   ENZYME REGULATION.
RX   PubMed=14565763; DOI=10.1021/tx0341097;
RA   Shiau Y.S., Huang P.T., Liou H.H., Liaw Y.C., Shiau Y.Y., Lou K.L.;
RT   "Structural basis of binding and inhibition of novel tarantula toxins
RT   in mammalian voltage-dependent potassium channels.";
RL   Chem. Res. Toxicol. 16:1217-1225(2003).
RN   [11]
RP   FUNCTION, SELF-ASSOCIATION, DOMAIN, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF GLU-71 AND ASP-79.
RX   PubMed=12560340; DOI=10.1074/jbc.M212973200;
RA   Ju M., Stevens L., Leadbitter E., Wray D.;
RT   "The Roles of N- and C-terminal determinants in the activation of the
RT   Kv2.1 potassium channel.";
RL   J. Biol. Chem. 278:12769-12778(2003).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=14988243; DOI=10.2337/diabetes.53.3.597;
RA   Yan L., Figueroa D.J., Austin C.P., Liu Y., Bugianesi R.M.,
RA   Slaughter R.S., Kaczorowski G.J., Kohler M.G.;
RT   "Expression of voltage-gated potassium channels in human and rhesus
RT   pancreatic islets.";
RL   Diabetes 53:597-607(2004).
RN   [13]
RP   REVIEW.
RX   PubMed=15858231; DOI=10.1385/CBB:42:2:167;
RA   Cox R.H.;
RT   "Molecular determinants of voltage-gated potassium currents in
RT   vascular smooth muscle.";
RL   Cell Biochem. Biophys. 42:167-195(2005).
RN   [14]
RP   SUBUNIT.
RX   PubMed=19357235; DOI=10.1152/ajpcell.00088.2009;
RA   Bocksteins E., Raes A.L., Van de Vijver G., Bruyns T.,
RA   Van Bogaert P.P., Snyders D.J.;
RT   "Kv2.1 and silent Kv subunits underlie the delayed rectifier K+
RT   current in cultured small mouse DRG neurons.";
RL   Am. J. Physiol. 296:C1271-C1278(2009).
RN   [15]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNG4, SELF-ASSOCIATION, DOMAIN,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF HIS-105, AND TISSUE SPECIFICITY.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
RN   [16]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-74 AND
RP   ASP-75.
RX   PubMed=19717558; DOI=10.1074/jbc.M109.039479;
RA   Bocksteins E., Labro A.J., Mayeur E., Bruyns T., Timmermans J.P.,
RA   Adriaensen D., Snyders D.J.;
RT   "Conserved negative charges in the N-terminal tetramerization domain
RT   mediate efficient assembly of Kv2.1 and Kv2.1/Kv6.4 channels.";
RL   J. Biol. Chem. 284:31625-31634(2009).
RN   [17]
RP   FUNCTION, SUMOYLATION, DESUMOYLATION, INTERACTION WITH SUMO1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19223394; DOI=10.1242/jcs.036632;
RA   Dai X.Q., Kolic J., Marchi P., Sipione S., Macdonald P.E.;
RT   "SUMOylation regulates Kv2.1 and modulates pancreatic beta-cell
RT   excitability.";
RL   J. Cell Sci. 122:775-779(2009).
RN   [18]
RP   FUNCTION.
RX   PubMed=23161216; DOI=10.1124/jpet.112.199083;
RA   Li X.N., Herrington J., Petrov A., Ge L., Eiermann G., Xiong Y.,
RA   Jensen M.V., Hohmeier H.E., Newgard C.B., Garcia M.L., Wagner M.,
RA   Zhang B.B., Thornberry N.A., Howard A.D., Kaczorowski G.J., Zhou Y.P.;
RT   "The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the
RT   regulation of insulin and somatostatin release from pancreatic
RT   islets.";
RL   J. Pharmacol. Exp. Ther. 344:407-416(2013).
RN   [19]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24477962; DOI=10.1002/cne.23551;
RA   King A.N., Manning C.F., Trimmer J.S.;
RT   "A unique ion channel clustering domain on the axon initial segment of
RT   mammalian neurons.";
RL   J. Comp. Neurol. 522:2594-2608(2014).
RN   [20]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNG4, SELF-ASSOCIATION, DOMAIN,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-74 AND ASP-75.
RX   PubMed=24901643; DOI=10.1371/journal.pone.0098960;
RA   Bocksteins E., Mayeur E., Van Tilborg A., Regnier G., Timmermans J.P.,
RA   Snyders D.J.;
RT   "The subfamily-specific interaction between Kv2.1 and Kv6.4 subunits
RT   is determined by interactions between the N- and C-termini.";
RL   PLoS ONE 9:E98960-E98960(2014).
RN   [21]
RP   VARIANTS EIEE26 ARG-347; ILE-374 AND ARG-379, CHARACTERIZATION OF
RP   VARIANTS EIEE26 ARG-347; ILE-374 AND ARG-379, AND INVOLVEMENT IN
RP   EIEE26.
RX   PubMed=25164438; DOI=10.1002/ana.24263;
RA   Torkamani A., Bersell K., Jorge B.S., Bjork R.L. Jr., Friedman J.R.,
RA   Bloss C.S., Cohen J., Gupta S., Naidu S., Vanoye C.G.,
RA   George A.L. Jr., Kearney J.A.;
RT   "De novo KCNB1 mutations in epileptic encephalopathy.";
RL   Ann. Neurol. 76:529-540(2014).
RN   [22]
RP   VARIANT EIEE26 ALA-378, CHARACTERIZATION OF VARIANT EIEE26 ALA-378,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=26503721; DOI=10.1085/jgp.201511444;
RA   Thiffault I., Speca D.J., Austin D.C., Cobb M.M., Eum K.S.,
RA   Safina N.P., Grote L., Farrow E.G., Miller N., Soden S.,
RA   Kingsmore S.F., Trimmer J.S., Saunders C.J., Sack J.T.;
RT   "A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion
RT   selectivity, expression, and localization.";
RL   J. Gen. Physiol. 146:399-410(2015).
RN   [23]
RP   VARIANTS EIEE26 CYS-306 AND ARG-401, AND CHARACTERIZATION OF VARIANTS
RP   EIEE26 CYS-306 AND ARG-401.
RX   PubMed=26477325; DOI=10.1038/srep15199;
RA   Saitsu H., Akita T., Tohyama J., Goldberg-Stern H., Kobayashi Y.,
RA   Cohen R., Kato M., Ohba C., Miyatake S., Tsurusaki Y., Nakashima M.,
RA   Miyake N., Fukuda A., Matsumoto N.;
RT   "De novo KCNB1 mutations in infantile epilepsy inhibit repetitive
RT   neuronal firing.";
RL   Sci. Rep. 5:15199-15199(2015).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain, but also in the pancreas and
CC       cardiovascular system. Contributes to the regulation of the action
CC       potential (AP) repolarization, duration and frequency of
CC       repetitive AP firing in neurons, muscle cells and endocrine cells
CC       and plays a role in homeostatic attenuation of electrical
CC       excitability throughout the brain (PubMed:23161216). Plays also a
CC       role in the regulation of exocytosis independently of its
CC       electrical function (By similarity). Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates
CC       between opened and closed conformations in response to the voltage
CC       difference across the membrane. Homotetrameric channels mediate a
CC       delayed-rectifier voltage-dependent outward potassium current that
CC       display rapid activation and slow inactivation in response to
CC       membrane depolarization (PubMed:8081723, PubMed:1283219,
CC       PubMed:10484328, PubMed:12560340, PubMed:19074135,
CC       PubMed:19717558, PubMed:24901643). Can form functional
CC       homotetrameric and heterotetrameric channels that contain variable
CC       proportions of KCNB2; channel properties depend on the type of
CC       alpha subunits that are part of the channel (By similarity). Can
CC       also form functional heterotetrameric channels with other alpha
CC       subunits that are non-conducting when expressed alone, such as
CC       KCNF1, KCNG1, KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and
CC       KCNV1, creating a functionally diverse range of channel complexes
CC       (PubMed:10484328, PubMed:11852086, PubMed:12060745,
CC       PubMed:19074135, PubMed:19717558, PubMed:24901643).
CC       Heterotetrameric channel activity formed with KCNS3 show increased
CC       current amplitude with the threshold for action potential
CC       activation shifted towards more negative values in hypoxic-treated
CC       pulmonary artery smooth muscle cells (By similarity). Channel
CC       properties are also modulated by cytoplasmic ancillary beta
CC       subunits such as AMIGO1, KCNE1, KCNE2 and KCNE3, slowing
CC       activation and inactivation rate of the delayed rectifier
CC       potassium channels (By similarity). In vivo, membranes probably
CC       contain a mixture of heteromeric potassium channel complexes,
CC       making it difficult to assign currents observed in intact tissues
CC       to any particular potassium channel family member. Major
CC       contributor to the slowly inactivating delayed-rectifier voltage-
CC       gated potassium current in neurons of the central nervous system,
CC       sympathetic ganglion neurons, neuroendocrine cells, pancreatic
CC       beta cells, cardiomyocytes and smooth muscle cells. Mediates the
CC       major part of the somatodendritic delayed-rectifier potassium
CC       current in hippocampal and cortical pyramidal neurons and
CC       sympathetic superior cervical ganglion (CGC) neurons that acts to
CC       slow down periods of firing, especially during high frequency
CC       stimulation. Plays a role in the induction of long-term
CC       potentiation (LTP) of neuron excitability in the CA3 layer of the
CC       hippocampus (By similarity). Contributes to the regulation of
CC       glucose-induced action potential amplitude and duration in
CC       pancreatic beta cells, hence limiting calcium influx and insulin
CC       secretion (PubMed:23161216). Plays a role in the regulation of
CC       resting membrane potential and contraction in hypoxia-treated
CC       pulmonary artery smooth muscle cells. May contribute to the
CC       regulation of the duration of both the action potential of
CC       cardiomyocytes and the heart ventricular repolarization QT
CC       interval. Contributes to the pronounced pro-apoptotic potassium
CC       current surge during neuronal apoptotic cell death in response to
CC       oxidative injury. May confer neuroprotection in response to
CC       hypoxia/ischemic insults by suppressing pyramidal neurons
CC       hyperexcitability in hippocampal and cortical regions (By
CC       similarity). Promotes trafficking of KCNG3, KCNH1 and KCNH2 to the
CC       cell surface membrane, presumably by forming heterotetrameric
CC       channels with these subunits (PubMed:12060745). Plays a role in
CC       the calcium-dependent recruitment and release of fusion-competent
CC       vesicles from the soma of neurons, neuroendocrine and glucose-
CC       induced pancreatic beta cells by binding key components of the
CC       fusion machinery in a pore-independent manner (By similarity).
CC       {ECO:0000250|UniProtKB:P15387, ECO:0000250|UniProtKB:Q03717,
CC       ECO:0000269|PubMed:10484328, ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:12560340,
CC       ECO:0000269|PubMed:1283219, ECO:0000269|PubMed:19074135,
CC       ECO:0000269|PubMed:19717558, ECO:0000269|PubMed:23161216,
CC       ECO:0000269|PubMed:24901643, ECO:0000269|PubMed:8081723}.
CC   -!- ENZYME REGULATION: Inhibited by 12.7 nM stromatoxin 1 (ScTx1), a
CC       spider venom toxin of the tarantula S.calceata (PubMed:14565763).
CC       Inhibited by 42 nM hanatoxin 1 (HaTx1), a spider venom toxin of
CC       the tarantula G.spatulata (PubMed:14565763). Modestly sensitive to
CC       millimolar levels of tetraethylammonium (TEA) (PubMed:8081723,
CC       PubMed:1283219). Modestly sensitive to millimolar levels of 4-
CC       aminopyridine (4-AP). Completely insensitive to toxins such as
CC       dendrotoxin (DTX) and charybdotoxin (CTX) (By similarity).
CC       {ECO:0000250|UniProtKB:P15387, ECO:0000269|PubMed:1283219,
CC       ECO:0000269|PubMed:14565763, ECO:0000269|PubMed:8081723,
CC       ECO:0000305|PubMed:10414301, ECO:0000305|PubMed:15858231}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels expressed in xenopus oocytes or in
CC         mammalian non-neuronal cells display delayed-rectifier voltage-
CC         dependent potassium currents which are activated during membrane
CC         depolarization, i.e within a risetime of about 20 msec
CC         (PubMed:8081723, PubMed:1283219). After that, inactivate very
CC         slowly, i.e within more than 5 sec (PubMed:8081723,
CC         PubMed:1283219). Their activation requires low threshold
CC         potentials of about -20 to -30 mV, with a midpoint activation at
CC         about 10 mV. For inactivation, the voltage at half-maximal
CC         amplitude is about -20 mV (PubMed:11852086). The time constant
CC         for recovery after inactivation is about 1.6 sec. Channels have
CC         an unitary conductance of about 8 pS (PubMed:10484328). The
CC         voltage-dependence of activation and inactivation and other
CC         channel characteristics vary depending on the experimental
CC         conditions, the expression system, the presence or absence of
CC         ancillary subunits and post-translational modifications.
CC         {ECO:0000250|UniProtKB:P15387, ECO:0000269|PubMed:10484328,
CC         ECO:0000269|PubMed:11852086, ECO:0000269|PubMed:1283219,
CC         ECO:0000269|PubMed:8081723, ECO:0000305|PubMed:10414301,
CC         ECO:0000305|PubMed:15858231};
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCNB2
CC       (PubMed:8081723, PubMed:1283219). Heterotetramer with non-
CC       conducting channel-forming alpha subunits such as KCNF1, KCNG1,
CC       KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1
CC       (PubMed:10484328, PubMed:11852086, PubMed:12060745,
CC       PubMed:19357235, PubMed:19074135, PubMed:19717558,
CC       PubMed:24901643). Channel activity is regulated by association
CC       with ancillary beta subunits such as AMIGO1, KCNE1, KCNE2 and
CC       KCNE3 (By similarity). Self-associates (via N-terminus and C-
CC       terminus) (PubMed:12560340, PubMed:24901643); self-association is
CC       required to regulate trafficking, gating and C-terminal
CC       phosphorylation-dependent modulation of the channel (By
CC       similarity). Interacts (via C-terminus) with STX1A (via C-
CC       terminus); this decreases the rate of channel activation and
CC       increases the rate of channel inactivation in pancreatic beta
CC       cells, induces also neuronal apoptosis in response to oxidative
CC       injury as well as pore-independent enhancement of exocytosis in
CC       neuroendocrine cells, chromaffin cells, pancreatic beta cells and
CC       from the soma of dorsal root ganglia (DRG) neurons. Interacts (via
CC       N-terminus) with SNAP25; this decreases the rate of channel
CC       inactivation in pancreatic beta cells and also increases
CC       interaction during neuronal apoptosis in a N-methyl-D-aspartate
CC       receptor (NMDAR)-dependent manner. Interacts (via N-terminus and
CC       C-terminus) with VAMP2 (via N-terminus); stimulates channel
CC       inactivation rate. Interacts with CREB1; this promotes channel
CC       acetylation in response to stimulation of incretin hormones.
CC       Interacts (via N-terminus and C-terminus) with MYL12B. Interacts
CC       (via N-terminus) with PIAS3; this increases the number of
CC       functional channels at the cell surface (By similarity). Interacts
CC       with SUMO1 (PubMed:19223394). Interacts (via phosphorylated form)
CC       with PTPRE; this reduces phosphorylation and channel activity in
CC       heterologous cells (By similarity). {ECO:0000250|UniProtKB:P15387,
CC       ECO:0000250|UniProtKB:Q03717, ECO:0000269|PubMed:10484328,
CC       ECO:0000269|PubMed:11852086, ECO:0000269|PubMed:12060745,
CC       ECO:0000269|PubMed:12560340, ECO:0000269|PubMed:1283219,
CC       ECO:0000269|PubMed:19074135, ECO:0000269|PubMed:19223394,
CC       ECO:0000269|PubMed:19357235, ECO:0000269|PubMed:19717558,
CC       ECO:0000269|PubMed:24901643, ECO:0000269|PubMed:8081723}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10484328,
CC       ECO:0000269|PubMed:11852086, ECO:0000269|PubMed:12060745,
CC       ECO:0000269|PubMed:12560340, ECO:0000269|PubMed:1283219,
CC       ECO:0000269|PubMed:19074135, ECO:0000269|PubMed:19223394,
CC       ECO:0000269|PubMed:19717558, ECO:0000269|PubMed:24477962,
CC       ECO:0000269|PubMed:24901643, ECO:0000269|PubMed:26503721,
CC       ECO:0000269|PubMed:8081723}. Perikaryon
CC       {ECO:0000269|PubMed:24477962}. Cell projection, axon
CC       {ECO:0000269|PubMed:24477962}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:24477962}. Membrane; Multi-pass membrane
CC       protein. Cell junction, synapse, postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:P15387}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P15387}. Cell junction, synapse,
CC       synaptosome {ECO:0000250|UniProtKB:P15387}. Lateral cell membrane
CC       {ECO:0000250|UniProtKB:P15387}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:P15387}. Note=Localizes to high-density
CC       somatodendritic clusters and non-clustered sites on the surface of
CC       neocortical and hippocampal pyramidal neurons in a cortical actin
CC       cytoskeleton-dependent manner (PubMed:24477962). Localizes also to
CC       high-density clusters in the axon initial segment (AIS), at
CC       ankyrin-G-deficient sites, on the surface of neocortical and
CC       hippocampal pyramidal neurons (PubMed:24477962). KCNB1-containing
CC       AIS clusters localize either in close apposition to smooth
CC       endoplasmic reticulum cisternal organelles or with GABA-A
CC       receptor-containing synapses of hippocampal and cortical pyramidal
CC       neurons, respectively (PubMed:24477962). Localizes to high-density
CC       clusters on the cell surface of atrial and ventricular myocytes
CC       and at the lateral plasma membrane in epithelial cells. Localizes
CC       both to the axial and transverse tubules (T tubule) and sarcolemma
CC       in ventricular myocytes. Associated with lipid raft domains. In
CC       cortical neurons, apoptotic injuries induce de novo plasma
CC       membrane insertion in a SNARE-dependent manner causing an
CC       apoptotic potassium current surge. {ECO:0000250|UniProtKB:P15387,
CC       ECO:0000250|UniProtKB:Q03717, ECO:0000269|PubMed:12060745,
CC       ECO:0000269|PubMed:19074135, ECO:0000269|PubMed:24477962,
CC       ECO:0000269|PubMed:24901643}.
CC   -!- TISSUE SPECIFICITY: Expressed in neocortical pyramidal cells
CC       (PubMed:24477962). Expressed in pancreatic beta cells (at protein
CC       level) (PubMed:12403834, PubMed:14988243). Expressed in brain,
CC       heart, lung, liver, colon, kidney and adrenal gland
CC       (PubMed:19074135). Expressed in the cortex, amygdala, cerebellum,
CC       pons, thalamus, hypothalamus, hippocampus and substantia nigra
CC       (PubMed:19074135). {ECO:0000269|PubMed:12403834,
CC       ECO:0000269|PubMed:14988243, ECO:0000269|PubMed:19074135,
CC       ECO:0000269|PubMed:24477962}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The N-terminal and C-terminal cytoplasmic regions mediate
CC       homooligomerization; self-association is required to regulate
CC       trafficking, gating and C-terminal phosphorylation-dependent
CC       modulation of the channel (PubMed:11852086, PubMed:12060745,
CC       PubMed:12560340, PubMed:19074135, PubMed:24901643). The N-terminal
CC       cytoplasmic region is important for interaction with other
CC       channel-forming alpha subunits and with ancillary beta subunits
CC       (PubMed:24901643). The C-terminus is necessary and sufficient for
CC       the restricted localization to, and clustering within, both in
CC       soma and proximal portions of dendrite of neurons and in lateral
CC       membrane of non-neuronal polarized cells. The C-terminus is both
CC       necessary and sufficient as a mediator of cholinergic and calcium-
CC       stimulated modulation of channel cell membrane clustering
CC       localization and activity in hippocampal neurons (By similarity).
CC       {ECO:0000250|UniProtKB:P15387, ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:12560340,
CC       ECO:0000269|PubMed:19074135, ECO:0000269|PubMed:24901643}.
CC   -!- PTM: Phosphorylated. Differential C-terminal phosphorylation on a
CC       subset of serines allows graded activity-dependent regulation of
CC       channel gating in hippocampal neurons. Ser-607 and Tyr-128 are
CC       significant sites of voltage-gated regulation through
CC       phosphorylation/dephosphorylation activities. Tyr-128 can be
CC       phosphorylated by Src and dephosphorylated by cytoplasmic form of
CC       the phosphatase PTPRE. CDK5-induced Ser-607 phosphorylation
CC       increases in response to acute blockade of neuronal activity.
CC       Phosphorylated on Tyr-128 by Src and on Ser-805 by MAPK14/P38MAPK;
CC       phosphorylations are necessary and sufficient for an increase in
CC       plasma membrane insertion, apoptotic potassium current surge and
CC       completion of the neuronal cell death program. Phosphorylated on
CC       Ser-520, Ser-607, Ser-656 and Ser-805 by CDK5; phosphorylation is
CC       necessary for KCNB1 channel clustering formation. The Ser-607
CC       phosphorylation state differs between KCNB1-containing clusters on
CC       the proximal and distal portions of the axon initial segment
CC       (AIS). Highly phosphorylated on serine residues in the C-terminal
CC       cytoplasmic tail in resting neurons. Phosphorylated in pancreatic
CC       beta cells in response to incretin hormones stimulation in a PKA-
CC       and RPS6KA5/MSK1-dependent signaling pathway, promoting beta cell
CC       survival. Phosphorylation on Ser-567 is reduced during postnatal
CC       development with low levels at P2 and P5; levels then increase to
CC       reach adult levels by P14. Phosphorylation on Ser-457, Ser-541,
CC       Ser-567, Ser-607, Ser-656 and Ser-720 as well as the N-terminal
CC       Ser-15 are sensitive to calcineurin-mediated dephosphorylation
CC       contributing to the modulation of the voltage-dependent gating
CC       properties. Dephosphorylation by phosphatase PTPRE confers
CC       neuroprotection by its inhibitory influence on the neuronal
CC       apoptotic potassium current surge in a Zn(2+)-dependent manner.
CC       Dephosphorylated at Ser-607 by protein phosphatase PPP1CA.
CC       Hypoxia-, seizure- or glutamate-induced neuronal activity promote
CC       calcium/calcineurin-dependent dephosphorylation resulting in a
CC       loss of KCNB1-containing clustering and enhanced channel activity.
CC       In response to brain ischemia, Ser-567 and Ser-607 are strongly
CC       dephosphorylated while Ser-457 and Ser-720 are less
CC       dephosphorylated. In response to brain seizures, phosphorylation
CC       levels on Ser-567 and Ser-607 are greatly reduced.
CC       Phosphorylated/dephosphorylated by Src or FYN tyrosine-protein
CC       kinases and tyrosine phosphatase PTPRE in primary Schwann cells
CC       and sciatic nerve tissue (By similarity).
CC       {ECO:0000250|UniProtKB:P15387, ECO:0000250|UniProtKB:Q03717}.
CC   -!- PTM: Acetylated. Acetylation occurs in pancreatic beta cells in
CC       response to stimulation by incretin hormones in a histone
CC       acetyltransferase (HAT)/histone deacetylase (HDAC)-dependent
CC       signaling pathway, promoting beta cell survival.
CC       {ECO:0000250|UniProtKB:P15387}.
CC   -!- PTM: Sumoylated on Lys-474, preferentially with SUMO1; sumoylation
CC       induces a positive shift in the voltage-dependence of activation
CC       and inhibits channel activity (PubMed:19223394). Sumoylation
CC       increases the frequency of repetitive action potential firing at
CC       the cell surface of hippocampal neurons and decreases its
CC       frequency in pancreatic beta cells (PubMed:19223394). Desumoylated
CC       by SENP1 (PubMed:19223394). {ECO:0000269|PubMed:19223394}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 26 (EIEE26)
CC       [MIM:616056]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE26 patients
CC       manifest multiple types of seizures, delayed psychomotor
CC       development, poor or absent speech, hypotonia, hypsarrhythmia.
CC       {ECO:0000269|PubMed:25164438, ECO:0000269|PubMed:26477325,
CC       ECO:0000269|PubMed:26503721}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. B (Shab)
CC       (TC 1.A.1.2) subfamily. Kv2.1/KCNB1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36156.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X68302; CAA48374.1; -; Genomic_DNA.
DR   EMBL; L02840; AAA36156.1; ALT_INIT; mRNA.
DR   EMBL; AF026005; AAB88808.1; -; mRNA.
DR   EMBL; AL035685; CAB89417.1; -; Genomic_DNA.
DR   CCDS; CCDS13418.1; -.
DR   PIR; S31761; S31761.
DR   RefSeq; NP_004966.1; NM_004975.3.
DR   RefSeq; XP_006723847.1; XM_006723784.3.
DR   RefSeq; XP_011527101.1; XM_011528799.2.
DR   UniGene; Hs.633143; -.
DR   UniGene; Hs.84244; -.
DR   ProteinModelPortal; Q14721; -.
DR   SMR; Q14721; -.
DR   BioGrid; 109947; 15.
DR   IntAct; Q14721; 1.
DR   STRING; 9606.ENSP00000360806; -.
DR   ChEMBL; CHEMBL2363000; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 546; -.
DR   TCDB; 1.A.1.2.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q14721; -.
DR   PhosphoSitePlus; Q14721; -.
DR   BioMuta; KCNB1; -.
DR   DMDM; 24418854; -.
DR   OGP; Q14721; -.
DR   MaxQB; Q14721; -.
DR   PaxDb; Q14721; -.
DR   PeptideAtlas; Q14721; -.
DR   PRIDE; Q14721; -.
DR   DNASU; 3745; -.
DR   Ensembl; ENST00000371741; ENSP00000360806; ENSG00000158445.
DR   Ensembl; ENST00000635465; ENSP00000489193; ENSG00000158445.
DR   GeneID; 3745; -.
DR   KEGG; hsa:3745; -.
DR   UCSC; uc002xur.2; human.
DR   CTD; 3745; -.
DR   DisGeNET; 3745; -.
DR   GeneCards; KCNB1; -.
DR   HGNC; HGNC:6231; KCNB1.
DR   HPA; CAB001979; -.
DR   HPA; HPA042434; -.
DR   MalaCards; KCNB1; -.
DR   MIM; 600397; gene.
DR   MIM; 616056; phenotype.
DR   neXtProt; NX_Q14721; -.
DR   OpenTargets; ENSG00000158445; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA209; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000113206; -.
DR   HOVERGEN; HBG052225; -.
DR   InParanoid; Q14721; -.
DR   KO; K04885; -.
DR   OMA; TEGVIDM; -.
DR   OrthoDB; EOG090B02MB; -.
DR   PhylomeDB; Q14721; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   SIGNOR; Q14721; -.
DR   GeneWiki; KCNB1; -.
DR   GenomeRNAi; 3745; -.
DR   PRO; PR:Q14721; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000158445; -.
DR   CleanEx; HS_KCNB1; -.
DR   Genevisible; Q14721; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0032182; F:ubiquitin-like protein binding; IPI:UniProtKB.
DR   GO; GO:0001508; P:action potential; IDA:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; ISS:UniProtKB.
DR   GO; GO:0033605; P:positive regulation of catecholamine secretion; ISS:UniProtKB.
DR   GO; GO:1900454; P:positive regulation of long term synaptic depression; ISS:UniProtKB.
DR   GO; GO:0010701; P:positive regulation of norepinephrine secretion; ISS:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098900; P:regulation of action potential; ISS:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:2000671; P:regulation of motor neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0006904; P:vesicle docking involved in exocytosis; ISS:UniProtKB.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003973; K_chnl_volt-dep_Kv2.
DR   InterPro; IPR004350; K_chnl_volt-dep_Kv2.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03521; Kv2channel; 2.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01514; KV21CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01495; SHABCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Disease mutation; Epilepsy; Exocytosis; Ion channel; Ion transport;
KW   Isopeptide bond; Membrane; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Synaptosome;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN         1    858       Potassium voltage-gated channel subfamily
FT                                B member 1.
FT                                /FTId=PRO_0000054042.
FT   TOPO_DOM      1    186       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    187    208       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    209    228       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    229    250       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    251    259       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    260    280       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    281    294       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    295    316       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    317    330       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    331    351       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    352    364       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    365    376       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    377    384       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    385    391       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    392    420       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    421    858       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION       59     75       Self-association.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   REGION      448    481       Self-association.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOTIF       377    382       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS    517    520       Poly-Ser.
FT   COMPBIAS    701    706       Poly-Ala.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     128    128       Phosphotyrosine; by Src.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     444    444       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03717}.
FT   MOD_RES     457    457       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03717}.
FT   MOD_RES     484    484       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     503    503       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     519    519       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     520    520       Phosphoserine; by CDK5; in vitro.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     590    590       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     607    607       Phosphoserine; by CDK5.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     656    656       Phosphoserine; by CDK5; in vitro.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     720    720       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     772    772       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     800    800       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   MOD_RES     805    805       Phosphoserine; by CDK5, MAPK14; in vitro.
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   CROSSLNK    474    474       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250|UniProtKB:P15387}.
FT   VARIANT     306    306       R -> C (in EIEE26; reduces sensitivity
FT                                and cooperativity of the voltage sensor
FT                                for channel opening and greatly
FT                                suppresses repetitive firing in cultured
FT                                cortical neurons).
FT                                {ECO:0000269|PubMed:26477325}.
FT                                /FTId=VAR_075573.
FT   VARIANT     347    347       S -> R (in EIEE26; inhibits ion
FT                                selectivity and gain of a depolarizing
FT                                inward cation conductance; trafficks
FT                                normally to the cell surface;
FT                                dbSNP:rs587777848).
FT                                {ECO:0000269|PubMed:25164438}.
FT                                /FTId=VAR_071991.
FT   VARIANT     374    374       T -> I (in EIEE26; inhibits ion
FT                                selectivity and gain of a depolarizing
FT                                inward cation conductance; trafficks
FT                                normally to the cell surface;
FT                                dbSNP:rs587777849).
FT                                {ECO:0000269|PubMed:25164438}.
FT                                /FTId=VAR_071992.
FT   VARIANT     378    378       V -> A (in EIEE26; change in the ion
FT                                selectivity from potassium-selective to
FT                                nonselective cation channels and
FT                                significant decrease in cell membrane
FT                                localization).
FT                                {ECO:0000269|PubMed:26503721}.
FT                                /FTId=VAR_075574.
FT   VARIANT     379    379       G -> R (in EIEE26; inhibits ion
FT                                selectivity and gain of a depolarizing
FT                                inward cation conductance; trafficks
FT                                normally to the cell surface;
FT                                dbSNP:rs587777850).
FT                                {ECO:0000269|PubMed:25164438}.
FT                                /FTId=VAR_071993.
FT   VARIANT     401    401       G -> R (in EIEE26; dominant-negative
FT                                mutation resulting in loss of endogenous
FT                                channel currents and greatly suppresses
FT                                repetitive firing in cultured cortical
FT                                neurons). {ECO:0000269|PubMed:26477325}.
FT                                /FTId=VAR_075575.
FT   VARIANT     616    616       T -> N (in dbSNP:rs2229006).
FT                                /FTId=VAR_062182.
FT   VARIANT     616    616       T -> S (in dbSNP:rs2229006).
FT                                /FTId=VAR_062183.
FT   VARIANT     825    825       P -> S (in dbSNP:rs34467662).
FT                                /FTId=VAR_034049.
FT   VARIANT     857    857       S -> N (in dbSNP:rs34280195).
FT                                /FTId=VAR_062184.
FT   MUTAGEN      71     71       E->Q: No effect on channel activity.
FT                                {ECO:0000269|PubMed:12560340}.
FT   MUTAGEN      74     74       D->R: Reduces interaction with KCNG1 and
FT                                self-interaction and impairs plasma
FT                                membrane subcellular localization,
FT                                homotetramerization and
FT                                hetetrotetramerization with KCNG4; when
FT                                associated with R-75.
FT                                {ECO:0000269|PubMed:19717558,
FT                                ECO:0000269|PubMed:24901643}.
FT   MUTAGEN      75     75       D->R: Reduces interaction with KCNG1 and
FT                                self-interaction and impairs plasma
FT                                membrane subcellular localization,
FT                                homotetramerization and
FT                                hetetrotetramerization with KCNG4; when
FT                                associated with R-74.
FT                                {ECO:0000269|PubMed:19717558,
FT                                ECO:0000269|PubMed:24901643}.
FT   MUTAGEN      79     79       D->E: Increases channel activity.
FT                                {ECO:0000269|PubMed:12560340}.
FT   MUTAGEN     105    105       H->V,R: Reduces channel activity.
FT                                Inhibits interaction with KCNG4. Impairs
FT                                hetetrotetramerization with KCNG1, KCNG3
FT                                or KCNG4. Does not impair
FT                                homotetramerization.
FT                                {ECO:0000269|PubMed:19074135}.
SQ   SEQUENCE   858 AA;  95878 MW;  C4B426174ED0DEE4 CRC64;
     MPAGMTKHGS RSTSSLPPEP MEIVRSKACS RRVRLNVGGL AHEVLWRTLD RLPRTRLGKL
     RDCNTHDSLL EVCDDYSLDD NEYFFDRHPG AFTSILNFYR TGRLHMMEEM CALSFSQELD
     YWGIDEIYLE SCCQARYHQK KEQMNEELKR EAETLREREG EEFDNTCCAE KRKKLWDLLE
     KPNSSVAAKI LAIISIMFIV LSTIALSLNT LPELQSLDEF GQSTDNPQLA HVEAVCIAWF
     TMEYLLRFLS SPKKWKFFKG PLNAIDLLAI LPYYVTIFLT ESNKSVLQFQ NVRRVVQIFR
     IMRILRILKL ARHSTGLQSL GFTLRRSYNE LGLLILFLAM GIMIFSSLVF FAEKDEDDTK
     FKSIPASFWW ATITMTTVGY GDIYPKTLLG KIVGGLCCIA GVLVIALPIP IIVNNFSEFY
     KEQKRQEKAI KRREALERAK RNGSIVSMNM KDAFARSIEM MDIVVEKNGE NMGKKDKVQD
     NHLSPNKWKW TKRTLSETSS SKSFETKEQG SPEKARSSSS PQHLNVQQLE DMYNKMAKTQ
     SQPILNTKES AAQSKPKEEL EMESIPSPVA PLPTRTEGVI DMRSMSSIDS FISCATDFPE
     ATRFSHSPLT SLPSKTGGST APEVGWRGAL GASGGRFVEA NPSPDASQHS SFFIESPKSS
     MKTNNPLKLR ALKVNFMEGD PSPLLPVLGM YHDPLRNRGS AAAAVAGLEC ATLLDKAVLS
     PESSIYTTAS AKTPPRSPEK HTAIAFNFEA GVHQYIDADT DDEGQLLYSV DSSPPKSLPG
     STSPKFSTGT RSEKNHFESS PLPTSPKFLR QNCIYSTEAL TGKGPSGQEK CKLENHISPD
     VRVLPGGGAH GSTRDQSI
//
ID   KCNB2_HUMAN             Reviewed;         911 AA.
AC   Q92953; Q7Z7D0; Q9BXD3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2002, sequence version 2.
DT   15-FEB-2017, entry version 149.
DE   RecName: Full=Potassium voltage-gated channel subfamily B member 2 {ECO:0000312|HGNC:HGNC:6232};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv2.2;
GN   Name=KCNB2 {ECO:0000312|HGNC:HGNC:6232};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Preisig-Mueller R., Derst C., Schnitzler M.M., Daut J.;
RT   "Cloning and characterization of two novel gamma Kv subunits.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Rae J.L.;
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-811.
RX   PubMed=9612272;
RA   Schmalz F., Kinsella J., Koh S.D., Vogalis F., Schneider A.,
RA   Flynn E.R., Kenyon J.L., Horowitz B.;
RT   "Molecular identification of a component of delayed rectifier current
RT   in gastrointestinal smooth muscles.";
RL   Am. J. Physiol. 274:G901-G911(1998).
RN   [4]
RP   REVIEW.
RX   PubMed=10414301; DOI=10.1111/j.1749-6632.1999.tb11293.x;
RA   Coetzee W.A., Amarillo Y., Chiu J., Chow A., Lau D., McCormack T.,
RA   Moreno H., Nadal M.S., Ozaita A., Pountney D., Saganich M.,
RA   Vega-Saenz de Miera E., Rudy B.;
RT   "Molecular diversity of K+ channels.";
RL   Ann. N. Y. Acad. Sci. 868:233-285(1999).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-450.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain and smooth muscle cells. Channels open or
CC       close in response to the voltage difference across the membrane,
CC       letting potassium ions pass in accordance with their
CC       electrochemical gradient. Homotetrameric channels mediate a
CC       delayed-rectifier voltage-dependent outward potassium current that
CC       display rapid activation and slow inactivation in response to
CC       membrane depolarization. Can form functional homotetrameric and
CC       heterotetrameric channels that contain variable proportions of
CC       KCNB1; channel properties depend on the type of alpha subunits
CC       that are part of the channel. Can also form functional
CC       heterotetrameric channels with other alpha subunits that are non-
CC       conducting when expressed alone, such as KCNS1 and KCNS2, creating
CC       a functionally diverse range of channel complexes. In vivo,
CC       membranes probably contain a mixture of heteromeric potassium
CC       channel complexes, making it difficult to assign currents observed
CC       in intact tissues to any particular potassium channel family
CC       member. Contributes to the delayed-rectifier voltage-gated
CC       potassium current in cortical pyramidal neurons and smooth muscle
CC       cells. {ECO:0000250|UniProtKB:A6H8H5,
CC       ECO:0000250|UniProtKB:Q63099}.
CC   -!- ENZYME REGULATION: Inhibited by quinine at micromolar levels.
CC       Modestly sensitive to millimolar levels of tetraethylammonium
CC       (TEA) and 4-aminopyridine (4-AP). {ECO:0000250|UniProtKB:Q63099,
CC       ECO:0000250|UniProtKB:Q95167, ECO:0000305|PubMed:10414301}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels expressed in xenopus oocytes or in
CC         mammalian non-neuronal cells display delayed-rectifier voltage-
CC         dependent potassium currents which are activated during membrane
CC         depolarization, i.e within a risetime of about 20 msec. After
CC         that, inactivate very slowly. Their activation requires low
CC         threshold potentials of about -20 to -30 mV, with a midpoint
CC         activation at about 10 mV. For inactivation, the voltage at
CC         half-maximal amplitude is about -30 mV. Channels have an unitary
CC         conductance of about 14 pS. The voltage-dependence of activation
CC         and inactivation and other channel characteristics vary
CC         depending on the experimental conditions, the expression system
CC         and post-translational modifications.
CC         {ECO:0000250|UniProtKB:Q63099, ECO:0000305|PubMed:10414301};
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCNB1. Heterotetramer
CC       with KCNS1 and KCNS2. {ECO:0000250|UniProtKB:Q63099}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q63099}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q63099}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63099}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q63099}. Note=Localized uniformly
CC       throughout cell bodies and dendrites. Colocalizes with KCNB1 to
CC       high-density somatodendritic clusters on cortical pyramidal
CC       neurons. {ECO:0000250|UniProtKB:Q63099}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Phosphorylated. {ECO:0000250|UniProtKB:Q63099}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. B (Shab)
CC       (TC 1.A.1.2) subfamily. Kv2.2/KCNB2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB08433.1; Type=Frameshift; Positions=768; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF450111; AAP46292.1; -; mRNA.
DR   EMBL; AF338730; AAK16585.1; -; mRNA.
DR   EMBL; U69962; AAB08433.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS6209.1; -.
DR   RefSeq; NP_004761.2; NM_004770.2.
DR   UniGene; Hs.661102; -.
DR   ProteinModelPortal; Q92953; -.
DR   BioGrid; 114724; 6.
DR   IntAct; Q92953; 2.
DR   STRING; 9606.ENSP00000430846; -.
DR   BindingDB; Q92953; -.
DR   ChEMBL; CHEMBL2321618; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 547; -.
DR   iPTMnet; Q92953; -.
DR   PhosphoSitePlus; Q92953; -.
DR   BioMuta; KCNB2; -.
DR   DMDM; 24418855; -.
DR   PaxDb; Q92953; -.
DR   PeptideAtlas; Q92953; -.
DR   PRIDE; Q92953; -.
DR   DNASU; 9312; -.
DR   Ensembl; ENST00000523207; ENSP00000430846; ENSG00000182674.
DR   GeneID; 9312; -.
DR   KEGG; hsa:9312; -.
DR   UCSC; uc003xzb.3; human.
DR   CTD; 9312; -.
DR   DisGeNET; 9312; -.
DR   GeneCards; KCNB2; -.
DR   HGNC; HGNC:6232; KCNB2.
DR   HPA; HPA065970; -.
DR   MIM; 607738; gene.
DR   neXtProt; NX_Q92953; -.
DR   OpenTargets; ENSG00000182674; -.
DR   PharmGKB; PA30025; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000113206; -.
DR   HOVERGEN; HBG052225; -.
DR   InParanoid; Q92953; -.
DR   KO; K04886; -.
DR   OMA; IHSNPGD; -.
DR   OrthoDB; EOG090B02MB; -.
DR   PhylomeDB; Q92953; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNB2; -.
DR   GenomeRNAi; 9312; -.
DR   PRO; PR:Q92953; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000182674; -.
DR   CleanEx; HS_KCNB2; -.
DR   Genevisible; Q92953; HS.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; TAS:ProtInc.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003973; K_chnl_volt-dep_Kv2.
DR   InterPro; IPR005826; K_chnl_volt-dep_Kv2.2.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03521; Kv2channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01515; KV22CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01495; SHABCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cell projection; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    911       Potassium voltage-gated channel subfamily
FT                                B member 2.
FT                                /FTId=PRO_0000054048.
FT   TOPO_DOM      1    190       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    191    212       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    213    232       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    233    254       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    255    265       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    266    284       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    285    296       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    297    317       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    318    332       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    333    354       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    355    368       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    369    380       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    381    388       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    389    395       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    396    424       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    425    911       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       381    386       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOD_RES     448    448       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63099}.
FT   CARBOHYD    287    287       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT     450    450       V -> I (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs770305852).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035774.
FT   VARIANT     657    657       E -> G (in dbSNP:rs16938507).
FT                                /FTId=VAR_034050.
FT   CONFLICT    161    162       ER -> DG (in Ref. 1; AAP46292).
FT                                {ECO:0000305}.
FT   CONFLICT    528    528       S -> F (in Ref. 1; AAP46292).
FT                                {ECO:0000305}.
SQ   SEQUENCE   911 AA;  102563 MW;  2261D7D6280CF81A CRC64;
     MAEKAPPGLN RKTSRSTLSL PPEPVDIIRS KTCSRRVKIN VGGLNHEVLW RTLDRLPRTR
     LGKLRDCNTH ESLLEVCDDY NLNENEYFFD RHPGAFTSIL NFYRTGKLHM MEEMCALSFG
     QELDYWGIDE IYLESCCQAR YHQKKEQMNE ELRREAETMR EREGEEFDNT CCPDKRKKLW
     DLLEKPNSSV AAKILAIVSI LFIVLSTIAL SLNTLPELQE TDEFGQLNDN RQLAHVEAVC
     IAWFTMEYLL RFLSSPNKWK FFKGPLNVID LLAILPYYVT IFLTESNKSV LQFQNVRRVV
     QIFRIMRILR ILKLARHSTG LQSLGFTLRR SYNELGLLIL FLAMGIMIFS SLVFFAEKDE
     DATKFTSIPA SFWWATITMT TVGYGDIYPK TLLGKIVGGL CCIAGVLVIA LPIPIIVNNF
     SEFYKEQKRQ EKAIKRREAL ERAKRNGSIV SMNLKDAFAR SMELIDVAVE KAGESANTKD
     SADDNHLSPS RWKWARKALS ETSSNKSFEN KYQEVSQKDS HEQLNNTSSS SPQHLSAQKL
     EMLYNEITKT QPHSHPNPDC QEKPERPSAY EEEIEMEEVV CPQEQLAVAQ TEVIVDMKST
     SSIDSFTSCA TDFTETERSP LPPPSASHLQ MKFPTDLPGT EEHQRARGPP FLTLSREKGP
     AARDGTLEYA PVDITVNLDA SGSQCGLHSP LQSDNATDSP KSSLKGSNPL KSRSLKVNFK
     ENRGSAPQTP PSTARPLPVT TADFSLTTPQ HISTILLEET PSQGDRPLLG TEVSAPCQGP
     SKGLSPRFPK QKLFPFSSRE RRSFTEIDTG DDEDFLELPG AREEKQVDSS PNCFADKPSD
     GRDPLREEGS VGSSSPQDTG HNCRQDIYHA VSEVKKDSSQ EGCKMENHLF APEIHSNPGD
     TGYCPTRETS M
//
ID   KCNC1_HUMAN             Reviewed;         511 AA.
AC   P48547; K4DI87;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   15-FEB-2017, entry version 153.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 1;
DE   AltName: Full=NGK2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4;
GN   Name=KCNC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8449507; DOI=10.1006/geno.1993.1075;
RA   Ried T., Rudy B., de Miera E., Lau D., Ward D.C., Sen K.;
RT   "Localization of a highly conserved human potassium channel gene
RT   (NGK2-KV4; KCNC1) to chromosome 11p15.";
RL   Genomics 15:405-411(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 244-475 (ISOFORM 1).
RX   PubMed=1400413;
RA   Grissmer S., Ghanshani S., Dethlefs B., McPherson J.D., Wasmuth J.J.,
RA   Gutman G.A., Cahalan M.D., Chandy K.G.;
RT   "The Shaw-related potassium channel gene, Kv3.1, on human chromosome
RT   11, encodes the type l K+ channel in T cells.";
RL   J. Biol. Chem. 267:20971-20979(1992).
RN   [5]
RP   INTERACTION WITH KCNC3.
RX   PubMed=23734863; DOI=10.1042/BJ20130034;
RA   Zhao J., Zhu J., Thornhill W.B.;
RT   "Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-
RT   histidine mutations affect both functional and protein expression on
RT   the cell surface.";
RL   Biochem. J. 454:259-265(2013).
RN   [6]
RP   INVOLVEMENT IN EPM7, VARIANT EPM7 HIS-320, CHARACTERIZATION OF VARIANT
RP   EPM7 HIS-320, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25401298; DOI=10.1038/ng.3144;
RA   Muona M., Berkovic S.F., Dibbens L.M., Oliver K.L., Maljevic S.,
RA   Bayly M.A., Joensuu T., Canafoglia L., Franceschetti S.,
RA   Michelucci R., Markkinen S., Heron S.E., Hildebrand M.S.,
RA   Andermann E., Andermann F., Gambardella A., Tinuper P., Licchetta L.,
RA   Scheffer I.E., Criscuolo C., Filla A., Ferlazzo E., Ahmad J.,
RA   Ahmad A., Baykan B., Said E., Topcu M., Riguzzi P., King M.D.,
RA   Ozkara C., Andrade D.M., Engelsen B.A., Crespel A., Lindenau M.,
RA   Lohmann E., Saletti V., Massano J., Privitera M., Espay A.J.,
RA   Kauffmann B., Duchowny M., Moeller R.S., Straussberg R., Afawi Z.,
RA   Ben-Zeev B., Samocha K.E., Daly M.J., Petrou S., Lerche H.,
RA   Palotie A., Lehesjoki A.E.;
RT   "A recurrent de novo mutation in KCNC1 causes progressive myoclonus
RT   epilepsy.";
RL   Nat. Genet. 47:39-46(2015).
CC   -!- FUNCTION: Voltage-gated potassium channel that plays an important
CC       role in the rapid repolarization of fast-firing brain neurons. The
CC       channel opens in response to the voltage difference across the
CC       membrane, forming a potassium-selective channel through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient (PubMed:25401298). Can form functional homotetrameric
CC       channels and heterotetrameric channels that contain variable
CC       proportions of KCNC2, and possibly other family members as well.
CC       Contributes to fire sustained trains of very brief action
CC       potentials at high frequency in pallidal neurons.
CC       {ECO:0000250|UniProtKB:P25122, ECO:0000269|PubMed:25401298}.
CC   -!- SUBUNIT: Heteromultimer with KCNG3, KCNG4 and KCNV2 (By
CC       similarity). Heteromultimer with KCNC2 (By similarity).
CC       Heterotetramer with KCNC3 (PubMed:23734863). Interacts with the
CC       ancillary subunits KCNE1 and KCNE2; the interaction modulates
CC       channel activity (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P25122, ECO:0000269|PubMed:23734863}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25401298};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P48547-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48547-2; Sequence=VSP_055129;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305}.
CC   -!- DOMAIN: The tail may be important in modulation of channel
CC       activity and/or targeting of the channel to specific subcellular
CC       compartments. {ECO:0000305}.
CC   -!- PTM: N-glycosylated; contains sialylated glycans.
CC       {ECO:0000250|UniProtKB:P25122}.
CC   -!- DISEASE: Epilepsy, progressive myoclonic 7 (EPM7) [MIM:616187]: A
CC       neurologic disorder characterized by progressive myoclonic
CC       epilepsy, manifesting in the first or second decades of life.
CC       Cognitive function may decline in some patients. Myoclonus is a
CC       brief, involuntary twitching of a muscle or a group of muscles.
CC       {ECO:0000269|PubMed:25401298}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw)
CC       (TC 1.A.1.2) subfamily. Kv3.1/KCNC1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S56770; AAB25764.1; -; mRNA.
DR   EMBL; AC124056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124078; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124301; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68425.1; -; Genomic_DNA.
DR   EMBL; M96747; AAA59458.1; -; mRNA.
DR   CCDS; CCDS44547.1; -. [P48547-2]
DR   CCDS; CCDS7827.1; -. [P48547-1]
DR   PIR; A46020; A46020.
DR   RefSeq; NP_001106212.1; NM_001112741.1. [P48547-2]
DR   RefSeq; NP_004967.1; NM_004976.4. [P48547-1]
DR   UniGene; Hs.552896; -.
DR   ProteinModelPortal; P48547; -.
DR   SMR; P48547; -.
DR   BioGrid; 109948; 8.
DR   STRING; 9606.ENSP00000265969; -.
DR   BindingDB; P48547; -.
DR   ChEMBL; CHEMBL5529; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   PhosphoSitePlus; P48547; -.
DR   BioMuta; KCNC1; -.
DR   DMDM; 1352085; -.
DR   PaxDb; P48547; -.
DR   PeptideAtlas; P48547; -.
DR   PRIDE; P48547; -.
DR   Ensembl; ENST00000265969; ENSP00000265969; ENSG00000129159. [P48547-2]
DR   Ensembl; ENST00000379472; ENSP00000368785; ENSG00000129159. [P48547-1]
DR   GeneID; 3746; -.
DR   KEGG; hsa:3746; -.
DR   UCSC; uc001mnk.5; human. [P48547-1]
DR   CTD; 3746; -.
DR   DisGeNET; 3746; -.
DR   GeneCards; KCNC1; -.
DR   HGNC; HGNC:6233; KCNC1.
DR   HPA; HPA047634; -.
DR   HPA; HPA048249; -.
DR   MalaCards; KCNC1; -.
DR   MIM; 176258; gene.
DR   MIM; 616187; phenotype.
DR   neXtProt; NX_P48547; -.
DR   OpenTargets; ENSG00000129159; -.
DR   PharmGKB; PA30026; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; P48547; -.
DR   KO; K04887; -.
DR   OMA; MGQGDDS; -.
DR   OrthoDB; EOG090B0510; -.
DR   PhylomeDB; P48547; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GenomeRNAi; 3746; -.
DR   PRO; PR:P48547; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000129159; -.
DR   CleanEx; HS_KCNC1; -.
DR   Genevisible; P48547; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0032589; C:neuron projection membrane; IEA:Ensembl.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021759; P:globus pallidus development; IEA:Ensembl.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0010996; P:response to auditory stimulus; IEA:Ensembl.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl.
DR   GO; GO:0009642; P:response to light intensity; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0035864; P:response to potassium ion; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005403; K_chnl_volt-dep_Kv3.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01581; KV31CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    511       Potassium voltage-gated channel subfamily
FT                                C member 1.
FT                                /FTId=PRO_0000054051.
FT   TOPO_DOM      1    190       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    191    209       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    248    267       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    268    276       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    277    295       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    309    331       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    332    344       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    345    366       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    415    436       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    437    511       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       400    405       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     160    160       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   MOD_RES     474    474       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   MOD_RES     483    483       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   CARBOHYD    220    220       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     502    511       GRKPLRGMSI -> DSKLNGEVAKAALANEDCPHIDQALTP
FT                                DEGLPFTRSGTRERYGPCFLLSTGEYACPPGGGMRKDLCKE
FT                                SPVIAKYMPTEAVRVT (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_055129.
FT   VARIANT     320    320       R -> H (in EPM7; causes a dominant-
FT                                negative loss of current upon membrane
FT                                depolarization; dbSNP:rs727502818).
FT                                {ECO:0000269|PubMed:25401298}.
FT                                /FTId=VAR_072705.
SQ   SEQUENCE   511 AA;  57942 MW;  10A93478F7120ABB CRC64;
     MGQGDESERI VINVGGTRHQ TYRSTLRTLP GTRLAWLAEP DAHSHFDYDP RADEFFFDRH
     PGVFAHILNY YRTGKLHCPA DVCGPLYEEE LAFWGIDETD VEPCCWMTYR QHRDAEEALD
     SFGGAPLDNS ADDADADGPG DSGDGEDELE MTKRLALSDS PDGRPGGFWR RWQPRIWALF
     EDPYSSRYAR YVAFASLFFI LVSITTFCLE THERFNPIVN KTEIENVRNG TQVRYYREAE
     TEAFLTYIEG VCVVWFTFEF LMRVIFCPNK VEFIKNSLNI IDFVAILPFY LEVGLSGLSS
     KAAKDVLGFL RVVRFVRILR IFKLTRHFVG LRVLGHTLRA STNEFLLLII FLALGVLIFA
     TMIYYAERIG AQPNDPSASE HTHFKNIPIG FWWAVVTMTT LGYGDMYPQT WSGMLVGALC
     ALAGVLTIAM PVPVIVNNFG MYYSLAMAKQ KLPKKKKKHI PRPPQLGSPN YCKSVVNSPH
     HSTQSDTCPL AQEEILEINR AGRKPLRGMS I
//
ID   KCNC2_HUMAN             Reviewed;         638 AA.
AC   Q96PR1; B7Z231; F5H030; J3KPP5; Q4LE77; Q86W09; Q8N1V9; Q96PR0;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-FEB-2017, entry version 129.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 2 {ECO:0000312|HGNC:HGNC:6234};
DE   AltName: Full=Shaw-like potassium channel {ECO:0000250|UniProtKB:P22462};
DE   AltName: Full=Voltage-gated potassium channel Kv3.2 {ECO:0000250|UniProtKB:P22462};
GN   Name=KCNC2 {ECO:0000312|HGNC:HGNC:6234};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RX   PubMed=8111118; DOI=10.1007/BF00357794;
RA   Haas M., Ward D.C., Lee J., Roses A.D., Clarke V., D'Eustachio P.,
RA   Lau D., Vega-Saenz de Miera E., Rudy B.;
RT   "Localization of Shaw-related K+ channel genes on mouse and human
RT   chromosomes.";
RL   Mamm. Genome 4:711-715(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Isbrandt D., Pongs O.;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6).
RC   TISSUE=Amygdala, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   REVIEW.
RX   PubMed=10414303; DOI=10.1111/j.1749-6632.1999.tb11295.x;
RA   Rudy B., Chow A., Lau D., Amarillo Y., Ozaita A., Saganich M.,
RA   Moreno H., Nadal M.S., Hernandez-Pineda R., Hernandez-Cruz A.,
RA   Erisir A., Leonard C., Vega-Saenz de Miera E.;
RT   "Contributions of Kv3 channels to neuronal excitability.";
RL   Ann. N. Y. Acad. Sci. 868:304-343(1999).
RN   [9]
RP   REVIEW.
RX   PubMed=11506885; DOI=10.1016/S0166-2236(00)01892-0;
RA   Rudy B., McBain C.J.;
RT   "Kv3 channels: voltage-gated K+ channels designed for high-frequency
RT   repetitive firing.";
RL   Trends Neurosci. 24:517-526(2001).
RN   [10]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15709110; DOI=10.1124/mol.105.011064;
RA   Yan L., Herrington J., Goldberg E., Dulski P.M., Bugianesi R.M.,
RA   Slaughter R.S., Banerjee P., Brochu R.M., Priest B.T.,
RA   Kaczorowski G.J., Rudy B., Garcia M.L.;
RT   "Stichodactyla helianthus peptide, a pharmacological tool for studying
RT   Kv3.2 channels.";
RL   Mol. Pharmacol. 67:1513-1521(2005).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain. Contributes to the regulation of the fast
CC       action potential repolarization and in sustained high-frequency
CC       firing in neurons of the central nervous system. Homotetramer
CC       channels mediate delayed-rectifier voltage-dependent potassium
CC       currents that activate rapidly at high-threshold voltages and
CC       inactivate slowly. Forms tetrameric channels through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient. The channel alternates between opened and closed
CC       conformations in response to the voltage difference across the
CC       membrane (PubMed:15709110). Can form functional homotetrameric and
CC       heterotetrameric channels that contain variable proportions of
CC       KCNC1, and possibly other family members as well; channel
CC       properties depend on the type of alpha subunits that are part of
CC       the channel. Channel properties may be modulated either by the
CC       association with ancillary subunits, such as KCNE1, KCNE2 or KCNE3
CC       or indirectly by nitric oxide (NO) through a cGMP- and PKG-
CC       mediated signaling cascade, slowing channel activation and
CC       deactivation of delayed rectifier potassium channels (By
CC       similarity). Contributes to fire sustained trains of very brief
CC       action potentials at high frequency in retinal ganglion cells,
CC       thalamocortical and suprachiasmatic nucleus (SCN) neurons and in
CC       hippocampal and neocortical interneurons (PubMed:15709110).
CC       Sustained maximal action potential firing frequency in inhibitory
CC       hippocampal interneurons is negatively modulated by histamine H2
CC       receptor activation in a cAMP- and protein kinase (PKA)
CC       phosphorylation-dependent manner. Plays a role in maintaining the
CC       fidelity of synaptic transmission in neocortical GABAergic
CC       interneurons by generating action potential (AP) repolarization at
CC       nerve terminals, thus reducing spike-evoked calcium influx and
CC       GABA neurotransmitter release. Required for long-range
CC       synchronization of gamma oscillations over distance in the
CC       neocortex. Contributes to the modulation of the circadian rhythm
CC       of spontaneous action potential firing in suprachiasmatic nucleus
CC       (SCN) neurons in a light-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:P22462, ECO:0000250|UniProtKB:Q14B80,
CC       ECO:0000269|PubMed:15709110, ECO:0000305|PubMed:10414303,
CC       ECO:0000305|PubMed:11506885}.
CC   -!- ENZYME REGULATION: Inhibited by Stichodactyla helianthus peptide
CC       ShK (PubMed:15709110). Inhibited by millimolar levels of
CC       tetraethylammonium (TEA). Contrary to other channels, inhibited
CC       only by millimolar levels of 4-aminopyridine (4-AP) (By
CC       similarity). {ECO:0000250|UniProtKB:P22462,
CC       ECO:0000269|PubMed:15709110, ECO:0000305|PubMed:10414303}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels expressed in xenopus oocytes or in
CC         mammalian non-neuronal cells display delayed-rectifier voltage-
CC         dependent potassium currents, that are rapidly activated during
CC         membrane depolarization, i.e within a risetime of a few msec.
CC         After that, inactivates very slowly, i.e within about >800 msec.
CC         Their activation requires a threshold potential at about -10 mV,
CC         with a midpoint activation at about 12.1 mV and a steepness
CC         parameter of about 8.4 mV. The voltage-dependence of activation
CC         and inactivation and other channel characteristics vary
CC         depending on the experimental conditions, the expression system,
CC         the presence or absence of ancillary subunits and post-
CC         translational modifications. {ECO:0000250|UniProtKB:P22462,
CC         ECO:0000269|PubMed:15709110, ECO:0000305|PubMed:10414303};
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-
CC       forming alpha subunits, such as KCNC1. Interacts with KCNC1.
CC       Homotetramer or heterotetramer channel activity is regulated by
CC       association with modulating ancillary subunits such as KCNE1,
CC       KCNE2 and KCNE3, creating a functionally diverse range of channel
CC       complexes. Interacts with KCNE1, KCNE2 and KCNE3.
CC       {ECO:0000250|UniProtKB:P22462, ECO:0000250|UniProtKB:Q14B80}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15709110};
CC       Multi-pass membrane protein {ECO:0000255}. Membrane
CC       {ECO:0000250|UniProtKB:Q14B80}; Multi-pass membrane protein
CC       {ECO:0000255}. Perikaryon {ECO:0000250|UniProtKB:Q14B80}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q14B80}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q14B80}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250|UniProtKB:Q14B80}. Cell
CC       junction, synapse, presynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q14B80}. Cell junction, synapse,
CC       synaptosome {ECO:0000250|UniProtKB:P22462}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P22462}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:P22462}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:P22462}. Note=Colocalizes with parvalbumin
CC       in globus pallidus neurons. Localizes in thalamocortical axons and
CC       synapses. Localizes on the surface of cell somata, proximal
CC       dendrites and axonal membranes. Also detected throughout the
CC       neuropil. Localized in starburst cell somata and proximal dendrite
CC       processes. Colocalized with GABA in presynaptic terminals.
CC       Clustered in patches in somatic and proximal dendritic membrane as
CC       well as in axons and presnypatic terminals of GABAergic
CC       interneurons; some of these patches are found near postsynaptic
CC       sites. {ECO:0000250|UniProtKB:P22462,
CC       ECO:0000250|UniProtKB:Q14B80}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Kv3.2b;
CC         IsoId=Q96PR1-1; Sequence=Displayed;
CC       Name=2; Synonyms=Kv3.2d;
CC         IsoId=Q96PR1-2; Sequence=VSP_029271;
CC       Name=3; Synonyms=Kv3.2a;
CC         IsoId=Q96PR1-3; Sequence=VSP_029272;
CC       Name=4; Synonyms=Kv3.2c;
CC         IsoId=Q96PR1-4; Sequence=VSP_029269, VSP_029270;
CC       Name=5;
CC         IsoId=Q96PR1-5; Sequence=VSP_044742;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q96PR1-6; Sequence=VSP_046002;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Phosphorylated by PKA in cortical synaptosomes. cAMP-
CC       dependent phosphorylation inhibits channel activity (By
CC       similarity). Histamine H2 receptor- and PKA-induced
CC       phosphorylation extends action potential spike duration, reduces
CC       action potential spike amplitude, sustains maximum firing
CC       frequency in hippocampal interneurons; also reduces the incidence
CC       of high-frequency oscillations in hippocampal CA3 pyramidal cell
CC       layers. {ECO:0000250|UniProtKB:P22462,
CC       ECO:0000250|UniProtKB:Q14B80}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw)
CC       (TC 1.A.1.2) subfamily. Kv3.2/KCNC2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE06076.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF268896; AAL27272.1; -; mRNA.
DR   EMBL; AF268897; AAL27273.1; -; mRNA.
DR   EMBL; AY243473; AAO89503.1; -; mRNA.
DR   EMBL; AY118169; AAM81577.1; -; mRNA.
DR   EMBL; AK094720; BAC04407.1; -; mRNA.
DR   EMBL; AK294269; BAH11717.1; -; mRNA.
DR   EMBL; AK309245; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB209994; BAE06076.1; ALT_INIT; mRNA.
DR   EMBL; AC073525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091534; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130405; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97287.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97288.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97289.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97291.1; -; Genomic_DNA.
DR   EMBL; BC093635; AAH93635.1; -; mRNA.
DR   EMBL; BC111991; AAI11992.1; -; mRNA.
DR   CCDS; CCDS58255.1; -. [Q96PR1-5]
DR   CCDS; CCDS58256.1; -. [Q96PR1-2]
DR   CCDS; CCDS58257.1; -. [Q96PR1-6]
DR   CCDS; CCDS9005.1; -. [Q96PR1-3]
DR   CCDS; CCDS9006.1; -. [Q96PR1-4]
DR   CCDS; CCDS9007.1; -. [Q96PR1-1]
DR   RefSeq; NP_001247426.1; NM_001260497.1. [Q96PR1-6]
DR   RefSeq; NP_001247427.1; NM_001260498.1. [Q96PR1-2]
DR   RefSeq; NP_001247428.1; NM_001260499.1. [Q96PR1-5]
DR   RefSeq; NP_631874.1; NM_139136.3. [Q96PR1-3]
DR   RefSeq; NP_631875.1; NM_139137.3. [Q96PR1-1]
DR   RefSeq; NP_715624.1; NM_153748.2. [Q96PR1-4]
DR   RefSeq; XP_006719445.1; XM_006719382.3. [Q96PR1-3]
DR   UniGene; Hs.27214; -.
DR   UniGene; Hs.741918; -.
DR   ProteinModelPortal; Q96PR1; -.
DR   BioGrid; 109949; 1.
DR   STRING; 9606.ENSP00000449253; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 549; -.
DR   iPTMnet; Q96PR1; -.
DR   PhosphoSitePlus; Q96PR1; -.
DR   BioMuta; KCNC2; -.
DR   DMDM; 74752079; -.
DR   PaxDb; Q96PR1; -.
DR   PeptideAtlas; Q96PR1; -.
DR   PRIDE; Q96PR1; -.
DR   TopDownProteomics; Q96PR1-4; -. [Q96PR1-4]
DR   Ensembl; ENST00000298972; ENSP00000298972; ENSG00000166006. [Q96PR1-3]
DR   Ensembl; ENST00000350228; ENSP00000319877; ENSG00000166006. [Q96PR1-4]
DR   Ensembl; ENST00000393288; ENSP00000376966; ENSG00000166006. [Q96PR1-6]
DR   Ensembl; ENST00000540018; ENSP00000438423; ENSG00000166006. [Q96PR1-5]
DR   Ensembl; ENST00000548513; ENSP00000449941; ENSG00000166006. [Q96PR1-3]
DR   Ensembl; ENST00000549446; ENSP00000449253; ENSG00000166006. [Q96PR1-1]
DR   Ensembl; ENST00000550433; ENSP00000448301; ENSG00000166006. [Q96PR1-2]
DR   GeneID; 3747; -.
DR   KEGG; hsa:3747; -.
DR   UCSC; uc001sxe.5; human. [Q96PR1-1]
DR   CTD; 3747; -.
DR   GeneCards; KCNC2; -.
DR   HGNC; HGNC:6234; KCNC2.
DR   HPA; CAB022571; -.
DR   HPA; HPA019664; -.
DR   MIM; 176256; gene.
DR   neXtProt; NX_Q96PR1; -.
DR   OpenTargets; ENSG00000166006; -.
DR   PharmGKB; PA35490; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; Q96PR1; -.
DR   KO; K04888; -.
DR   OMA; NCSSHGG; -.
DR   OrthoDB; EOG090B0510; -.
DR   PhylomeDB; Q96PR1; -.
DR   TreeFam; TF352511; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   GeneWiki; KCNC2; -.
DR   GenomeRNAi; 3747; -.
DR   PRO; PR:Q96PR1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000166006; -.
DR   CleanEx; HS_KCNC2; -.
DR   ExpressionAtlas; Q96PR1; baseline and differential.
DR   Genevisible; Q96PR1; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0071242; P:cellular response to ammonium ion; IEA:Ensembl.
DR   GO; GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB.
DR   GO; GO:0097237; P:cellular response to toxic substance; IEA:Ensembl.
DR   GO; GO:0021759; P:globus pallidus development; IEA:Ensembl.
DR   GO; GO:0038060; P:nitric oxide-cGMP-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0009642; P:response to light intensity; IEA:Ensembl.
DR   GO; GO:0032026; P:response to magnesium ion; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Postsynaptic cell membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Synapse;
KW   Synaptosome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    638       Potassium voltage-gated channel subfamily
FT                                C member 2.
FT                                /FTId=PRO_0000310416.
FT   TOPO_DOM      1    229       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    284    303       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    304    313       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    314    334       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    346    368       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    369    381       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    382    402       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    453    473       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    474    638       Cytoplasmic. {ECO:0000255}.
FT   REGION      437    442       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS     56     99       Gly/Pro-rich (insert).
FT   MOD_RES     600    600       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14B80}.
FT   CARBOHYD    259    259       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     539    593       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044742.
FT   VAR_SEQ     539    558       VLSGDDSTGSEPPLSPPERL -> DNCKEVVITGYTQAEAR
FT                                SLT (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029269.
FT   VAR_SEQ     559    638       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029270.
FT   VAR_SEQ     594    638       GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPI
FT                                PSIL -> VLYRIYHGLLTAEKGTVEFSHTKDYTGNRLLLL
FT                                NVP (in isoform 2).
FT                                {ECO:0000303|PubMed:8111118}.
FT                                /FTId=VSP_029271.
FT   VAR_SEQ     594    638       GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPI
FT                                PSIL -> DNCKEVVITGYTQAEARSLT (in isoform
FT                                3). {ECO:0000303|PubMed:8111118}.
FT                                /FTId=VSP_029272.
FT   VAR_SEQ     595    638       YEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPIP
FT                                SIL -> IRNGHSILHHLDNGTKCHYLRIIF (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046002.
FT   CONFLICT     31     31       G -> V (in Ref. 3; AK309245).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       P -> S (in Ref. 4; BAE06076).
FT                                {ECO:0000305}.
FT   CONFLICT    476    476       F -> S (in Ref. 3; BAH11717).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       Q -> H (in Ref. 3; AK309245).
FT                                {ECO:0000305}.
SQ   SEQUENCE   638 AA;  70226 MW;  211CAF8395A58C5D CRC64;
     MGKIENNERV ILNVGGTRHE TYRSTLKTLP GTRLALLASS EPPGDCLTTA GDKLQPSPPP
     LSPPPRAPPL SPGPGGCFEG GAGNCSSRGG RASDHPGGGR EFFFDRHPGV FAYVLNYYRT
     GKLHCPADVC GPLFEEELAF WGIDETDVEP CCWMTYRQHR DAEEALDIFE TPDLIGGDPG
     DDEDLAAKRL GIEDAAGLGG PDGKSGRWRR LQPRMWALFE DPYSSRAARF IAFASLFFIL
     VSITTFCLET HEAFNIVKNK TEPVINGTSV VLQYEIETDP ALTYVEGVCV VWFTFEFLVR
     IVFSPNKLEF IKNLLNIIDF VAILPFYLEV GLSGLSSKAA KDVLGFLRVV RFVRILRIFK
     LTRHFVGLRV LGHTLRASTN EFLLLIIFLA LGVLIFATMI YYAERVGAQP NDPSASEHTQ
     FKNIPIGFWW AVVTMTTLGY GDMYPQTWSG MLVGALCALA GVLTIAMPVP VIVNNFGMYY
     SLAMAKQKLP RKRKKHIPPA PQASSPTFCK TELNMACNST QSDTCLGKDN RLLEHNRSVL
     SGDDSTGSEP PLSPPERLPI RRSSTRDKNR RGETCFLLTT GDYTCASDGG IRKGYEKSRS
     LNNIAGLAGN ALRLSPVTSP YNSPCPLRRS RSPIPSIL
//
ID   KCNC3_HUMAN             Reviewed;         757 AA.
AC   Q14003;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 3.
DT   15-FEB-2017, entry version 156.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 3;
DE   AltName: Full=KSHIIID;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.3;
GN   Name=KCNC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLY-63, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Lens epithelium;
RX   PubMed=10712820; DOI=10.1006/exer.1999.0796;
RA   Rae J.L., Shepard A.R.;
RT   "Kv3.3 potassium channels in lens epithelium and corneal
RT   endothelium.";
RL   Exp. Eye Res. 70:339-348(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 291-651.
RA   Lee J.E., Garbutt J.H., Phillips K.L., Roses A.D.;
RT   "A human chromosome 19 Shaw type potassium channel gene.";
RL   Submitted (JAN-1992) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH HAX1 AND ARP3, AND
RP   DOMAIN.
RX   PubMed=26997484; DOI=10.1016/j.cell.2016.02.009;
RA   Zhang Y., Zhang X.F., Fleming M.R., Amiri A., El-Hassar L.,
RA   Surguchev A.A., Hyland C., Jenkins D.P., Desai R., Brown M.R.,
RA   Gazula V.R., Waters M.F., Large C.H., Horvath T.L., Navaratnam D.,
RA   Vaccarino F.M., Forscher P., Kaczmarek L.K.;
RT   "Kv3.3 channels bind Hax-1 and Arp2/3 to assemble a stable local actin
RT   network that regulates channel gating.";
RL   Cell 165:434-448(2016).
RN   [5]
RP   CHARACTERIZATION OF VARIANTS SCA13 HIS-420; HIS-423 AND LEU-448,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22289912; DOI=10.1113/jphysiol.2012.228205;
RA   Minassian N.A., Lin M.C., Papazian D.M.;
RT   "Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia
RT   type 13.";
RL   J. Physiol. (Lond.) 590:1599-1614(2012).
RN   [6]
RP   CHARACTERIZATION OF VARIANTS SCA13 HIS-366; HIS-420; HIS-423 AND
RP   LEU-448, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH
RP   KCNC1, AND MUTAGENESIS OF ARG-366; ARG-420 AND ARG-423.
RX   PubMed=23734863; DOI=10.1042/BJ20130034;
RA   Zhao J., Zhu J., Thornhill W.B.;
RT   "Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-
RT   histidine mutations affect both functional and protein expression on
RT   the cell surface.";
RL   Biochem. J. 454:259-265(2013).
RN   [7]
RP   CHARACTERIZATION OF VARIANTS SCA13 HIS-420 AND LEU-448, SUBCELLULAR
RP   LOCATION, AND GLYCOSYLATION.
RX   PubMed=25152487; DOI=10.1016/j.nbd.2014.08.020;
RA   Gallego-Iradi C., Bickford J.S., Khare S., Hall A., Nick J.A.,
RA   Salmasinia D., Wawrowsky K., Bannykh S., Huynh D.P.,
RA   Rincon-Limas D.E., Pulst S.M., Nick H.S., Fernandez-Funez P.,
RA   Waters M.F.;
RT   "KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar
RT   ataxia 13 displays aberrant intracellular trafficking.";
RL   Neurobiol. Dis. 71:270-279(2014).
RN   [8]
RP   VARIANTS SCA13 HIS-420 AND LEU-448, CHARACTERIZATION OF VARIANTS SCA13
RP   HIS-420 AND LEU-448, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16501573; DOI=10.1038/ng1758;
RA   Waters M.F., Minassian N.A., Stevanin G., Figueroa K.P.,
RA   Bannister J.P.A., Nolte D., Mock A.F., Evidente V.G.H., Fee D.B.,
RA   Mueller U., Duerr A., Brice A., Papazian D.M., Pulst S.M.;
RT   "Mutations in voltage-gated potassium channel KCNC3 cause degenerative
RT   and developmental nervous system phenotypes.";
RL   Nat. Genet. 38:447-451(2006).
RN   [9]
RP   VARIANTS SCA13 HIS-366; HIS-420 AND HIS-423, CHARACTERIZATION OF
RP   VARIANTS SCA13 HIS-366 AND HIS-423, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19953606; DOI=10.1002/humu.21165;
RA   Figueroa K.P., Minassian N.A., Stevanin G., Waters M., Garibyan V.,
RA   Forlani S., Strzelczyk A., Buerk K., Brice A., Duerr A.,
RA   Papazian D.M., Pulst S.M.;
RT   "KCNC3: phenotype, mutations, channel biophysics-a study of 260
RT   familial ataxia patients.";
RL   Hum. Mutat. 31:191-196(2010).
RN   [10]
RP   VARIANT SCA13 HIS-423, VARIANT ASP-263, CHARACTERIZATION OF VARIANT
RP   ASP-263, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21479265; DOI=10.1371/journal.pone.0017811;
RA   Figueroa K.P., Waters M.F., Garibyan V., Bird T.D., Gomez C.M.,
RA   Ranum L.P., Minassian N.A., Papazian D.M., Pulst S.M.;
RT   "Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia
RT   13 (SCA13).";
RL   PLoS ONE 6:E17811-E17811(2011).
RN   [11]
RP   VARIANTS SCA13 ASN-129; HIS-420; HIS-423; ASN-477; MET-535; GLY-591;
RP   SER-643; ARG-645 AND ASN-746, VARIANTS HIS-41 AND GLY-63,
RP   CHARACTERIZATION OF VARIANTS SCA13 ASN-129; HIS-420; HIS-423; ASN-477;
RP   MET-535; GLY-591; SER-643; ARG-645 AND ASN-746, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=25756792; DOI=10.1371/journal.pone.0116599;
RA   Duarri A., Nibbeling E.A., Fokkens M.R., Meijer M., Boerrigter M.,
RA   Verschuuren-Bemelmans C.C., Kremer B.P., van de Warrenburg B.P.,
RA   Dooijes D., Boddeke E., Sinke R.J., Verbeek D.S.;
RT   "Functional analysis helps to define KCNC3 mutational spectrum in
RT   dutch ataxia cases.";
RL   PLoS ONE 10:E0116599-E0116599(2015).
CC   -!- FUNCTION: Voltage-gated potassium channel that plays an important
CC       role in the rapid repolarization of fast-firing brain neurons. The
CC       channel opens in response to the voltage difference across the
CC       membrane, forming a potassium-selective channel through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient. The channel displays rapid activation and inactivation
CC       kinetics (PubMed:10712820, PubMed:26997484, PubMed:22289912,
CC       PubMed:23734863, PubMed:16501573, PubMed:19953606,
CC       PubMed:21479265, PubMed:25756792). It plays a role in the
CC       regulation of the frequency, shape and duration of action
CC       potentials in Purkinje cells. Required for normal survival of
CC       cerebellar neurons, probably via its role in regulating the
CC       duration and frequency of action potentials that in turn regulate
CC       the activity of voltage-gated Ca(2+) channels and cellular Ca(2+)
CC       homeostasis (By similarity). Required for normal motor function
CC       (PubMed:23734863, PubMed:16501573, PubMed:19953606,
CC       PubMed:21479265, PubMed:25756792). Plays a role in the
CC       reorganization of the cortical actin cytoskeleton and the
CC       formation of actin veil structures in neuronal growth cones via
CC       its interaction with HAX1 and the Arp2/3 complex
CC       (PubMed:26997484). {ECO:0000250|UniProtKB:Q63959,
CC       ECO:0000269|PubMed:10712820, ECO:0000269|PubMed:16501573,
CC       ECO:0000269|PubMed:19953606, ECO:0000269|PubMed:21479265,
CC       ECO:0000269|PubMed:22289912, ECO:0000269|PubMed:23734863,
CC       ECO:0000269|PubMed:25756792, ECO:0000269|PubMed:26997484}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with KCNC1
CC       (PubMed:23734863). Interacts (via C-terminus) with HAX1
CC       (PubMed:26997484). Identified in a complex with ACTR3, a subunit
CC       of the Arp2/3 complex; this interaction is indirect and depends on
CC       the presence of HAX1 (PubMed:26997484). Interaction with HAX1
CC       modulates channel gating (PubMed:26997484).
CC       {ECO:0000269|PubMed:23734863, ECO:0000269|PubMed:26997484}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10712820,
CC       ECO:0000269|PubMed:16501573, ECO:0000269|PubMed:19953606,
CC       ECO:0000269|PubMed:21479265, ECO:0000269|PubMed:22289912,
CC       ECO:0000269|PubMed:23734863, ECO:0000269|PubMed:25152487,
CC       ECO:0000269|PubMed:25756792, ECO:0000269|PubMed:26997484}; Multi-
CC       pass membrane protein {ECO:0000255}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:Q63959}; Multi-
CC       pass membrane protein {ECO:0000255}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63959}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63959}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q63959}. Cell projection, dendritic spine
CC       membrane {ECO:0000250|UniProtKB:Q01956}; Multi-pass membrane
CC       protein {ECO:0000255}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:26997484}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:26997484}. Note=Detected on Purkinje cell
CC       dendritic spines (By similarity). Detected at presynaptic calices
CC       of Held (By similarity). Colocalizes with the cortical actin
CC       cytoskeleton and the Arp2/3 complex (PubMed:26997484).
CC       {ECO:0000250|UniProtKB:Q01956, ECO:0000250|UniProtKB:Q63959,
CC       ECO:0000269|PubMed:26997484}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305}.
CC   -!- DOMAIN: The cytoplasmic N-terminus mediates N-type inactivation.
CC       {ECO:0000269|PubMed:26997484}.
CC   -!- DOMAIN: The C-terminal cytoplasmic tail contributes to the
CC       regulation of channel inactivation and to the interaction with
CC       HAX1 and the Arp2/3 complex. {ECO:0000269|PubMed:26997484}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25152487}.
CC   -!- DISEASE: Spinocerebellar ataxia 13 (SCA13) [MIM:605259]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA13 is an autosomal dominant cerebellar ataxia (ADCA)
CC       characterized by slow progression and variable age at onset,
CC       ranging from childhood to late adulthood. Mental retardation can
CC       be present in some patients. {ECO:0000269|PubMed:16501573,
CC       ECO:0000269|PubMed:19953606, ECO:0000269|PubMed:21479265,
CC       ECO:0000269|PubMed:22289912, ECO:0000269|PubMed:23734863,
CC       ECO:0000269|PubMed:25152487, ECO:0000269|PubMed:25756792}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw)
CC       (TC 1.A.1.2) subfamily. Kv3.3/KCNC3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF055989; AAC24118.1; -; mRNA.
DR   EMBL; AC008655; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z11585; CAA77671.1; -; Genomic_DNA.
DR   CCDS; CCDS12793.1; -.
DR   PIR; S19552; S19552.
DR   RefSeq; NP_004968.2; NM_004977.2.
DR   RefSeq; XP_006723266.1; XM_006723203.2.
DR   RefSeq; XP_011525228.1; XM_011526926.1.
DR   UniGene; Hs.467146; -.
DR   ProteinModelPortal; Q14003; -.
DR   BioGrid; 109950; 1.
DR   STRING; 9606.ENSP00000434241; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   TCDB; 1.A.1.2.13; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q14003; -.
DR   PhosphoSitePlus; Q14003; -.
DR   BioMuta; KCNC3; -.
DR   DMDM; 212276500; -.
DR   MaxQB; Q14003; -.
DR   PaxDb; Q14003; -.
DR   PeptideAtlas; Q14003; -.
DR   PRIDE; Q14003; -.
DR   DNASU; 3748; -.
DR   Ensembl; ENST00000477616; ENSP00000434241; ENSG00000131398.
DR   GeneID; 3748; -.
DR   KEGG; hsa:3748; -.
DR   UCSC; uc002pru.1; human.
DR   CTD; 3748; -.
DR   DisGeNET; 3748; -.
DR   GeneCards; KCNC3; -.
DR   GeneReviews; KCNC3; -.
DR   H-InvDB; HIX0202872; -.
DR   HGNC; HGNC:6235; KCNC3.
DR   HPA; HPA018041; -.
DR   MalaCards; KCNC3; -.
DR   MIM; 176264; gene.
DR   MIM; 605259; phenotype.
DR   neXtProt; NX_Q14003; -.
DR   OpenTargets; ENSG00000131398; -.
DR   Orphanet; 98768; Spinocerebellar ataxia type 13.
DR   PharmGKB; PA30027; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; Q14003; -.
DR   KO; K04889; -.
DR   OMA; GTWWRRW; -.
DR   OrthoDB; EOG090B0510; -.
DR   PhylomeDB; Q14003; -.
DR   TreeFam; TF352511; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNC3; human.
DR   GeneWiki; KCNC3; -.
DR   GenomeRNAi; 3748; -.
DR   PRO; PR:Q14003; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000131398; -.
DR   CleanEx; HS_KCNC3; -.
DR   ExpressionAtlas; Q14003; baseline and differential.
DR   Genevisible; Q14003; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005404; K_chnl_volt-dep_Kv3.3.
DR   InterPro; IPR021105; K_chnl_volt-dep_Kv3_ID.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11404; Potassium_chann; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01582; KV33CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Disease mutation; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Methylation; Neurodegeneration;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Spinocerebellar ataxia; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    757       Potassium voltage-gated channel subfamily
FT                                C member 3.
FT                                /FTId=PRO_0000054055.
FT   TOPO_DOM      1    290       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    291    309       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    351    370       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    371    379       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    380    398       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    412    434       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    435    447       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    448    469       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    518    539       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    540    757       Cytoplasmic. {ECO:0000305}.
FT   REGION        1     78       Important for normal N-type inactivation.
FT                                {ECO:0000269|PubMed:26997484}.
FT   MOTIF       503    508       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS     31     38       Poly-Pro.
FT   COMPBIAS     39     42       Poly-Gln.
FT   COMPBIAS     81     85       Poly-Gly.
FT   COMPBIAS    229    234       Poly-Gly.
FT   COMPBIAS    577    587       Poly-Pro.
FT   COMPBIAS    596    599       Poly-Pro.
FT   COMPBIAS    668    673       Poly-Ala.
FT   MOD_RES     625    625       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q63959}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63959}.
FT   MOD_RES     691    691       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63959}.
FT   CARBOHYD    320    320       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    483    483       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT      41     41       Q -> H (rare polymorphism;
FT                                dbSNP:rs185017345).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074192.
FT   VARIANT      63     63       D -> G (rare polymorphism;
FT                                dbSNP:rs375912738).
FT                                {ECO:0000269|PubMed:10712820,
FT                                ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074193.
FT   VARIANT     129    129       D -> N (in SCA13; unknown pathological
FT                                significance; changes channel activity;
FT                                shifts the voltage dependence of
FT                                activation).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074194.
FT   VARIANT     263    263       G -> D (rare polymorphism; changes
FT                                channel activity; activates more quickly
FT                                and deactivates more slowly).
FT                                {ECO:0000269|PubMed:21479265}.
FT                                /FTId=VAR_074195.
FT   VARIANT     366    366       R -> H (in SCA13; unknown pathological
FT                                significance; dominant negative that
FT                                decreases channel activity; decreases
FT                                protein abundance; decreases protein
FT                                stability; decreases localization to the
FT                                plasma membrane; no effect on
FT                                tetramerization; dbSNP:rs769502387).
FT                                {ECO:0000269|PubMed:19953606,
FT                                ECO:0000269|PubMed:23734863}.
FT                                /FTId=VAR_074196.
FT   VARIANT     420    420       R -> H (in SCA13; dominant negative that
FT                                induces loss of channel activity;
FT                                decreases protein abundance; decreases
FT                                protein stability; decreases localization
FT                                to the plasma membrane and alters the
FT                                localization of the wild-type protein;
FT                                impairs N-glycosylation; no effect on
FT                                tetramerization; dbSNP:rs104894699).
FT                                {ECO:0000269|PubMed:16501573,
FT                                ECO:0000269|PubMed:19953606,
FT                                ECO:0000269|PubMed:22289912,
FT                                ECO:0000269|PubMed:23734863,
FT                                ECO:0000269|PubMed:25152487,
FT                                ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_029530.
FT   VARIANT     423    423       R -> H (in SCA13; dominant negative that
FT                                reduces channel activity; alters gating;
FT                                decreases protein abundance; decreases
FT                                localization to the plasma membrane; no
FT                                effect on tetramerization;
FT                                dbSNP:rs797044872).
FT                                {ECO:0000269|PubMed:19953606,
FT                                ECO:0000269|PubMed:21479265,
FT                                ECO:0000269|PubMed:22289912,
FT                                ECO:0000269|PubMed:23734863,
FT                                ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074197.
FT   VARIANT     448    448       F -> L (in SCA13; alters gating; slows
FT                                channel closing; decreases protein
FT                                abundance; no effect on localization to
FT                                the plasma membrane; no effect on N-
FT                                glycosylation; no effect on
FT                                tetramerization; dbSNP:rs104894700).
FT                                {ECO:0000269|PubMed:16501573,
FT                                ECO:0000269|PubMed:22289912,
FT                                ECO:0000269|PubMed:23734863,
FT                                ECO:0000269|PubMed:25152487}.
FT                                /FTId=VAR_029531.
FT   VARIANT     477    477       D -> N (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity; dbSNP:rs148033381).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074198.
FT   VARIANT     535    535       V -> M (in SCA13; changes channel
FT                                activity; shifts the voltage dependence
FT                                of activation).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074199.
FT   VARIANT     591    591       S -> G (in SCA13; unknown pathological
FT                                significance; reduces channel activity;
FT                                shifts the voltage dependence of
FT                                activation; dbSNP:rs549394447).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074200.
FT   VARIANT     643    643       G -> S (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity; dbSNP:rs778523009).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074201.
FT   VARIANT     645    645       P -> R (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity). {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074202.
FT   VARIANT     746    746       D -> N (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity). {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074203.
FT   MUTAGEN       1     78       Missing: Loss of N-type inactivation.
FT                                {ECO:0000269|PubMed:26997484}.
FT   MUTAGEN     366    366       R->K,A: Decreases protein abundance.
FT                                {ECO:0000269|PubMed:23734863}.
FT   MUTAGEN     420    420       R->K,A: Decreases protein abundance.
FT                                {ECO:0000269|PubMed:23734863}.
FT   MUTAGEN     423    423       R->K,A: Decreases protein abundance.
FT                                {ECO:0000269|PubMed:23734863}.
FT   MUTAGEN     592    592       G->R: Loss of interaction with ACTR3. No
FT                                effect on voltage-dependent channel
FT                                opening or current amplitude, but
FT                                decreased rate of inactivation during
FT                                prolonged depolarization.
FT                                {ECO:0000269|PubMed:26997484}.
SQ   SEQUENCE   757 AA;  80578 MW;  B44306B850DFD797 CRC64;
     MLSSVCVSSF RGRQGASKQQ PAPPPQPPES PPPPPLPPQQ QQPAQPGPAA SPAGPPAPRG
     PGDRRAEPCP GLPAAAMGRH GGGGGDSGKI VINVGGVRHE TYRSTLRTLP GTRLAGLTEP
     EAAARFDYDP GADEFFFDRH PGVFAYVLNY YRTGKLHCPA DVCGPLFEEE LGFWGIDETD
     VEACCWMTYR QHRDAEEALD SFEAPDPAGA ANAANAAGAH DGGLDDEAGA GGGGLDGAGG
     ELKRLCFQDA GGGAGGPPGG AGGAGGTWWR RWQPRVWALF EDPYSSRAAR YVAFASLFFI
     LISITTFCLE THEGFIHISN KTVTQASPIP GAPPENITNV EVETEPFLTY VEGVCVVWFT
     FEFLMRITFC PDKVEFLKSS LNIIDCVAIL PFYLEVGLSG LSSKAAKDVL GFLRVVRFVR
     ILRIFKLTRH FVGLRVLGHT LRASTNEFLL LIIFLALGVL IFATMIYYAE RIGADPDDIL
     GSNHTYFKNI PIGFWWAVVT MTTLGYGDMY PKTWSGMLVG ALCALAGVLT IAMPVPVIVN
     NFGMYYSLAM AKQKLPKKKN KHIPRPPQPG SPNYCKPDPP PPPPPHPHHG SGGISPPPPI
     TPPSMGVTVA GAYPAGPHTH PGLLRGGAGG LGIMGLPPLP APGEPCPLAQ EEVIEINRAD
     PRPNGDPAAA ALAHEDCPAI DQPAMSPEDK SPITPGSRGR YSRDRACFLL TDYAPSPDGS
     IRKATGAPPL PPQDWRKPGP PSFLPDLNAN AAAWISP
//
ID   KCNC4_HUMAN             Reviewed;         635 AA.
AC   Q03721; Q3MIM4; Q5TBI6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 2.
DT   15-FEB-2017, entry version 153.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 4;
DE   AltName: Full=KSHIIIC;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.4;
GN   Name=KCNC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=1381835; DOI=10.1098/rspb.1992.0036;
RA   de Miera E.V.-S., Moreno H., Fruhling D., Kentros C., Rudy B.;
RT   "Cloning of ShIII (Shaw-like) cDNAs encoding a novel high-voltage-
RT   activating, TEA-sensitive, type-A K+ channel.";
RL   Proc. R. Soc. B 248:9-18(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 166-635 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION AT SER-15 AND SER-21, AND MUTAGENESIS OF SER-15 AND
RP   SER-21.
RX   PubMed=7993631; DOI=10.1016/0896-6273(94)90425-1;
RA   Covarrubias M., Wei A., Salkoff L., Vyas T.B.;
RT   "Elimination of rapid potassium channel inactivation by
RT   phosphorylation of the inactivation gate.";
RL   Neuron 13:1403-1412(1994).
RN   [5]
RP   PHOSPHORYLATION AT SER-8 AND SER-9, AND MUTAGENESIS OF SER-8; SER-9;
RP   SER-15 AND SER-21.
RX   PubMed=9649584; DOI=10.1085/jgp.112.1.71;
RA   Beck E.J., Sorensen R.G., Slater S.J., Covarrubias M.;
RT   "Interactions between multiple phosphorylation sites in the
RT   inactivation particle of a K+ channel. Insights into the molecular
RT   mechanism of protein kinase C action.";
RL   J. Gen. Physiol. 112:71-84(1998).
RN   [6]
RP   STRUCTURE BY NMR OF 1-30.
RX   PubMed=9000078; DOI=10.1038/385272a0;
RA   Antz C., Geyer M., Fakler B., Schott M.K., Guy H.R., Frank R.,
RA   Ruppersberg J.P., Kalbitzer H.R.;
RT   "NMR structure of inactivation gates from mammalian voltage-dependent
RT   potassium channels.";
RL   Nature 385:272-275(1997).
RN   [7]
RP   STRUCTURE BY NMR OF 1-30.
RX   PubMed=10048926; DOI=10.1038/5833;
RA   Antz C., Bauer T., Kalbacher H., Frank R., Covarrubias M.,
RA   Kalbitzer H.R., Ruppersberg J.P., Baukrowitz T., Fakler B.;
RT   "Control of K+ channel gating by protein phosphorylation: structural
RT   switches of the inactivation gate.";
RL   Nat. Struct. Biol. 6:146-150(1999).
CC   -!- FUNCTION: This protein mediates the voltage-dependent potassium
CC       ion permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient.
CC   -!- SUBUNIT: Homotetramer (Probable). Heterotetramer of potassium
CC       channel proteins (By similarity). {ECO:0000250, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q03721-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q03721-2; Sequence=VSP_020581, VSP_020582;
CC         Note=Could be a cloning artifact.;
CC       Name=3;
CC         IsoId=Q03721-3; Sequence=VSP_040033;
CC         Note=Gene prediction based on EST data.;
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DOMAIN: The tail may be important in modulation of channel
CC       activity and/or targeting of the channel to specific subcellular
CC       compartments.
CC   -!- PTM: Phosphorylation of serine residues in the inactivation gate
CC       inhibits rapid channel closure. {ECO:0000269|PubMed:7993631,
CC       ECO:0000269|PubMed:9649584}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw)
CC       (TC 1.A.1.2) subfamily. Kv3.4/KCNC4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64676; AAA57263.1; -; mRNA.
DR   EMBL; AL137790; CAI18831.1; -; Genomic_DNA.
DR   EMBL; BC019010; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC101769; AAI01770.1; -; mRNA.
DR   CCDS; CCDS44193.1; -. [Q03721-3]
DR   CCDS; CCDS821.1; -. [Q03721-1]
DR   RefSeq; NP_001034663.1; NM_001039574.2. [Q03721-3]
DR   RefSeq; NP_004969.2; NM_004978.4. [Q03721-1]
DR   UniGene; Hs.153521; -.
DR   PDB; 1B4G; NMR; -; A=1-30.
DR   PDB; 1B4I; NMR; -; A=1-30.
DR   PDB; 1ZTN; NMR; -; A=1-30.
DR   PDBsum; 1B4G; -.
DR   PDBsum; 1B4I; -.
DR   PDBsum; 1ZTN; -.
DR   ProteinModelPortal; Q03721; -.
DR   SMR; Q03721; -.
DR   BioGrid; 109951; 27.
DR   IntAct; Q03721; 1.
DR   STRING; 9606.ENSP00000358802; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q03721; -.
DR   PhosphoSitePlus; Q03721; -.
DR   BioMuta; KCNC4; -.
DR   DMDM; 66774206; -.
DR   PaxDb; Q03721; -.
DR   PeptideAtlas; Q03721; -.
DR   PRIDE; Q03721; -.
DR   TopDownProteomics; Q03721-3; -. [Q03721-3]
DR   Ensembl; ENST00000369787; ENSP00000358802; ENSG00000116396. [Q03721-1]
DR   Ensembl; ENST00000438661; ENSP00000393655; ENSG00000116396. [Q03721-3]
DR   Ensembl; ENST00000469655; ENSP00000436656; ENSG00000116396. [Q03721-1]
DR   GeneID; 3749; -.
DR   KEGG; hsa:3749; -.
DR   UCSC; uc001dzg.4; human. [Q03721-1]
DR   CTD; 3749; -.
DR   DisGeNET; 3749; -.
DR   GeneCards; KCNC4; -.
DR   H-InvDB; HIX0023584; -.
DR   HGNC; HGNC:6236; KCNC4.
DR   HPA; HPA014740; -.
DR   MIM; 176265; gene.
DR   neXtProt; NX_Q03721; -.
DR   OpenTargets; ENSG00000116396; -.
DR   PharmGKB; PA30028; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; Q03721; -.
DR   KO; K04890; -.
DR   OMA; GCEFFFD; -.
DR   OrthoDB; EOG090B0510; -.
DR   PhylomeDB; Q03721; -.
DR   TreeFam; TF352511; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   SIGNOR; Q03721; -.
DR   EvolutionaryTrace; Q03721; -.
DR   GeneWiki; KCNC4; -.
DR   GenomeRNAi; 3749; -.
DR   PRO; PR:Q03721; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116396; -.
DR   CleanEx; HS_KCNC4; -.
DR   ExpressionAtlas; Q03721; baseline and differential.
DR   Genevisible; Q03721; HS.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005405; K_chnl_volt-dep_Kv3.4.
DR   InterPro; IPR021105; K_chnl_volt-dep_Kv3_ID.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11404; Potassium_chann; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01583; KV34CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    635       Potassium voltage-gated channel subfamily
FT                                C member 4.
FT                                /FTId=PRO_0000054058.
FT   TOPO_DOM      1    226       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    299    312       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    345    364       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    365    380       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    452    472       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    473    635       Cytoplasmic. {ECO:0000255}.
FT   REGION        1     28       Inactivation gate.
FT   MOTIF       436    441       Selectivity filter. {ECO:0000250}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000269|PubMed:9649584}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000269|PubMed:9649584}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000269|PubMed:7993631}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000269|PubMed:7993631}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     539    582       DSKQNGDANAVLSDEEGAGLTQPLASSPTPEERRALRRSTT
FT                                RDR -> GEIRGWEGKSLFPQWPREFPNGPQTLGFGMCFVW
FT                                GFPKHKDVPL (in isoform 2).
FT                                {ECO:0000303|PubMed:1381835,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020581.
FT   VAR_SEQ     583    635       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1381835,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020582.
FT   VAR_SEQ     607    635       GTFVLRDLPLQHSPEAACPPTAGTLFLPH -> ETCQDALS
FT                                SNYAQAEVLTLS (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_040033.
FT   VARIANT     318    318       D -> Y (in dbSNP:rs35167146).
FT                                /FTId=VAR_034051.
FT   VARIANT     516    516       R -> Q (in dbSNP:rs59123361).
FT                                /FTId=VAR_062185.
FT   VARIANT     520    520       C -> Y (in dbSNP:rs12411176).
FT                                /FTId=VAR_027505.
FT   MUTAGEN       8      8       S->A: Decreased inhibition of channel
FT                                closure by PKC. Inhibition of channel
FT                                closure is nearly abolished; when
FT                                associated with A-9.
FT                                {ECO:0000269|PubMed:9649584}.
FT   MUTAGEN       8      8       S->D: Decreased rate of channel
FT                                inactivation. Loss of channel
FT                                inactivation; when associated with D-9;
FT                                D-15 and D-21.
FT                                {ECO:0000269|PubMed:9649584}.
FT   MUTAGEN       9      9       S->A: Strong decrease of inhibition of
FT                                channel closure by PKC. Inhibition of
FT                                channel closure is nearly abolished; when
FT                                associated with A-8.
FT                                {ECO:0000269|PubMed:9649584}.
FT   MUTAGEN       9      9       S->D: Decreased rate of channel
FT                                inactivation. Loss of channel
FT                                inactivation; when associated with D-8;
FT                                D-15 and D-21.
FT                                {ECO:0000269|PubMed:9649584}.
FT   MUTAGEN      15     15       S->A: Decreased inhibition of channel
FT                                closure by PKC.
FT                                {ECO:0000269|PubMed:7993631,
FT                                ECO:0000269|PubMed:9649584}.
FT   MUTAGEN      15     15       S->D: Slightly decreased rate of channel
FT                                inactivation. Loss of channel
FT                                inactivation; when associated with D-8;
FT                                D-9 and D-21.
FT                                {ECO:0000269|PubMed:7993631,
FT                                ECO:0000269|PubMed:9649584}.
FT   MUTAGEN      21     21       S->A: Decreased inhibition of channel
FT                                closure by PKC.
FT                                {ECO:0000269|PubMed:7993631,
FT                                ECO:0000269|PubMed:9649584}.
FT   MUTAGEN      21     21       S->D: Slightly decreased rate of channel
FT                                inactivation. Loss of channel
FT                                inactivation; when associated with D-8;
FT                                D-9 and D-15.
FT                                {ECO:0000269|PubMed:7993631,
FT                                ECO:0000269|PubMed:9649584}.
FT   CONFLICT     86     86       S -> T (in Ref. 1; AAA57263).
FT                                {ECO:0000305}.
FT   CONFLICT    351    351       F -> I (in Ref. 1; AAA57263).
FT                                {ECO:0000305}.
FT   TURN          3      5       {ECO:0000244|PDB:1B4G}.
FT   STRAND       14     16       {ECO:0000244|PDB:1B4G}.
FT   STRAND       19     21       {ECO:0000244|PDB:1B4I}.
FT   TURN         26     29       {ECO:0000244|PDB:1ZTN}.
SQ   SEQUENCE   635 AA;  69767 MW;  8A36F0A16AD17722 CRC64;
     MISSVCVSSY RGRKSGNKPP SKTCLKEEMA KGEASEKIII NVGGTRHETY RSTLRTLPGT
     RLAWLADPDG GGRPETDGGG VGSSGSSGGG GCEFFFDRHP GVFAYVLNYY RTGKLHCPAD
     VCGPLFEEEL TFWGIDETDV EPCCWMTYRQ HRDAEEALDI FESPDGGGSG AGPSDEAGDD
     ERELALQRLG PHEGGAGHGA GSGGCRGWQP RMWALFEDPY SSRAARVVAF ASLFFILVSI
     TTFCLETHEA FNIDRNVTEI LRVGNITSVH FRREVETEPI LTYIEGVCVL WFTLEFLVRI
     VCCPDTLDFV KNLLNIIDFV AILPFYLEVG LSGLSSKAAR DVLGFLRVVR FVRILRIFKL
     TRHFVGLRVL GHTLRASTNE FLLLIIFLAL GVLIFATMIY YAERIGARPS DPRGNDHTDF
     KNIPIGFWWA VVTMTTLGYG DMYPKTWSGM LVGALCALAG VLTIAMPVPV IVNNFGMYYS
     LAMAKQKLPK KRKKHVPRPA QLESPMYCKS EETSPRDSTC SDTSPPAREE GMIERKRADS
     KQNGDANAVL SDEEGAGLTQ PLASSPTPEE RRALRRSTTR DRNKKAAACF LLSTGDYACA
     DGSVRKGTFV LRDLPLQHSP EAACPPTAGT LFLPH
//
ID   KCND1_HUMAN             Reviewed;         647 AA.
AC   Q9NSA2; A6NEF1; B2RCG0; O75671;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2003, sequence version 2.
DT   15-FEB-2017, entry version 143.
DE   RecName: Full=Potassium voltage-gated channel subfamily D member 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.1;
GN   Name=KCND1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=10729221; DOI=10.1006/geno.2000.6117;
RA   Isbrandt D., Leicher T., Waldschuetz R., Zhu X.-R., Luhmann U.,
RA   Michel U., Sauter K., Pongs O.;
RT   "Gene structures and expression profiles of three human KCND (Kv4)
RT   potassium channels mediating A-type currents I(TO) and I(SA).";
RL   Genomics 64:144-154(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Makita N., Shirai N., Sawa H., Sasaki K., Nagashima K., Yoshida M.C.,
RA   Kitabatake A.;
RT   "Homo sapiens mRNA for shal-type potassium channel KCND1 (Kv4.1).";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Strom T.M., Nyakatura G., Hellebrand H., Drescher B., Rosenthal A.,
RA   Meindl A.;
RT   "Transcription map in Xp11.23.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH DPP10.
RX   PubMed=15454437; DOI=10.1529/biophysj.104.042358;
RA   Jerng H.H., Qian Y., Pfaffinger P.J.;
RT   "Modulation of Kv4.2 channel expression and gating by dipeptidyl
RT   peptidase 10 (DPP10).";
RL   Biophys. J. 87:2380-2396(2004).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated rapidly
CC       inactivating A-type potassium channels. May contribute to I(To)
CC       current in heart and I(Sa) current in neurons. Channel properties
CC       are modulated by interactions with other alpha subunits and with
CC       regulatory subunits.
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND2 and/or KCND3.
CC       Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and
CC       KCNIP4 (By similarity). Interacts with DPP10 (Probable).
CC       {ECO:0000250, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       projection, dendrite {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NSA2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NSA2-2; Sequence=VSP_057040;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in brain,
CC       in particular in cerebellum and thalamus; detected at lower levels
CC       in the other parts of the brain. {ECO:0000269|PubMed:10729221}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal)
CC       (TC 1.A.1.2) subfamily. Kv4.1/KCND1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF166003; AAF65516.1; -; mRNA.
DR   EMBL; AF166006; AAF65617.1; -; Genomic_DNA.
DR   EMBL; AF166004; AAF65617.1; JOINED; Genomic_DNA.
DR   EMBL; AF166005; AAF65617.1; JOINED; Genomic_DNA.
DR   EMBL; AB021865; BAA96454.1; -; mRNA.
DR   EMBL; AJ005898; CAA06755.1; -; mRNA.
DR   EMBL; AK094431; BAG52865.1; -; mRNA.
DR   EMBL; AK315092; BAG37557.1; -; mRNA.
DR   EMBL; AF207550; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471224; EAW50720.1; -; Genomic_DNA.
DR   EMBL; CH471224; EAW50721.1; -; Genomic_DNA.
DR   EMBL; BC045659; AAH45659.1; -; mRNA.
DR   CCDS; CCDS14314.1; -. [Q9NSA2-1]
DR   RefSeq; NP_004970.3; NM_004979.5. [Q9NSA2-1]
DR   RefSeq; XP_011542212.1; XM_011543910.2. [Q9NSA2-1]
DR   UniGene; Hs.55276; -.
DR   ProteinModelPortal; Q9NSA2; -.
DR   SMR; Q9NSA2; -.
DR   STRING; 9606.ENSP00000218176; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 552; -.
DR   iPTMnet; Q9NSA2; -.
DR   PhosphoSitePlus; Q9NSA2; -.
DR   BioMuta; KCND1; -.
DR   DMDM; 38258256; -.
DR   PaxDb; Q9NSA2; -.
DR   PeptideAtlas; Q9NSA2; -.
DR   PRIDE; Q9NSA2; -.
DR   DNASU; 3750; -.
DR   Ensembl; ENST00000218176; ENSP00000218176; ENSG00000102057. [Q9NSA2-1]
DR   Ensembl; ENST00000376477; ENSP00000365660; ENSG00000102057. [Q9NSA2-2]
DR   GeneID; 3750; -.
DR   KEGG; hsa:3750; -.
DR   UCSC; uc004dlw.1; human. [Q9NSA2-1]
DR   CTD; 3750; -.
DR   GeneCards; KCND1; -.
DR   HGNC; HGNC:6237; KCND1.
DR   HPA; HPA000524; -.
DR   HPA; HPA001066; -.
DR   MIM; 300281; gene.
DR   neXtProt; NX_Q9NSA2; -.
DR   OpenTargets; ENSG00000102057; -.
DR   PharmGKB; PA30029; -.
DR   eggNOG; KOG4390; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231013; -.
DR   HOVERGEN; HBG106687; -.
DR   InParanoid; Q9NSA2; -.
DR   KO; K04891; -.
DR   OMA; PREQPCG; -.
DR   OrthoDB; EOG090B07GO; -.
DR   PhylomeDB; Q9NSA2; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   GeneWiki; KCND1; -.
DR   GenomeRNAi; 3750; -.
DR   PRO; PR:Q9NSA2; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102057; -.
DR   CleanEx; HS_KCND1; -.
DR   ExpressionAtlas; Q9NSA2; baseline and differential.
DR   Genevisible; Q9NSA2; HS.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004054; K_chnl_volt-dep_Kv4.1.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01516; KV41CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel; Zinc.
FT   CHAIN         1    647       Potassium voltage-gated channel subfamily
FT                                D member 1.
FT                                /FTId=PRO_0000054061.
FT   TOPO_DOM      1    184       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    185    205       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    248    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    313    325       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    365    385       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    387    407       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    408    647       Cytoplasmic. {ECO:0000255}.
FT   REGION        2     20       Interaction with KCNIP2. {ECO:0000250}.
FT   REGION      474    489       Mediates dendritic targeting.
FT                                {ECO:0000250}.
FT   MOTIF       372    377       Selectivity filter. {ECO:0000250}.
FT   METAL       104    104       Zinc. {ECO:0000250}.
FT   METAL       131    131       Zinc. {ECO:0000250}.
FT   METAL       132    132       Zinc. {ECO:0000250}.
FT   MOD_RES     458    458       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03719}.
FT   MOD_RES     555    555       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62897}.
FT   CARBOHYD    352    352       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ       1    377       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057040.
FT   CONFLICT    358    358       S -> N (in Ref. 2; BAA96454).
FT                                {ECO:0000305}.
FT   CONFLICT    406    406       V -> I (in Ref. 2; BAA96454).
FT                                {ECO:0000305}.
SQ   SEQUENCE   647 AA;  71330 MW;  8672C299CDB7C5AA CRC64;
     MAAGLATWLP FARAAAVGWL PLAQQPLPPA PGVKASRGDE VLVVNVSGRR FETWKNTLDR
     YPDTLLGSSE KEFFYDADSG EYFFDRDPDM FRHVLNFYRT GRLHCPRQEC IQAFDEELAF
     YGLVPELVGD CCLEEYRDRK KENAERLAED EEAEQAGDGP ALPAGSSLRQ RLWRAFENPH
     TSTAALVFYY VTGFFIAVSV IANVVETIPC RGSARRSSRE QPCGERFPQA FFCMDTACVL
     IFTGEYLLRL FAAPSRCRFL RSVMSLIDVV AILPYYIGLL VPKNDDVSGA FVTLRVFRVF
     RIFKFSRHSQ GLRILGYTLK SCASELGFLL FSLTMAIIIF ATVMFYAEKG TNKTNFTSIP
     AAFWYTIVTM TTLGYGDMVP STIAGKIFGS ICSLSGVLVI ALPVPVIVSN FSRIYHQNQR
     ADKRRAQQKV RLARIRLAKS GTTNAFLQYK QNGGLEDSGS GEEQALCVRN RSAFEQQHHH
     LLHCLEKTTC HEFTDELTFS EALGAVSPGG RTSRSTSVSS QPVGPGSLLS SCCPRRAKRR
     AIRLANSTAS VSRGSMQELD MLAGLRRSHA PQSRSSLNAK PHDSLDLNCD SRDFVAAIIS
     IPTPPANTPD ESQPSSPGGG GRAGSTLRNS SLGTPCLFPE TVKISSL
//
ID   KCND2_HUMAN             Reviewed;         630 AA.
AC   Q9NZV8; O95012; O95021; Q2TBD3; Q9UBY7; Q9UN98; Q9UNH9;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2003, sequence version 2.
DT   15-FEB-2017, entry version 156.
DE   RecName: Full=Potassium voltage-gated channel subfamily D member 2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.2;
GN   Name=KCND2; Synonyms=KIAA1044;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9843794;
RA   Kong W., Po S., Yamagishi T., Ashen M.D., Stetten G., Tomaselli G.F.;
RT   "Isolation and characterization of the human gene encoding Ito:
RT   further diversity by alternative mRNA splicing.";
RL   Am. J. Physiol. 275:H1963-H1970(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=10551270;
RA   Zhu X.-R., Wulf A., Schwarz M., Isbrandt D., Pongs O.;
RT   "Characterization of human Kv4.2 mediating a rapidly-inactivating
RT   transient voltage-sensitive K+ current.";
RL   Recept. Channels 6:387-400(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=10729221; DOI=10.1006/geno.2000.6117;
RA   Isbrandt D., Leicher T., Waldschuetz R., Zhu X.-R., Luhmann U.,
RA   Michel U., Sauter K., Pongs O.;
RT   "Gene structures and expression profiles of three human KCND (Kv4)
RT   potassium channels mediating A-type currents I(TO) and I(SA).";
RL   Genomics 64:144-154(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MUTAGENESIS OF 601-PRO--PRO-604, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH FLNA AND FLNC.
RX   PubMed=11102480;
RA   Petrecca K., Miller D.M., Shrier A.;
RT   "Localization and enhanced current density of the Kv4.2 potassium
RT   channel by interaction with the actin-binding protein filamin.";
RL   J. Neurosci. 20:8736-8744(2000).
RN   [8]
RP   INTERACTION WITH KCNIP1.
RX   PubMed=10676964; DOI=10.1038/35000592;
RA   An W.F., Bowlby M.R., Betty M., Cao J., Ling H.-P., Mendoza G.,
RA   Hinson J.W., Mattsson K.I., Strassle B.W., Trimmer J.S., Rhodes K.J.;
RT   "Modulation of A-type potassium channels by a family of calcium
RT   sensors.";
RL   Nature 403:553-556(2000).
RN   [9]
RP   INTERACTION WITH KCNIP2.
RX   PubMed=11287421; DOI=10.1074/jbc.M101320200;
RA   Baehring R., Dannenberg J., Peters H.C., Leicher T., Pongs O.,
RA   Isbrandt D.;
RT   "Conserved Kv4 N-terminal domain critical for effects of Kv channel-
RT   interacting protein 2.2 on channel expression and gating.";
RL   J. Biol. Chem. 276:23888-23894(2001).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   DOMAIN.
RX   PubMed=11507158; DOI=10.1111/j.1469-7793.2001.00065.x;
RA   Baehring R., Boland L.M., Varghese A., Gebauer M., Pongs O.;
RT   "Kinetic analysis of open- and closed-state inactivation transitions
RT   in human Kv4.2 A-type potassium channels.";
RL   J. Physiol. (Lond.) 535:65-81(2001).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=12395204; DOI=10.1007/s00395-002-0377-4;
RA   Bertaso F., Sharpe C.C., Hendry B.M., James A.F.;
RT   "Expression of voltage-gated K+ channels in human atrium.";
RL   Basic Res. Cardiol. 97:424-433(2002).
RN   [12]
RP   INTERACTION WITH KCNIP4.
RX   PubMed=11847232; DOI=10.1074/jbc.M200897200;
RA   Morohashi Y., Hatano N., Ohya S., Takikawa R., Watabiki T.,
RA   Takasugi N., Imaizumi Y., Tomita T., Iwatsubo T.;
RT   "Molecular cloning and characterization of CALP/KChIP4, a novel EF-
RT   hand protein interacting with presenilin 2 and voltage-gated potassium
RT   channel subunit Kv4.";
RL   J. Biol. Chem. 277:14965-14975(2002).
RN   [13]
RP   INTERACTION WITH KCNIP3.
RX   PubMed=12451113;
RA   Schrader L.A., Anderson A.E., Mayne A., Pfaffinger P.J., Sweatt J.D.;
RT   "PKA modulation of Kv4.2-encoded A-type potassium channels requires
RT   formation of a supramolecular complex.";
RL   J. Neurosci. 22:10123-10133(2002).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=14695263; DOI=10.1016/S0006-3495(04)74097-7;
RA   Gebauer M., Isbrandt D., Sauter K., Callsen B., Nolting A., Pongs O.,
RA   Baehring R.;
RT   "N-type inactivation features of Kv4.2 channel gating.";
RL   Biophys. J. 86:210-223(2004).
RN   [15]
RP   FUNCTION, INTERACTION WITH DPP10 AND DPP6, AND SUBCELLULAR LOCATION.
RX   PubMed=15454437; DOI=10.1529/biophysj.104.042358;
RA   Jerng H.H., Qian Y., Pfaffinger P.J.;
RT   "Modulation of Kv4.2 channel expression and gating by dipeptidyl
RT   peptidase 10 (DPP10).";
RL   Biophys. J. 87:2380-2396(2004).
RN   [16]
RP   INTERACTION WITH KCNIP1 AND KCNIP2, SUBUNIT, AND DOMAIN.
RX   PubMed=15358149; DOI=10.1016/j.bbrc.2004.07.006;
RA   Lin Y.-L., Chen C.Y., Cheng C.P., Chang L.S.;
RT   "Protein-protein interactions of KChIP proteins and Kv4.2.";
RL   Biochem. Biophys. Res. Commun. 321:606-610(2004).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, DOMAIN, AND ROLE IN DISEASE.
RX   PubMed=16934482; DOI=10.1016/j.nbd.2006.07.001;
RA   Singh B., Ogiwara I., Kaneda M., Tokonami N., Mazaki E., Baba K.,
RA   Matsuda K., Inoue Y., Yamakawa K.;
RT   "A Kv4.2 truncation mutation in a patient with temporal lobe
RT   epilepsy.";
RL   Neurobiol. Dis. 24:245-253(2006).
RN   [18]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [19]
RP   REVIEW.
RX   PubMed=18357523; DOI=10.1007/s11064-008-9650-8;
RA   Covarrubias M., Bhattacharji A., De Santiago-Castillo J.A.,
RA   Dougherty K., Kaulin Y.A., Na-Phuket T.R., Wang G.;
RT   "The neuronal Kv4 channel complex.";
RL   Neurochem. Res. 33:1558-1567(2008).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND MUTAGENESIS OF GLY-309;
RP   ARG-311; ILE-312; LEU-313; GLY-314; TYR-315; THR-316; LEU-317;
RP   LYS-318; SER-319; CYS-320; SER-322; GLU-323; LEU-324; LEU-327;
RP   LEU-328; VAL-397; ILE-398; ALA-399; PRO-401; 402-VAL--VAL-404;
RP   PRO-403; ILE-405; VAL-406; SER-407; ASN-408 AND PHE-409.
RX   PubMed=19171772; DOI=10.1085/jgp.200810073;
RA   Barghaan J., Baehring R.;
RT   "Dynamic coupling of voltage sensor and gate involved in closed-state
RT   inactivation of Kv4.2 channels.";
RL   J. Gen. Physiol. 133:205-224(2009).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH KCNIP4.
RX   PubMed=24811166; DOI=10.1074/jbc.M114.563452;
RA   Kitazawa M., Kubo Y., Nakajo K.;
RT   "The stoichiometry and biophysical properties of the Kv4 potassium
RT   channel complex with K+ channel-interacting protein (KChIP) subunits
RT   are variable, depending on the relative expression level.";
RL   J. Biol. Chem. 289:17597-17609(2014).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (21 ANGSTROMS) OF THE KCND2-KCNIP2
RP   COMPLEX, FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=14980201; DOI=10.1016/S0896-6273(04)00050-9;
RA   Kim L.A., Furst J., Gutierrez D., Butler M.H., Xu S., Goldstein S.A.,
RA   Grigorieff N.;
RT   "Three-dimensional structure of I(to); Kv4.2-KChIP2 ion channels by
RT   electron microscopy at 21 Angstrom resolution.";
RL   Neuron 41:513-519(2004).
RN   [23]
RP   INTERACTION WITH KCNIP2, FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=14623880; DOI=10.1074/jbc.M311332200;
RA   Kim L.A., Furst J., Butler M.H., Xu S., Grigorieff N., Goldstein S.A.;
RT   "Ito channels are octameric complexes with four subunits of each Kv4.2
RT   and K+ channel-interacting protein 2.";
RL   J. Biol. Chem. 279:5549-5554(2004).
RN   [24]
RP   TISSUE SPECIFICITY.
RX   PubMed=15991246; DOI=10.1002/jcp.20453;
RA   Kunz L., Ramsch R., Krieger A., Young K.A., Dissen G.A.,
RA   Stouffer R.L., Ojeda S.R., Mayerhofer A.;
RT   "Voltage-dependent K+ channel acts as sex steroid sensor in endocrine
RT   cells of the human ovary.";
RL   J. Cell. Physiol. 206:167-174(2006).
RN   [25]
RP   INTERACTION WITH KCNIP1.
RX   PubMed=14980207; DOI=10.1016/S0896-6273(04)00049-2;
RA   Scannevin R.H., Wang K., Jow F., Megules J., Kopsco D.C., Edris W.,
RA   Carroll K.C., Lu Q., Xu W., Xu Z., Katz A.H., Olland S., Lin L.,
RA   Taylor M., Stahl M., Malakian K., Somers W., Mosyak L., Bowlby M.R.,
RA   Chanda P., Rhodes K.J.;
RT   "Two N-terminal domains of Kv4 K(+) channels regulate binding to and
RT   modulation by KChIP1.";
RL   Neuron 41:587-598(2004).
RN   [26]
RP   INTERACTION WITH DLG1.
RX   PubMed=19213956; DOI=10.1161/CIRCRESAHA.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [27]
RP   VARIANT MET-404, CHARACTERIZATION OF VARIANT MET-404, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24501278; DOI=10.1093/hmg/ddu056;
RA   Lee H., Lin M.C., Kornblum H.I., Papazian D.M., Nelson S.F.;
RT   "Exome sequencing identifies de novo gain of function missense
RT   mutation in KCND2 in identical twins with autism and seizures that
RT   slows potassium channel inactivation.";
RL   Hum. Mol. Genet. 23:3481-3489(2014).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain. Mediates the major part of the dendritic
CC       A-type current I(SA) in brain neurons (By similarity). This
CC       current is activated at membrane potentials that are below the
CC       threshold for action potentials. It regulates neuronal
CC       excitability, prolongs the latency before the first spike in a
CC       series of action potentials, regulates the frequency of repetitive
CC       action potential firing, shortens the duration of action
CC       potentials and regulates the back-propagation of action potentials
CC       from the neuronal cell body to the dendrites. Contributes to the
CC       regulation of the circadian rhythm of action potential firing in
CC       suprachiasmatic nucleus neurons, which regulates the circadian
CC       rhythm of locomotor activity (By similarity). Functions downstream
CC       of the metabotropic glutamate receptor GRM5 and plays a role in
CC       neuronal excitability and in nociception mediated by activation of
CC       GRM5 (By similarity). Mediates the transient outward current I(to)
CC       in rodent heart left ventricle apex cells, but not in human heart,
CC       where this current is mediated by another family member. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient
CC       (PubMed:10551270, PubMed:15454437, PubMed:14695263,
CC       PubMed:14623880, PubMed:14980201, PubMed:16934482,
CC       PubMed:24811166, PubMed:24501278). The channel alternates between
CC       opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:11507158). Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCND2 and KCND3; channel
CC       properties depend on the type of pore-forming alpha subunits that
CC       are part of the channel. In vivo, membranes probably contain a
CC       mixture of heteromeric potassium channel complexes. Interaction
CC       with specific isoforms of the regulatory subunits KCNIP1, KCNIP2,
CC       KCNIP3 or KCNIP4 strongly increases expression at the cell surface
CC       and thereby increases channel activity; it modulates the kinetics
CC       of channel activation and inactivation, shifts the threshold for
CC       channel activation to more negative voltage values, shifts the
CC       threshold for inactivation to less negative voltages and
CC       accelerates recovery after inactivation (PubMed:15454437,
CC       PubMed:14623880, PubMed:14980201, PubMed:19171772,
CC       PubMed:24501278, PubMed:24811166). Likewise, interaction with DPP6
CC       or DPP10 promotes expression at the cell membrane and regulates
CC       both channel characteristics and activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q63881, ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:10551270, ECO:0000269|PubMed:10729221,
CC       ECO:0000269|PubMed:11507158, ECO:0000269|PubMed:14623880,
CC       ECO:0000269|PubMed:14695263, ECO:0000269|PubMed:14980201,
CC       ECO:0000269|PubMed:15454437, ECO:0000269|PubMed:16934482,
CC       ECO:0000269|PubMed:19171772, ECO:0000269|PubMed:24501278,
CC       ECO:0000269|PubMed:24811166}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels activate rapidly, i.e within a few
CC         msec. After that, they inactivate rapidly, i.e within about 50-
CC         100 msec. The voltage-dependence of activation and inactivation
CC         and other channel characteristics vary depending on the
CC         experimental conditions, the expression system and the presence
CC         or absence of ancillary subunits. Homotetrameric channels have a
CC         unitary conductance of about 4 pS when expressed in a
CC         heterologous system. For the activation of homotetrameric
CC         channels expressed in xenopus oocytes, the voltage at half-
CC         maximal amplitude is about -10 mV. The time constant for
CC         inactivation is about 20 msec. For inactivation, the voltage at
CC         half-maximal amplitude is -62 mV. The time constant for recovery
CC         after inactivation is about 70 msec.
CC         {ECO:0000305|PubMed:11507158, ECO:0000305|PubMed:17917103};
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND1 or KCND3
CC       (PubMed:14980201, PubMed:16934482, PubMed:24811166). Associates
CC       with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and KCNIP4
CC       (PubMed:10676964, PubMed:11287421, PubMed:11847232,
CC       PubMed:12451113, PubMed:15358149, PubMed:14623880,
CC       PubMed:14980201, PubMed:14980207, PubMed:24811166). In vivo,
CC       probably exists as heteromeric complex containing variable
CC       proportions of KCND1, KCND2, KCND3, KCNIP1, KCNIP2, KCNIP3,
CC       KCNIP4, DPP6 and DPP10 (PubMed:19171772). The tetrameric channel
CC       can associate with up to four regulatory subunits, such as KCNIP2
CC       or KCNIP4 (PubMed:14623880, PubMed:14980201, PubMed:24811166).
CC       Interaction with four KCNIP4 chains does not reduce interaction
CC       with DPP10 (PubMed:24811166). Interacts with DLG4 and NCS1/FREQ
CC       (By similarity). Interacts with DLG1 (PubMed:19213956). Probably
CC       part of a complex consisting of KCNIP1, KCNIP2 isoform 3 and KCND2
CC       (PubMed:15358149). Interacts with FLNA, FLNC, DPP6 and DPP10
CC       (PubMed:11102480, PubMed:15454437, PubMed:24811166).
CC       {ECO:0000250|UniProtKB:Q63881, ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:11287421, ECO:0000269|PubMed:11847232,
CC       ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:14623880,
CC       ECO:0000269|PubMed:14980201, ECO:0000269|PubMed:14980207,
CC       ECO:0000269|PubMed:15358149, ECO:0000269|PubMed:15454437,
CC       ECO:0000269|PubMed:16934482, ECO:0000269|PubMed:19213956,
CC       ECO:0000269|PubMed:24811166, ECO:0000305|PubMed:19171772}.
CC   -!- INTERACTION:
CC       Q9NZI2:KCNIP1; NbExp=4; IntAct=EBI-1646745, EBI-2120635;
CC       Q9NS61:KCNIP2; NbExp=3; IntAct=EBI-1646745, EBI-1052975;
CC       Q9NS61-3:KCNIP2; NbExp=3; IntAct=EBI-1646745, EBI-1053010;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:11507158, ECO:0000269|PubMed:14623880,
CC       ECO:0000269|PubMed:14695263, ECO:0000269|PubMed:14980201,
CC       ECO:0000269|PubMed:15454437, ECO:0000269|PubMed:16934482,
CC       ECO:0000269|PubMed:19171772, ECO:0000269|PubMed:24501278,
CC       ECO:0000269|PubMed:24811166}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:14980201,
CC       ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:11102480}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q63881}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63881}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250|UniProtKB:Q63881}. Cell
CC       projection, dendritic spine {ECO:0000250|UniProtKB:Q63881}. Cell
CC       junction {ECO:0000250|UniProtKB:Q63881}. Note=In neurons,
CC       primarily detected on dendrites, dendritic spines and on the
CC       neuron cell body, but not on axons. Localized preferentially at
CC       the dendrites of pyramidal cells in the hippocampus CA1 layer.
CC       Detected at GABAergic synapses. Detected at cell junctions that
CC       are distinct from synaptic cell contacts. Detected in lipid rafts.
CC       Detected primarily at the endoplasmic reticulum or Golgi when
CC       expressed by itself (PubMed:15454437). Interaction with KCNIP1,
CC       KCNIP2, KCNIP3 or KCNIP4 promotes expression at the cell membrane
CC       (PubMed:15454437, PubMed:24811166). Interaction with DPP6 or DPP10
CC       promotes expression at the cell membrane (By similarity).
CC       Internalized from the cell membrane by clathrin-dependent
CC       endocytosis in response to activation of AMPA-selective glutamate
CC       receptors and PKA-mediated phosphorylation at Ser-552.
CC       Redistributed from dendritic spines to the main dendritic shaft in
CC       response to activation of AMPA-selective glutamate receptors and
CC       activation of PKA (By similarity). {ECO:0000250|UniProtKB:Q63881,
CC       ECO:0000250|UniProtKB:Q9Z0V2, ECO:0000269|PubMed:15454437,
CC       ECO:0000269|PubMed:24811166}.
CC   -!- TISSUE SPECIFICITY: Detected in ovary, in corpus luteum and in
CC       granulosa and theca cells in the follicle (at protein level)
CC       (PubMed:15991246). Highly expressed throughout the brain
CC       (PubMed:10551270, PubMed:10729221). Detected in amygdala, caudate
CC       nucleus, cerebellum, hippocampus, substantia nigra and thalamus
CC       (PubMed:10551270, PubMed:10729221). Expression is not detectable
CC       or very low in heart, kidney, liver, lung, pancreas and skeletal
CC       muscle (PubMed:10551270, PubMed:10729221). Not detectable in human
CC       heart atrium (PubMed:12395204). {ECO:0000269|PubMed:10551270,
CC       ECO:0000269|PubMed:10729221, ECO:0000269|PubMed:12395204,
CC       ECO:0000269|PubMed:15991246}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The N-terminal cytoplasmic region can mediate N-type
CC       inactivation by physically blocking the channel (PubMed:14695263).
CC       This probably does not happen in vivo, where the N-terminal region
CC       mediates interaction with regulatory subunits, such as KCNIP1 and
CC       KCNIP2 (PubMed:15358149). The zinc binding sites in the N-terminal
CC       domain are important for tetramerization and assembly of a
CC       functional channel complex (By similarity). Most likely, the
CC       channel undergoes closed-state inactivation, where a subtle
CC       conformation change would render the protein less sensitive to
CC       activation. {ECO:0000250|UniProtKB:Q63881,
CC       ECO:0000305|PubMed:11507158, ECO:0000305|PubMed:14695263,
CC       ECO:0000305|PubMed:15358149, ECO:0000305|PubMed:18357523}.
CC   -!- DOMAIN: The C-terminal cytoplasmic region is important for normal
CC       expression at the cell membrane and modulates the voltage-
CC       dependence of channel activation and inactivation
CC       (PubMed:16934482). It is required for interaction with KCNIP2, and
CC       probably other family members as well (By similarity).
CC       {ECO:0000250|UniProtKB:Q63881, ECO:0000269|PubMed:16934482}.
CC   -!- PTM: Phosphorylation at Ser-438 in response to MAPK activation is
CC       increased in stimulated dendrites. Interaction with KCNIP2 and
CC       DPP6 propomtes phosphorylation by PKA at Ser-552. Phosphorylation
CC       at Ser-552 has no effect on interaction with KCNIP3, but is
CC       required for the regulation of channel activity by KCNIP3.
CC       Phosphorylation at Ser-552 leads to KCND2 internalization (By
CC       similarity). Phosphorylated by MAPK in response to signaling via
CC       the metabotropic glutamate receptor GRM5 (By similarity).
CC       Phosphorylation at Ser-616 is required for the down-regulation of
CC       neuronal A-type currents in response to signaling via GRM5 (By
CC       similarity). {ECO:0000250|UniProtKB:Q63881,
CC       ECO:0000250|UniProtKB:Q9Z0V2}.
CC   -!- DISEASE: Note=KNCD2 mutations have been found in a family with
CC       autism and epilepsy and may play a role in disease pathogenesis.
CC       Autism is a complex multifactorial, pervasive developmental
CC       disorder characterized by impairments in reciprocal social
CC       interaction and communication, restricted and stereotyped patterns
CC       of interests and activities, and the presence of developmental
CC       abnormalities by 3 years of age. Epilepsy is characterized by
CC       paroxysmal transient disturbances of the electrical activity of
CC       the brain that may be manifested as episodic impairment or loss of
CC       consciousness, abnormal motor phenomena, psychic or sensory
CC       disturbances, or perturbation of the autonomic nervous system.
CC       {ECO:0000269|PubMed:24501278}.
CC   -!- DISEASE: Note=A KCND2 mutation leading to the production of a C-
CC       terminally truncated protein has been identified in a patient with
CC       epilepsy. Epilepsy is characterized by paroxysmal transient
CC       disturbances of the electrical activity of the brain that may be
CC       manifested as episodic impairment or loss of consciousness,
CC       abnormal motor phenomena, psychic or sensory disturbances, or
CC       perturbation of the autonomic nervous system.
CC       {ECO:0000269|PubMed:16934482}.
CC   -!- MISCELLANEOUS: The transient neuronal A-type potassium current
CC       called I(SA) is triggered at membrane potentials that are below
CC       the threshold for action potentials. It inactivates rapidly and
CC       recovers rapidly from inactivation. It regulates the firing of
CC       action potentials and plays a role in synaptic integration and
CC       plasticity. Potassium channels containing KCND2 account for about
CC       80% of the neuronal A-type potassium current. In contrast, the
CC       potassium channel responsible for the cardiac I(to) current
CC       differs between species; it is mediated by KCND2 in rodents. In
CC       human and other non-rodents KCND3 may play an equivalent role.
CC       {ECO:0000269|PubMed:10551270, ECO:0000305|PubMed:17917103,
CC       ECO:0000305|PubMed:18357523}.
CC   -!- MISCELLANEOUS: Is specifically and reversibly inhibited by the
CC       scorpion toxin Ts8 (AC P69940). {ECO:0000250|UniProtKB:Q63881}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal)
CC       (TC 1.A.1.2) subfamily. Kv4.2/KCND2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA82996.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF121104; AAD22053.1; -; mRNA.
DR   EMBL; AB028967; BAA82996.2; ALT_INIT; mRNA.
DR   EMBL; AJ010969; CAB56841.1; -; mRNA.
DR   EMBL; AF166008; AAF65618.1; -; Genomic_DNA.
DR   EMBL; AF166007; AAF65618.1; JOINED; Genomic_DNA.
DR   EMBL; AC004888; AAC83405.1; -; Genomic_DNA.
DR   EMBL; AC004946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF142568; AAD52159.1; -; Genomic_DNA.
DR   EMBL; BC110449; AAI10450.1; -; mRNA.
DR   EMBL; BC110450; AAI10451.1; -; mRNA.
DR   CCDS; CCDS5776.1; -.
DR   RefSeq; NP_036413.1; NM_012281.2.
DR   UniGene; Hs.654739; -.
DR   ProteinModelPortal; Q9NZV8; -.
DR   SMR; Q9NZV8; -.
DR   BioGrid; 109953; 18.
DR   IntAct; Q9NZV8; 2.
DR   STRING; 9606.ENSP00000333496; -.
DR   ChEMBL; CHEMBL5885; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB00280; Disopyramide.
DR   DrugBank; DB00458; Imipramine.
DR   TCDB; 1.A.1.2.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9NZV8; -.
DR   PhosphoSitePlus; Q9NZV8; -.
DR   BioMuta; KCND2; -.
DR   DMDM; 38258257; -.
DR   EPD; Q9NZV8; -.
DR   PaxDb; Q9NZV8; -.
DR   PeptideAtlas; Q9NZV8; -.
DR   PRIDE; Q9NZV8; -.
DR   Ensembl; ENST00000331113; ENSP00000333496; ENSG00000184408.
DR   GeneID; 3751; -.
DR   KEGG; hsa:3751; -.
DR   UCSC; uc003vjj.2; human.
DR   CTD; 3751; -.
DR   DisGeNET; 3751; -.
DR   GeneCards; KCND2; -.
DR   HGNC; HGNC:6238; KCND2.
DR   HPA; HPA029068; -.
DR   MIM; 605410; gene.
DR   neXtProt; NX_Q9NZV8; -.
DR   OpenTargets; ENSG00000184408; -.
DR   PharmGKB; PA30030; -.
DR   eggNOG; KOG4390; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOVERGEN; HBG106687; -.
DR   InParanoid; Q9NZV8; -.
DR   KO; K04892; -.
DR   OMA; NYTSANQ; -.
DR   OrthoDB; EOG090B07GO; -.
DR   PhylomeDB; Q9NZV8; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   ChiTaRS; KCND2; human.
DR   GeneWiki; KCND2; -.
DR   GenomeRNAi; 3751; -.
DR   PRO; PR:Q9NZV8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000184408; -.
DR   CleanEx; HS_KCND2; -.
DR   ExpressionAtlas; Q9NZV8; baseline and differential.
DR   Genevisible; Q9NZV8; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0044853; C:plasma membrane raft; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; TAS:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:UniProtKB.
DR   GO; GO:0045475; P:locomotor rhythm; IEA:Ensembl.
DR   GO; GO:0019228; P:neuronal action potential; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0019233; P:sensory perception of pain; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004055; K_chnl_volt-dep_Kv4.2.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01517; KV42CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Autism; Autism spectrum disorder; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Disease mutation; Epilepsy;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel; Zinc.
FT   CHAIN         1    630       Potassium voltage-gated channel subfamily
FT                                D member 2.
FT                                /FTId=PRO_0000054064.
FT   TOPO_DOM      1    182       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    183    204       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    205    228       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    229    250       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    251    261       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    262    279       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    280    286       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    287    306       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    307    321       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    322    343       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    344    357       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    358    369       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    370    377       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    378    384       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    385    413       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    414    630       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        2     20       Interaction with KCNIP1, KCNIP2, and
FT                                other family members.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   REGION       71     90       Interaction with KCNIP1.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   REGION      308    321       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      474    630       Important for normal channel activation
FT                                and inactivation, for interaction with
FT                                KCNIP2, and probably other family members
FT                                as well. {ECO:0000250|UniProtKB:Q63881,
FT                                ECO:0000305|PubMed:16934482}.
FT   REGION      474    489       Required for dendritic targeting.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   MOTIF       370    375       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       627    630       PDZ-binding.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   METAL       105    105       Zinc; via pros nitrogen.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   METAL       132    132       Zinc. {ECO:0000250|UniProtKB:Q63881}.
FT   METAL       133    133       Zinc. {ECO:0000250|UniProtKB:Q63881}.
FT   MOD_RES      38     38       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   MOD_RES     548    548       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   MOD_RES     552    552       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V2}.
FT   MOD_RES     572    572       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V2}.
FT   MOD_RES     575    575       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V2}.
FT   MOD_RES     602    602       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   MOD_RES     607    607       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   MOD_RES     616    616       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63881}.
FT   VARIANT     404    404       V -> M (probable disease-associated
FT                                mutation found in a family with atypical
FT                                autism and severe epilepsy; disrupts
FT                                potassium current inactivation;
FT                                dbSNP:rs587777631).
FT                                {ECO:0000269|PubMed:24501278}.
FT                                /FTId=VAR_072076.
FT   MUTAGEN     309    309       G->A: Increases peak current amplitude
FT                                and causes a negative shift in the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     311    311       R->A: No effect on peak current
FT                                amplitude, but causes a positive shift in
FT                                the voltage-dependence of activation. May
FT                                increase the affinity for the closed-
FT                                inactivated state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     312    312       I->A: Increases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     313    313       L->A: Causes a positive shift in the
FT                                voltage-dependence of activation. May
FT                                decrease the affinity for the closed-
FT                                inactivated state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     314    314       G->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     315    315       Y->A: Increases peak current amplitude
FT                                but has a minor effect on the voltage-
FT                                dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     316    316       T->A: Increases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     317    317       L->A: Increases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     318    318       K->A: Increases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     319    319       S->A: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     320    320       C->A: Increases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     320    320       C->S: Increases peak current amplitude
FT                                and slows the onset of inactivation at
FT                                low voltage, but has no effect on the
FT                                voltage-dependence of activation.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     322    322       S->A: Increases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation. May
FT                                increase the affinity for the closed-
FT                                inactivated state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     323    323       E->A: Slightly increases peak current
FT                                amplitude and causes a negative shift in
FT                                the voltage-dependence of activation. May
FT                                decrease the affinity for the closed-
FT                                inactivated state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     324    324       L->A: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     327    327       L->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     328    328       L->A: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     329    329       F->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     397    397       V->A: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     398    398       I->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     399    399       A->V: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     401    401       P->A: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     402    404       VPV->IPI: Increases pak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation and
FT                                steady-state inactivation. May increase
FT                                the affinity for the closed-inactivated
FT                                state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     403    403       P->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     405    405       I->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     406    406       V->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     407    407       S->A: Increases peak current amplitude
FT                                but has no effect on the voltage-
FT                                dependence of activation. May increase
FT                                the affinity for the closed-inactivated
FT                                state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     408    408       N->A: Decreases peak current amplitude
FT                                and causes a positive shift in the
FT                                voltage-dependence of activation. May
FT                                increase the affinity for the closed-
FT                                inactivated state of the channel.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     409    409       F->A: May impair protein folding.
FT                                {ECO:0000269|PubMed:19171772}.
FT   MUTAGEN     601    604       PTPP->ATAA: Abolishes interaction with
FT                                FLNC. {ECO:0000269|PubMed:11102480}.
FT   CONFLICT    450    450       N -> S (in Ref. 1; AAD22053).
FT                                {ECO:0000305}.
FT   CONFLICT    464    464       Q -> P (in Ref. 1; AAD22053).
FT                                {ECO:0000305}.
FT   CONFLICT    550    550       Q -> R (in Ref. 1; AAD22053).
FT                                {ECO:0000305}.
FT   CONFLICT    553    553       I -> V (in Ref. 1; AAD22053).
FT                                {ECO:0000305}.
SQ   SEQUENCE   630 AA;  70537 MW;  0C11E62FFA220421 CRC64;
     MAAGVAAWLP FARAAAIGWM PVASGPMPAP PRQERKRTQD ALIVLNVSGT RFQTWQDTLE
     RYPDTLLGSS ERDFFYHPET QQYFFDRDPD IFRHILNFYR TGKLHYPRHE CISAYDEELA
     FFGLIPEIIG DCCYEEYKDR RRENAERLQD DADTDTAGES ALPTMTARQR VWRAFENPHT
     STMALVFYYV TGFFIAVSVI ANVVETVPCG SSPGHIKELP CGERYAVAFF CLDTACVMIF
     TVEYLLRLAA APSRYRFVRS VMSIIDVVAI LPYYIGLVMT DNEDVSGAFV TLRVFRVFRI
     FKFSRHSQGL RILGYTLKSC ASELGFLLFS LTMAIIIFAT VMFYAEKGSS ASKFTSIPAA
     FWYTIVTMTT LGYGDMVPKT IAGKIFGSIC SLSGVLVIAL PVPVIVSNFS RIYHQNQRAD
     KRRAQKKARL ARIRAAKSGS ANAYMQSKRN GLLSNQLQSS EDEQAFVSKS GSSFETQHHH
     LLHCLEKTTN HEFVDEQVFE ESCMEVATVN RPSSHSPSLS SQQGVTSTCC SRRHKKTFRI
     PNANVSGSHQ GSIQELSTIQ IRCVERTPLS NSRSSLNAKM EECVKLNCEQ PYVTTAIISI
     PTPPVTTPEG DDRPESPEYS GGNIVRVSAL
//
ID   KCND3_HUMAN             Reviewed;         655 AA.
AC   Q9UK17; O60576; O60577; Q14D71; Q5T0M0; Q9UH85; Q9UH86; Q9UK16;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   15-FEB-2017, entry version 156.
DE   RecName: Full=Potassium voltage-gated channel subfamily D member 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.3;
GN   Name=KCND3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RC   TISSUE=Heart;
RX   PubMed=9843794;
RA   Kong W., Po S., Yamagishi T., Ashen M.D., Stetten G., Tomaselli G.F.;
RT   "Isolation and characterization of the human gene encoding Ito:
RT   further diversity by alternative mRNA splicing.";
RL   Am. J. Physiol. 275:H1963-H1970(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain, and Heart;
RX   PubMed=10200233;
RA   Dilks D., Ling H.-P., Cockett M., Sokol P., Numann R.;
RT   "Cloning and expression of the human Kv4.3 potassium channel.";
RL   J. Neurophysiol. 81:1974-1977(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Calmels T.P.G., Faivre J.-F., Javre J.-L., Cheval B., Rouanet S.,
RA   Bril A.;
RT   "Long and short human isoforms of the Kv4.3 channel: cloning,
RT   expression, electrophysiology, pharmacology and phosphorylation by
RT   protein kinase C.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=10729221; DOI=10.1006/geno.2000.6117;
RA   Isbrandt D., Leicher T., Waldschuetz R., Zhu X.-R., Luhmann U.,
RA   Michel U., Sauter K., Pongs O.;
RT   "Gene structures and expression profiles of three human KCND (Kv4)
RT   potassium channels mediating A-type currents I(TO) and I(SA).";
RL   Genomics 64:144-154(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH KCNIP2; KCNE1; KCNE2; SCN1B AND KCNAB1.
RX   PubMed=12297301; DOI=10.1016/S0014-5793(02)03296-9;
RA   Deschenes I., Tomaselli G.F.;
RT   "Modulation of Kv4.3 current by accessory subunits.";
RL   FEBS Lett. 528:183-188(2002).
RN   [9]
RP   INTERACTION WITH DLG1.
RX   PubMed=19213956; DOI=10.1161/CIRCRESAHA.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [10]
RP   INVOLVEMENT IN BRGDA9, VARIANTS BRGDA9 PHE-450 AND ARG-600, AND
RP   CHARACTERIZATION OF VARIANT BRGDA9 PHE-450.
RX   PubMed=21349352; DOI=10.1016/j.hrthm.2011.02.021;
RA   Giudicessi J.R., Ye D., Tester D.J., Crotti L., Mugione A.,
RA   Nesterenko V.V., Albertson R.M., Antzelevitch C., Schwartz P.J.,
RA   Ackerman M.J.;
RT   "Transient outward current (I(to)) gain-of-function mutations in the
RT   KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.";
RL   Heart Rhythm 8:1024-1032(2011).
RN   [11]
RP   INVOLVEMENT IN BRGDA9, VARIANTS BRGDA9 ILE-392; ARG-530 AND ARG-600,
RP   AND CHARACTERIZATION OF VARIANTS BRGDA9 ILE-392; ARG-530 AND ARG-600.
RX   PubMed=22457051; DOI=10.1002/humu.22058;
RA   Giudicessi J.R., Ye D., Kritzberger C.J., Nesterenko V.V.,
RA   Tester D.J., Antzelevitch C., Ackerman M.J.;
RT   "Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with
RT   autopsy-negative sudden unexplained death.";
RL   Hum. Mutat. 33:989-997(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 29-143, AND INTERACTION WITH
RP   KCNIP1.
RX   PubMed=14980207; DOI=10.1016/S0896-6273(04)00049-2;
RA   Scannevin R.H., Wang K., Jow F., Megules J., Kopsco D.C., Edris W.,
RA   Carroll K.C., Lu Q., Xu W., Xu Z., Katz A.H., Olland S., Lin L.,
RA   Taylor M., Stahl M., Malakian K., Somers W., Mosyak L., Bowlby M.R.,
RA   Chanda P., Rhodes K.J.;
RT   "Two N-terminal domains of Kv4 K(+) channels regulate binding to and
RT   modulation by KChIP1.";
RL   Neuron 41:587-598(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 6-145 IN COMPLEX WITH KCNIP1,
RP   AND SUBUNIT.
RX   PubMed=17187064; DOI=10.1038/nn1822;
RA   Wang H., Yan Y., Liu Q., Huang Y., Shen Y., Chen L., Chen Y., Yang Q.,
RA   Hao Q., Wang K., Chai J.;
RT   "Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP
RT   subunits.";
RL   Nat. Neurosci. 10:32-39(2007).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-94.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANTS SCA19 PHE-227 DEL; GLU-338; VAL-345 AND MET-377, AND
RP   CHARACTERIZATION OF VARIANT PHE-227 DEL.
RX   PubMed=23280837; DOI=10.1002/ana.23701;
RA   Lee Y.C., Durr A., Majczenko K., Huang Y.H., Liu Y.C., Lien C.C.,
RA   Tsai P.C., Ichikawa Y., Goto J., Monin M.L., Li J.Z., Chung M.Y.,
RA   Mundwiller E., Shakkottai V., Liu T.T., Tesson C., Lu Y.C., Brice A.,
RA   Tsuji S., Burmeister M., Stevanin G., Soong B.W.;
RT   "Mutations in KCND3 cause spinocerebellar ataxia type 22.";
RL   Ann. Neurol. 72:859-869(2012).
RN   [16]
RP   VARIANTS SCA19 PRO-352; ILE-373 AND ASN-390, AND CHARACTERIZATION OF
RP   VARIANTS SCA19 PRO-352; ILE-373 AND ASN-390.
RX   PubMed=23280838; DOI=10.1002/ana.23700;
RA   Duarri A., Jezierska J., Fokkens M., Meijer M., Schelhaas H.J.,
RA   den Dunnen W.F., van Dijk F., Verschuuren-Bemelmans C., Hageman G.,
RA   van de Vlies P., Kusters B., van de Warrenburg B.P., Kremer B.,
RA   Wijmenga C., Sinke R.J., Swertz M.A., Kampinga H.H., Boddeke E.,
RA   Verbeek D.S.;
RT   "Mutations in potassium channel kcnd3 cause spinocerebellar ataxia
RT   type 19.";
RL   Ann. Neurol. 72:870-880(2012).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated rapidly
CC       inactivating A-type potassium channels. May contribute to I(To)
CC       current in heart and I(Sa) current in neurons. Channel properties
CC       are modulated by interactions with other alpha subunits and with
CC       regulatory subunits. {ECO:0000269|PubMed:10200233,
CC       ECO:0000269|PubMed:9843794}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND1 and/or KCND2.
CC       Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and
CC       KCNIP4 (By similarity). Interacts with KCNE1, KCNE2, SCN1B and
CC       KCNAB1 and DLG1. {ECO:0000250, ECO:0000269|PubMed:12297301,
CC       ECO:0000269|PubMed:14980207, ECO:0000269|PubMed:17187064,
CC       ECO:0000269|PubMed:19213956}.
CC   -!- INTERACTION:
CC       Q9NZI2:KCNIP1; NbExp=3; IntAct=EBI-9825212, EBI-2120635;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q62897}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:Q62897}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q62897}. Note=Interaction with
CC       palmitoylated KCNIP2 and KCNIP3 enhances cell surface expression.
CC       {ECO:0000250|UniProtKB:Q62897}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=KCND3L, Long;
CC         IsoId=Q9UK17-1; Sequence=Displayed;
CC       Name=2; Synonyms=KCND3S, Short;
CC         IsoId=Q9UK17-2; Sequence=VSP_008826;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and brain, in
CC       particular in cortex, cerebellum, amygdala and caudate nucleus.
CC       Detected at lower levels in liver, skeletal muscle, kidney and
CC       pancreas. Isoform 1 predominates in most tissues. Isoform 1 and
CC       isoform 2 are detected at similar levels in brain, skeletal muscle
CC       and pancreas. {ECO:0000269|PubMed:10200233,
CC       ECO:0000269|PubMed:10729221, ECO:0000269|PubMed:9843794}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Regulated through phosphorylation at Ser-569 by CaMK2D.
CC       {ECO:0000250}.
CC   -!- DISEASE: Spinocerebellar ataxia 19 (SCA19) [MIM:607346]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive
CC       incoordination of gait and often poor coordination of hands,
CC       speech and eye movements, due to degeneration of the cerebellum
CC       with variable involvement of the brainstem and spinal cord. SCA19
CC       is a relatively mild, cerebellar ataxic syndrome with cognitive
CC       impairment, pyramidal tract involvement, tremor and peripheral
CC       neuropathy, and mild atrophy of the cerebellar hemispheres and
CC       vermis. {ECO:0000269|PubMed:23280837,
CC       ECO:0000269|PubMed:23280838}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Brugada syndrome 9 (BRGDA9) [MIM:616399]: A
CC       tachyarrhythmia characterized by right bundle branch block and ST
CC       segment elevation on an electrocardiogram (ECG). It can cause the
CC       ventricles to beat so fast that the blood is prevented from
CC       circulating efficiently in the body. When this situation occurs,
CC       the individual will faint and may die in a few minutes if the
CC       heart is not reset. {ECO:0000269|PubMed:21349352,
CC       ECO:0000269|PubMed:22457051}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal)
CC       (TC 1.A.1.2) subfamily. Kv4.3/KCND3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Potassium voltage-gated channel, Shal-related
CC       subfamily, member 3 (KCND3); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://www.lovd.nl/KCND3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF048712; AAC05121.1; -; mRNA.
DR   EMBL; AF048713; AAC05122.1; -; mRNA.
DR   EMBL; AF187963; AAF01044.1; -; mRNA.
DR   EMBL; AF187964; AAF01045.1; -; mRNA.
DR   EMBL; AF205856; AAF20924.1; -; mRNA.
DR   EMBL; AF205857; AAF20925.1; -; mRNA.
DR   EMBL; AF120491; AAD38898.1; -; mRNA.
DR   EMBL; AF166011; AAF68177.1; -; Genomic_DNA.
DR   EMBL; AF166009; AAF68177.1; JOINED; Genomic_DNA.
DR   EMBL; AF166010; AAF68177.1; JOINED; Genomic_DNA.
DR   EMBL; AF166011; AAF68178.1; -; Genomic_DNA.
DR   EMBL; AF166009; AAF68178.1; JOINED; Genomic_DNA.
DR   EMBL; AF166010; AAF68178.1; JOINED; Genomic_DNA.
DR   EMBL; AL512665; CAI16956.1; -; Genomic_DNA.
DR   EMBL; AL049557; CAI16956.1; JOINED; Genomic_DNA.
DR   EMBL; AL450997; CAI16956.1; JOINED; Genomic_DNA.
DR   EMBL; AL450997; CAI19096.1; -; Genomic_DNA.
DR   EMBL; AL049557; CAI19096.1; JOINED; Genomic_DNA.
DR   EMBL; AL512665; CAI19096.1; JOINED; Genomic_DNA.
DR   EMBL; AL049557; CAI22711.1; -; Genomic_DNA.
DR   EMBL; AL450997; CAI22711.1; JOINED; Genomic_DNA.
DR   EMBL; AL512665; CAI22711.1; JOINED; Genomic_DNA.
DR   EMBL; CH471122; EAW56511.1; -; Genomic_DNA.
DR   EMBL; BC113475; AAI13476.1; -; mRNA.
DR   EMBL; BC113477; AAI13478.1; -; mRNA.
DR   CCDS; CCDS843.1; -. [Q9UK17-1]
DR   CCDS; CCDS844.1; -. [Q9UK17-2]
DR   RefSeq; NP_004971.2; NM_004980.4. [Q9UK17-1]
DR   RefSeq; NP_751948.1; NM_172198.2. [Q9UK17-2]
DR   RefSeq; XP_005270908.1; XM_005270851.4. [Q9UK17-1]
DR   RefSeq; XP_006710692.1; XM_006710629.3. [Q9UK17-1]
DR   RefSeq; XP_006710693.1; XM_006710630.3. [Q9UK17-2]
DR   RefSeq; XP_016856733.1; XM_017001244.1. [Q9UK17-1]
DR   UniGene; Hs.666367; -.
DR   UniGene; Hs.730579; -.
DR   PDB; 1S1G; X-ray; 2.60 A; A/B=29-143.
DR   PDB; 2NZ0; X-ray; 3.20 A; B/D=6-145.
DR   PDBsum; 1S1G; -.
DR   PDBsum; 2NZ0; -.
DR   ProteinModelPortal; Q9UK17; -.
DR   SMR; Q9UK17; -.
DR   BioGrid; 109954; 35.
DR   IntAct; Q9UK17; 1.
DR   STRING; 9606.ENSP00000319591; -.
DR   BindingDB; Q9UK17; -.
DR   ChEMBL; CHEMBL1964; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB00280; Disopyramide.
DR   DrugBank; DB00458; Imipramine.
DR   TCDB; 1.A.1.2.19; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9UK17; -.
DR   PhosphoSitePlus; Q9UK17; -.
DR   BioMuta; KCND3; -.
DR   DMDM; 92090984; -.
DR   PaxDb; Q9UK17; -.
DR   PeptideAtlas; Q9UK17; -.
DR   PRIDE; Q9UK17; -.
DR   DNASU; 3752; -.
DR   Ensembl; ENST00000302127; ENSP00000306923; ENSG00000171385. [Q9UK17-2]
DR   Ensembl; ENST00000315987; ENSP00000319591; ENSG00000171385. [Q9UK17-1]
DR   Ensembl; ENST00000369697; ENSP00000358711; ENSG00000171385. [Q9UK17-2]
DR   GeneID; 3752; -.
DR   KEGG; hsa:3752; -.
DR   UCSC; uc001ebu.2; human. [Q9UK17-1]
DR   CTD; 3752; -.
DR   DisGeNET; 3752; -.
DR   GeneCards; KCND3; -.
DR   HGNC; HGNC:6239; KCND3.
DR   HPA; HPA029452; -.
DR   MalaCards; KCND3; -.
DR   MIM; 605411; gene.
DR   MIM; 607346; phenotype.
DR   MIM; 616399; phenotype.
DR   neXtProt; NX_Q9UK17; -.
DR   OpenTargets; ENSG00000171385; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 98772; Spinocerebellar ataxia type 19/22.
DR   PharmGKB; PA210; -.
DR   eggNOG; KOG4390; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOVERGEN; HBG106687; -.
DR   InParanoid; Q9UK17; -.
DR   KO; K04893; -.
DR   OMA; PNQKEVP; -.
DR   OrthoDB; EOG090B07GO; -.
DR   PhylomeDB; Q9UK17; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   EvolutionaryTrace; Q9UK17; -.
DR   GeneWiki; KCND3; -.
DR   GenomeRNAi; 3752; -.
DR   PRO; PR:Q9UK17; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171385; -.
DR   CleanEx; HS_KCND3; -.
DR   ExpressionAtlas; Q9UK17; baseline and differential.
DR   Genevisible; Q9UK17; HS.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; TAS:ProtInc.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086009; P:membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; TAS:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IEA:GOC.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0099625; P:ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004056; K_chnl_volt-dep_Kv4.3.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01518; KV43CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Brugada syndrome; Cell membrane;
KW   Cell projection; Complete proteome; Disease mutation; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Neurodegeneration;
KW   Phosphoprotein; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Spinocerebellar ataxia;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel;
KW   Zinc.
FT   CHAIN         1    655       Potassium voltage-gated channel subfamily
FT                                D member 3.
FT                                /FTId=PRO_0000054068.
FT   TOPO_DOM      1    181       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    182    202       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    243    256       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    308    320       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    321    341       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    360    380       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    382    402       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    403    655       Cytoplasmic. {ECO:0000255}.
FT   REGION        2     20       Interaction with KCNIP2. {ECO:0000250}.
FT   REGION      472    487       Mediates dendritic targeting.
FT                                {ECO:0000250}.
FT   MOTIF       367    372       Selectivity filter. {ECO:0000250}.
FT   METAL       104    104       Zinc.
FT   METAL       131    131       Zinc.
FT   METAL       132    132       Zinc.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V1}.
FT   MOD_RES     459    459       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V1}.
FT   MOD_RES     569    569       Phosphoserine; by CaMK2D. {ECO:0000250}.
FT   MOD_RES     585    585       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V1}.
FT   VAR_SEQ     488    506       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10200233,
FT                                ECO:0000303|PubMed:10729221,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9843794}.
FT                                /FTId=VSP_008826.
FT   VARIANT      94     94       V -> M (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035775.
FT   VARIANT     227    227       Missing (in SCA19; results in reduced
FT                                channel activity consistent with impaired
FT                                cell surface expression of the mutant
FT                                protein). {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070785.
FT   VARIANT     338    338       V -> E (in SCA19).
FT                                {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070786.
FT   VARIANT     345    345       G -> V (in SCA19; dbSNP:rs797045634).
FT                                {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070787.
FT   VARIANT     352    352       T -> P (in SCA19; loss of channel
FT                                activity; dbSNP:rs397515476).
FT                                {ECO:0000269|PubMed:23280838}.
FT                                /FTId=VAR_070788.
FT   VARIANT     373    373       M -> I (in SCA19; causes reduced channel
FT                                activity; dbSNP:rs397515477).
FT                                {ECO:0000269|PubMed:23280838}.
FT                                /FTId=VAR_070789.
FT   VARIANT     377    377       T -> M (in SCA19).
FT                                {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070790.
FT   VARIANT     390    390       S -> N (in SCA19; results in impaired
FT                                cell surface expression;
FT                                dbSNP:rs397515478).
FT                                {ECO:0000269|PubMed:23280838}.
FT                                /FTId=VAR_070791.
FT   VARIANT     392    392       V -> I (in BRGDA9; gain of function
FT                                mutation; dbSNP:rs786205867).
FT                                {ECO:0000269|PubMed:22457051}.
FT                                /FTId=VAR_067694.
FT   VARIANT     450    450       L -> F (in BRGDA9; gain of function
FT                                mutation; dbSNP:rs150401343).
FT                                {ECO:0000269|PubMed:21349352}.
FT                                /FTId=VAR_073831.
FT   VARIANT     530    530       S -> R (in BRGDA9; does not affect the
FT                                electrophysiological properties of the
FT                                channel). {ECO:0000269|PubMed:22457051}.
FT                                /FTId=VAR_067695.
FT   VARIANT     600    600       G -> R (in BRGDA9; gain of function
FT                                mutation; dbSNP:rs149344567).
FT                                {ECO:0000269|PubMed:21349352,
FT                                ECO:0000269|PubMed:22457051}.
FT                                /FTId=VAR_067696.
FT   CONFLICT    239    239       V -> G (in Ref. 1; AAC05121/AAC05122 and
FT                                4; AAD38898). {ECO:0000305}.
FT   CONFLICT    375    375       P -> L (in Ref. 1; AAC05121/AAC05122 and
FT                                4; AAD38898). {ECO:0000305}.
FT   CONFLICT    408    408       R -> G (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       E -> G (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    531    531       T -> Q (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    564    564       A -> D (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    646    646       A -> T (in Ref. 1; AAC05121/AAC05122, 2;
FT                                AAF01045 and 4; AAD38898). {ECO:0000305}.
FT   CONFLICT    654    654       A -> V (in Ref. 1; AAC05121/AAC05122, 2;
FT                                AAF01044 and 4; AAD38898). {ECO:0000305}.
FT   HELIX         9     14       {ECO:0000244|PDB:2NZ0}.
FT   TURN         15     19       {ECO:0000244|PDB:2NZ0}.
FT   STRAND       20     23       {ECO:0000244|PDB:2NZ0}.
FT   HELIX        32     34       {ECO:0000244|PDB:2NZ0}.
FT   STRAND       41     46       {ECO:0000244|PDB:1S1G}.
FT   STRAND       49     54       {ECO:0000244|PDB:1S1G}.
FT   HELIX        55     58       {ECO:0000244|PDB:1S1G}.
FT   TURN         65     67       {ECO:0000244|PDB:2NZ0}.
FT   HELIX        70     73       {ECO:0000244|PDB:1S1G}.
FT   STRAND       74     76       {ECO:0000244|PDB:2NZ0}.
FT   STRAND       77     79       {ECO:0000244|PDB:1S1G}.
FT   STRAND       81     84       {ECO:0000244|PDB:1S1G}.
FT   HELIX        88    100       {ECO:0000244|PDB:1S1G}.
FT   STRAND      101    103       {ECO:0000244|PDB:2NZ0}.
FT   HELIX       111    120       {ECO:0000244|PDB:1S1G}.
FT   HELIX       125    127       {ECO:0000244|PDB:1S1G}.
FT   HELIX       130    143       {ECO:0000244|PDB:1S1G}.
SQ   SEQUENCE   655 AA;  73451 MW;  ADD1402A97204764 CRC64;
     MAAGVAAWLP FARAAAIGWM PVANCPMPLA PADKNKRQDE LIVLNVSGRR FQTWRTTLER
     YPDTLLGSTE KEFFFNEDTK EYFFDRDPEV FRCVLNFYRT GKLHYPRYEC ISAYDDELAF
     YGILPEIIGD CCYEEYKDRK RENAERLMDD NDSENNQESM PSLSFRQTMW RAFENPHTST
     LALVFYYVTG FFIAVSVITN VVETVPCGTV PGSKELPCGE RYSVAFFCLD TACVMIFTVE
     YLLRLFAAPS RYRFIRSVMS IIDVVAIMPY YIGLVMTNNE DVSGAFVTLR VFRVFRIFKF
     SRHSQGLRIL GYTLKSCASE LGFLLFSLTM AIIIFATVMF YAEKGSSASK FTSIPASFWY
     TIVTMTTLGY GDMVPKTIAG KIFGSICSLS GVLVIALPVP VIVSNFSRIY HQNQRADKRR
     AQKKARLARI RVAKTGSSNA YLHSKRNGLL NEALELTGTP EEEHMGKTTS LIESQHHHLL
     HCLEKTTGLS YLVDDPLLSV RTSTIKNHEF IDEQMFEQNC MESSMQNYPS TRSPSLSSHP
     GLTTTCCSRR SKKTTHLPNS NLPATRLRSM QELSTIHIQG SEQPSLTTSR SSLNLKADDG
     LRPNCKTSQI TTAIISIPTP PALTPEGESR PPPASPGPNT NIPSIASNVV KVSAL
//
ID   KCNF1_HUMAN             Reviewed;         494 AA.
AC   Q9H3M0; O43527; Q585L3;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-FEB-2017, entry version 132.
DE   RecName: Full=Potassium voltage-gated channel subfamily F member 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv5.1;
DE   AltName: Full=kH1;
GN   Name=KCNF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=9434767; DOI=10.1006/bbrc.1997.7830;
RA   Su K., Kyaw H., Fan P., Zeng Z., Shell B.K., Carter K.C., Li Y.;
RT   "Isolation, characterization, and mapping of two human potassium
RT   channels.";
RL   Biochem. Biophys. Res. Commun. 241:675-681(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Chen J., Ptacek J.L.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH DLG1.
RX   PubMed=12445884; DOI=10.1016/S0008-6363(02)00602-8;
RA   Godreau D., Vranckx R., Maguy A., Rucker-Martin C., Goyenvalle C.,
RA   Abdelshafy S., Tessier S., Couetil J.P., Hatem S.N.;
RT   "Expression, regulation and role of the MAGUK protein SAP-97 in human
RT   atrial myocardium.";
RL   Cardiovasc. Res. 56:433-442(2002).
CC   -!- FUNCTION: Putative voltage-gated potassium channel.
CC   -!- SUBUNIT: Heteromultimer with KCNG3, KCNG4 and KCNV2. Interacts
CC       with DLG1. {ECO:0000269|PubMed:12445884}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected in heart, brain, liver, skeletal
CC       muscle, kidney and pancreas.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. F
CC       (TC 1.A.1.2) subfamily. Kv5.1/KCNF1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF033382; AAC05597.1; -; mRNA.
DR   EMBL; AF029780; AAG43055.1; -; mRNA.
DR   EMBL; AC019041; AAX81991.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00946.1; -; Genomic_DNA.
DR   EMBL; BC026110; AAH26110.1; -; mRNA.
DR   CCDS; CCDS1676.1; -.
DR   PIR; JC5919; JC5919.
DR   RefSeq; NP_002227.2; NM_002236.4.
DR   UniGene; Hs.23735; -.
DR   ProteinModelPortal; Q9H3M0; -.
DR   SMR; Q9H3M0; -.
DR   BioGrid; 109956; 4.
DR   IntAct; Q9H3M0; 1.
DR   STRING; 9606.ENSP00000295082; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.18; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9H3M0; -.
DR   PhosphoSitePlus; Q9H3M0; -.
DR   BioMuta; KCNF1; -.
DR   DMDM; 24418476; -.
DR   PaxDb; Q9H3M0; -.
DR   PeptideAtlas; Q9H3M0; -.
DR   PRIDE; Q9H3M0; -.
DR   DNASU; 3754; -.
DR   Ensembl; ENST00000295082; ENSP00000295082; ENSG00000162975.
DR   GeneID; 3754; -.
DR   KEGG; hsa:3754; -.
DR   UCSC; uc002rax.3; human.
DR   CTD; 3754; -.
DR   GeneCards; KCNF1; -.
DR   HGNC; HGNC:6246; KCNF1.
DR   HPA; CAB004678; -.
DR   HPA; HPA014738; -.
DR   MIM; 603787; gene.
DR   neXtProt; NX_Q9H3M0; -.
DR   OpenTargets; ENSG00000162975; -.
DR   PharmGKB; PA30033; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q9H3M0; -.
DR   KO; K04899; -.
DR   OMA; NEMEFWK; -.
DR   OrthoDB; EOG090705AG; -.
DR   PhylomeDB; Q9H3M0; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNF1; -.
DR   GenomeRNAi; 3754; -.
DR   PRO; PR:Q9H3M0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000162975; -.
DR   CleanEx; HS_KCNF1; -.
DR   Genevisible; Q9H3M0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    494       Potassium voltage-gated channel subfamily
FT                                F member 1.
FT                                /FTId=PRO_0000054072.
FT   TOPO_DOM      1    183       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    224    244       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    245    249       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    311    324       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    325    345       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    358    378       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    386    406       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    407    494       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       370    375       Selectivity filter. {ECO:0000250}.
FT   CONFLICT    186    186       V -> E (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       G -> D (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       S -> N (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
FT   CONFLICT    383    383       G -> S (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
SQ   SEQUENCE   494 AA;  55584 MW;  87E2FB117F927F60 CRC64;
     MDGSGERSLP EPGSQSSAAS DDIEIVVNVG GVRQVLYGDL LSQYPETRLA ELINCLAGGY
     DTIFSLCDDY DPGKREFYFD RDPDAFKCVI EVYYFGEVHM KKGICPICFK NEMDFWKVDL
     KFLDDCCKSH LSEKREELEE IARRVQLILD DLGVDAAEGR WRRCQKCVWK FLEKPESSCP
     ARVVAVLSFL LILVSSVVMC MGTIPELQVL DAEGNRVEHP TLENVETACI GWFTLEYLLR
     LFSSPNKLHF ALSFMNIVDV LAILPFYVSL TLTHLGARMM ELTNVQQAVQ ALRIMRIARI
     FKLARHSSGL QTLTYALKRS FKELGLLLMY LAVGIFVFSA LGYTMEQSHP ETLFKSIPQS
     FWWAIITMTT VGYGDIYPKT TLGKLNAAIS FLCGVIAIAL PIHPIINNFV RYYNKQRVLE
     TAAKHELELM ELNSSSGGEG KTGGSRSDLD NLPPEPAGKE APSCSSRLKL SHSDTFIPLL
     TEEKHHRTRL QSCK
//
ID   KCNG1_HUMAN             Reviewed;         513 AA.
AC   Q9UIX4; A8K3S4; O43528; Q5JXL5; Q9BRC1;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-FEB-2017, entry version 149.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.1;
DE   AltName: Full=kH2;
GN   Name=KCNG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9434767; DOI=10.1006/bbrc.1997.7830;
RA   Su K., Kyaw H., Fan P., Zeng Z., Shell B.K., Carter K.C., Li Y.;
RT   "Isolation, characterization, and mapping of two human potassium
RT   channels.";
RL   Biochem. Biophys. Res. Commun. 241:675-681(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1; modulates the delayed rectifier voltage-gated
CC       potassium channel activation and deactivation rates of KCNB1
CC       (PubMed:19074135). {ECO:0000269|PubMed:19074135}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:19074135).
CC       {ECO:0000269|PubMed:19074135}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19074135};
CC       Multi-pass membrane protein {ECO:0000305}. Note=Colocalizes with
CC       KCNB1 at the plasma membrane (PubMed:19074135).
CC       {ECO:0000269|PubMed:19074135}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UIX4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UIX4-2; Sequence=VSP_001024, VSP_001025;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and placenta, and at much
CC       lower levels in kidney and pancreas (PubMed:9434767).
CC       {ECO:0000269|PubMed:9434767}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G
CC       (TC 1.A.1.2) subfamily. Kv6.1/KCNG1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF033383; AAC05635.1; -; mRNA.
DR   EMBL; AK290689; BAF83378.1; -; mRNA.
DR   EMBL; AL050404; CAB51753.1; -; Genomic_DNA.
DR   EMBL; AL050404; CAI23445.1; -; Genomic_DNA.
DR   EMBL; AL121785; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75605.1; -; Genomic_DNA.
DR   EMBL; BC006367; AAH06367.1; -; mRNA.
DR   CCDS; CCDS13436.1; -. [Q9UIX4-1]
DR   PIR; JC5920; JC5920.
DR   RefSeq; NP_002228.2; NM_002237.3. [Q9UIX4-1]
DR   RefSeq; XP_006723848.1; XM_006723785.2. [Q9UIX4-1]
DR   RefSeq; XP_011527102.1; XM_011528800.1. [Q9UIX4-1]
DR   RefSeq; XP_011527103.1; XM_011528801.1. [Q9UIX4-1]
DR   RefSeq; XP_011527104.1; XM_011528802.1. [Q9UIX4-1]
DR   RefSeq; XP_011527105.1; XM_011528803.2. [Q9UIX4-1]
DR   RefSeq; XP_011527106.1; XM_011528804.1. [Q9UIX4-1]
DR   RefSeq; XP_011527107.1; XM_011528805.2. [Q9UIX4-1]
DR   RefSeq; XP_011527108.1; XM_011528806.1. [Q9UIX4-1]
DR   UniGene; Hs.118695; -.
DR   UniGene; Hs.735151; -.
DR   ProteinModelPortal; Q9UIX4; -.
DR   BioGrid; 109957; 4.
DR   IntAct; Q9UIX4; 1.
DR   STRING; 9606.ENSP00000360626; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q9UIX4; -.
DR   PhosphoSitePlus; Q9UIX4; -.
DR   BioMuta; KCNG1; -.
DR   DMDM; 24418479; -.
DR   PaxDb; Q9UIX4; -.
DR   PeptideAtlas; Q9UIX4; -.
DR   PRIDE; Q9UIX4; -.
DR   Ensembl; ENST00000371571; ENSP00000360626; ENSG00000026559. [Q9UIX4-1]
DR   GeneID; 3755; -.
DR   KEGG; hsa:3755; -.
DR   UCSC; uc002xwa.5; human. [Q9UIX4-1]
DR   CTD; 3755; -.
DR   GeneCards; KCNG1; -.
DR   H-InvDB; HIX0015916; -.
DR   HGNC; HGNC:6248; KCNG1.
DR   HPA; HPA039530; -.
DR   HPA; HPA040024; -.
DR   MIM; 603788; gene.
DR   neXtProt; NX_Q9UIX4; -.
DR   OpenTargets; ENSG00000026559; -.
DR   PharmGKB; PA30034; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q9UIX4; -.
DR   KO; K04900; -.
DR   OMA; GQCSQMC; -.
DR   OrthoDB; EOG090B05CZ; -.
DR   PhylomeDB; Q9UIX4; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNG1; human.
DR   GeneWiki; KCNG1; -.
DR   GenomeRNAi; 3755; -.
DR   PRO; PR:Q9UIX4; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000026559; -.
DR   CleanEx; HS_KCNG1; -.
DR   ExpressionAtlas; Q9UIX4; baseline and differential.
DR   Genevisible; Q9UIX4; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:Ensembl.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; NAS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; NAS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003969; K_chnl_volt-dep_Kv6.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01492; KV6CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    513       Potassium voltage-gated channel subfamily
FT                                G member 1.
FT                                /FTId=PRO_0000054073.
FT   TOPO_DOM      1    224       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    225    246       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    247    267       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    268    289       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    290    300       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    301    321       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    322    338       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    339    359       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    360    374       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    375    396       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    397    411       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    412    423       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    424    431       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    432    438       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    439    467       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    468    513       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       424    429       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS     61     64       Poly-Arg.
FT   COMPBIAS    254    257       Poly-Glu.
FT   VAR_SEQ     259    275       GHCSQMCHNVFIVESVC -> VRAHAPRGNAPPRGKGL
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001024.
FT   VAR_SEQ     276    513       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001025.
FT   VARIANT     304    304       I -> M (in dbSNP:rs17791052).
FT                                /FTId=VAR_053860.
FT   CONFLICT    426    426       G -> D (in Ref. 1; AAC05635).
FT                                {ECO:0000305}.
FT   CONFLICT    465    465       R -> P (in Ref. 1; AAC05635).
FT                                {ECO:0000305}.
SQ   SEQUENCE   513 AA;  57913 MW;  A002F1C0EF2FBDC5 CRC64;
     MTLLPGDNSD YDYSALSCTS DASFHPAFLP QRQAIKGAFY RRAQRLRPQD EPRQGCQPED
     RRRRIIINVG GIKYSLPWTT LDEFPLTRLG QLKACTNFDD ILNVCDDYDV TCNEFFFDRN
     PGAFGTILTF LRAGKLRLLR EMCALSFQEE LLYWGIAEDH LDGCCKRRYL QKIEEFAEMV
     EREEEDDALD SEGRDSEGPA EGEGRLGRCM RRLRDMVERP HSGLPGKVFA CLSVLFVTVT
     AVNLSVSTLP SLREEEEQGH CSQMCHNVFI VESVCVGWFS LEFLLRLIQA PSKFAFLRSP
     LTLIDLVAIL PYYITLLVDG AAAGRRKPGA GNSYLDKVGL VLRVLRALRI LYVMRLARHS
     LGLQTLGLTA RRCTREFGLL LLFLCVAIAL FAPLLYVIEN EMADSPEFTS IPACYWWAVI
     TMTTVGYGDM VPRSTPGQVV ALSSILSGIL LMAFPVTSIF HTFSRSYLEL KQEQERVMFR
     RAQFLIKTKS QLSVSQDSDI LFGSASSDTR DNN
//
ID   KCNG2_HUMAN             Reviewed;         466 AA.
AC   Q9UJ96;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-FEB-2017, entry version 129.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 2;
DE   AltName: Full=Cardiac potassium channel subunit;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.2;
GN   Name=KCNG2; Synonyms=KCNF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=10551266;
RA   Zhu X.-R., Netzer R., Boehlke K., Liu Q., Pongs O.;
RT   "Structural and functional characterization of Kv6.2, a new gamma-
RT   subunit of voltage-gated potassium channel.";
RL   Recept. Channels 6:337-350(1999).
CC   -!- FUNCTION: Potassium channel subunit. Modulates channel activity by
CC       shifting the threshold and the half-maximal activation to more
CC       negative values.
CC   -!- SUBUNIT: Heterodimer with KCNB1. Does not form homomultimers.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, liver, skeletal
CC       muscle, kidney and pancreas. Detected at low levels in brain, lung
CC       and placenta.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- MISCELLANEOUS: Heterodimers with KCNB1 are highly sensitive to
CC       inhibition by tetraethylammonium (TEA) and propafenone.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G
CC       (TC 1.A.1.2) subfamily. Kv6.2/KCNG2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ011021; CAB56834.1; -; mRNA.
DR   CCDS; CCDS12019.1; -.
DR   RefSeq; NP_036415.1; NM_012283.1.
DR   RefSeq; XP_011524220.1; XM_011525918.2.
DR   RefSeq; XP_011524222.1; XM_011525920.2.
DR   RefSeq; XP_016881194.1; XM_017025705.1.
DR   UniGene; Hs.247905; -.
DR   ProteinModelPortal; Q9UJ96; -.
DR   SMR; Q9UJ96; -.
DR   BioGrid; 117638; 1.
DR   STRING; 9606.ENSP00000315654; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q9UJ96; -.
DR   PhosphoSitePlus; Q9UJ96; -.
DR   BioMuta; KCNG2; -.
DR   DMDM; 24418480; -.
DR   PaxDb; Q9UJ96; -.
DR   PRIDE; Q9UJ96; -.
DR   Ensembl; ENST00000316249; ENSP00000315654; ENSG00000178342.
DR   GeneID; 26251; -.
DR   KEGG; hsa:26251; -.
DR   UCSC; uc010xfl.2; human.
DR   CTD; 26251; -.
DR   GeneCards; KCNG2; -.
DR   HGNC; HGNC:6249; KCNG2.
DR   HPA; HPA048628; -.
DR   MIM; 605696; gene.
DR   neXtProt; NX_Q9UJ96; -.
DR   OpenTargets; ENSG00000178342; -.
DR   PharmGKB; PA30035; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q9UJ96; -.
DR   KO; K04901; -.
DR   OMA; SETTQCA; -.
DR   OrthoDB; EOG090A097K; -.
DR   PhylomeDB; Q9UJ96; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   GeneWiki; KCNG2; -.
DR   GenomeRNAi; 26251; -.
DR   PRO; PR:Q9UJ96; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000178342; -.
DR   CleanEx; HS_KCNG2; -.
DR   Genevisible; Q9UJ96; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0008016; P:regulation of heart contraction; TAS:ProtInc.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003969; K_chnl_volt-dep_Kv6.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01492; KV6CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    466       Potassium voltage-gated channel subfamily
FT                                G member 2.
FT                                /FTId=PRO_0000054074.
FT   TOPO_DOM      1    177       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    288    308       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    309    321       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    322    342       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    357    377       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    385    405       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    406    466       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       369    374       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS      9     13       Poly-Gly.
SQ   SEQUENCE   466 AA;  51240 MW;  0D978934F5E71469 CRC64;
     MEPWPCSPGG GGGTRARHVI INVGGCRVRL AWAALARCPL ARLERLRACR GHDDLLRVCD
     DYDVSRDEFF FDRSPCAFRA IVALLRAGKL RLLRGPCALA FRDELAYWGI DEARLERCCL
     RRLRRREEEA AEARAGPTER GAQGSPARAL GPRGRLQRGR RRLRDVVDNP HSGLAGKLFA
     CVSVSFVAVT AVGLCLSTMP DIRAEEERGE CSPKCRSLFV LETVCVAWFS FEFLLRSLQA
     ESKCAFLRAP LNIIDILALL PFYVSLLLGL AAGPGGTKLL ERAGLVLRLL RALRVLYVMR
     LARHSLGLRS LGLTMRRCAR EFGLLLLFLC VAMALFAPLV HLAERELGAR RDFSSVPASY
     WWAVISMTTV GYGDMVPRSL PGQVVALSSI LSGILLMAFP VTSIFHTFSR SYSELKEQQQ
     RAASPEPALQ EDSTHSATAT EDSSQGPDSA GLADDSADAL WVRAGR
//
ID   KCNG3_HUMAN             Reviewed;         436 AA.
AC   Q8TAE7; Q53SC1;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-FEB-2017, entry version 131.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.3;
GN   Name=KCNG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, INTERACTION
RP   WITH KCNB1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11852086; DOI=10.1016/S0014-5793(02)02267-6;
RA   Sano Y., Mochizuki S., Miyake A., Kitada C., Inamura K., Yokoi H.,
RA   Nozawa K., Matsushime H., Furuichi K.;
RT   "Molecular cloning and characterization of Kv6.3, a novel modulatory
RT   subunit for voltage-gated K(+) channel Kv2.1.";
RL   FEBS Lett. 512:230-234(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, INTERACTION
RP   WITH KCNB1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Vega-Saenz de Miera E.C., Rudy B.;
RT   "Kv10.1a and Kv10.1b: two novel alternatively spliced potassium
RT   channel subunits.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself (PubMed:11852086). Can form functional
CC       heterotetrameric channels with KCNB1; this promotes a reduction in
CC       the rate of activation and inactivation of the delayed rectifier
CC       voltage-gated potassium channel KCNB1 (PubMed:11852086,
CC       PubMed:19074135). {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:19074135}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:11852086,
CC       PubMed:12060745, PubMed:19074135). Does not form homomultimers
CC       (PubMed:12060745). {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135}; Multi-
CC       pass membrane protein {ECO:0000305}. Cytoplasm
CC       {ECO:0000269|PubMed:12060745}. Note=Has to be associated with
CC       KCNB1 or possibly another partner to get inserted in the plasma
CC       membrane (PubMed:12060745). Colocalizes with KCNB1 at the plasma
CC       membrane (PubMed:12060745, PubMed:19074135). Remains intracellular
CC       in the absence of KCNB1 (PubMed:12060745).
CC       {ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Kv10.1b;
CC         IsoId=Q8TAE7-1; Sequence=Displayed;
CC       Name=2; Synonyms=Kv10.1a;
CC         IsoId=Q8TAE7-2; Sequence=VSP_001026;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, liver, testis, small
CC       intestine, colon, thymus and adrenal gland (PubMed:11852086,
CC       PubMed:12060745). {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G
CC       (TC 1.A.1.2) subfamily. Kv6.3/KCNG3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB070604; BAB85520.1; -; mRNA.
DR   EMBL; AF348982; AAL83909.1; -; mRNA.
DR   EMBL; AF454547; AAM93548.1; -; mRNA.
DR   EMBL; AF454548; AAM93549.1; -; mRNA.
DR   EMBL; AC025750; AAY24039.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00319.1; -; Genomic_DNA.
DR   EMBL; BC071558; AAH71558.1; -; mRNA.
DR   CCDS; CCDS1809.1; -. [Q8TAE7-1]
DR   CCDS; CCDS42674.1; -. [Q8TAE7-2]
DR   RefSeq; NP_579875.1; NM_133329.5. [Q8TAE7-1]
DR   RefSeq; NP_758847.1; NM_172344.2. [Q8TAE7-2]
DR   UniGene; Hs.352633; -.
DR   ProteinModelPortal; Q8TAE7; -.
DR   BioGrid; 128090; 4.
DR   IntAct; Q8TAE7; 1.
DR   STRING; 9606.ENSP00000304127; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   PhosphoSitePlus; Q8TAE7; -.
DR   BioMuta; KCNG3; -.
DR   DMDM; 24418472; -.
DR   PaxDb; Q8TAE7; -.
DR   PeptideAtlas; Q8TAE7; -.
DR   PRIDE; Q8TAE7; -.
DR   DNASU; 170850; -.
DR   Ensembl; ENST00000306078; ENSP00000304127; ENSG00000171126. [Q8TAE7-1]
DR   Ensembl; ENST00000394973; ENSP00000378424; ENSG00000171126. [Q8TAE7-2]
DR   GeneID; 170850; -.
DR   KEGG; hsa:170850; -.
DR   UCSC; uc002rsm.4; human. [Q8TAE7-1]
DR   CTD; 170850; -.
DR   DisGeNET; 170850; -.
DR   GeneCards; KCNG3; -.
DR   HGNC; HGNC:18306; KCNG3.
DR   HPA; HPA041625; -.
DR   MIM; 606767; gene.
DR   neXtProt; NX_Q8TAE7; -.
DR   OpenTargets; ENSG00000171126; -.
DR   PharmGKB; PA30036; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q8TAE7; -.
DR   KO; K04902; -.
DR   OMA; DMYPITM; -.
DR   OrthoDB; EOG090B08E8; -.
DR   PhylomeDB; Q8TAE7; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNG3; -.
DR   GenomeRNAi; 170850; -.
DR   PRO; PR:Q8TAE7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000171126; -.
DR   CleanEx; HS_KCNG3; -.
DR   Genevisible; Q8TAE7; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Ion channel; Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    436       Potassium voltage-gated channel subfamily
FT                                G member 3.
FT                                /FTId=PRO_0000054077.
FT   TOPO_DOM      1    168       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    169    190       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    191    220       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    221    242       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    243    253       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    254    274       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    275    284       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    285    305       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    306    320       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    321    342       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    343    360       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    361    372       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    373    380       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    381    387       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    388    416       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    417    436       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       373    378       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   VAR_SEQ     212    222       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_001026.
SQ   SEQUENCE   436 AA;  49593 MW;  3C289CFF0B462513 CRC64;
     MTFGRSGAAS VVLNVGGARY SLSRELLKDF PLRRVSRLHG CRSERDVLEV CDDYDRERNE
     YFFDRHSEAF GFILLYVRGH GKLRFAPRMC ELSFYNEMIY WGLEGAHLEY CCQRRLDDRM
     SDTYTFYSAD EPGVLGRDEA RPGGAEAAPS RRWLERMRRT FEEPTSSLAA QILASVSVVF
     VIVSMVVLCA STLPDWRNAA ADNRSLDDRS RYSAGPGREP SGIIEAICIG WFTAECIVRF
     IVSKNKCEFV KRPLNIIDLL AITPYYISVL MTVFTGENSQ LQRAGVTLRV LRMMRIFWVI
     KLARHFIGLQ TLGLTLKRCY REMVMLLVFI CVAMAIFSAL SQLLEHGLDL ETSNKDFTSI
     PAACWWVIIS MTTVGYGDMY PITVPGRILG GVCVVSGIVL LALPITFIYH SFVQCYHELK
     FRSARYSRSL STEFLN
//
ID   KCNG4_HUMAN             Reviewed;         519 AA.
AC   Q8TDN1; Q96H24;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-FEB-2017, entry version 143.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 4;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.4;
GN   Name=KCNG4; Synonyms=KCNG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1; modulates the delayed rectifier voltage-gated
CC       potassium channel activation and deactivation rates of KCNB1
CC       (PubMed:19074135). {ECO:0000269|PubMed:19074135}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:19074135).
CC       {ECO:0000269|PubMed:19074135}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19074135};
CC       Multi-pass membrane protein {ECO:0000305}. Note=Has to be
CC       associated with KCNB1 or possibly another partner to get inserted
CC       in the plasma membrane. Colocalizes with KCNB1 at the plasma
CC       membrane. Remains intracellular in the absence of KCNB1
CC       (PubMed:19074135). {ECO:0000269|PubMed:19074135}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TDN1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDN1-2; Sequence=VSP_001029, VSP_001030;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, and at lower levels
CC       in liver, small intestine and colon.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G
CC       (TC 1.A.1.2) subfamily. Kv6.4/KCNG4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF348984; AAL83911.1; -; mRNA.
DR   EMBL; BC008969; AAH08969.1; -; mRNA.
DR   CCDS; CCDS10945.1; -. [Q8TDN1-1]
DR   RefSeq; NP_758857.1; NM_172347.2. [Q8TDN1-1]
DR   UniGene; Hs.335877; -.
DR   UniGene; Hs.560407; -.
DR   UniGene; Hs.737415; -.
DR   ProteinModelPortal; Q8TDN1; -.
DR   BioGrid; 125002; 5.
DR   STRING; 9606.ENSP00000312129; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   PhosphoSitePlus; Q8TDN1; -.
DR   SwissPalm; Q8TDN1; -.
DR   BioMuta; KCNG4; -.
DR   DMDM; 26006803; -.
DR   PaxDb; Q8TDN1; -.
DR   PeptideAtlas; Q8TDN1; -.
DR   PRIDE; Q8TDN1; -.
DR   DNASU; 93107; -.
DR   Ensembl; ENST00000308251; ENSP00000312129; ENSG00000168418. [Q8TDN1-1]
DR   Ensembl; ENST00000568181; ENSP00000457897; ENSG00000168418. [Q8TDN1-2]
DR   GeneID; 93107; -.
DR   KEGG; hsa:93107; -.
DR   UCSC; uc002fhu.1; human. [Q8TDN1-1]
DR   CTD; 93107; -.
DR   DisGeNET; 93107; -.
DR   GeneCards; KCNG4; -.
DR   HGNC; HGNC:19697; KCNG4.
DR   HPA; HPA039161; -.
DR   MIM; 607603; gene.
DR   neXtProt; NX_Q8TDN1; -.
DR   OpenTargets; ENSG00000168418; -.
DR   PharmGKB; PA134989953; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q8TDN1; -.
DR   KO; K04903; -.
DR   OMA; CCLRKLL; -.
DR   OrthoDB; EOG090B05CZ; -.
DR   PhylomeDB; Q8TDN1; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNG4; -.
DR   GenomeRNAi; 93107; -.
DR   PRO; PR:Q8TDN1; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000168418; -.
DR   CleanEx; HS_KCNG3; -.
DR   CleanEx; HS_KCNG4; -.
DR   ExpressionAtlas; Q8TDN1; baseline and differential.
DR   Genevisible; Q8TDN1; HS.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    519       Potassium voltage-gated channel subfamily
FT                                G member 4.
FT                                /FTId=PRO_0000054080.
FT   TOPO_DOM      1    218       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    219    240       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    241    261       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    262    283       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    284    294       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    295    314       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    315    328       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    329    353       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    354    368       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    369    390       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    391    405       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    406    417       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    418    425       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    426    432       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    433    461       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    462    519       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       418    423       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   VAR_SEQ     253    256       GECS -> VSGL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001029.
FT   VAR_SEQ     257    519       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001030.
FT   VARIANT       8      8       G -> W (in dbSNP:rs35379218).
FT                                /FTId=VAR_053861.
FT   VARIANT     206    206       R -> W (in dbSNP:rs11646443).
FT                                /FTId=VAR_053862.
FT   VARIANT     255    255       C -> Y (in dbSNP:rs17736370).
FT                                /FTId=VAR_053863.
FT   VARIANT     321    321       E -> K (in dbSNP:rs4782905).
FT                                /FTId=VAR_053864.
FT   VARIANT     325    325       G -> R (in dbSNP:rs7196482).
FT                                /FTId=VAR_053865.
FT   VARIANT     427    427       R -> H (in dbSNP:rs35649980).
FT                                /FTId=VAR_053866.
SQ   SEQUENCE   519 AA;  58979 MW;  E5BBA354931AB0A4 CRC64;
     MPMPSRDGGL HPRHHHYGSH SPWSQLLSSP METPSIKGLY YRRVRKVGAL DASPVDLKKE
     ILINVGGRRY LLPWSTLDRF PLSRLSKLRL CRSYEEIVQL CDDYDEDSQE FFFDRSPSAF
     GVIVSFLAAG KLVLLQEMCA LSFQEELAYW GIEEAHLERC CLRKLLRKLE ELEELAKLHR
     EDVLRQQRET RRPASHSSRW GLCMNRLREM VENPQSGLPG KVFACLSILF VATTAVSLCV
     STMPDLRAEE DQGECSRKCY YIFIVETICV AWFSLEFCLR FVQAQDKCQF FQGPLNIIDI
     LAISPYYVSL AVSEEPPEDG ERPSGSSYLE KVGLVLRVLR ALRILYVMRL ARHSLGLQTL
     GLTVRRCTRE FGLLLLFLAV AITLFSPLVY VAEKESGRVL EFTSIPASYW WAIISMTTVG
     YGDMVPRSVP GQMVALSSIL SGILIMAFPA TSIFHTFSHS YLELKKEQEQ LQARLRHLQN
     TGPASECELL DPHVASEHEL MNDVNDLILE GPALPIMHM
//
ID   KCNQ1_HUMAN             Reviewed;         676 AA.
AC   P51787; O00347; O60607; O94787; Q14D14; Q7Z6G9; Q92960; Q9UMN8;
AC   Q9UMN9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 3.
DT   15-FEB-2017, entry version 189.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 1 {ECO:0000305};
DE   AltName: Full=IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 {ECO:0000305|PubMed:9312006};
DE   AltName: Full=KQT-like 1 {ECO:0000305};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.1 {ECO:0000305|PubMed:20533308};
GN   Name=KCNQ1 {ECO:0000312|HGNC:HGNC:6294};
GN   Synonyms=KCNA8 {ECO:0000312|HGNC:HGNC:6294},
GN   KCNA9 {ECO:0000312|HGNC:HGNC:6294},
GN   KVLQT1 {ECO:0000303|PubMed:9312006};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CHARACTERIZATION
RP   OF VARIANT LQT1 CYS-555.
RC   TISSUE=Kidney;
RX   PubMed=9312006; DOI=10.1093/emboj/16.17.5472;
RA   Chouabe C., Neyroud N., Guicheney P., Lazdunski M., Romey G.,
RA   Barhanin J.;
RT   "Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell
RT   and Lange-Nielsen inherited cardiac arrhythmias.";
RL   EMBO J. 16:5472-5479(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=9305853; DOI=10.1074/jbc.272.39.24109;
RA   Jiang M., Tseng-Crank J., Tseng G.-N.;
RT   "Suppression of slow delayed rectifier current by a truncated isoform
RT   of KvLQT1 cloned from normal human heart.";
RL   J. Biol. Chem. 272:24109-24112(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), VARIANTS LQT1
RP   ASN-242; HIS-250; SER-314 AND MET-587, AND VARIANT SER-643.
RX   PubMed=9799083; DOI=10.1007/s004390050819;
RA   Itoh T., Tanaka T., Nagai R., Kikuchi K., Ogawa S., Okada S.,
RA   Yamagata S., Yano K., Yazaki Y., Nakamura Y.;
RT   "Genomic organization and mutational analysis of KVLQT1, a gene
RT   responsible for familial long QT syndrome.";
RL   Hum. Genet. 103:290-294(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   LQT1 MET-587 AND HIS-591.
RX   PubMed=10024302; DOI=10.1161/01.RES.84.3.290;
RA   Neyroud N., Richard P., Vignier N., Donger C., Denjoy I., Demay L.,
RA   Shkolnikova M., Pesce R., Chevalier P., Hainque B., Coumel P.,
RA   Schwartz K., Guicheney P.;
RT   "Genomic organization of the KCNQ1 K+ channel gene and identification
RT   of C-terminal mutations in the long-QT syndrome.";
RL   Circ. Res. 84:290-297(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Seebohm G.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-129, AND FUNCTION.
RX   PubMed=9108097; DOI=10.1073/pnas.94.8.4017;
RA   Yang W.-P., Levesque P.C., Little W.A., Conder M.L., Shalaby F.Y.,
RA   Blanar M.A.;
RT   "KvLQT1, a voltage-gated potassium channel responsible for human
RT   cardiac arrhythmias.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4017-4021(1997).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 107-676, AND FUNCTION.
RC   TISSUE=Pancreas;
RX   PubMed=8900283; DOI=10.1038/384080a0;
RA   Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S.,
RA   Atkinson D.L., Keating M.T.;
RT   "Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks)
RT   potassium channel.";
RL   Nature 384:80-83(1996).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 130-676, AND VARIANTS LQT1.
RX   PubMed=8528244; DOI=10.1038/ng0196-17;
RA   Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M.,
RA   Vanraay T.J., Shen J., Timothy K.W., Vincent G.M., de Jager T.,
RA   Schwartz P.J., Towbin J.A., Moss A.J., Atkinson D.L., Landes G.M.,
RA   Connors T.D., Keating M.T.;
RT   "Positional cloning of a novel potassium channel gene: KVLQT1
RT   mutations cause cardiac arrhythmias.";
RL   Nat. Genet. 12:17-23(1996).
RN   [13]
RP   IDENTIFICATION OF C-TERMINAL ASSEMBLY DOMAIN.
RX   PubMed=10654932; DOI=10.1093/emboj/19.3.332;
RA   Schmitt N., Schwarz M., Peretz A., Abitbol I., Attali B., Pongs O.;
RT   "A recessive C-terminal Jervell and Lange-Nielsen mutation of the
RT   KCNQ1 channel impairs subunit assembly.";
RL   EMBO J. 19:332-340(2000).
RN   [14]
RP   INTERACTION WITH KCNE2, AND FUNCTION.
RX   PubMed=11101505; DOI=10.1093/emboj/19.23.6326;
RA   Tinel N., Diochot S., Borsotto M., Lazdunski M., Barhanin J.;
RT   "KCNE2 confers background current characteristics to the cardiac KCNQ1
RT   potassium channel.";
RL   EMBO J. 19:6326-6330(2000).
RN   [15]
RP   FUNCTION.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10646604; DOI=10.1038/35003200;
RA   Schroeder B.C., Waldegger S., Fehr S., Bleich M., Warth R., Greger R.,
RA   Jentsch T.J.;
RT   "A constitutively open potassium channel formed by KCNQ1 and KCNE3.";
RL   Nature 403:196-199(2000).
RN   [17]
RP   FUNCTION.
RX   PubMed=12324418; DOI=10.1016/S0006-3495(02)73961-1;
RA   Angelo K., Jespersen T., Grunnet M., Nielsen M.S., Klaerke D.A.,
RA   Olesen S.P.;
RT   "KCNE5 induces time- and voltage-dependent modulation of the KCNQ1
RT   current.";
RL   Biophys. J. 83:1997-2006(2002).
RN   [18]
RP   INTERACTION WITH AKAP9, PHOSPHORYLATION AT SER-27, CHARACTERIZATION OF
RP   VARIANT LQT1 ASP-589, AND MUTAGENESIS OF SER-27; LEU-602 AND ILE-609.
RX   PubMed=11799244; DOI=10.1126/science.1066843;
RA   Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J.,
RA   Marks A.R., Kass R.S.;
RT   "Requirement of a macromolecular signaling complex for beta adrenergic
RT   receptor modulation of the KCNQ1-KCNE1 potassium channel.";
RL   Science 295:496-499(2002).
RN   [19]
RP   FUNCTION, DOMAIN, INTERACTION WITH KCNE4, AND MUTAGENESIS OF VAL-324;
RP   LYS-326; THR-327; ILE-328; SER-338 AND PHE-340.
RX   PubMed=19687231; DOI=10.1085/jgp.200910234;
RA   Vanoye C.G., Welch R.C., Daniels M.A., Manderfield L.J., Tapper A.R.,
RA   Sanders C.R., George A.L. Jr.;
RT   "Distinct subdomains of the KCNQ1 S6 segment determine channel
RT   modulation by different KCNE subunits.";
RL   J. Gen. Physiol. 134:207-217(2009).
RN   [20]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KCNE1; KCNE2; KCNE3; KCNE4
RP   AND KCNE5.
RX   PubMed=20533308; DOI=10.1002/jcp.22265;
RA   Roura-Ferrer M., Sole L., Oliveras A., Dahan R., Bielanska J.,
RA   Villarroel A., Comes N., Felipe A.;
RT   "Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface
RT   targeting.";
RL   J. Cell. Physiol. 225:692-700(2010).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21228319; DOI=10.1152/ajpcell.00390.2010;
RA   Andersen M.N., Olesen S.P., Rasmussen H.B.;
RT   "Kv7.1 surface expression is regulated by epithelial cell
RT   polarization.";
RL   Am. J. Physiol. 300:C814-C824(2011).
RN   [22]
RP   INTERACTION WITH NEDD4L AND USP2, UBIQUITINATED, DEUBIQUITINATED, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22024150; DOI=10.1016/j.hrthm.2011.10.026;
RA   Krzystanek K., Rasmussen H.B., Grunnet M., Staub O., Olesen S.P.,
RA   Abriel H., Jespersen T.;
RT   "Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated
RT   downregulation of KCNQ1 potassium channels.";
RL   Heart Rhythm 9:440-448(2012).
RN   [23]
RP   INTERACTION WITH AP2M1 AND NEDD4L, AND SUBCELLULAR LOCATION.
RX   PubMed=23529131; DOI=10.1113/jphysiol.2013.251678;
RA   Rapetti-Mauss R., O'Mahony F., Sepulveda F.V., Urbach V., Harvey B.J.;
RT   "Oestrogen promotes KCNQ1 potassium channel endocytosis and
RT   postendocytic trafficking in colonic epithelium.";
RL   J. Physiol. (Lond.) 591:2813-2831(2013).
RN   [24]
RP   INTERACTION WITH KCNQ5, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=24855057; DOI=10.1161/ATVBAHA.114.303801;
RA   Oliveras A., Roura-Ferrer M., Sole L., de la Cruz A., Prieto A.,
RA   Etxebarria A., Manils J., Morales-Cano D., Condom E., Soler C.,
RA   Cogolludo A., Valenzuela C., Villarroel A., Comes N., Felipe A.;
RT   "Functional assembly of Kv7.1/Kv7.5 channels with emerging properties
RT   on vascular muscle physiology.";
RL   Arterioscler. Thromb. Vasc. Biol. 34:1522-1530(2014).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 574-622, INTERACTION WITH
RP   CALM, SUBCELLULAR LOCATION, MUTAGENESIS OF GLY-589; ALA-590 AND
RP   ASN-593, CHARACTERIZATION OF VARIANT LQT1 ASP-589, AND
RP   TETRAMERIZATION.
RX   PubMed=18165683; DOI=10.1074/jbc.M707541200;
RA   Wiener R., Haitin Y., Shamgar L., Fernandez-Alonso M.C., Martos A.,
RA   Chomsky-Hecht O., Rivas G., Attali B., Hirsch J.A.;
RT   "The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit
RT   assembly and protein interaction.";
RL   J. Biol. Chem. 283:5815-5830(2008).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 583-611, SUBUNIT, AND
RP   COILED-COIL.
RX   PubMed=19693805; DOI=10.1002/pro.224;
RA   Xu Q., Minor D.L. Jr.;
RT   "Crystal structure of a trimeric form of the K(V)7.1 (KCNQ1) A-domain
RT   tail coiled-coil reveals structural plasticity and context dependent
RT   changes in a putative coiled-coil trimerization motif.";
RL   Protein Sci. 18:2100-2114(2009).
RN   [27]
RP   CHARACTERIZATION OF VARIANTS LQT1 PRO-178; PHE-273 AND ILE-312.
RX   PubMed=9323054; DOI=10.1161/01.CIR.96.6.1733;
RA   Shalaby F.Y., Levesque P.C., Yang W.-P., Little W.A., Conder M.L.,
RA   Jenkins-West T., Blanar M.A.;
RT   "Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT
RT   syndrome.";
RL   Circulation 96:1733-1736(1997).
RN   [28]
RP   REVIEW ON VARIANTS.
RX   PubMed=10704188;
RX   DOI=10.1002/(SICI)1096-8628(19990924)89:3<137::AID-AJMG4>3.3.CO;2-3;
RA   Tranebjaerg L., Bathen J., Tyson J., Bitner-Glindzicz M.;
RT   "Jervell and Lange-Nielsen syndrome: a Norwegian perspective.";
RL   Am. J. Med. Genet. 89:137-146(1999).
RN   [29]
RP   VARIANTS LQT1 SER-314 AND VAL-341.
RX   PubMed=8872472; DOI=10.1093/hmg/5.9.1319;
RA   Russell M.W., Dick M. II, Collins F.S., Brody L.C.;
RT   "KVLQT1 mutations in three families with familial or sporadic long QT
RT   syndrome.";
RL   Hum. Mol. Genet. 5:1319-1324(1996).
RN   [30]
RP   VARIANT LQT1 VAL-341.
RX   PubMed=8818942; DOI=10.1136/jmg.33.7.567;
RA   de Jager T., Corbett C.H., Badenhorst J.C., Brink P.A., Corfield V.A.;
RT   "Evidence of a long QT founder gene with varying phenotypic expression
RT   in South African families.";
RL   J. Med. Genet. 33:567-573(1996).
RN   [31]
RP   VARIANTS LQT1 MET-254 AND MET-417.
RA   Wedekind H., Schulze-Bahr E., Lange S., Rubie C., Haverkamp W.,
RA   Hoerdt M., Borggrefe M., Assmann G., Breithardt G., Funke H.;
RT   "A severe form of long-QT syndrome caused by KVLQT1 mutations located
RT   in cis (Abstract #2051).";
RL   Am. J. Hum. Genet. Suppl. 61:A350-A350(1997).
RN   [32]
RP   VARIANTS LQT1 THR-178; MET-313; ARG-325 AND PRO-366.
RX   PubMed=9024139; DOI=10.1161/01.CIR.95.3.565;
RA   Tanaka T., Nagai R., Tomoike H., Takata S., Yano K., Yabuta K.,
RA   Haneda N., Nakano O., Shibata A., Sawayama T., Kasai H., Yazaki Y.,
RA   Nakamura Y.;
RT   "Four novel KVLQT1 and four novel HERG mutations in familial long-QT
RT   syndrome.";
RL   Circulation 95:565-567(1997).
RN   [33]
RP   VARIANTS LQT1.
RX   PubMed=9386136; DOI=10.1161/01.CIR.96.9.2778;
RA   Donger C., Denjoy I., Berthet M., Neyroud N., Cruaud C., Bennaceur M.,
RA   Chivoret G., Schwartz K., Coumel P., Guicheney P.;
RT   "KVLQT1 C-terminal missense mutation causes a forme fruste long-QT
RT   syndrome.";
RL   Circulation 96:2778-2781(1997).
RN   [34]
RP   VARIANT LQT1 ARG-216.
RX   PubMed=9272155; DOI=10.1007/s004390050516;
RA   van den Berg M.H., Wilde A.A.M., Robles de Medina E.O., Meyer H.,
RA   Geelen J.L.M.C., Jongbloed R.J.E., Wellens H.J., Geraedts J.P.M.;
RT   "The long QT syndrome: a novel missense mutation in the S6 region of
RT   the KVLQT1 gene.";
RL   Hum. Genet. 100:356-361(1997).
RN   [35]
RP   VARIANT LQT1 ASN-317.
RX   PubMed=9302275; DOI=10.1093/hmg/6.11.1943;
RA   Wollnik B., Schroeder B.C., Kubisch C., Esperer H.D., Wieacker P.,
RA   Jentsch T.J.;
RT   "Pathophysiological mechanisms of dominant and recessive KVLQT1 K+
RT   channel mutations found in inherited cardiac arrhythmias.";
RL   Hum. Mol. Genet. 6:1943-1949(1997).
RN   [36]
RP   VARIANT LQT1 VAL-341.
RX   PubMed=9570196; DOI=10.1161/01.CIR.97.13.1264;
RA   Li H., Chen Q., Moss A.J., Robinson J.L., Goytia V., Perry J.C.,
RA   Vincent G.M., Priori S.G., Lehmann M.H., Denfield S.W., Duff D.,
RA   Kaine S., Shimizu W., Schwartz P.J., Wang Q., Towbin J.A.;
RT   "New mutations in the KVLQT1 potassium channel that cause long-QT
RT   syndrome.";
RL   Circulation 97:1264-1269(1998).
RN   [37]
RP   VARIANT LQT1 THR-300.
RX   PubMed=9641694; DOI=10.1161/01.CIR.97.24.2420;
RA   Priori S.G., Schwartz P.J., Napolitano C., Bianchi L., Dennis A.T.,
RA   de Fusco M., Brown A.M., Casari G.;
RT   "A recessive variant of the Romano-Ward Long-QT syndrome?";
RL   Circulation 97:2420-2425(1998).
RN   [38]
RP   VARIANT JLNS1 SER-305.
RX   PubMed=9781056; DOI=10.1038/sj.ejhg.5200165;
RA   Neyroud N., Denjoy I., Donger C., Gary F., Villain E., Leenhardt A.,
RA   Benali K., Schwartz K., Coumel P., Guicheney P.;
RT   "Heterozygous mutation in the pore of potassium channel gene KvLQT1
RT   causes an apparently normal phenotype in long QT syndrome.";
RL   Eur. J. Hum. Genet. 6:129-133(1998).
RN   [39]
RP   VARIANTS LQT1 ARG-168; SER-314; CYS-315; ASN-318; PRO-353 AND TRP-366.
RX   PubMed=9693036; DOI=10.1006/geno.1998.5361;
RA   Splawski I., Shen J., Timothy K.W., Vincent G.M., Lehmann M.H.,
RA   Keating M.T.;
RT   "Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and
RT   KCNE1.";
RL   Genomics 51:86-97(1998).
RN   [40]
RP   VARIANTS LQT1 ILE-311 AND ASN-317.
RX   PubMed=9482580;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:2<158::AID-HUMU9>3.0.CO;2-F;
RA   Saarinen K., Swan H., Kainulainen K., Toivonen L., Viitasalo M.,
RA   Kontula K.;
RT   "Molecular genetics of the long QT syndrome: two novel mutations of
RT   the KVLQT1 gene and phenotypic expression of the mutant gene in a
RT   large kindred.";
RL   Hum. Mutat. 11:158-165(1998).
RN   [41]
RP   VARIANT LQT1 PHE-339 DEL.
RX   PubMed=9702906; DOI=10.1203/00006450-199808000-00002;
RA   Ackerman M.J., Schroeder J.J., Berry R., Schaid D.J., Porter C.-B.J.,
RA   Michels V.V., Thibodeau S.N.;
RT   "A novel mutation in KVLQT1 is the molecular basis of inherited long
RT   QT syndrome in a near-drowning patient's family.";
RL   Pediatr. Res. 44:148-153(1998).
RN   [42]
RP   VARIANT JLNS1 HIS-243.
RX   PubMed=10090886; DOI=10.1086/302346;
RA   Mohammad-Panah R., Demolombe S., Neyroud N., Guicheney P., Kyndt F.,
RA   van den Hoff M., Baro I., Escande D.;
RT   "Mutations in a dominant-negative isoform correlate with phenotype in
RT   inherited cardiac arrhythmias.";
RL   Am. J. Hum. Genet. 64:1015-1023(1999).
RN   [43]
RP   VARIANT LQT1 HIS-174.
RX   PubMed=10367071;
RA   Denjoy I., Lupoglazoff J.M., Donger C., Berthet M., Richard P.,
RA   Neyroud N., Villain E., Lucet V., Coumel P., Guicheney P.;
RT   "Congenital long QT syndrome. The value of genetics in prognostic
RT   evaluation.";
RL   Arch. Mal. Coeur Vaiss. 92:557-563(1999).
RN   [44]
RP   VARIANTS LQT1 LEU-225; CYS-281 AND CYS-315.
RX   PubMed=9927399; DOI=10.1161/01.CIR.99.4.529;
RA   Priori S.G., Napolitano C., Schwartz P.J.;
RT   "Low penetrance in the long-QT syndrome: clinical impact.";
RL   Circulation 99:529-533(1999).
RN   [45]
RP   VARIANT LQT1 THR-525.
RX   PubMed=10482963; DOI=10.1038/sj.ejhg.5200323;
RA   Larsen L.A., Fosdal I., Andersen P.S., Kanters J.K., Vuust J.,
RA   Wettrell G., Christiansen M.;
RT   "Recessive Romano-Ward syndrome associated with compound
RT   heterozygosity for two mutations in the KVLQT1 gene.";
RL   Eur. J. Hum. Genet. 7:724-728(1999).
RN   [46]
RP   VARIANTS LQT1 SER-184; ARG-189; SER-314; SER-315; ARG-345; PRO-373 AND
RP   ARG-392.
RX   PubMed=10220144;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.0.CO;2-V;
RA   Jongbloed R.J.E., Wilde A.A.M., Geelen J.L.M.C., Doevendans P.,
RA   Schaap C., van Langen I., van Tintelen J.P., Cobben J.M.,
RA   Beaufort-Krol G.C.M., Geraedts J.P.M., Smeets H.J.M.;
RT   "Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.";
RL   Hum. Mutat. 13:301-310(1999).
RN   [47]
RP   VARIANT LQT1 CYS-157.
RX   PubMed=10220146;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<318::AID-HUMU9>3.0.CO;2-F;
RA   Larsen L.A., Christiansen M., Vuust J., Andersen P.S.;
RT   "High-throughput single-strand conformation polymorphism analysis by
RT   automated capillary electrophoresis: robust multiplex analysis and
RT   pattern-based identification of allelic variants.";
RL   Hum. Mutat. 13:318-327(1999).
RN   [48]
RP   CHARACTERIZATION OF VARIANTS LQT1 CYS-243; ARG-248 AND LYS-261.
RX   PubMed=10409658; DOI=10.1074/jbc.274.30.21063;
RA   Franqueza L., Lin M., Shen J., Keating M.T., Sanguinetti M.C.;
RT   "Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1
RT   potassium channels modify gating and interaction with minK subunits.";
RL   J. Biol. Chem. 274:21063-21070(1999).
RN   [49]
RP   ERRATUM.
RA   Franqueza L., Lin M., Shen J., Keating M.T., Sanguinetti M.C.;
RL   J. Biol. Chem. 274:25188-25188(1999).
RN   [50]
RP   VARIANTS LQT1 GLN-190; TRP-533 AND TRP-539, VARIANT JLNS1 HIS-243,
RP   CHARACTERIZATION OF VARIANTS LQT1 GLN-190; TRP-533 AND TRP-539, AND
RP   CHARACTERIZATION OF VARIANT JLNS1 HIS-243.
RX   PubMed=10728423; DOI=10.1016/S0008-6363(99)00411-3;
RA   Chouabe C., Neyroud N., Richard P., Denjoy I., Hainque B., Romey G.,
RA   Drici M.-D., Guicheney P., Barhanin J.;
RT   "Novel mutations in KvLQT1 that affect Iks activation through
RT   interactions with Isk.";
RL   Cardiovasc. Res. 45:971-980(2000).
RN   [51]
RP   VARIANTS LQT1.
RX   PubMed=10973849; DOI=10.1161/01.CIR.102.10.1178;
RA   Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S.G.,
RA   Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M.,
RA   Keating M.T.;
RT   "Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A,
RT   KCNE1, and KCNE2.";
RL   Circulation 102:1178-1185(2000).
RN   [52]
RP   VARIANTS LQT1 PRO-191; SER-275; LEU-277 AND VAL-306.
RX   PubMed=12442276; DOI=10.1002/humu.9085;
RA   Liu W., Yang J., Hu D., Kang C., Li C., Zhang S., Li P., Chen Z.,
RA   Qin X., Ying K., Li Y., Li Y., Li Z., Cheng X., Li L., Qi Y., Chen S.,
RA   Wang Q.;
RT   "KCNQ1 and KCNH2 mutations associated with long QT syndrome in a
RT   Chinese population.";
RL   Hum. Mutat. 20:475-476(2002).
RN   [53]
RP   VARIANT ATFB3 GLY-140.
RX   PubMed=12522251; DOI=10.1126/science.1077771;
RA   Chen Y.-H., Xu S.-J., Bendahhou S., Wang X.-L., Wang Y., Xu W.-Y.,
RA   Jin H.-W., Sun H., Su X.-Y., Zhuang Q.-N., Yang Y.-Q., Li Y.-B.,
RA   Liu Y., Xu H.-J., Li X.-F., Ma N., Mou C.-P., Chen Z., Barhanin J.,
RA   Huang W.;
RT   "KCNQ1 gain-of-function mutation in familial atrial fibrillation.";
RL   Science 299:251-254(2003).
RN   [54]
RP   VARIANT SQT2 LEU-307, AND CHARACTERIZATION OF VARIANT SQT2 LEU-307.
RX   PubMed=15159330; DOI=10.1161/01.CIR.0000130409.72142.FE;
RA   Bellocq C., van Ginneken A.C.G., Bezzina C.R., Alders M., Escande D.,
RA   Mannens M.M.A.M., Baro I., Wilde A.A.M.;
RT   "Mutation in the KCNQ1 gene leading to the short QT-interval
RT   syndrome.";
RL   Circulation 109:2394-2397(2004).
RN   [55]
RP   VARIANTS LQT1 71-ALA--PRO-73 DEL; THR-73; GLY-115; TYR-122; ILE-133;
RP   PHE-136; LYS-160; ARG-168; CYS-174; GLN-190; PHE-204; LEU-225;
RP   ASN-235; ASN-242; CYS-243; MET-254; 254-VAL--PHE-256 DEL; CYS-259;
RP   LEU-259; ASP-261; PRO-266; SER-269; ASP-269; PHE-273; ARG-273; SER-276
RP   DEL; LEU-277; HIS-278; LYS-290; ASP-292; CYS-293; VAL-302; ARG-304;
RP   SER-305; ILE-312; SER-314; ARG-314; ASP-314; CYS-315; ARG-316;
RP   ALA-322; PHE-339 DEL; VAL-341; SER-343; GLU-344; VAL-344; GLU-345;
RP   TRP-349; PRO-353; ARG-362; TRP-366; HIS-374; SER-380; TYR-389;
RP   TRP-452; GLY-524; GLU-526; TRP-539; LEU-546; CYS-555; HIS-555;
RP   TYR-566; SER-567; ARG-568; MET-587; THR-590; HIS-591; GLN-594; MET-619
RP   AND SER-626.
RX   PubMed=15840476; DOI=10.1016/j.hrthm.2005.01.020;
RA   Tester D.J., Will M.L., Haglund C.M., Ackerman M.J.;
RT   "Compendium of cardiac channel mutations in 541 consecutive unrelated
RT   patients referred for long QT syndrome genetic testing.";
RL   Heart Rhythm 2:507-517(2005).
RN   [56]
RP   VARIANTS LQT1 THR-46; PHE-137; LYS-146; ASP-173; PRO-174; TRP-190;
RP   PRO-192; HIS-202; MET-204; PHE-209; MET-215; HIS-231; PRO-239;
RP   LEU-254; ARG-258; ASN-258; VAL-262; ASP-272; TRP-277; GLU-280;
RP   GLU-287; THR-302; ASP-308; GLU-316; MET-322; ARG-343; LEU-343;
RP   PRO-349; ARG-350; SER-351; THR-360; ASP-372; MET-393; GLY-518;
RP   PRO-518; ASP-548; ALA-554; THR-567; LEU-573; HIS-583 AND ASP-586.
RX   PubMed=16414944; DOI=10.1001/jama.294.23.2975;
RA   Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E.,
RA   Nastoli J., Bottelli G., Cerrone M., Leonardi S.;
RT   "Genetic testing in the long QT syndrome: development and validation
RT   of an efficient approach to genotyping in clinical practice.";
RL   JAMA 294:2975-2980(2005).
RN   [57]
RP   VARIANTS LQT1 CYS-231; PRO-243; CYS-259; HIS-259; PHE-273; SER-314;
RP   GLU-316; VAL-341; VAL-344 AND SER-626.
RX   PubMed=16922724; DOI=10.1111/j.1399-0004.2006.00671.x;
RA   Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P.,
RA   Kugener B., Fayol L., Gonzalez Armengod C., Oddou B., Chanavat V.,
RA   Froidefond E., Perraudin R., Rousson R., Rodriguez-Lafrasse C.;
RT   "Spectrum of pathogenic mutations and associated polymorphisms in a
RT   cohort of 44 unrelated patients with long QT syndrome.";
RL   Clin. Genet. 70:214-227(2006).
RN   [58]
RP   VARIANT JLNS1 MET-322, AND VARIANT LQT1 MET-322.
RX   PubMed=18400097; DOI=10.1186/1471-2350-9-24;
RA   Zhang S., Yin K., Ren X., Wang P., Zhang S., Cheng L., Yang J.,
RA   Liu J.Y., Liu M., Wang Q.K.;
RT   "Identification of a novel KCNQ1 mutation associated with both Jervell
RT   and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a
RT   Chinese family.";
RL   BMC Med. Genet. 9:24-24(2008).
RN   [59]
RP   VARIANT JLNS1 PHE-248, AND CHARACTERIZATION OF VARIANT JLNS1 PHE-248.
RX   PubMed=18441444; DOI=10.1253/circj.72.687;
RA   Ohno S., Kubota T., Yoshida H., Tsuji K., Makiyama T., Yamada S.,
RA   Kuga K., Yamaguchi I., Kita T., Horie M.;
RT   "A novel mutation associated with Jervell and Lange-Nielsen syndrome
RT   in a Japanese family.";
RL   Circ. J. 72:687-693(2008).
RN   [60]
RP   INVOLVEMENT IN NIDDM.
RX   PubMed=18711367; DOI=10.1038/ng.207;
RA   Yasuda K., Miyake K., Horikawa Y., Hara K., Osawa H., Furuta H.,
RA   Hirota Y., Mori H., Jonsson A., Sato Y., Yamagata K., Hinokio Y.,
RA   Wang H.Y., Tanahashi T., Nakamura N., Oka Y., Iwasaki N., Iwamoto Y.,
RA   Yamada Y., Seino Y., Maegawa H., Kashiwagi A., Takeda J., Maeda E.,
RA   Shin H.D., Cho Y.M., Park K.S., Lee H.K., Ng M.C., Ma R.C., So W.Y.,
RA   Chan J.C., Lyssenko V., Tuomi T., Nilsson P., Groop L., Kamatani N.,
RA   Sekine A., Nakamura Y., Yamamoto K., Yoshida T., Tokunaga K.,
RA   Itakura M., Makino H., Nanjo K., Kadowaki T., Kasuga M.;
RT   "Variants in KCNQ1 are associated with susceptibility to type 2
RT   diabetes mellitus.";
RL   Nat. Genet. 40:1092-1097(2008).
RN   [61]
RP   INVOLVEMENT IN NIDDM.
RX   PubMed=18711366; DOI=10.1038/ng.208;
RA   Unoki H., Takahashi A., Kawaguchi T., Hara K., Horikoshi M.,
RA   Andersen G., Ng D.P., Holmkvist J., Borch-Johnsen K., Jorgensen T.,
RA   Sandbaek A., Lauritzen T., Hansen T., Nurbaya S., Tsunoda T., Kubo M.,
RA   Babazono T., Hirose H., Hayashi M., Iwamoto Y., Kashiwagi A., Kaku K.,
RA   Kawamori R., Tai E.S., Pedersen O., Kamatani N., Kadowaki T.,
RA   Kikkawa R., Nakamura Y., Maeda S.;
RT   "SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes
RT   in East Asian and European populations.";
RL   Nat. Genet. 40:1098-1102(2008).
RN   [62]
RP   INVOLVEMENT IN NIDDM.
RX   PubMed=24390345; DOI=10.1038/nature12828;
RG   The SIGMA Type 2 Diabetes Consortium;
RT   "Sequence variants in SLC16A11 are a common risk factor for type 2
RT   diabetes in Mexico.";
RL   Nature 506:97-101(2014).
RN   [63]
RP   VARIANTS LQT1 VAL-2; SER-7; THR-46; 64-PRO--PRO-70 DEL; PHE-66;
RP   THR-73; CYS-111; LEU-117; LEU-127; ILE-133; PRO-134; ALA-144; MET-153;
RP   MET-162; ARG-168; MET-172; CYS-174; HIS-174; THR-178; SER-179;
RP   HIS-184; ARG-186; GLN-190; LEU-190; TRP-195; VAL-198; ALA-199;
RP   MET-204; MET-215; MET-224; LEU-225; CYS-231; HIS-231; ASN-235;
RP   GLY-241; ASN-242; CYS-243; PRO-250; MET-254; CYS-259; LEU-259;
RP   VAL-262; PRO-266; SER-268; ASP-269; SER-269; ASP-272; PHE-273;
RP   VAL-274; LEU-277; PRO-277; GLU-280; CYS-281; PRO-282; GLY-283;
RP   ASP-292; CYS-293; GLU-302; VAL-302; PRO-303; ARG-305; SER-305;
RP   ARG-306; ILE-312; CYS-314; SER-314; CYS-315; VAL-316; SER-320;
RP   ALA-322; MET-322; ARG-325; TYR-339; GLU-341; GLY-341; VAL-341;
RP   PHE-342; LEU-343; ARG-350; SER-351; ARG-354; MET-360; ARG-362;
RP   HIS-365; GLN-366; TRP-366; HIS-374; GLY-379; LYS-385; PRO-389; THR-391
RP   INS; TRP-397; ARG-398; GLU-446; LEU-448; TRP-451; SER-460; LEU-477;
RP   TRP-511; GLN-518; ARG-520; SER-522; GLY-524; THR-525; VAL-525;
RP   TRP-533; GLN-539; TRP-539; ILE-541; LYS-543; LEU-546; ARG-547;
RP   CYS-555; HIS-555; SER-555; GLU-557; PHE-566; PRO-566; TYR-566;
RP   THR-567; ARG-568; GLU-569; LEU-571; MET-587; ASP-589; CYS-591;
RP   HIS-591; GLN-594; PRO-594; GLU-596 DEL; LYS-596; MET-600; ASN-611;
RP   HIS-614 DEL; SER-626 AND ARG-635.
RX   PubMed=19716085; DOI=10.1016/j.hrthm.2009.05.021;
RA   Kapplinger J.D., Tester D.J., Salisbury B.A., Carr J.L.,
RA   Harris-Kerr C., Pollevick G.D., Wilde A.A., Ackerman M.J.;
RT   "Spectrum and prevalence of mutations from the first 2,500 consecutive
RT   unrelated patients referred for the FAMILION long QT syndrome genetic
RT   test.";
RL   Heart Rhythm 6:1297-1303(2009).
RN   [64]
RP   VARIANT LQT1 HIS-320, AND CHARACTERIZATION OF VARIANTS LQT1 ALA-320
RP   AND HIS-320.
RX   PubMed=19540844; DOI=10.1016/j.yjmcc.2009.06.009;
RA   Thomas D., Khalil M., Alter M., Schweizer P.A., Karle C.A.,
RA   Wimmer A.B., Licka M., Katus H.A., Koenen M., Ulmer H.E., Zehelein J.;
RT   "Biophysical characterization of KCNQ1 P320 mutations linked to long
RT   QT syndrome 1.";
RL   J. Mol. Cell. Cardiol. 48:230-237(2010).
RN   [65]
RP   VARIANT LQT1 LEU-277, AND CHARACTERIZATION OF VARIANT LQT1 LEU-277.
RX   PubMed=21241800; DOI=10.1016/j.bbadis.2011.01.008;
RA   Aidery P., Kisselbach J., Schweizer P.A., Becker R., Katus H.A.,
RA   Thomas D.;
RT   "Biophysical properties of mutant KCNQ1 S277L channels linked to
RT   hereditary long QT syndrome with phenotypic variability.";
RL   Biochim. Biophys. Acta 1812:488-494(2011).
RN   [66]
RP   VARIANT LQT1 GLU-557, AND CHARACTERIZATION OF VARIANT LQT1 GLU-557.
RX   PubMed=25139741; DOI=10.1093/cvr/cvu191;
RA   Spaetjens R.L., Bebarova M., Seyen S.R., Lentink V., Jongbloed R.J.,
RA   Arens Y.H., Heijman J., Volders P.G.;
RT   "Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs,
RT   but preserved cAMP-dependent up-regulation.";
RL   Cardiovasc. Res. 104:216-225(2014).
RN   [67]
RP   VARIANTS LQT1 ASN-235; CYS-315 AND ALA-322, AND CHARACTERIZATION OF
RP   VARIANT LQT1 ASN-235.
RX   PubMed=24269949; DOI=10.1016/j.hrthm.2013.11.021;
RA   Bartos D.C., Giudicessi J.R., Tester D.J., Ackerman M.J., Ohno S.,
RA   Horie M., Gollob M.H., Burgess D.E., Delisle B.P.;
RT   "A KCNQ1 mutation contributes to the concealed type 1 long QT
RT   phenotype by limiting the Kv7.1 channel conformational changes
RT   associated with protein kinase A phosphorylation.";
RL   Heart Rhythm 11:459-468(2014).
RN   [68]
RP   VARIANT LQT1 SER-269, AND CHARACTERIZATION OF VARIANT LQT1 SER-269.
RX   PubMed=24184248; DOI=10.1016/j.jacc.2013.08.1648;
RA   Wu J., Naiki N., Ding W.G., Ohno S., Kato K., Zang W.J., Delisle B.P.,
RA   Matsuura H., Horie M.;
RT   "A molecular mechanism for adrenergic-induced long QT syndrome.";
RL   J. Am. Coll. Cardiol. 63:819-827(2014).
RN   [69]
RP   CHARACTERIZATION OF VARIANTS LQT1 LEU-546; CYS-555; HIS-555; GLU-557
RP   AND ASP-589, INTERACTION WITH KCNE1 AND AKAP9, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=25037568; DOI=10.1242/jcs.147033;
RA   Dvir M., Strulovich R., Sachyani D., Ben-Tal Cohen I., Haitin Y.,
RA   Dessauer C., Pongs O., Kass R., Hirsch J.A., Attali B.;
RT   "Long QT mutations at the interface between KCNQ1 helix C and KCNE1
RT   disrupt I(KS) regulation by PKA and PIP(2).";
RL   J. Cell Sci. 127:3943-3955(2014).
RN   [70]
RP   VARIANT LQT1 THR-590, AND CHARACTERIZATION OF VARIANT LQT1 THR-590.
RX   PubMed=24713462; DOI=10.1016/j.yjmcc.2014.03.019;
RA   Kinoshita K., Komatsu T., Nishide K., Hata Y., Hisajima N.,
RA   Takahashi H., Kimoto K., Aonuma K., Tsushima E., Tabata T.,
RA   Yoshida T., Mori H., Nishida K., Yamaguchi Y., Ichida F.,
RA   Fukurotani K., Inoue H., Nishida N.;
RT   "A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel
RT   trafficking and function but not Yotiao interaction.";
RL   J. Mol. Cell. Cardiol. 72:273-280(2014).
RN   [71]
RP   CHARACTERIZATION OF VARIANTS LQT1 ASN-242; PRO-243; HIS-250; VAL-306;
RP   ASN-317; ASP-586 AND MET-619, AND CHARACTERIZATION OF VARIANTS JLNS1
RP   PHE-248; ILE-311; MET-322 AND ASP-589.
RX   PubMed=25705178; DOI=10.3389/fncel.2015.00032;
RA   Mousavi Nik A., Gharaie S., Jeong Kim H.;
RT   "Cellular mechanisms of mutations in Kv7.1: auditory functions in
RT   Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome.";
RL   Front. Cell. Neurosci. 9:32-32(2015).
CC   -!- FUNCTION: Potassium channel that plays an important role in a
CC       number of tissues, including heart, inner ear, stomach and colon
CC       (By similarity) (PubMed:10646604). Associates with KCNE beta
CC       subunits that modulates current kinetics (By similarity)
CC       (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604,
CC       PubMed:11101505, PubMed:19687231). Induces a voltage-dependent by
CC       rapidly activating and slowly deactivating potassium-selective
CC       outward current (By similarity) (PubMed:9312006, PubMed:9108097,
CC       PubMed:8900283, PubMed:10646604, PubMed:11101505). Promotes also a
CC       delayed voltage activated potassium current showing outward
CC       rectification characteristic (By similarity). During beta-
CC       adrenergic receptor stimulation participates in cardiac
CC       repolarization by associating with KCNE1 to form the I(Ks) cardiac
CC       potassium current that increases the amplitude and slows down the
CC       activation kinetics of outward potassium current I(Ks) (By
CC       similarity) (PubMed:9312006, PubMed:9108097, PubMed:8900283,
CC       PubMed:10646604, PubMed:11101505). Muscarinic agonist
CC       oxotremorine-M strongly suppresses KCNQ1/KCNE1 current
CC       (PubMed:10713961). When associated with KCNE3, forms the potassium
CC       channel that is important for cyclic AMP-stimulated intestinal
CC       secretion of chloride ions (PubMed:10646604). This interaction
CC       with KCNE3 is reduced by 17beta-estradiol, resulting in the
CC       reduction of currents (By similarity). During conditions of
CC       increased substrate load, maintains the driving force for proximal
CC       tubular and intestinal sodium ions absorption, gastric acid
CC       secretion, and cAMP-induced jejunal chloride ions secretion (By
CC       similarity). Allows the provision of potassium ions to the luminal
CC       membrane of the secretory canaliculus in the resting state as well
CC       as during stimulated acid secretion (By similarity). When
CC       associated with KCNE2, forms a heterooligomer complex leading to
CC       currents with an apparently instantaneous activation, a rapid
CC       deactivation process and a linear current-voltage relationship and
CC       decreases the amplitude of the outward current (PubMed:11101505).
CC       When associated with KCNE4, inhibits voltage-gated potassium
CC       channel activity (PubMed:19687231). When associated with KCNE5,
CC       this complex only conducts current upon strong and continued
CC       depolarization (PubMed:12324418). Also forms a heterotetramer with
CC       KCNQ5; has a voltage-gated potassium channel activity
CC       (PubMed:24855057). Binds with phosphatidylinositol 4,5-
CC       bisphosphate (PubMed:25037568). {ECO:0000250|UniProtKB:P97414,
CC       ECO:0000250|UniProtKB:Q9Z0N7, ECO:0000269|PubMed:10646604,
CC       ECO:0000269|PubMed:10713961, ECO:0000269|PubMed:11101505,
CC       ECO:0000269|PubMed:12324418, ECO:0000269|PubMed:19687231,
CC       ECO:0000269|PubMed:24855057, ECO:0000269|PubMed:25037568,
CC       ECO:0000269|PubMed:8900283, ECO:0000269|PubMed:9108097,
CC       ECO:0000269|PubMed:9312006}.
CC   -!- FUNCTION: Isoform 2: Non-functional alone but modulatory when
CC       coexpressed with the full-length isoform 1.
CC       {ECO:0000269|PubMed:9305853}.
CC   -!- SUBUNIT: Tetramer (PubMed:18165683, PubMed:19693805).
CC       Heterotetramer with KCNE1; targets to the membrane raft
CC       (PubMed:25037568, PubMed:19693805, PubMed:20533308). Interacts
CC       (via C-terminus) with CALM; forms a heterotetramer in a calcium-
CC       independent manner (PubMed:18165683). Interacts with AKAP9;
CC       targets protein kinase A (PKA) catalytic and regulatory subunits
CC       and protein phosphatase 1 (PP1) to the KCNQ1-KCNE1 complex,
CC       allowing PKA-mediated phosphorylation and increase of delayed
CC       rectifier potassium channel activity (PubMed:11799244,
CC       PubMed:25037568). Interacts with KCNE2; forms a heterooligomer
CC       complex that targets to the membrane raft and leading to currents
CC       with an apparently instantaneous activation, a rapid deactivation
CC       process and a linear current-voltage relationship and decreases
CC       the amplitude of the outward current (PubMed:11101505,
CC       PubMed:20533308). Interacts with AP2M1; mediates estrogen-induced
CC       internalization via clathrin-coated vesicles (PubMed:23529131).
CC       Interacts with NEDD4L; promotes internalization and decreases
CC       I(Ks) currents (PubMed:23529131, PubMed:22024150). Interacts with
CC       USP2; counteracts the NEDD4L-specific down-regulation of I(Ks) and
CC       restore plasma membrane localization (PubMed:22024150).
CC       Heterotetramer with KCNQ5; has a voltage-gated potassium channel
CC       activity (PubMed:24855057). Interacts with KCNE3; alters membrane
CC       raft localization (PubMed:20533308). Interacts with KCNE4; impairs
CC       KCNQ1 localization in lipid rafts and inhibits voltage-gated
CC       potassium channel activity (PubMed:19687231, PubMed:20533308).
CC       Interacts with KCNE5; impairs KCNQ1 localization in lipid rafts
CC       and only conducts current upon strong and continued depolarization
CC       (PubMed:20533308, PubMed:12324418). {ECO:0000269|PubMed:11101505,
CC       ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12324418,
CC       ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:19687231,
CC       ECO:0000269|PubMed:19693805, ECO:0000269|PubMed:20533308,
CC       ECO:0000269|PubMed:22024150, ECO:0000269|PubMed:23529131,
CC       ECO:0000269|PubMed:24855057, ECO:0000269|PubMed:25037568}.
CC   -!- INTERACTION:
CC       P15382:KCNE1; NbExp=4; IntAct=EBI-359667, EBI-7043557;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10646604,
CC       ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:21228319,
CC       ECO:0000269|PubMed:22024150, ECO:0000269|PubMed:25037568}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:18165683}. Cytoplasmic
CC       vesicle membrane {ECO:0000269|PubMed:18165683,
CC       ECO:0000269|PubMed:23529131}. Early endosome
CC       {ECO:0000269|PubMed:23529131}. Membrane raft
CC       {ECO:0000269|PubMed:20533308, ECO:0000269|PubMed:24855057}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:21228319,
CC       ECO:0000269|PubMed:24855057}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:21228319}. Note=Colocalized with KCNE3 at the
CC       plasma membrane (PubMed:10646604). Upon 17beta-oestradiol
CC       treatment, colocalizes with RAB5A at early endosome
CC       (PubMed:23529131). Heterotetramer with KCNQ5 is highly retained at
CC       the endoplasmic reticulum and is localized outside of lipid raft
CC       microdomains (PubMed:24855057). During the early stages of
CC       epithelial cell polarization induced by the calcium switch it
CC       removed from plasma membrane to the endoplasmic reticulum where it
CC       retained and it is redistributed to the basolateral cell surface
CC       in a PI3K-dependent manner at a later stage (PubMed:21228319).
CC       {ECO:0000269|PubMed:10646604, ECO:0000269|PubMed:21228319,
CC       ECO:0000269|PubMed:23529131, ECO:0000269|PubMed:24855057}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P51787-1; Sequence=Displayed;
CC       Name=2; Synonyms=TKvLQT1;
CC         IsoId=P51787-2; Sequence=VSP_000981, VSP_000982;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in heart, pancreas,
CC       prostate, kidney, small intestine and peripheral blood leukocytes.
CC       Less abundant in placenta, lung, spleen, colon, thymus, testis and
CC       ovaries.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DOMAIN: The coiled-coil domain mediates tetramerization.
CC       {ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:19693805}.
CC   -!- DOMAIN: The segment S6 is involved in the inhibition of voltage-
CC       gated potassium channel activity by KCNE4.
CC       {ECO:0000269|PubMed:19687231}.
CC   -!- DOMAIN: The C-terminal assembly domain promotes self-interactiona;
CC       allows functional channel. {ECO:0000269|PubMed:10654932}.
CC   -!- PTM: Phosphorylation at Ser-27 by PKA; increases delayed rectifier
CC       potassium channel activity of the KCNQ1-KCNE1 complex through a
CC       macromolecular complex that includes PKA, PP1, and the targeting
CC       protein AKAP9. {ECO:0000269|PubMed:11799244,
CC       ECO:0000269|PubMed:25037568}.
CC   -!- PTM: Ubiquitinated by NEDD4L; promotes internalization
CC       (PubMed:22024150). The ubiquitinylated form is internalized
CC       through a clathrin-mediated endocytosis by interacting with AP2M1
CC       and is recycled back to the cell membrane via RAB4A and RAB11A
CC       (PubMed:23529131). {ECO:0000269|PubMed:22024150,
CC       ECO:0000269|PubMed:23529131}.
CC   -!- PTM: Deubiquitinated by USP2; counteracts the NEDD4L-specific
CC       down-regulation of I(Ks) and restores the membrane localization.
CC       {ECO:0000269|PubMed:22024150}.
CC   -!- DISEASE: Long QT syndrome 1 (LQT1) [MIM:192500]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:10024302, ECO:0000269|PubMed:10220144,
CC       ECO:0000269|PubMed:10220146, ECO:0000269|PubMed:10367071,
CC       ECO:0000269|PubMed:10409658, ECO:0000269|PubMed:10482963,
CC       ECO:0000269|PubMed:10728423, ECO:0000269|PubMed:10973849,
CC       ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12442276,
CC       ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16414944,
CC       ECO:0000269|PubMed:16922724, ECO:0000269|PubMed:18165683,
CC       ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:19540844,
CC       ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:21241800,
CC       ECO:0000269|PubMed:24184248, ECO:0000269|PubMed:24269949,
CC       ECO:0000269|PubMed:24713462, ECO:0000269|PubMed:25037568,
CC       ECO:0000269|PubMed:25139741, ECO:0000269|PubMed:25705178,
CC       ECO:0000269|PubMed:8528244, ECO:0000269|PubMed:8818942,
CC       ECO:0000269|PubMed:8872472, ECO:0000269|PubMed:9024139,
CC       ECO:0000269|PubMed:9272155, ECO:0000269|PubMed:9302275,
CC       ECO:0000269|PubMed:9312006, ECO:0000269|PubMed:9323054,
CC       ECO:0000269|PubMed:9386136, ECO:0000269|PubMed:9482580,
CC       ECO:0000269|PubMed:9570196, ECO:0000269|PubMed:9641694,
CC       ECO:0000269|PubMed:9693036, ECO:0000269|PubMed:9702906,
CC       ECO:0000269|PubMed:9799083, ECO:0000269|PubMed:9927399,
CC       ECO:0000269|Ref.31}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Jervell and Lange-Nielsen syndrome 1 (JLNS1)
CC       [MIM:220400]: An autosomal recessive disorder characterized by
CC       congenital deafness, prolongation of the QT interval, syncopal
CC       attacks due to ventricular arrhythmias, and a high risk of sudden
CC       death. {ECO:0000269|PubMed:10090886, ECO:0000269|PubMed:10728423,
CC       ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:18441444,
CC       ECO:0000269|PubMed:25705178, ECO:0000269|PubMed:9781056}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554]: An
CC       autosomal dominant form of atrial fibrillation, a common sustained
CC       cardiac rhythm disturbance. Atrial fibrillation is characterized
CC       by disorganized atrial electrical activity and ineffective atrial
CC       contraction promoting blood stasis in the atria and reduces
CC       ventricular filling. It can result in palpitations, syncope,
CC       thromboembolic stroke, and congestive heart failure.
CC       {ECO:0000269|PubMed:12522251}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Short QT syndrome 2 (SQT2) [MIM:609621]: A heart disorder
CC       characterized by idiopathic persistently and uniformly short QT
CC       interval on ECG in the absence of structural heart disease in
CC       affected individuals. It causes syncope and sudden death.
CC       {ECO:0000269|PubMed:15159330}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:18711366,
CC       ECO:0000269|PubMed:18711367, ECO:0000269|PubMed:24390345}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out by
CC       expressing in Xenopus oocytes or COS-7 cells KCNQ1 mutants either
CC       individually (homomultimers) or in combination with both wild-type
CC       KCNQ1 (mut/wt homomultimers) and minK (heteromultimers).
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT
CC       (TC 1.A.1.15) subfamily. Kv7.1/KCNQ1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51781.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=BAA34739.1; Type=Frameshift; Positions=129, 159; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=KvLQT1 entry;
CC       URL="https://en.wikipedia.org/wiki/KvLQT1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000571; AAC51776.1; -; mRNA.
DR   EMBL; AF051426; AAC05705.1; -; mRNA.
DR   EMBL; AB015163; BAA34738.1; -; Genomic_DNA.
DR   EMBL; AB015163; BAA34739.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AJ006345; CAB44649.1; -; Genomic_DNA.
DR   EMBL; AJ006345; CAB44650.1; -; Genomic_DNA.
DR   EMBL; AY114213; AAM94040.1; -; mRNA.
DR   EMBL; AK290618; BAF83307.1; -; mRNA.
DR   EMBL; AC013791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021424; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP006463; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455303; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455306; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459741; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471158; EAX02517.1; -; Genomic_DNA.
DR   EMBL; BC113545; AAI13546.1; -; mRNA.
DR   EMBL; U86146; AAB53974.1; -; mRNA.
DR   EMBL; U89364; AAC51781.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS7736.1; -. [P51787-1]
DR   RefSeq; NP_000209.2; NM_000218.2. [P51787-1]
DR   RefSeq; NP_861463.1; NM_181798.1. [P51787-2]
DR   UniGene; Hs.95162; -.
DR   PDB; 3BJ4; X-ray; 2.00 A; A/B=574-622.
DR   PDB; 3HFC; X-ray; 2.45 A; A/B/C=583-611.
DR   PDB; 3HFE; X-ray; 1.70 A; A/B/C=583-611.
DR   PDB; 4UMO; X-ray; 3.00 A; A/B=352-539.
DR   PDB; 4V0C; X-ray; 2.86 A; A/B=352-539.
DR   PDBsum; 3BJ4; -.
DR   PDBsum; 3HFC; -.
DR   PDBsum; 3HFE; -.
DR   PDBsum; 4UMO; -.
DR   PDBsum; 4V0C; -.
DR   ProteinModelPortal; P51787; -.
DR   SMR; P51787; -.
DR   BioGrid; 109985; 15.
DR   DIP; DIP-27591N; -.
DR   DIP; DIP-29941N; -.
DR   IntAct; P51787; 4.
DR   MINT; MINT-1145466; -.
DR   STRING; 9606.ENSP00000155840; -.
DR   BindingDB; P51787; -.
DR   ChEMBL; CHEMBL1866; -.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00808; Indapamide.
DR   GuidetoPHARMACOLOGY; 560; -.
DR   TCDB; 1.A.1.15.6; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P51787; -.
DR   PhosphoSitePlus; P51787; -.
DR   BioMuta; KCNQ1; -.
DR   DMDM; 6166005; -.
DR   PaxDb; P51787; -.
DR   PeptideAtlas; P51787; -.
DR   PRIDE; P51787; -.
DR   DNASU; 3784; -.
DR   Ensembl; ENST00000155840; ENSP00000155840; ENSG00000053918. [P51787-1]
DR   Ensembl; ENST00000335475; ENSP00000334497; ENSG00000053918. [P51787-2]
DR   GeneID; 3784; -.
DR   KEGG; hsa:3784; -.
DR   UCSC; uc001lwn.4; human. [P51787-1]
DR   CTD; 3784; -.
DR   DisGeNET; 3784; -.
DR   GeneCards; KCNQ1; -.
DR   GeneReviews; KCNQ1; -.
DR   HGNC; HGNC:6294; KCNQ1.
DR   HPA; CAB018656; -.
DR   HPA; HPA048553; -.
DR   MalaCards; KCNQ1; -.
DR   MIM; 125853; phenotype.
DR   MIM; 192500; phenotype.
DR   MIM; 220400; phenotype.
DR   MIM; 607542; gene.
DR   MIM; 607554; phenotype.
DR   MIM; 609621; phenotype.
DR   neXtProt; NX_P51787; -.
DR   OpenTargets; ENSG00000053918; -.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 51083; Familial short QT syndrome.
DR   Orphanet; 90647; Jervell and Lange-Nielsen syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA223; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; P51787; -.
DR   KO; K04926; -.
DR   OMA; EVSTPHF; -.
DR   OrthoDB; EOG090B03AO; -.
DR   PhylomeDB; P51787; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   SignaLink; P51787; -.
DR   ChiTaRS; KCNQ1; human.
DR   EvolutionaryTrace; P51787; -.
DR   GeneWiki; KvLQT1; -.
DR   GenomeRNAi; 3784; -.
DR   PRO; PR:P51787; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000053918; -.
DR   CleanEx; HS_KCNQ1; -.
DR   ExpressionAtlas; P51787; baseline and differential.
DR   Genevisible; P51787; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005769; C:early endosome; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0034702; C:ion channel complex; IPI:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:BHF-UCL.
DR   GO; GO:0005764; C:lysosome; IDA:BHF-UCL.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IDA:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IDA:BHF-UCL.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IDA:BHF-UCL.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0072358; P:cardiovascular system development; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IDA:BHF-UCL.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; TAS:BHF-UCL.
DR   GO; GO:0016458; P:gene silencing; IEA:Ensembl.
DR   GO; GO:0048839; P:inner ear development; ISS:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; ISS:UniProtKB.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0098914; P:membrane repolarization during atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:1903817; P:negative regulation of voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0010460; P:positive regulation of heart rate; IMP:BHF-UCL.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0060453; P:regulation of gastric acid secretion; ISS:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl.
DR   GO; GO:0008016; P:regulation of heart contraction; IC:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0070293; P:renal absorption; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR005827; K_chnl_volt-dep_KCQN1.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF189; PTHR11537:SF189; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01460; KCNQ1CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Atrial fibrillation;
KW   Calmodulin-binding; Cell membrane; Coiled coil; Complete proteome;
KW   Cytoplasmic vesicle; Deafness; Diabetes mellitus; Disease mutation;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Ion channel;
KW   Ion transport; Long QT syndrome; Membrane; Phosphoprotein;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Short QT syndrome; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN         1    676       Potassium voltage-gated channel subfamily
FT                                KQT member 1.
FT                                /FTId=PRO_0000054022.
FT   TRANSMEM    122    142       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    143    147       Extracellular. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    169    196       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    197    217       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    218    225       Extracellular. {ECO:0000255}.
FT   TRANSMEM    226    248       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    249    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    283    299       Extracellular. {ECO:0000255}.
FT   INTRAMEM    300    320       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    321    327       Extracellular. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    349    676       Cytoplasmic. {ECO:0000255}.
FT   REGION      535    572       Interaction with KCNE1 C-terminus.
FT                                {ECO:0000269|PubMed:25037568}.
FT   REGION      588    616       Interaction with AKAP9.
FT                                {ECO:0000269|PubMed:11799244}.
FT   REGION      589    620       C-terminal assembly domain.
FT                                {ECO:0000269|PubMed:10654932}.
FT   COILED      585    621       {ECO:0000269|PubMed:19693805}.
FT   MOTIF       312    317       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      27     27       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:11799244}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97414}.
FT   MOD_RES     409    409       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97414}.
FT   CARBOHYD    289    289       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ       1    127       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9305853}.
FT                                /FTId=VSP_000981.
FT   VAR_SEQ     128    129       AV -> MD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9305853}.
FT                                /FTId=VSP_000982.
FT   VARIANT       2      2       A -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473442).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074927.
FT   VARIANT       7      7       P -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473443).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074928.
FT   VARIANT      46     46       A -> T (in LQT1; dbSNP:rs199473671).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074929.
FT   VARIANT      64     70       Missing (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074930.
FT   VARIANT      66     66       S -> F (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473446).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074931.
FT   VARIANT      71     73       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_009917.
FT   VARIANT      73     73       P -> T (in LQT1; dbSNP:rs199472676).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068287.
FT   VARIANT     111    111       Y -> C (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472678).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009918.
FT   VARIANT     115    115       E -> G (in LQT1; dbSNP:rs199472679).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068288.
FT   VARIANT     117    117       P -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074191).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074932.
FT   VARIANT     122    122       C -> Y (in LQT1; dbSNP:rs199472681).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068289.
FT   VARIANT     127    127       F -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472682).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074933.
FT   VARIANT     133    133       V -> I (in LQT1; dbSNP:rs199473449).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068290.
FT   VARIANT     134    134       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472685).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074934.
FT   VARIANT     136    136       C -> F (in LQT1; dbSNP:rs199472686).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068291.
FT   VARIANT     137    137       L -> F (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473450).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074935.
FT   VARIANT     140    140       S -> G (in ATFB3; gain of function;
FT                                dbSNP:rs120074192).
FT                                {ECO:0000269|PubMed:12522251}.
FT                                /FTId=VAR_015742.
FT   VARIANT     144    144       T -> A (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473451).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074936.
FT   VARIANT     146    146       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472688).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074937.
FT   VARIANT     153    153       T -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs143709408).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074938.
FT   VARIANT     157    157       F -> C (in LQT1; dbSNP:rs199472690).
FT                                {ECO:0000269|PubMed:10220146}.
FT                                /FTId=VAR_008124.
FT   VARIANT     160    160       E -> K (in LQT1; dbSNP:rs199473453).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_009919.
FT   VARIANT     162    162       V -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472692).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074939.
FT   VARIANT     167    168       FG -> W (in LQT1).
FT                                /FTId=VAR_001515.
FT   VARIANT     168    168       G -> R (in LQT1; dbSNP:rs179489).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_001516.
FT   VARIANT     172    172       V -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472694).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074940.
FT   VARIANT     173    173       V -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472695).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074941.
FT   VARIANT     174    174       R -> C (in LQT1; dbSNP:rs199472696).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001517.
FT   VARIANT     174    174       R -> H (in LQT1; dbSNP:rs199472697).
FT                                {ECO:0000269|PubMed:10367071,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008939.
FT   VARIANT     174    174       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472697).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074942.
FT   VARIANT     178    178       A -> P (in LQT1; loss of channel
FT                                activity; dbSNP:rs120074177).
FT                                {ECO:0000269|PubMed:9323054}.
FT                                /FTId=VAR_001518.
FT   VARIANT     178    178       A -> T (in LQT1; dbSNP:rs120074177).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_009920.
FT   VARIANT     179    179       G -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473394).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009921.
FT   VARIANT     184    184       Y -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473661).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074943.
FT   VARIANT     184    184       Y -> S (in LQT1; dbSNP:rs199473397).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008125.
FT   VARIANT     186    186       G -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473398).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074944.
FT   VARIANT     189    189       G -> R (in LQT1; familial sudden death;
FT                                dbSNP:rs104894252).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_001519.
FT   VARIANT     190    190       R -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074178).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074945.
FT   VARIANT     190    190       R -> Q (in LQT1; loss of channel
FT                                activity; dbSNP:rs120074178).
FT                                {ECO:0000269|PubMed:10728423,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001520.
FT   VARIANT     190    190       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473662).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074946.
FT   VARIANT     191    191       L -> P (in LQT1; dbSNP:rs199473401).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074687.
FT   VARIANT     192    192       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472698).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074947.
FT   VARIANT     194    194       A -> P (in LQT1; dbSNP:rs199472699).
FT                                /FTId=VAR_009922.
FT   VARIANT     195    195       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs150172393).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074948.
FT   VARIANT     198    198       I -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472700).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074949.
FT   VARIANT     199    199       S -> A (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472701).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074950.
FT   VARIANT     202    202       D -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472702).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074951.
FT   VARIANT     204    204       I -> F (in LQT1; dbSNP:rs199472703).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068292.
FT   VARIANT     204    204       I -> M (in LQT1; dbSNP:rs199473455).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074952.
FT   VARIANT     209    209       S -> F (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472704).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074953.
FT   VARIANT     215    215       V -> M (in LQT1; dbSNP:rs17215479).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074954.
FT   VARIANT     216    216       G -> R (in LQT1).
FT                                {ECO:0000269|PubMed:9272155}.
FT                                /FTId=VAR_001521.
FT   VARIANT     224    224       T -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472706).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074955.
FT   VARIANT     225    225       S -> L (in LQT1; dbSNP:rs199473456).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9927399}.
FT                                /FTId=VAR_009923.
FT   VARIANT     231    231       R -> C (in LQT1; dbSNP:rs199473457).
FT                                {ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074956.
FT   VARIANT     231    231       R -> H (in LQT1; dbSNP:rs199472709).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074957.
FT   VARIANT     235    235       I -> N (in LQT1; decreases delayed
FT                                rectifier potassium current Iks; prevents
FT                                the up-regulation of Iks through PKA
FT                                activation; dbSNP:rs199472710).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24269949}.
FT                                /FTId=VAR_068293.
FT   VARIANT     239    239       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473458).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074958.
FT   VARIANT     241    241       V -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472711).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074959.
FT   VARIANT     242    242       D -> N (in LQT1; decreases outward
FT                                potassium current; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472712).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008940.
FT   VARIANT     243    243       R -> C (in LQT1; slower rate of
FT                                activation and voltage dependence of
FT                                activation-inactivation shifted to more
FT                                positive potentials (homomultimers);
FT                                channels non-functional
FT                                (heteromultimers); dbSNP:rs199472713).
FT                                {ECO:0000269|PubMed:10409658,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_010933.
FT   VARIANT     243    243       R -> H (in JLNS1; minor changes of wt
FT                                current (homomultimers); positive voltage
FT                                shift of the channel activation
FT                                (heteromultimers); dbSNP:rs120074196).
FT                                {ECO:0000269|PubMed:10090886,
FT                                ECO:0000269|PubMed:10728423}.
FT                                /FTId=VAR_008941.
FT   VARIANT     243    243       R -> P (in LQT1; complete loss of outward
FT                                potassium current; enhances outward
FT                                potassium current when co-transfected
FT                                with wild type; decreases plasma membrane
FT                                localization; dbSNP:rs120074196).
FT                                {ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074688.
FT   VARIANT     248    248       W -> F (in JLNS1; requires 2 nucleotide
FT                                substitutions; does not affect plasma
FT                                membrane localization; complete loss of
FT                                outward currents; enhances outward
FT                                currents when coexpressed with wild type
FT                                at equimolar ratio; dbSNP:rs397508123).
FT                                {ECO:0000269|PubMed:18441444,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074689.
FT   VARIANT     248    248       W -> R (in LQT1; slower rate of
FT                                activation and voltage dependence of
FT                                activation-inactivation shifted to more
FT                                positive potentials (homomultimers);
FT                                channels non-functional
FT                                (heteromultimers); dbSNP:rs199473459).
FT                                {ECO:0000269|PubMed:10409658}.
FT                                /FTId=VAR_008942.
FT   VARIANT     250    250       L -> H (in LQT1; complete loss of outward
FT                                potassium current; enhances outward
FT                                potassium current when co-transfected
FT                                with wild type; decreases plasma membrane
FT                                localization; dbSNP:rs199472715).
FT                                {ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008943.
FT   VARIANT     250    250       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472715).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074960.
FT   VARIANT     254    256       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068294.
FT   VARIANT     254    254       V -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074179).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074961.
FT   VARIANT     254    254       V -> M (in LQT1; associated with M-417 in
FT                                a patient; dbSNP:rs120074179).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|Ref.31}.
FT                                /FTId=VAR_001522.
FT   VARIANT     258    258       H -> N (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472717).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074962.
FT   VARIANT     258    258       H -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472718).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074963.
FT   VARIANT     259    259       R -> C (in LQT1; dbSNP:rs199472719).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068295.
FT   VARIANT     259    259       R -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472720).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_074964.
FT   VARIANT     259    259       R -> L (in LQT1; dbSNP:rs199472720).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068296.
FT   VARIANT     261    261       E -> D (in JLNS1; dbSNP:rs199472721).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_008944.
FT   VARIANT     261    261       E -> K (in LQT1; loss of channel activity
FT                                and no interaction with wt KVLQT1 or MINK
FT                                subunits; dbSNP:rs199472722).
FT                                {ECO:0000269|PubMed:10409658}.
FT                                /FTId=VAR_001523.
FT   VARIANT     262    262       L -> V (in LQT1; dbSNP:rs199472723).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074965.
FT   VARIANT     266    266       L -> P (in LQT1; dbSNP:rs199473460).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009924.
FT   VARIANT     268    268       I -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472725).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074966.
FT   VARIANT     269    269       G -> D (in LQT1; dbSNP:rs120074194).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001524.
FT   VARIANT     269    269       G -> S (in LQT1; decreases IKs amplitude;
FT                                accelerates the IKs deactivation; effect
FT                                on plasma membrane localization; reduces
FT                                up-regulation of Iks through PKA
FT                                activation; dbSNP:rs120074193).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24184248}.
FT                                /FTId=VAR_009925.
FT   VARIANT     272    272       G -> D (in LQT1; dbSNP:rs199472726).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074967.
FT   VARIANT     273    273       L -> F (in LQT1; functional channel with
FT                                reduced macroscopic conductance
FT                                (homomultimers); alteration of normal
FT                                KVLQT1 function (mut/wt homomultimers);
FT                                dbSNP:rs120074180).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9323054}.
FT                                /FTId=VAR_001525.
FT   VARIANT     273    273       L -> R (in LQT1; dbSNP:rs199472727).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068297.
FT   VARIANT     274    274       I -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472728).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074968.
FT   VARIANT     275    275       F -> S (in LQT1; dbSNP:rs199472729).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074690.
FT   VARIANT     276    276       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068298.
FT   VARIANT     277    277       S -> L (in LQT1; loss of function
FT                                mutation acting in a dominant-negative
FT                                manner; dbSNP:rs199472730).
FT                                {ECO:0000269|PubMed:12442276,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:21241800}.
FT                                /FTId=VAR_065777.
FT   VARIANT     277    277       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473461).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074969.
FT   VARIANT     277    277       S -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472730).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074970.
FT   VARIANT     278    278       Y -> H (in LQT1; dbSNP:rs199472731).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068299.
FT   VARIANT     280    280       V -> E (in LQT1; dbSNP:rs199473462).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074971.
FT   VARIANT     281    281       Y -> C (in LQT1; dbSNP:rs199472732).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9927399}.
FT                                /FTId=VAR_008945.
FT   VARIANT     282    282       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472733).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074972.
FT   VARIANT     283    283       A -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473463).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074973.
FT   VARIANT     287    287       A -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472735).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074974.
FT   VARIANT     290    290       E -> K (in LQT1; dbSNP:rs199473464).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068300.
FT   VARIANT     292    292       G -> D (in LQT1; dbSNP:rs199472736).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068301.
FT   VARIANT     293    293       R -> C (in LQT1; dbSNP:rs199472737).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068302.
FT   VARIANT     300    300       A -> T (in LQT1; dbSNP:rs120074187).
FT                                {ECO:0000269|PubMed:9641694}.
FT                                /FTId=VAR_001526.
FT   VARIANT     302    302       A -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs193922365).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074975.
FT   VARIANT     302    302       A -> T (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472739).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074976.
FT   VARIANT     302    302       A -> V (in LQT1; dbSNP:rs193922365).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068303.
FT   VARIANT     303    303       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472740).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074977.
FT   VARIANT     304    304       W -> R (in LQT1; dbSNP:rs199473466).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068304.
FT   VARIANT     305    305       W -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472741).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074978.
FT   VARIANT     305    305       W -> S (in JLNS1; dbSNP:rs120074186).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9781056}.
FT                                /FTId=VAR_001527.
FT   VARIANT     306    306       G -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074181).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001528.
FT   VARIANT     306    306       G -> V (in LQT1; complete loss of outward
FT                                potassium current; enhances outward
FT                                potassium current when co-transfected
FT                                with wild type; decreases plasma membrane
FT                                localization; dbSNP:rs199472742).
FT                                {ECO:0000269|PubMed:12442276,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074691.
FT   VARIANT     307    307       V -> L (in SQT2; gain of function;
FT                                dbSNP:rs120074195).
FT                                {ECO:0000269|PubMed:15159330}.
FT                                /FTId=VAR_023841.
FT   VARIANT     308    308       V -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473467).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074979.
FT   VARIANT     309    309       T -> R (in LQT1; dbSNP:rs199472743).
FT                                /FTId=VAR_001529.
FT   VARIANT     310    310       V -> I (in LQT1; dbSNP:rs199472745).
FT                                /FTId=VAR_009926.
FT   VARIANT     311    311       T -> I (in LQT1 and JLNS1; impairs
FT                                outward potassium current; affects plasma
FT                                membrane localization;
FT                                dbSNP:rs199472746).
FT                                {ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9482580}.
FT                                /FTId=VAR_009927.
FT   VARIANT     312    312       T -> I (in LQT1; loss of channel
FT                                activity; dbSNP:rs120074182).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9323054}.
FT                                /FTId=VAR_001530.
FT   VARIANT     313    313       I -> M (in LQT1; dbSNP:rs199472747).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_001531.
FT   VARIANT     314    314       G -> C (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074184).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074980.
FT   VARIANT     314    314       G -> D (in LQT1; dbSNP:rs199472748).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068305.
FT   VARIANT     314    314       G -> R (in LQT1; dbSNP:rs120074184).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068306.
FT   VARIANT     314    314       G -> S (in LQT1; dbSNP:rs120074184).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8872472,
FT                                ECO:0000269|PubMed:9693036,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_001532.
FT   VARIANT     315    315       Y -> C (in LQT1; dbSNP:rs74462309).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24269949,
FT                                ECO:0000269|PubMed:9693036,
FT                                ECO:0000269|PubMed:9927399}.
FT                                /FTId=VAR_008946.
FT   VARIANT     315    315       Y -> S (in LQT1; dbSNP:rs74462309).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_001533.
FT   VARIANT     316    316       G -> E (in LQT1; dbSNP:rs199472749).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_074981.
FT   VARIANT     316    316       G -> R (in LQT1; dbSNP:rs104894255).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068307.
FT   VARIANT     316    316       G -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472749).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074982.
FT   VARIANT     317    317       D -> N (in LQT1; complete loss of outward
FT                                potassium current when expressed alone
FT                                and even in the presence of the wild type
FT                                at variable ratios; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472751).
FT                                {ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9302275,
FT                                ECO:0000269|PubMed:9482580}.
FT                                /FTId=VAR_001534.
FT   VARIANT     318    318       K -> N (in LQT1; dbSNP:rs199472752).
FT                                {ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008947.
FT   VARIANT     320    320       P -> A (in LQT1; loss of function
FT                                mutation acting in a dominant-negative
FT                                manner; dbSNP:rs199472753).
FT                                {ECO:0000269|PubMed:19540844}.
FT                                /FTId=VAR_001535.
FT   VARIANT     320    320       P -> H (in LQT1; loss of function
FT                                mutation acting in a dominant-negative
FT                                manner; dbSNP:rs199473470).
FT                                {ECO:0000269|PubMed:19540844}.
FT                                /FTId=VAR_065778.
FT   VARIANT     320    320       P -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472753).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074983.
FT   VARIANT     322    322       T -> A (in LQT1; dbSNP:rs199472754).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24269949}.
FT                                /FTId=VAR_068308.
FT   VARIANT     322    322       T -> M (in JLNS1 and LQT1; impairs
FT                                outward potassium current; affects plasma
FT                                membrane localization;
FT                                dbSNP:rs199472755).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:18400097,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074692.
FT   VARIANT     325    325       G -> R (in LQT1; dbSNP:rs199472756).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_001536.
FT   VARIANT     339    339       F -> Y (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472759).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074984.
FT   VARIANT     339    339       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9702906}.
FT                                /FTId=VAR_001537.
FT   VARIANT     341    341       A -> E (in LQT1; dbSNP:rs12720459).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001538.
FT   VARIANT     341    341       A -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs12720459).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074985.
FT   VARIANT     341    341       A -> V (in LQT1; dbSNP:rs12720459).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8818942,
FT                                ECO:0000269|PubMed:8872472,
FT                                ECO:0000269|PubMed:9570196}.
FT                                /FTId=VAR_001539.
FT   VARIANT     342    342       L -> F (in LQT1; dbSNP:rs199472760).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001540.
FT   VARIANT     343    343       P -> L (in LQT1; dbSNP:rs199472761).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074986.
FT   VARIANT     343    343       P -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472761).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074987.
FT   VARIANT     343    343       P -> S (in LQT1; dbSNP:rs199472762).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068309.
FT   VARIANT     344    344       A -> E (in LQT1; dbSNP:rs199472763).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068310.
FT   VARIANT     344    344       A -> V (in LQT1; dbSNP:rs199472763).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_001541.
FT   VARIANT     345    345       G -> E (in LQT1; dbSNP:rs120074183).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_001542.
FT   VARIANT     345    345       G -> R (in LQT1; familial sudden death;
FT                                dbSNP:rs199473471).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008126.
FT   VARIANT     349    349       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472764).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074988.
FT   VARIANT     349    349       S -> W (in LQT1; dbSNP:rs199472765).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_009928.
FT   VARIANT     350    350       G -> R (in LQT1; dbSNP:rs199472824).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074989.
FT   VARIANT     351    351       F -> S (in LQT1; dbSNP:rs199473402).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074990.
FT   VARIANT     353    353       L -> P (in LQT1; dbSNP:rs199473403).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_009180.
FT   VARIANT     354    354       K -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473404).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074991.
FT   VARIANT     360    360       R -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473407).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074992.
FT   VARIANT     360    360       R -> T (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473407).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074993.
FT   VARIANT     362    362       K -> R (in LQT1; dbSNP:rs12720458).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_048025.
FT   VARIANT     365    365       N -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473409).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074994.
FT   VARIANT     366    366       R -> P (in LQT1; dbSNP:rs199473410).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_001543.
FT   VARIANT     366    366       R -> Q (in LQT1; dbSNP:rs199473410).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009929.
FT   VARIANT     366    366       R -> W (in LQT1; dbSNP:rs199473411).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008948.
FT   VARIANT     371    371       A -> T (in LQT1; dbSNP:rs199473412).
FT                                /FTId=VAR_001544.
FT   VARIANT     372    372       A -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473472).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074995.
FT   VARIANT     373    373       S -> P (in LQT1; dbSNP:rs199472766).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008127.
FT   VARIANT     374    374       L -> H (in LQT1; dbSNP:rs199472767).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068311.
FT   VARIANT     379    379       W -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472768).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074996.
FT   VARIANT     380    380       R -> S (in LQT1; dbSNP:rs199472771).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068312.
FT   VARIANT     385    385       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473473).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074997.
FT   VARIANT     389    389       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472772).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074998.
FT   VARIANT     389    389       S -> Y (in LQT1; dbSNP:rs199472773).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068313.
FT   VARIANT     391    391       T -> I (in LQT1; dbSNP:rs199473474).
FT                                /FTId=VAR_009930.
FT   VARIANT     391    391       T -> TT (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074999.
FT   VARIANT     392    392       W -> R (in LQT1; dbSNP:rs199472774).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008128.
FT   VARIANT     393    393       K -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472775).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075000.
FT   VARIANT     393    393       K -> N (in dbSNP:rs12720457).
FT                                /FTId=VAR_048026.
FT   VARIANT     397    397       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472776).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075001.
FT   VARIANT     398    398       K -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472777).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075002.
FT   VARIANT     417    417       V -> M (in LQT1; associated with M-254 in
FT                                a patient; dbSNP:rs267607197).
FT                                {ECO:0000269|Ref.31}.
FT                                /FTId=VAR_010934.
FT   VARIANT     446    446       D -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472780).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075003.
FT   VARIANT     448    448       P -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs12720449).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075004.
FT   VARIANT     448    448       P -> R (in LQT1; dbSNP:rs12720449).
FT                                /FTId=VAR_009931.
FT   VARIANT     451    451       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472782).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075005.
FT   VARIANT     452    452       R -> W (in LQT1; dbSNP:rs140452381).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068314.
FT   VARIANT     460    460       G -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472783).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075006.
FT   VARIANT     477    477       P -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472784).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075007.
FT   VARIANT     511    511       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472785).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075008.
FT   VARIANT     518    518       R -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs17215500).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075009.
FT   VARIANT     518    518       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs145974930).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075010.
FT   VARIANT     518    518       R -> Q (in LQT1; unknown pathological
FT                                significance; dbSNP:rs145974930).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075011.
FT   VARIANT     520    520       M -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473479).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075012.
FT   VARIANT     522    522       Y -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472789).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075013.
FT   VARIANT     524    524       V -> G (in LQT1; dbSNP:rs199472790).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068315.
FT   VARIANT     525    525       A -> T (in LQT1; dbSNP:rs120074188).
FT                                {ECO:0000269|PubMed:10482963,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009181.
FT   VARIANT     525    525       A -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472791).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075014.
FT   VARIANT     526    526       K -> E (in LQT1; dbSNP:rs199472792).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068316.
FT   VARIANT     533    533       R -> W (in LQT1; minor changes of wt
FT                                current (homomultimers); positive voltage
FT                                shift of the channel activation
FT                                (heteromultimers); dbSNP:rs199472793).
FT                                {ECO:0000269|PubMed:10728423,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008949.
FT   VARIANT     539    539       R -> Q (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472794).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075015.
FT   VARIANT     539    539       R -> W (in LQT1; minor changes of wt
FT                                current (homomultimers); positive voltage
FT                                shift of the channel activation
FT                                (heteromultimers); dbSNP:rs199472795).
FT                                {ECO:0000269|PubMed:10728423,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008950.
FT   VARIANT     541    541       V -> I (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472796).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075016.
FT   VARIANT     543    543       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472797).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075017.
FT   VARIANT     546    546       S -> L (in LQT1; decreases interaction
FT                                with KCNE1 C-terminus; does not affect
FT                                plasma membrane localization; reduces IKS
FT                                current density; impairs binding with
FT                                Phosphatidylinositol 4,5-bisphosphate;
FT                                dbSNP:rs199473480).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568}.
FT                                /FTId=VAR_068317.
FT   VARIANT     547    547       Q -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472798).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075018.
FT   VARIANT     548    548       G -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472799).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075019.
FT   VARIANT     554    554       V -> A (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473481).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075020.
FT   VARIANT     555    555       R -> C (in LQT1; associated with a fruste
FT                                phenotype; decreases interaction with
FT                                KCNE1 C-terminus; does not affect plasma
FT                                membrane localization; reduces IKS
FT                                current density; shifts activation of the
FT                                voltage dependence; deactivates more
FT                                rapidly; impairs binding with
FT                                phosphatidylinositol 4,5-bisphosphate;
FT                                dbSNP:rs120074185).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568,
FT                                ECO:0000269|PubMed:9312006}.
FT                                /FTId=VAR_001545.
FT   VARIANT     555    555       R -> H (in LQT1; decreases interaction
FT                                with KCNE1 C-terminus; does not affect
FT                                plasma membrane localization; reduces IKS
FT                                current density; impairs binding with
FT                                Phosphatidylinositol 4,5-bisphosphate;
FT                                dbSNP:rs199472800).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568}.
FT                                /FTId=VAR_068318.
FT   VARIANT     555    555       R -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074185).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075021.
FT   VARIANT     557    557       K -> E (in LQT1; no effect on cell
FT                                membrane localization; slows activation
FT                                kinetics; accelerates deactivation
FT                                kinetics; rightshifts the voltage-
FT                                dependent activation; does not affect
FT                                cAMP-dependent up-regulation; decreases
FT                                interaction with KCNE1 C-terminus; does
FT                                not affect plasma membrane localization;
FT                                does not affect phosphorylation at S-27
FT                                during cAMP-dependent stimulation;
FT                                reduces IKS current density; impairs
FT                                binding with Phosphatidylinositol 4,5-
FT                                bisphosphate; dbSNP:rs199472801).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568,
FT                                ECO:0000269|PubMed:25139741}.
FT                                /FTId=VAR_074693.
FT   VARIANT     566    566       S -> F (in LQT1; dbSNP:rs199472804).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009932.
FT   VARIANT     566    566       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472803).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075022.
FT   VARIANT     566    566       S -> Y (in LQT1; dbSNP:rs199472804).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068319.
FT   VARIANT     567    567       I -> S (in LQT1; dbSNP:rs199472805).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068320.
FT   VARIANT     567    567       I -> T (in LQT1; dbSNP:rs199472805).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075023.
FT   VARIANT     568    568       G -> R (in LQT1; dbSNP:rs199472807).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068321.
FT   VARIANT     569    569       K -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472808).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075024.
FT   VARIANT     571    571       S -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472809).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075025.
FT   VARIANT     573    573       F -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472810).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075026.
FT   VARIANT     583    583       R -> C (in LQT1; dbSNP:rs17221854).
FT                                /FTId=VAR_009933.
FT   VARIANT     583    583       R -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473482).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075027.
FT   VARIANT     586    586       N -> D (in LQT1; decreases outward
FT                                potassium current; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472812).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074694.
FT   VARIANT     587    587       T -> M (in LQT1; dbSNP:rs120074189).
FT                                {ECO:0000269|PubMed:10024302,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008951.
FT   VARIANT     589    589       G -> D (in LQT1 and JLNS1; affects plasma
FT                                membrane localization; strongly reduces
FT                                potassium current; impairs binding to
FT                                AKAP9 and the targeting protein kinase A
FT                                (PKA) catalytic subunit and protein
FT                                phosphatase 1 (PP1); dbSNP:rs120074190).
FT                                {ECO:0000269|PubMed:11799244,
FT                                ECO:0000269|PubMed:18165683,
FT                                ECO:0000269|PubMed:25037568,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_008952.
FT   VARIANT     590    590       A -> T (in LQT1; reduces IKs density and
FT                                causes a right-shift of the
FT                                current?voltage relation of channel
FT                                activation; reduces cell surface
FT                                expression; no effect on interaction with
FT                                AKAP9; does not affect the cAMP-dependent
FT                                IKs up-regulation; dbSNP:rs199472813).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:24713462}.
FT                                /FTId=VAR_068322.
FT   VARIANT     591    591       R -> C (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473483).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075028.
FT   VARIANT     591    591       R -> H (in LQT1; dbSNP:rs199472814).
FT                                {ECO:0000269|PubMed:10024302,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008953.
FT   VARIANT     594    594       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472815).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075029.
FT   VARIANT     594    594       R -> Q (in LQT1; dbSNP:rs199472815).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009934.
FT   VARIANT     596    596       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472816).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075030.
FT   VARIANT     596    596       Missing (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075031.
FT   VARIANT     600    600       T -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs34516117).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075032.
FT   VARIANT     611    611       D -> N (in LQT1; unknown pathological
FT                                significance; dbSNP:rs147445322).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075033.
FT   VARIANT     614    614       Missing (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075034.
FT   VARIANT     619    619       L -> M (in LQT1; decreases outward
FT                                potassium current; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472819).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_068323.
FT   VARIANT     626    626       G -> S (in LQT1; dbSNP:rs199472821).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068324.
FT   VARIANT     635    635       G -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473484).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075035.
FT   VARIANT     643    643       G -> S (in dbSNP:rs1800172).
FT                                {ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008954.
FT   MUTAGEN      27     27       S->A: No phosphorylation by PKA.
FT                                Decreases delayed rectifier potassium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:11799244}.
FT   MUTAGEN     324    324       V->L: Has a voltage-gated potassium
FT                                channel activity. Inhibition of voltage-
FT                                gated potassium channel activity by
FT                                KCNE4. {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     326    326       K->R: Has a voltage-gated potassium
FT                                channel activity. Disrupts KCNE4-mediated
FT                                voltage-gated potassium channel activity
FT                                inhibition.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     327    327       T->V: Has a voltage-gated potassium
FT                                channel activity. Disrupts KCNE4-mediated
FT                                voltage-gated potassium channel activity
FT                                inhibition.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     328    328       I->L: Has a voltage-gated potassium
FT                                channel activity. Inhibition of voltage-
FT                                gated potassium channel activity by
FT                                KCNE4. {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     338    338       S->C: Inhibits voltage-gated potassium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     340    340       F->C: Inhibits voltage-gated potassium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     589    589       G->M: No effect.
FT                                {ECO:0000269|PubMed:18165683}.
FT   MUTAGEN     590    590       A->W: Reduced cell surface expression and
FT                                strongly reduced potassium current.
FT                                {ECO:0000269|PubMed:18165683}.
FT   MUTAGEN     593    593       N->G: Reduced cell surface expression and
FT                                moderately reduced potassium current.
FT                                {ECO:0000269|PubMed:18165683}.
FT   MUTAGEN     602    602       L->A: Does not interact with AKAP9 and
FT                                the targeting protein kinase A (PKA)
FT                                catalytic subunit and protein phosphatase
FT                                1 (PP1); when associated with I-609.
FT                                {ECO:0000269|PubMed:11799244}.
FT   MUTAGEN     609    609       I->A: Does not interact with AKAP9 and
FT                                the kinase A (PKA) catalytic subunit and
FT                                protein phosphatase 1 (PP1); when
FT                                associated with L-602.
FT                                {ECO:0000269|PubMed:11799244}.
FT   CONFLICT     64     65       PA -> HV (in Ref. 4; CAB44649).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       Missing (in Ref. 2; AAC05705).
FT                                {ECO:0000305}.
FT   CONFLICT    607    608       AL -> VI (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    619    644       LHGGSTPGSGGPPREGGAHITQPCGS -> MQQGGPTCNSR
FT                                SQVVASNE (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    648    649       VD -> IN (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    658    658       T -> S (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    669    670       RR -> QT (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   HELIX       359    384       {ECO:0000244|PDB:4V0C}.
FT   STRAND      386    391       {ECO:0000244|PDB:4V0C}.
FT   HELIX       392    394       {ECO:0000244|PDB:4V0C}.
FT   HELIX       502    533       {ECO:0000244|PDB:4V0C}.
FT   HELIX       588    609       {ECO:0000244|PDB:3HFE}.
SQ   SEQUENCE   676 AA;  74699 MW;  ADFCA9E2B9763B21 CRC64;
     MAAASSPPRA ERKRWGWGRL PGARRGSAGL AKKCPFSLEL AEGGPAGGAL YAPIAPGAPG
     PAPPASPAAP AAPPVASDLG PRPPVSLDPR VSIYSTRRPV LARTHVQGRV YNFLERPTGW
     KCFVYHFAVF LIVLVCLIFS VLSTIEQYAA LATGTLFWME IVLVVFFGTE YVVRLWSAGC
     RSKYVGLWGR LRFARKPISI IDLIVVVASM VVLCVGSKGQ VFATSAIRGI RFLQILRMLH
     VDRQGGTWRL LGSVVFIHRQ ELITTLYIGF LGLIFSSYFV YLAEKDAVNE SGRVEFGSYA
     DALWWGVVTV TTIGYGDKVP QTWVGKTIAS CFSVFAISFF ALPAGILGSG FALKVQQKQR
     QKHFNRQIPA AASLIQTAWR CYAAENPDSS TWKIYIRKAP RSHTLLSPSP KPKKSVVVKK
     KKFKLDKDNG VTPGEKMLTV PHITCDPPEE RRLDHFSVDG YDSSVRKSPT LLEVSMPHFM
     RTNSFAEDLD LEGETLLTPI THISQLREHH RATIKVIRRM QYFVAKKKFQ QARKPYDVRD
     VIEQYSQGHL NLMVRIKELQ RRLDQSIGKP SLFISVSEKS KDRGSNTIGA RLNRVEDKVT
     QLDQRLALIT DMLHQLLSLH GGSTPGSGGP PREGGAHITQ PCGSGGSVDP ELFLPSNTLP
     TYEQLTVPRR GPDEGS
//
ID   KCNQ2_HUMAN             Reviewed;         872 AA.
AC   O43526; O43796; O75580; O95845; Q4VXP4; Q4VXR6; Q5VYT8; Q96J59;
AC   Q99454;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   15-FEB-2017, entry version 181.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 2;
DE   AltName: Full=KQT-like 2;
DE   AltName: Full=Neuroblastoma-specific potassium channel subunit alpha KvLQT2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.2;
GN   Name=KCNQ2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RC   TISSUE=Neuroblastoma;
RX   PubMed=9039501; DOI=10.1093/dnares/3.5.311;
RA   Yokoyama M., Nishi Y., Yoshii J., Okubo K., Matsubara K.;
RT   "Identification and cloning of neuroblastoma-specific and nerve
RT   tissue-specific genes through compiled expression profiles.";
RL   DNA Res. 3:311-320(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS BFNS1 CYS-284 AND
RP   THR-306.
RC   TISSUE=Brain, Fetal brain, and Temporal cortex;
RX   PubMed=9425895; DOI=10.1038/ng0198-25;
RA   Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J.,
RA   Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V.,
RA   McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E.,
RA   Leppert M.;
RT   "A novel potassium channel gene, KCNQ2, is mutated in an inherited
RT   epilepsy of newborns.";
RL   Nat. Genet. 18:25-29(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Fetal brain;
RX   PubMed=9430594; DOI=10.1126/science.279.5349.403;
RA   Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P.,
RA   Jentsch T.J., Steinlein O.K.;
RT   "A potassium channel mutation in neonatal human epilepsy.";
RL   Science 279:403-406(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=9836639; DOI=10.1126/science.282.5395.1890;
RA   Wang H.-S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S.,
RA   Dixon J.E., McKinnon D.;
RT   "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of
RT   the M-channel.";
RL   Science 282:1890-1893(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 5).
RX   PubMed=9827540; DOI=10.1016/S0014-5793(98)01296-4;
RA   Tinel N., Lauritzen I., Chouabe C., Lazdunski M., Borsotto M.;
RT   "The KCNQ2 potassium channel: splice variants, functional and
RT   developmental expression. Brain localization and comparison with
RT   KCNQ3.";
RL   FEBS Lett. 438:171-176(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Brain, and Fetal brain;
RX   PubMed=9677360; DOI=10.1074/jbc.273.31.19419;
RA   Yang W.-P., Levesque P.C., Little W.A., Conder M.L., Ramakrishnan P.,
RA   Neubauer M.G., Blanar M.A.;
RT   "Functional expression of two KvLQT1-related potassium channels
RT   responsible for an inherited idiopathic epilepsy.";
RL   J. Biol. Chem. 273:19419-19423(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11160379;
RA   Smith J.S., Iannotti C.A., Dargis P.G., Christian E.P., Aiyar J.;
RT   "Differential expression of KCNQ2 splice variants: implications to M
RT   current function during neuronal development.";
RL   J. Neurosci. 21:1096-1103(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   MUTAGENESIS OF SER-52 AND GLY-279, PHOSPHORYLATION AT SER-52, AND
RP   CHARACTERIZATION OF VARIANTS CYS-284 AND THR-306.
RX   PubMed=9872318; DOI=10.1038/25367;
RA   Schroeder B.C., Kubisch C., Stein V., Jentsch T.J.;
RT   "Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+
RT   channels causes epilepsy.";
RL   Nature 396:687-690(1998).
RN   [11]
RP   INVOLVEMENT IN M-LIKE CURRENT.
RX   PubMed=10479678;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Delmas P.,
RA   Buckley N.J., London B., Brown D.A.;
RT   "Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to
RT   the M-like current in a mammalian neuronal cell.";
RL   J. Neurosci. 19:7742-7756(1999).
RN   [12]
RP   ASSOCIATION WITH KCNE2.
RX   PubMed=11034315; DOI=10.1016/S0014-5793(00)01918-9;
RA   Tinel N., Diochot S., Lauritzen I., Barhanin J., Lazdunski M.,
RA   Borsotto M.;
RT   "M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2
RT   subunit.";
RL   FEBS Lett. 480:137-141(2000).
RN   [13]
RP   SURFACE EXPRESSION OF HETEROMERS.
RX   PubMed=10788442; DOI=10.1074/jbc.275.18.13343;
RA   Schwake M., Pusch M., Kharkovets T., Jentsch T.J.;
RT   "Surface expression and single channel properties of KCNQ2/KCNQ3, M-
RT   type K+ channels involved in epilepsy.";
RL   J. Biol. Chem. 275:13343-13348(2000).
RN   [14]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10684873;
RA   Shapiro M.S., Roche J.P., Kaftan E.J., Cruzblanca H., Mackie K.,
RA   Hille B.;
RT   "Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+)
RT   channels that underlie the neuronal M current.";
RL   J. Neurosci. 20:1710-1721(2000).
RN   [15]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [16]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10908292;
RA   Main M.J., Cryan J.E., Dupere J.R., Cox B., Clare J.J., Burbidge S.A.;
RT   "Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant
RT   retigabine.";
RL   Mol. Pharmacol. 58:253-262(2000).
RN   [17]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10953053;
RA   Wickenden A.D., Yu W., Zou A., Jegla T., Wagoner P.K.;
RT   "Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3
RT   potassium channels.";
RL   Mol. Pharmacol. 58:591-600(2000).
RN   [18]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10713399; DOI=10.1016/S0304-3940(00)00866-1;
RA   Rundfeldt C., Netzer R.;
RT   "The novel anticonvulsant retigabine activates M-currents in Chinese
RT   hamster ovary-cells transfected with human KCNQ2/3 subunits.";
RL   Neurosci. Lett. 282:73-76(2000).
RN   [19]
RP   TISSUE SPECIFICITY, AND BIOCHEMICAL CHARACTERIZATION.
RX   PubMed=10781098; DOI=10.1073/pnas.090092797;
RA   Cooper E.C., Aldape K.D., Abosch A., Barbaro N.M., Berger M.S.,
RA   Peacock W.S., Jan Y.N., Jan L.Y.;
RT   "Colocalization and coassembly of two human brain M-type potassium
RT   channel subunits that are mutated in epilepsy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4914-4919(2000).
RN   [20]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [21]
RP   PHOSPHORYLATION AT THR-217, AND MUTAGENESIS OF THR-217.
RX   PubMed=16319223; DOI=10.1073/pnas.0509122102;
RA   Surti T.S., Huang L., Jan Y.N., Jan L.Y., Cooper E.C.;
RT   "Identification by mass spectrometry and functional characterization
RT   of two phosphorylation sites of KCNQ2/KCNQ3 channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:17828-17833(2005).
RN   [22]
RP   VARIANT THR-780.
RX   PubMed=10323247; DOI=10.1007/s004390050941;
RA   Biervert C., Steinlein O.K.;
RT   "Structural and mutational analysis of KCNQ2, the major gene locus for
RT   benign familial neonatal convulsions.";
RL   Hum. Genet. 104:234-240(1999).
RN   [23]
RP   VARIANT BFNS1 TRP-214.
RX   PubMed=11175290; DOI=10.1038/sj.ejhg.5200570;
RA   Miraglia del Giudice E., Coppola G., Scuccimarra G., Cirillo G.,
RA   Bellini G., Pascotto A.;
RT   "Benign familial neonatal convulsions (BFNC) resulting from mutation
RT   of the KCNQ2 voltage sensor.";
RL   Eur. J. Hum. Genet. 8:994-997(2000).
RN   [24]
RP   VARIANT BFNS1 TRP-207, AND CHARACTERIZATION OF VARIANT BFNS1 TRP-207.
RX   PubMed=11572947; DOI=10.1073/pnas.211431298;
RA   Dedek K., Kunath B., Kananura C., Reuner U., Jentsch T.J.,
RA   Steinlein O.K.;
RT   "Myokymia and neonatal epilepsy caused by a mutation in the voltage
RT   sensor of the KCNQ2 K+ channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12272-12277(2001).
RN   [25]
RP   VARIANTS BFNS1 VAL-208; GLN-228; PHE-243; CYS-284; THR-306 AND
RP   GLN-333, AND CHARACTERIZATION OF VARIANTS BFNS1 VAL-208 AND GLN-333.
RX   PubMed=14534157; DOI=10.1093/brain/awg286;
RG   The BFNC physician consortium;
RA   Singh N.A., Westenskow P., Charlier C., Pappas C., Leslie J.,
RA   Dillon J., Anderson V.E., Sanguinetti M.C., Leppert M.F.;
RT   "KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal
RT   convulsions: expansion of the functional and mutation spectrum.";
RL   Brain 126:2726-2737(2003).
RN   [26]
RP   VARIANT EIEE7 TRP-247, AND CHARACTERIZATION OF VARIANT EIEE7 TRP-247.
RX   PubMed=12742592; DOI=10.1016/S0920-1211(03)00037-8;
RA   Dedek K., Fusco L., Teloy N., Steinlein O.K.;
RT   "Neonatal convulsions and epileptic encephalopathy in an Italian
RT   family with a missense mutation in the fifth transmembrane region of
RT   KCNQ2.";
RL   Epilepsy Res. 54:21-27(2003).
RN   [27]
RP   VARIANT BFNS1 ASN-554, VARIANT EIEE7 ASN-554, AND CHARACTERIZATION OF
RP   VARIANT BFNS1 ASN-554.
RX   PubMed=15249611; DOI=10.1212/01.WNL.0000132979.08394.6D;
RA   Borgatti R., Zucca C., Cavallini A., Ferrario M., Panzeri C.,
RA   Castaldo P., Soldovieri M.V., Baschirotto C., Bresolin N.,
RA   Dalla Bernardina B., Taglialatela M., Bassi M.T.;
RT   "A novel mutation in KCNQ2 associated with BFNC, drug resistant
RT   epilepsy, and mental retardation.";
RL   Neurology 63:57-65(2004).
RN   [28]
RP   VARIANT GLN-207, AND CHARACTERIZATION OF VARIANT GLN-207.
RX   PubMed=17872363; DOI=10.1212/01.wnl.0000275523.95103.36;
RA   Wuttke T.V., Jurkat-Rott K., Paulus W., Garncarek M., Lehmann-Horn F.,
RA   Lerche H.;
RT   "Peripheral nerve hyperexcitability due to dominant-negative KCNQ2
RT   mutations.";
RL   Neurology 69:2045-2053(2007).
CC   -!- FUNCTION: Probably important in the regulation of neuronal
CC       excitability. Associates with KCNQ3 to form a potassium channel
CC       with essentially identical properties to the channel underlying
CC       the native M-current, a slowly activating and deactivating
CC       potassium conductance which plays a critical role in determining
CC       the subthreshold electrical excitability of neurons as well as the
CC       responsiveness to synaptic inputs. KCNQ2/KCNQ3 current is blocked
CC       by linopirdine and XE991, and activated by the anticonvulsant
CC       retigabine. Muscarinic agonist oxotremorine-M strongly suppress
CC       KCNQ2/KCNQ3 current in cells in which cloned KCNQ2/KCNQ3 channels
CC       were coexpressed with M1 muscarinic receptors.
CC   -!- SUBUNIT: Heteromultimer with KCNQ3. May associate with KCNE2.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=O43526-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43526-2; Sequence=VSP_000988;
CC       Name=3;
CC         IsoId=O43526-3; Sequence=VSP_000985, VSP_000988;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=4;
CC         IsoId=O43526-4; Sequence=VSP_000989, VSP_000990;
CC       Name=5;
CC         IsoId=O43526-5; Sequence=VSP_000984, VSP_000988;
CC       Name=6; Synonyms=HNSPC;
CC         IsoId=O43526-6; Sequence=VSP_000986, VSP_000987;
CC   -!- TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in
CC       areas containing neuronal cell bodies, low in spinal chord and
CC       corpus callosum. Isoform 2 is preferentially expressed in
CC       differentiated neurons. Isoform 6 is prominent in fetal brain,
CC       undifferentiated neuroblastoma cells and brain tumors.
CC       {ECO:0000269|PubMed:10781098}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- PTM: In Xenopus oocytes KCNQ2/KCNQ3 heteromeric current can be
CC       increased by intracellular cyclic AMP, an effect that depends on
CC       phosphorylation of Ser-52 in the N-terminal region.
CC       {ECO:0000269|PubMed:16319223, ECO:0000269|PubMed:9872318}.
CC   -!- DISEASE: Seizures, benign familial neonatal 1 (BFNS1)
CC       [MIM:121200]: A disorder characterized by clusters of seizures
CC       occurring in the first days of life. Most patients have
CC       spontaneous remission by 12 months of age and show normal
CC       psychomotor development. Some rare cases manifest an atypical
CC       severe phenotype associated with epileptic encephalopathy and
CC       psychomotor retardation. The disorder is distinguished from benign
CC       familial infantile seizures by an earlier age at onset. In some
CC       patients, neonatal convulsions are followed later in life by
CC       myokymia, a benign condition characterized by spontaneous
CC       involuntary contractions of skeletal muscles fiber groups that can
CC       be observed as vermiform movement of the overlying skin.
CC       Electromyography typically shows continuous motor unit activity
CC       with spontaneous oligo- and multiplet-discharges of high
CC       intraburst frequency (myokymic discharges). Some patients may have
CC       isolated myokymia. {ECO:0000269|PubMed:11175290,
CC       ECO:0000269|PubMed:11572947, ECO:0000269|PubMed:14534157,
CC       ECO:0000269|PubMed:15249611, ECO:0000269|PubMed:9425895}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 7 (EIEE7)
CC       [MIM:613720]: An autosomal dominant seizure disorder characterized
CC       by infantile onset of refractory seizures with resultant delayed
CC       neurologic development and persistent neurologic abnormalities.
CC       {ECO:0000269|PubMed:12742592, ECO:0000269|PubMed:15249611}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Inclusion of isoform 6 in heteromultimers results
CC       in attenuation of potassium current. Prominent expression of
CC       isoform 6 in the developing brain may alter firing repertoires of
CC       immature neurons excitability to provide cues for proliferation
CC       rather than differentiation.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out in Xenopus
CC       oocytes by coexpression of either KCNQ2(mut) and KCNQ3 at the
CC       ratio of 1:1, or of KCNQ2(mut), KCNQ2(wt) and KCNQ3 at the ratio
CC       of 1:1:2, to mimic the situation in a heterozygous patient with
CC       BFNC1 disease.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT
CC       (TC 1.A.1.15) subfamily. Kv7.2/KCNQ2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D82346; BAA11557.1; -; mRNA.
DR   EMBL; AF033348; AAB97315.1; -; mRNA.
DR   EMBL; Y15065; CAA75348.1; -; mRNA.
DR   EMBL; AF110020; AAD16988.1; -; mRNA.
DR   EMBL; AF074247; AAC25921.1; -; mRNA.
DR   EMBL; AL353658; CAH72958.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAH72958.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAH72958.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAH72959.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAH72959.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAH72959.1; JOINED; Genomic_DNA.
DR   EMBL; AL121827; CAI95054.1; -; Genomic_DNA.
DR   EMBL; AL121829; CAI95054.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAI95054.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAI95740.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAI95740.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAI95740.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAI95744.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAI95744.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAI95744.1; JOINED; Genomic_DNA.
DR   EMBL; BC000699; AAH00699.1; -; mRNA.
DR   CCDS; CCDS13518.1; -. [O43526-3]
DR   CCDS; CCDS13519.1; -. [O43526-2]
DR   CCDS; CCDS13520.1; -. [O43526-1]
DR   CCDS; CCDS13521.1; -. [O43526-6]
DR   CCDS; CCDS46629.1; -. [O43526-4]
DR   PIR; JC5275; JC5275.
DR   RefSeq; NP_004509.2; NM_004518.5. [O43526-3]
DR   RefSeq; NP_742104.1; NM_172106.2. [O43526-2]
DR   RefSeq; NP_742105.1; NM_172107.3. [O43526-1]
DR   RefSeq; NP_742106.1; NM_172108.4. [O43526-4]
DR   RefSeq; NP_742107.1; NM_172109.2. [O43526-6]
DR   UniGene; Hs.161851; -.
DR   UniGene; Hs.652468; -.
DR   PDB; 5J03; X-ray; 2.00 A; A=530-557.
DR   PDBsum; 5J03; -.
DR   ProteinModelPortal; O43526; -.
DR   BioGrid; 109986; 6.
DR   IntAct; O43526; 1.
DR   MINT; MINT-8402812; -.
DR   STRING; 9606.ENSP00000352035; -.
DR   BindingDB; O43526; -.
DR   ChEMBL; CHEMBL2476; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB00939; Meclofenamic acid.
DR   GuidetoPHARMACOLOGY; 561; -.
DR   TCDB; 1.A.1.15.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O43526; -.
DR   PhosphoSitePlus; O43526; -.
DR   BioMuta; KCNQ2; -.
DR   PaxDb; O43526; -.
DR   PeptideAtlas; O43526; -.
DR   PRIDE; O43526; -.
DR   DNASU; 3785; -.
DR   Ensembl; ENST00000344425; ENSP00000345523; ENSG00000075043. [O43526-6]
DR   Ensembl; ENST00000344462; ENSP00000339611; ENSG00000075043. [O43526-4]
DR   Ensembl; ENST00000359125; ENSP00000352035; ENSG00000075043. [O43526-1]
DR   Ensembl; ENST00000360480; ENSP00000353668; ENSG00000075043. [O43526-3]
DR   Ensembl; ENST00000626839; ENSP00000486706; ENSG00000075043. [O43526-2]
DR   GeneID; 3785; -.
DR   KEGG; hsa:3785; -.
DR   UCSC; uc002yey.2; human. [O43526-1]
DR   CTD; 3785; -.
DR   DisGeNET; 3785; -.
DR   GeneCards; KCNQ2; -.
DR   GeneReviews; KCNQ2; -.
DR   HGNC; HGNC:6296; KCNQ2.
DR   HPA; HPA016642; -.
DR   HPA; HPA057112; -.
DR   MalaCards; KCNQ2; -.
DR   MIM; 121200; phenotype.
DR   MIM; 602235; gene.
DR   MIM; 613720; phenotype.
DR   neXtProt; NX_O43526; -.
DR   OpenTargets; ENSG00000075043; -.
DR   Orphanet; 306; Benign familial infantile epilepsy.
DR   Orphanet; 1949; Benign familial neonatal seizures.
DR   Orphanet; 140927; Benign familial neonatal-infantile seizures.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA30074; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; O43526; -.
DR   KO; K04927; -.
DR   OMA; PRQGHGT; -.
DR   OrthoDB; EOG090B027U; -.
DR   PhylomeDB; O43526; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-445095; Interaction between L1 and Ankyrins.
DR   SIGNOR; O43526; -.
DR   ChiTaRS; KCNQ2; human.
DR   GeneWiki; KvLQT2; -.
DR   GenomeRNAi; 3785; -.
DR   PRO; PR:O43526; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000075043; -.
DR   CleanEx; HS_KCNQ2; -.
DR   ExpressionAtlas; O43526; baseline and differential.
DR   Genevisible; O43526; HS.
DR   GO; GO:0043194; C:axon initial segment; ISS:BHF-UCL.
DR   GO; GO:0033268; C:node of Ranvier; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0030506; F:ankyrin binding; IPI:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   InterPro; IPR020969; Ankyrin-G_BS.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR003947; K_chnl_volt-dep_KCNQ2.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   Pfam; PF11956; KCNQC3-Ank-G_bd; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01461; KCNQ2CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; Epilepsy; Ion channel; Ion transport; Membrane;
KW   Mental retardation; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    872       Potassium voltage-gated channel subfamily
FT                                KQT member 2.
FT                                /FTId=PRO_0000054030.
FT   TRANSMEM     92    112       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    113    122       Extracellular. {ECO:0000255}.
FT   TRANSMEM    123    143       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    144    166       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    167    187       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    188    195       Extracellular. {ECO:0000255}.
FT   TRANSMEM    196    218       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    219    231       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    232    252       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    253    264       Extracellular. {ECO:0000255}.
FT   INTRAMEM    265    285       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    286    291       Extracellular. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    313    872       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       277    282       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      52     52       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:9872318}.
FT   MOD_RES     217    217       Phosphothreonine.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     472    472       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     476    476       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     478    478       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     507    507       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   MOD_RES     672    672       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   MOD_RES     801    801       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   MOD_RES     803    803       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   VAR_SEQ     310    320       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:9827540}.
FT                                /FTId=VSP_000984.
FT   VAR_SEQ     373    393       SSQTQTYGASRLIPPLNQLEL -> RYRRRAPATKQLFHFL
FT                                FSICS (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9039501}.
FT                                /FTId=VSP_000986.
FT   VAR_SEQ     373    382       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9430594}.
FT                                /FTId=VSP_000985.
FT   VAR_SEQ     394    872       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9039501}.
FT                                /FTId=VSP_000987.
FT   VAR_SEQ     417    446       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9836639}.
FT                                /FTId=VSP_000989.
FT   VAR_SEQ     417    434       Missing (in isoform 2, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:11160379,
FT                                ECO:0000303|PubMed:9430594,
FT                                ECO:0000303|PubMed:9827540}.
FT                                /FTId=VSP_000988.
FT   VAR_SEQ     509    509       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9836639}.
FT                                /FTId=VSP_000990.
FT   VARIANT     207    207       R -> Q (found in a patient with isolated
FT                                myokymia; leads to a shift of voltage-
FT                                dependent activation; dbSNP:rs118192200).
FT                                {ECO:0000269|PubMed:17872363}.
FT                                /FTId=VAR_043819.
FT   VARIANT     207    207       R -> W (in BFNS1; phenotype
FT                                manifestations include myokymia in some
FT                                patients; leads to a shift of voltage-
FT                                dependent activation of the channel and a
FT                                dramatic slowing of activation upon
FT                                depolarization; dbSNP:rs74315391).
FT                                {ECO:0000269|PubMed:11572947}.
FT                                /FTId=VAR_026987.
FT   VARIANT     208    208       M -> V (in BFNS1; minor effect on maximal
FT                                current but clearly exhibits a faster
FT                                rate of deactivation; dbSNP:rs118192201).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026988.
FT   VARIANT     214    214       R -> W (in BFNS1; dbSNP:rs28939684).
FT                                {ECO:0000269|PubMed:11175290}.
FT                                /FTId=VAR_010929.
FT   VARIANT     228    228       H -> Q (in BFNS1; dbSNP:rs118192204).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026989.
FT   VARIANT     243    243       L -> F (in BFNS1; dbSNP:rs118192205).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026990.
FT   VARIANT     247    247       S -> W (in EIEE7; reduces channel
FT                                currents by more than 50% in homomeric
FT                                channels; dbSNP:rs74315392).
FT                                {ECO:0000269|PubMed:12742592}.
FT                                /FTId=VAR_026991.
FT   VARIANT     284    284       Y -> C (in BFNS1; 30%-60% reduction of wt
FT                                current in heteromeric channels;
FT                                dbSNP:rs28939683).
FT                                {ECO:0000269|PubMed:14534157,
FT                                ECO:0000269|PubMed:9425895,
FT                                ECO:0000269|PubMed:9872318}.
FT                                /FTId=VAR_010930.
FT   VARIANT     306    306       A -> T (in BFNS1; 20%-40% reduction of wt
FT                                current in heteromeric channels;
FT                                dbSNP:rs74315390).
FT                                {ECO:0000269|PubMed:14534157,
FT                                ECO:0000269|PubMed:9425895,
FT                                ECO:0000269|PubMed:9872318}.
FT                                /FTId=VAR_010931.
FT   VARIANT     333    333       R -> Q (in BFNS1; moderate effect; less
FT                                than 50% reduction in current compared
FT                                with wt heteromeric channels;
FT                                dbSNP:rs118192216).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026992.
FT   VARIANT     554    554       K -> N (in BFNS1 and EIEE7; decreases the
FT                                voltage-dependence of the channel;
FT                                dbSNP:rs267607198).
FT                                {ECO:0000269|PubMed:15249611}.
FT                                /FTId=VAR_026993.
FT   VARIANT     780    780       N -> T (in dbSNP:rs1801475).
FT                                {ECO:0000269|PubMed:10323247}.
FT                                /FTId=VAR_010932.
FT   MUTAGEN      52     52       S->E: 40% increase in potassium current
FT                                amplitude. Ratio of 1:1.
FT                                {ECO:0000269|PubMed:9872318}.
FT   MUTAGEN      52     52       S->Q: Decrease of PKA stimulation. Ratio
FT                                of 1:1. {ECO:0000269|PubMed:9872318}.
FT   MUTAGEN     217    217       T->A: No effect on current or expression.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MUTAGEN     217    217       T->D: Abolishes currents without reducing
FT                                channel protein expression.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MUTAGEN     279    279       G->S: More than 50% reduction of wt
FT                                heteromeric current. Ratio of 1:1 and
FT                                1:1:2. {ECO:0000269|PubMed:9872318}.
FT   CONFLICT    699    699       K -> E (in Ref. 4; AAD16988).
FT                                {ECO:0000305}.
FT   CONFLICT    854    854       R -> C (in Ref. 4; AAD16988).
FT                                {ECO:0000305}.
FT   HELIX       535    556       {ECO:0000244|PDB:5J03}.
SQ   SEQUENCE   872 AA;  95848 MW;  22E8A0880A27B58C CRC64;
     MVQKSRNGGV YPGPSGEKKL KVGFVGLDPG APDSTRDGAL LIAGSEAPKR GSILSKPRAG
     GAGAGKPPKR NAFYRKLQNF LYNVLERPRG WAFIYHAYVF LLVFSCLVLS VFSTIKEYEK
     SSEGALYILE IVTIVVFGVE YFVRIWAAGC CCRYRGWRGR LKFARKPFCV IDIMVLIASI
     AVLAAGSQGN VFATSALRSL RFLQILRMIR MDRRGGTWKL LGSVVYAHSK ELVTAWYIGF
     LCLILASFLV YLAEKGENDH FDTYADALWW GLITLTTIGY GDKYPQTWNG RLLAATFTLI
     GVSFFALPAG ILGSGFALKV QEQHRQKHFE KRRNPAAGLI QSAWRFYATN LSRTDLHSTW
     QYYERTVTVP MYSSQTQTYG ASRLIPPLNQ LELLRNLKSK SGLAFRKDPP PEPSPSKGSP
     CRGPLCGCCP GRSSQKVSLK DRVFSSPRGV AAKGKGSPQA QTVRRSPSAD QSLEDSPSKV
     PKSWSFGDRS RARQAFRIKG AASRQNSEEA SLPGEDIVDD KSCPCEFVTE DLTPGLKVSI
     RAVCVMRFLV SKRKFKESLR PYDVMDVIEQ YSAGHLDMLS RIKSLQSRVD QIVGRGPAIT
     DKDRTKGPAE AELPEDPSMM GRLGKVEKQV LSMEKKLDFL VNIYMQRMGI PPTETEAYFG
     AKEPEPAPPY HSPEDSREHV DRHGCIVKIV RSSSSTGQKN FSAPPAAPPV QCPPSTSWQP
     QSHPRQGHGT SPVGDHGSLV RIPPPPAHER SLSAYGGGNR ASMEFLRQED TPGCRPPEGN
     LRDSDTSISI PSVDHEELER SFSGFSISQS KENLDALNSC YAAVAPCAKV RPYIAEGESD
     TDSDLCTPCG PPPRSATGEG PFGDVGWAGP RK
//
ID   KCNQ3_HUMAN             Reviewed;         872 AA.
AC   O43525; A2VCT8; B4DJY4; E7EQ89;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   15-FEB-2017, entry version 165.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 3;
DE   AltName: Full=KQT-like 3;
DE   AltName: Full=Potassium channel subunit alpha KvLQT3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.3;
GN   Name=KCNQ3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHARACTERIZATION OF VARIANT BFNS2
RP   VAL-310, AND MUTAGENESIS OF GLY-318.
RC   TISSUE=Brain;
RX   PubMed=9872318; DOI=10.1038/25367;
RA   Schroeder B.C., Kubisch C., Stein V., Jentsch T.J.;
RT   "Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+
RT   channels causes epilepsy.";
RL   Nature 396:687-690(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Brain, and Fetal brain;
RX   PubMed=9677360; DOI=10.1074/jbc.273.31.19419;
RA   Yang W.-P., Levesque P.C., Little W.A., Conder M.L., Ramakrishnan P.,
RA   Neubauer M.G., Blanar M.A.;
RT   "Functional expression of two KvLQT1-related potassium channels
RT   responsible for an inherited idiopathic epilepsy.";
RL   J. Biol. Chem. 273:19419-19423(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-7; 34-588 AND 601-872
RP   (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 48-872 (ISOFORM 1), AND VARIANT BFNS2
RP   VAL-310.
RC   TISSUE=Brain;
RX   PubMed=9425900; DOI=10.1038/ng0198-53;
RA   Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J.,
RA   Leppert M.;
RT   "A pore mutation in a novel KQT-like potassium channel gene in an
RT   idiopathic epilepsy family.";
RL   Nat. Genet. 18:53-55(1998).
RN   [7]
RP   INVOLVEMENT IN M-LIKE CURRENT.
RX   PubMed=10479678;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Delmas P.,
RA   Buckley N.J., London B., Brown D.A.;
RT   "Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to
RT   the M-like current in a mammalian neuronal cell.";
RL   J. Neurosci. 19:7742-7756(1999).
RN   [8]
RP   ASSOCIATION WITH KCNE2.
RX   PubMed=11034315; DOI=10.1016/S0014-5793(00)01918-9;
RA   Tinel N., Diochot S., Lauritzen I., Barhanin J., Lazdunski M.,
RA   Borsotto M.;
RT   "M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2
RT   subunit.";
RL   FEBS Lett. 480:137-141(2000).
RN   [9]
RP   SURFACE EXPRESSION OF HETEROMERS.
RX   PubMed=10788442; DOI=10.1074/jbc.275.18.13343;
RA   Schwake M., Pusch M., Kharkovets T., Jentsch T.J.;
RT   "Surface expression and single channel properties of KCNQ2/KCNQ3, M-
RT   type K+ channels involved in epilepsy.";
RL   J. Biol. Chem. 275:13343-13348(2000).
RN   [10]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10684873;
RA   Shapiro M.S., Roche J.P., Kaftan E.J., Cruzblanca H., Mackie K.,
RA   Hille B.;
RT   "Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+)
RT   channels that underlie the neuronal M current.";
RL   J. Neurosci. 20:1710-1721(2000).
RN   [11]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [12]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10908292;
RA   Main M.J., Cryan J.E., Dupere J.R., Cox B., Clare J.J., Burbidge S.A.;
RT   "Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant
RT   retigabine.";
RL   Mol. Pharmacol. 58:253-262(2000).
RN   [13]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10953053;
RA   Wickenden A.D., Yu W., Zou A., Jegla T., Wagoner P.K.;
RT   "Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3
RT   potassium channels.";
RL   Mol. Pharmacol. 58:591-600(2000).
RN   [14]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10713399; DOI=10.1016/S0304-3940(00)00866-1;
RA   Rundfeldt C., Netzer R.;
RT   "The novel anticonvulsant retigabine activates M-currents in Chinese
RT   hamster ovary-cells transfected with human KCNQ2/3 subunits.";
RL   Neurosci. Lett. 282:73-76(2000).
RN   [15]
RP   CHARACTERIZATION, AND ACTIVATION BY RETICABINE.
RX   PubMed=11159685; DOI=10.1038/sj.bjp.0703861;
RA   Wickenden A.D., Zou A., Wagoner P.K., Jegla T.;
RT   "Characterization of KCNQ5/Q3 potassium channels expressed in
RT   mammalian cells.";
RL   Br. J. Pharmacol. 132:381-384(2001).
RN   [16]
RP   PHOSPHORYLATION AT THR-246, AND MUTAGENESIS OF THR-246.
RX   PubMed=16319223; DOI=10.1073/pnas.0509122102;
RA   Surti T.S., Huang L., Jan Y.N., Jan L.Y., Cooper E.C.;
RT   "Identification by mass spectrometry and functional characterization
RT   of two phosphorylation sites of KCNQ2/KCNQ3 channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:17828-17833(2005).
RN   [17]
RP   VARIANT BFNS2 ARG-309.
RX   PubMed=10852552;
RX   DOI=10.1002/1531-8249(200006)47:6<822::AID-ANA19>3.3.CO;2-O;
RA   Hirose S., Zenri F., Akiyoshi H., Fukuma G., Iwata H., Inoue T.,
RA   Yonetani M., Tsutsumi M., Muranaka H., Kurokawa T., Hanai T., Wada K.,
RA   Kaneko S., Mitsudome A.;
RT   "A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with
RT   benign familial neonatal convulsions.";
RL   Ann. Neurol. 47:822-826(2000).
RN   [18]
RP   VARIANTS BFNS2 GLY-305 AND VAL-310, CHARACTERIZATION OF VARIANT BFNS2
RP   GLY-305, VARIANT SER-468, AND CHARACTERIZATION OF VARIANT SER-468.
RX   PubMed=14534157; DOI=10.1093/brain/awg286;
RG   The BFNC physician consortium;
RA   Singh N.A., Westenskow P., Charlier C., Pappas C., Leslie J.,
RA   Dillon J., Anderson V.E., Sanguinetti M.C., Leppert M.F.;
RT   "KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal
RT   convulsions: expansion of the functional and mutation spectrum.";
RL   Brain 126:2726-2737(2003).
RN   [19]
RP   VARIANT SER-574.
RX   PubMed=22612257; DOI=10.1111/j.1528-1167.2012.03516.x;
RA   Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C.,
RA   Steiner I., Hansen J., Courage C., Gallati S., Buerki S., Strozzi S.,
RA   Simonetti B.G., Grunt S., Steinlin M., Alber M., Wolff M.,
RA   Klopstock T., Prott E.C., Lorenz R., Spaich C., Rona S.,
RA   Lakshminarasimhan M., Kroell J., Dorn T., Kraemer G., Synofzik M.,
RA   Becker F., Weber Y.G., Lerche H., Boehm D., Biskup S.;
RT   "Targeted next generation sequencing as a diagnostic tool in epileptic
RT   disorders.";
RL   Epilepsia 53:1387-1398(2012).
CC   -!- FUNCTION: Probably important in the regulation of neuronal
CC       excitability. Associates with KCNQ2 or KCNQ5 to form a potassium
CC       channel with essentially identical properties to the channel
CC       underlying the native M-current, a slowly activating and
CC       deactivating potassium conductance which plays a critical role in
CC       determining the subthreshold electrical excitability of neurons as
CC       well as the responsiveness to synaptic inputs.
CC   -!- SUBUNIT: Heteromultimer with KCNQ2 or KCNQ5. May associate with
CC       KCNE2.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43525-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43525-2; Sequence=VSP_044906, VSP_044907;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- DISEASE: Seizures, benign familial neonatal 2 (BFNS2)
CC       [MIM:121201]: A disorder characterized by clusters of seizures
CC       occurring in the first days of life. Most patients have
CC       spontaneous remission by 12 months of age and show normal
CC       psychomotor development. The disorder is distinguished from benign
CC       familial infantile seizures by an earlier age at onset.
CC       {ECO:0000269|PubMed:10852552, ECO:0000269|PubMed:14534157,
CC       ECO:0000269|PubMed:9425900, ECO:0000269|PubMed:9872318}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Note=Defects in KCNQ3 may be involved in epileptic
CC       disorders. These are characterized by paroxysmal transient
CC       disturbances of the electrical activity of the brain that may be
CC       manifested as episodic impairment or loss of consciousness,
CC       abnormal motor phenomena, psychic or sensory disturbances, or
CC       perturbation of the autonomic nervous system.
CC       {ECO:0000269|PubMed:22612257}.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out in Xenopus
CC       oocytes by coexpression of either KCNQ3(mut) and KCNQ2 at the
CC       ratio of 1:1, or of KCNQ3(mut), KCNQ3(wt) and KCNQ2 at the ratio
CC       of 1:1:2, to mimic the situation in a heterozygous patient with
CC       BFNC2 disease.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT
CC       (TC 1.A.1.15) subfamily. Kv7.3/KCNQ3 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI28577.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAI28577.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF071491; AAC96101.1; -; Genomic_DNA.
DR   EMBL; AF071478; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071479; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071480; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071481; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071482; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071483; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071484; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071485; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071486; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071487; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071488; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071489; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AF071490; AAC96101.1; JOINED; Genomic_DNA.
DR   EMBL; AK296293; BAG58996.1; -; mRNA.
DR   EMBL; AC018540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC123776; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131042; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136373; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC128576; AAI28577.1; ALT_SEQ; mRNA.
DR   EMBL; AF033347; AAB97314.1; -; mRNA.
DR   CCDS; CCDS34943.1; -. [O43525-1]
DR   CCDS; CCDS56554.1; -. [O43525-2]
DR   RefSeq; NP_001191753.1; NM_001204824.1. [O43525-2]
DR   RefSeq; NP_004510.1; NM_004519.3. [O43525-1]
DR   UniGene; Hs.374023; -.
DR   PDB; 5J03; X-ray; 2.00 A; A=354-409.
DR   PDBsum; 5J03; -.
DR   ProteinModelPortal; O43525; -.
DR   SMR; O43525; -.
DR   BioGrid; 109987; 2.
DR   STRING; 9606.ENSP00000373648; -.
DR   BindingDB; O43525; -.
DR   ChEMBL; CHEMBL2684; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB00939; Meclofenamic acid.
DR   GuidetoPHARMACOLOGY; 562; -.
DR   TCDB; 1.A.1.15.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O43525; -.
DR   PhosphoSitePlus; O43525; -.
DR   BioMuta; KCNQ3; -.
DR   PaxDb; O43525; -.
DR   PeptideAtlas; O43525; -.
DR   PRIDE; O43525; -.
DR   DNASU; 3786; -.
DR   Ensembl; ENST00000388996; ENSP00000373648; ENSG00000184156. [O43525-1]
DR   Ensembl; ENST00000521134; ENSP00000429799; ENSG00000184156. [O43525-2]
DR   GeneID; 3786; -.
DR   KEGG; hsa:3786; -.
DR   UCSC; uc003yti.4; human. [O43525-1]
DR   CTD; 3786; -.
DR   DisGeNET; 3786; -.
DR   GeneCards; KCNQ3; -.
DR   HGNC; HGNC:6297; KCNQ3.
DR   MalaCards; KCNQ3; -.
DR   MIM; 121201; phenotype.
DR   MIM; 602232; gene.
DR   neXtProt; NX_O43525; -.
DR   OpenTargets; ENSG00000184156; -.
DR   Orphanet; 306; Benign familial infantile epilepsy.
DR   Orphanet; 1949; Benign familial neonatal seizures.
DR   Orphanet; 307; Juvenile myoclonic epilepsy.
DR   PharmGKB; PA30075; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; O43525; -.
DR   KO; K04928; -.
DR   OMA; FFAHDPV; -.
DR   OrthoDB; EOG090B02IT; -.
DR   PhylomeDB; O43525; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-445095; Interaction between L1 and Ankyrins.
DR   SIGNOR; O43525; -.
DR   ChiTaRS; KCNQ3; human.
DR   GeneWiki; KvLQT3; -.
DR   GenomeRNAi; 3786; -.
DR   PRO; PR:O43525; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000184156; -.
DR   CleanEx; HS_KCNQ3; -.
DR   ExpressionAtlas; O43525; baseline and differential.
DR   Genevisible; O43525; HS.
DR   GO; GO:0043194; C:axon initial segment; ISS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0033268; C:node of Ranvier; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0060081; P:membrane hyperpolarization; IEA:Ensembl.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   InterPro; IPR020969; Ankyrin-G_BS.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR003948; K_chnl_volt-dep_KCNQ3.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF174; PTHR11537:SF174; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   Pfam; PF11956; KCNQC3-Ank-G_bd; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01462; KCNQ3CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; Epilepsy; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    872       Potassium voltage-gated channel subfamily
FT                                KQT member 3.
FT                                /FTId=PRO_0000054034.
FT   TRANSMEM    122    142       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    153    173       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    197    217       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    226    247       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    304    324       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    331    351       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       316    321       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS     13     24       Poly-Gly.
FT   MOD_RES      81     81       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O88944}.
FT   MOD_RES     246    246       Phosphothreonine.
FT                                {ECO:0000269|PubMed:16319223}.
FT   VAR_SEQ       1      9       MGLKARRAA -> MKPAEHATM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044906.
FT   VAR_SEQ      10    129       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044907.
FT   VARIANT     305    305       D -> G (in BFNS2; reduces the maximal
FT                                heteromeric current by 40% with no
FT                                alteration in voltage dependence of
FT                                activation or deactivation kinetics;
FT                                dbSNP:rs118192248).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026994.
FT   VARIANT     309    309       W -> R (in BFNS2; dbSNP:rs118192249).
FT                                {ECO:0000269|PubMed:10852552}.
FT                                /FTId=VAR_010935.
FT   VARIANT     310    310       G -> V (in BFNS2; about 50% reduction of
FT                                wild-type heteromeric current; ratio of
FT                                1:1; or 20%; ratio of 1:1:2;
FT                                dbSNP:rs118192250).
FT                                {ECO:0000269|PubMed:14534157,
FT                                ECO:0000269|PubMed:9425900,
FT                                ECO:0000269|PubMed:9872318}.
FT                                /FTId=VAR_001546.
FT   VARIANT     414    414       E -> G (in dbSNP:rs2303995).
FT                                /FTId=VAR_053859.
FT   VARIANT     468    468       N -> S (has no statistically significant
FT                                effect on the current or biophysical
FT                                properties of the heteromeric channel;
FT                                dbSNP:rs118192252).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026995.
FT   VARIANT     574    574       P -> S (rare variant; found in a patient
FT                                with rolandic epilepsy and additional
FT                                features such as mild developmental delay
FT                                and abnormal behavior; unknown
FT                                pathological significance;
FT                                dbSNP:rs74582884).
FT                                {ECO:0000269|PubMed:22612257}.
FT                                /FTId=VAR_072741.
FT   MUTAGEN     246    246       T->A: No effect on current or expression.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MUTAGEN     246    246       T->D: Abolishes currents without reducing
FT                                channel protein expression.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MUTAGEN     318    318       G->S: >50% Reduction of wt heteromeric
FT                                current; ratio of 1:1 and 1:1:2.
FT                                {ECO:0000269|PubMed:9872318}.
FT   CONFLICT     62     62       D -> N (in Ref. 5; AAI28577).
FT                                {ECO:0000305}.
FT   CONFLICT    233    233       Q -> L (in Ref. 3; BAG58996).
FT                                {ECO:0000305}.
FT   HELIX       363    386       {ECO:0000244|PDB:5J03}.
FT   HELIX       397    403       {ECO:0000244|PDB:5J03}.
SQ   SEQUENCE   872 AA;  96742 MW;  BB79C69EE8591A84 CRC64;
     MGLKARRAAG AAGGGGDGGG GGGGAANPAG GDAAAAGDEE RKVGLAPGDV EQVTLALGAG
     ADKDGTLLLE GGGRDEGQRR TPQGIGLLAK TPLSRPVKRN NAKYRRIQTL IYDALERPRG
     WALLYHALVF LIVLGCLILA VLTTFKEYET VSGDWLLLLE TFAIFIFGAE FALRIWAAGC
     CCRYKGWRGR LKFARKPLCM LDIFVLIASV PVVAVGNQGN VLATSLRSLR FLQILRMLRM
     DRRGGTWKLL GSAICAHSKE LITAWYIGFL TLILSSFLVY LVEKDVPEVD AQGEEMKEEF
     ETYADALWWG LITLATIGYG DKTPKTWEGR LIAATFSLIG VSFFALPAGI LGSGLALKVQ
     EQHRQKHFEK RRKPAAELIQ AAWRYYATNP NRIDLVATWR FYESVVSFPF FRKEQLEAAS
     SQKLGLLDRV RLSNPRGSNT KGKLFTPLNV DAIEESPSKE PKPVGLNNKE RFRTAFRMKA
     YAFWQSSEDA GTGDPMAEDR GYGNDFPIED MIPTLKAAIR AVRILQFRLY KKKFKETLRP
     YDVKDVIEQY SAGHLDMLSR IKYLQTRIDM IFTPGPPSTP KHKKSQKGSA FTFPSQQSPR
     NEPYVARPST SEIEDQSMMG KFVKVERQVQ DMGKKLDFLV DMHMQHMERL QVQVTEYYPT
     KGTSSPAEAE KKEDNRYSDL KTIICNYSET GPPEPPYSFH QVTIDKVSPY GFFAHDPVNL
     PRGGPSSGKV QATPPSSATT YVERPTVLPI LTLLDSRVSC HSQADLQGPY SDRISPRQRR
     SITRDSDTPL SLMSVNHEEL ERSPSGFSIS QDRDDYVFGP NGGSSWMREK RYLAEGETDT
     DTDPFTPSGS MPLSSTGDGI SDSVWTPSNK PI
//
ID   KCNQ4_HUMAN             Reviewed;         695 AA.
AC   P56696; O96025;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   15-FEB-2017, entry version 161.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 4;
DE   AltName: Full=KQT-like 4;
DE   AltName: Full=Potassium channel subunit alpha KvLQT4;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.4;
GN   Name=KCNQ4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), VARIANT
RP   DFNA2A SER-285, VARIANT GLN-455, AND CHARACTERIZATION OF VARIANT
RP   DFNA2A SER-285.
RC   TISSUE=Retina;
RX   PubMed=10025409; DOI=10.1016/S0092-8674(00)80556-5;
RA   Kubisch C., Schroeder B.C., Friedrich T., Luetjohann B.,
RA   El-Amraoui A., Marlin S., Petit C., Jentsch T.J.;
RT   "KCNQ4, a novel potassium channel expressed in sensory outer hair
RT   cells, is mutated in dominant deafness.";
RL   Cell 96:437-446(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [4]
RP   PHARMACOLOGICAL CHARACTERIZATION, AND POSSIBLE FUNCTION.
RX   PubMed=11245603;
RA   Soegaard R., Ljungstroem T., Pedersen K.A., Oelesen S.-P.,
RA   Jensen B.S.;
RT   "KCNQ4 channels expressed in mammalian cells: functional
RT   characteristics and pharmacology.";
RL   Am. J. Physiol. 280:C859-C866(2001).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 610-640, SUBUNIT, AND DOMAIN
RP   COILED-COIL.
RX   PubMed=17329207; DOI=10.1016/j.neuron.2007.02.010;
RA   Howard R.J., Clark K.A., Holton J.M., Minor D.L. Jr.;
RT   "Structural insight into KCNQ (Kv7) channel assembly and
RT   channelopathy.";
RL   Neuron 53:663-675(2007).
RN   [6]
RP   VARIANTS DFNA2A SER-276; CYS-285 AND SER-321.
RX   PubMed=10369879; DOI=10.1093/hmg/8.7.1321;
RA   Coucke P.J., Van Hauwe P., Kelley P.M., Kunst H., Schatteman I.,
RA   Van Velzen D., Meyers J., Ensink R.J., Verstreken M., Declau F.,
RA   Marres H., Kastury K., Bhasin S., McGuirt W.T., Smith R.J.H.,
RA   Cremers C.W.R.J., Van de Heyning P., Willems P.J., Smith S.D.,
RA   Van Camp G.;
RT   "Mutations in the KCNQ4 gene are responsible for autosomal dominant
RT   deafness in four DFNA2 families.";
RL   Hum. Mol. Genet. 8:1321-1328(1999).
RN   [7]
RP   VARIANT DFNA2A SER-281.
RX   PubMed=10571947;
RX   DOI=10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P;
RA   Talebizadeh Z., Kelley P.M., Askew J.W., Beisel K.W., Smith S.D.;
RT   "Novel mutation in the KCNQ4 gene in a large kindred with dominant
RT   progressive hearing loss.";
RL   Hum. Mutat. 14:493-501(1999).
RN   [8]
RP   VARIANT DFNA2A HIS-274.
RX   PubMed=10925378;
RX   DOI=10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5;
RA   Van Hauwe P., Coucke P.J., Ensink R.J., Huygen P., Cremers C.W.R.J.,
RA   Van Camp G.;
RT   "Mutations in the KCNQ4 K+ channel gene, responsible for autosomal
RT   dominant hearing loss, cluster in the channel pore region.";
RL   Am. J. Med. Genet. 93:184-187(2000).
RN   [9]
RP   VARIANT DFNA2A ARG-287.
RX   PubMed=21242547; DOI=10.1001/archoto.2010.234;
RA   Arnett J., Emery S.B., Kim T.B., Boerst A.K., Lee K., Leal S.M.,
RA   Lesperance M.M.;
RT   "Autosomal dominant progressive sensorineural hearing loss due to a
RT   novel mutation in the KCNQ4 gene.";
RL   Arch. Otolaryngol. Head Neck Surg. 137:54-59(2011).
CC   -!- FUNCTION: Probably important in the regulation of neuronal
CC       excitability. May underlie a potassium current involved in
CC       regulating the excitability of sensory cells of the cochlea. KCNQ4
CC       channels are blocked by linopirdin, XE991 and bepridil, whereas
CC       clofilium is without significant effect. Muscarinic agonist
CC       oxotremorine-M strongly suppress KCNQ4 current in CHO cells in
CC       which cloned KCNQ4 channels were coexpressed with M1 muscarinic
CC       receptors.
CC   -!- SUBUNIT: Homotetramer. May form heteromultimers with KCNQ3.
CC       {ECO:0000269|PubMed:17329207}.
CC   -!- SUBCELLULAR LOCATION: Basal cell membrane; Multi-pass membrane
CC       protein. Note=Situated at the basal membrane of cochlear outer
CC       hair cells. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P56696-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56696-2; Sequence=VSP_001013;
CC   -!- TISSUE SPECIFICITY: Expressed in the outer, but not the inner,
CC       sensory hair cells of the cochlea. Slightly expressed in heart,
CC       brain and skeletal muscle.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- DOMAIN: The A-domain tail carries the major determinants of
CC       channel assembly specificity. Its coiled-coil region is Four-
CC       stranded. {ECO:0000269|PubMed:17329207}.
CC   -!- DISEASE: Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner
CC       ear, the nerve pathways to the brain, or the area of the brain
CC       that receives sound information. {ECO:0000269|PubMed:10025409,
CC       ECO:0000269|PubMed:10369879, ECO:0000269|PubMed:10571947,
CC       ECO:0000269|PubMed:10925378, ECO:0000269|PubMed:21242547}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out by
CC       expressing in Xenopus oocytes KCNQ4 mutants either individually
CC       (homomultimers) or in combination with wild-type KCNQ4 (mut/wt
CC       homomultimers) in a ratio of 1:1, to mimic the situation in a
CC       heterozygous DFNA2 patient.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT
CC       (TC 1.A.1.15) subfamily. Kv7.4/KCNQ4 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Hereditary hearing loss homepage; Note=Gene
CC       page;
CC       URL="http://hereditaryhearingloss.org/main.aspx?c=.HHH&n=86162";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF105202; AAD14680.1; -; mRNA.
DR   EMBL; AF105216; AAD14681.1; -; Genomic_DNA.
DR   EMBL; AF105203; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105204; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105205; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105206; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105207; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105208; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105209; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105210; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105211; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105212; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105213; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105214; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105215; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AC119677; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS456.1; -. [P56696-1]
DR   RefSeq; NP_004691.2; NM_004700.3. [P56696-1]
DR   RefSeq; NP_751895.1; NM_172163.2. [P56696-2]
DR   UniGene; Hs.473058; -.
DR   PDB; 2OVC; X-ray; 2.07 A; A=610-640.
DR   PDB; 4GOW; X-ray; 2.60 A; A=522-593.
DR   PDBsum; 2OVC; -.
DR   PDBsum; 4GOW; -.
DR   ProteinModelPortal; P56696; -.
DR   SMR; P56696; -.
DR   BioGrid; 114580; 6.
DR   STRING; 9606.ENSP00000262916; -.
DR   BindingDB; P56696; -.
DR   ChEMBL; CHEMBL3576; -.
DR   DrugBank; DB04953; Ezogabine.
DR   GuidetoPHARMACOLOGY; 563; -.
DR   TCDB; 1.A.1.15.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P56696; -.
DR   PhosphoSitePlus; P56696; -.
DR   BioMuta; KCNQ4; -.
DR   DMDM; 259016259; -.
DR   PaxDb; P56696; -.
DR   PRIDE; P56696; -.
DR   Ensembl; ENST00000347132; ENSP00000262916; ENSG00000117013. [P56696-1]
DR   Ensembl; ENST00000509682; ENSP00000423756; ENSG00000117013. [P56696-2]
DR   GeneID; 9132; -.
DR   KEGG; hsa:9132; -.
DR   UCSC; uc001cgh.2; human. [P56696-1]
DR   CTD; 9132; -.
DR   DisGeNET; 9132; -.
DR   GeneCards; KCNQ4; -.
DR   GeneReviews; KCNQ4; -.
DR   H-InvDB; HIX0200020; -.
DR   HGNC; HGNC:6298; KCNQ4.
DR   HPA; HPA018305; -.
DR   MalaCards; KCNQ4; -.
DR   MIM; 600101; phenotype.
DR   MIM; 603537; gene.
DR   neXtProt; NX_P56696; -.
DR   OpenTargets; ENSG00000117013; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA30076; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; P56696; -.
DR   KO; K04929; -.
DR   OMA; WAFVYHV; -.
DR   OrthoDB; EOG090B09CG; -.
DR   PhylomeDB; P56696; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNQ4; human.
DR   EvolutionaryTrace; P56696; -.
DR   GeneWiki; KCNQ4; -.
DR   GenomeRNAi; 9132; -.
DR   PRO; PR:P56696; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117013; -.
DR   CleanEx; HS_KCNQ4; -.
DR   ExpressionAtlas; P56696; baseline and differential.
DR   Genevisible; P56696; HS.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR015573; KCQN4.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF214; PTHR11537:SF214; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Coiled coil;
KW   Complete proteome; Deafness; Disease mutation; Hearing; Ion channel;
KW   Ion transport; Membrane; Non-syndromic deafness; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    695       Potassium voltage-gated channel subfamily
FT                                KQT member 4.
FT                                /FTId=PRO_0000054037.
FT   TOPO_DOM      1     97       Cytoplasmic.
FT   TRANSMEM     98    118       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    119    131       Extracellular.
FT   TRANSMEM    132    152       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    153    172       Cytoplasmic.
FT   TRANSMEM    173    193       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    194    201       Extracellular.
FT   TRANSMEM    202    224       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    225    237       Cytoplasmic.
FT   TRANSMEM    238    258       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    259    270       Extracellular.
FT   INTRAMEM    271    292       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    293    296       Extracellular.
FT   TRANSMEM    297    317       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    318    695       Cytoplasmic.
FT   REGION      546    650       A-domain (Tetramerization).
FT   COILED      610    645
FT   MOTIF       283    288       Selectivity filter. {ECO:0000250}.
FT   VAR_SEQ     377    430       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10025409}.
FT                                /FTId=VSP_001013.
FT   VARIANT     274    274       L -> H (in DFNA2A; dbSNP:rs80358276).
FT                                {ECO:0000269|PubMed:10925378}.
FT                                /FTId=VAR_010936.
FT   VARIANT     276    276       W -> S (in DFNA2A; dbSNP:rs80358277).
FT                                {ECO:0000269|PubMed:10369879}.
FT                                /FTId=VAR_008726.
FT   VARIANT     281    281       L -> S (in DFNA2A; dbSNP:rs80358278).
FT                                {ECO:0000269|PubMed:10571947}.
FT                                /FTId=VAR_010937.
FT   VARIANT     285    285       G -> C (in DFNA2A; loss of potassium
FT                                selectivity of the pore;
FT                                dbSNP:rs28937588).
FT                                {ECO:0000269|PubMed:10369879}.
FT                                /FTId=VAR_008727.
FT   VARIANT     285    285       G -> S (in DFNA2A; dominant negative
FT                                effect; abolishes potassium current;
FT                                dbSNP:rs28937588).
FT                                {ECO:0000269|PubMed:10025409}.
FT                                /FTId=VAR_001547.
FT   VARIANT     287    287       G -> R (in DFNA2A; dbSNP:rs137853969).
FT                                {ECO:0000269|PubMed:21242547}.
FT                                /FTId=VAR_065779.
FT   VARIANT     321    321       G -> S (in DFNA2A; dbSNP:rs28939710).
FT                                {ECO:0000269|PubMed:10369879}.
FT                                /FTId=VAR_008728.
FT   VARIANT     455    455       H -> Q (in dbSNP:rs34287852).
FT                                {ECO:0000269|PubMed:10025409}.
FT                                /FTId=VAR_058971.
FT   HELIX       526    548       {ECO:0000244|PDB:4GOW}.
FT   HELIX       612    637       {ECO:0000244|PDB:2OVC}.
SQ   SEQUENCE   695 AA;  77101 MW;  51390F5E00E8C157 CRC64;
     MAEAPPRRLG LGPPPGDAPR AELVALTAVQ SEQGEAGGGG SPRRLGLLGS PLPPGAPLPG
     PGSGSGSACG QRSSAAHKRY RRLQNWVYNV LERPRGWAFV YHVFIFLLVF SCLVLSVLST
     IQEHQELANE CLLILEFVMI VVFGLEYIVR VWSAGCCCRY RGWQGRFRFA RKPFCVIDFI
     VFVASVAVIA AGTQGNIFAT SALRSMRFLQ ILRMVRMDRR GGTWKLLGSV VYAHSKELIT
     AWYIGFLVLI FASFLVYLAE KDANSDFSSY ADSLWWGTIT LTTIGYGDKT PHTWLGRVLA
     AGFALLGISF FALPAGILGS GFALKVQEQH RQKHFEKRRM PAANLIQAAW RLYSTDMSRA
     YLTATWYYYD SILPSFRELA LLFEHVQRAR NGGLRPLEVR RAPVPDGAPS RYPPVATCHR
     PGSTSFCPGE SSRMGIKDRI RMGSSQRRTG PSKQHLAPPT MPTSPSSEQV GEATSPTKVQ
     KSWSFNDRTR FRASLRLKPR TSAEDAPSEE VAEEKSYQCE LTVDDIMPAV KTVIRSIRIL
     KFLVAKRKFK ETLRPYDVKD VIEQYSAGHL DMLGRIKSLQ TRVDQIVGRG PGDRKAREKG
     DKGPSDAEVV DEISMMGRVV KVEKQVQSIE HKLDLLLGFY SRCLRSGTSA SLGAVQVPLF
     DPDITSDYHS PVDHEDISVS AQTLSISRSV STNMD
//
ID   KCNQ5_HUMAN             Reviewed;         932 AA.
AC   Q9NR82; A6NKT6; A6PVT6; A8MSQ5; B4DS33; B5MC83; B7ZL37; F5GZV0;
AC   Q17RE1; Q5VVP3; Q86W40; Q9NRN0; Q9NYA6;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 3.
DT   15-FEB-2017, entry version 145.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 5;
DE   AltName: Full=KQT-like 5;
DE   AltName: Full=Potassium channel subunit alpha KvLQT5;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.5;
GN   Name=KCNQ5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10787416; DOI=10.1074/jbc.M002378200;
RA   Lerche C., Scherer C.R., Seebohm G., Derst C., Wei A.D., Busch A.E.,
RA   Steinmeyer K.;
RT   "Molecular cloning and functional expression of KCNQ5, a potassium
RT   channel subunit that may contribute to neuronal M-current diversity.";
RL   J. Biol. Chem. 275:22395-22400(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 19-822 (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-932 (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=10816588; DOI=10.1074/jbc.M003245200;
RA   Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C.,
RA   Jentsch T.J.;
RT   "KCNQ5, a novel potassium channel broadly expressed in brain, mediates
RT   M-type currents.";
RL   J. Biol. Chem. 275:24089-24095(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-932.
RA   Kananura C., Biervert B., Hechenberger M., Engels H., Steinlein O.K.;
RT   "The new voltage gated potassium channel KCNQ5 and early infantile
RT   convulsions.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 72-932 (ISOFORM 1).
RC   TISSUE=Brain, and Retina;
RA   Kniazeva M., Han M.;
RT   "A new gene of the voltage-gated potassium channel KCNQ family, KCNQ5,
RT   is a candidate gene for retinal disorders.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   CHARACTERIZATION, AND ACTIVATION BY RETICABINE.
RX   PubMed=11159685; DOI=10.1038/sj.bjp.0703861;
RA   Wickenden A.D., Zou A., Wagoner P.K., Jegla T.;
RT   "Characterization of KCNQ5/Q3 potassium channels expressed in
RT   mammalian cells.";
RL   Br. J. Pharmacol. 132:381-384(2001).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=24855057; DOI=10.1161/ATVBAHA.114.303801;
RA   Oliveras A., Roura-Ferrer M., Sole L., de la Cruz A., Prieto A.,
RA   Etxebarria A., Manils J., Morales-Cano D., Condom E., Soler C.,
RA   Cogolludo A., Valenzuela C., Villarroel A., Comes N., Felipe A.;
RT   "Functional assembly of Kv7.1/Kv7.5 channels with emerging properties
RT   on vascular muscle physiology.";
RL   Arterioscler. Thromb. Vasc. Biol. 34:1522-1530(2014).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-191 AND CYS-244.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Probably important in the regulation of neuronal
CC       excitability. Associates with KCNQ3 to form a potassium channel
CC       which contributes to M-type current, a slowly activating and
CC       deactivating potassium conductance which plays a critical role in
CC       determining the subthreshold electrical excitability of neurons.
CC       May contribute, with other potassium channels, to the molecular
CC       diversity of a heterogeneous population of M-channels, varying in
CC       kinetic and pharmacological properties, which underlie this
CC       physiologically important current. Insensitive to
CC       tetraethylammonium, but inhibited by barium, linopirdine and
CC       XE991. Activated by niflumic acid and the anticonvulsant
CC       retigabine. Muscarine suppresses KCNQ5 current in Xenopus oocytes
CC       in which cloned KCNQ5 channels were coexpressed with M(1)
CC       muscarinic receptors.
CC   -!- SUBUNIT: Heteromultimer with KCNQ3 (PubMed:11159685).
CC       Heterotetramer with KCNQ1; has a voltage-gated potassium channel
CC       activity (PubMed:24855057). {ECO:0000269|PubMed:11159685,
CC       ECO:0000269|PubMed:24855057}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q9NR82-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NR82-2; Sequence=VSP_001014;
CC       Name=3;
CC         IsoId=Q9NR82-3; Sequence=VSP_001015;
CC       Name=4;
CC         IsoId=Q9NR82-4; Sequence=VSP_022318, VSP_022319;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9NR82-5; Sequence=VSP_045487;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q9NR82-6; Sequence=VSP_056731;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=Q9NR82-7; Sequence=VSP_056730;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in brain and skeletal
CC       muscle. In brain, expressed in cerebral cortex, occipital pole,
CC       frontal lobe and temporal lobe. Lower levels in hippocampus and
CC       putamen. Low to undetectable levels in medulla, cerebellum and
CC       thalamus.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT
CC       (TC 1.A.1.15) subfamily. Kv7.5/KCNQ5 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG61495.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF249278; AAF91335.1; -; mRNA.
DR   EMBL; AL445569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360236; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FO393414; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671823; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050689; AAH50689.1; -; mRNA.
DR   EMBL; BC117359; AAI17360.1; -; mRNA.
DR   EMBL; BC143554; AAI43555.1; -; mRNA.
DR   EMBL; AK299550; BAG61495.1; ALT_INIT; mRNA.
DR   EMBL; AF202977; AAF69797.1; -; mRNA.
DR   EMBL; AJ272506; CAC88112.1; -; Genomic_DNA.
DR   EMBL; AJ272507; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272508; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272509; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272510; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272511; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272512; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272513; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272514; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272515; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272516; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272517; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272518; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272519; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AF263835; AAF73446.1; -; mRNA.
DR   CCDS; CCDS4976.1; -. [Q9NR82-1]
DR   CCDS; CCDS55034.1; -. [Q9NR82-6]
DR   CCDS; CCDS55035.1; -. [Q9NR82-5]
DR   CCDS; CCDS55037.1; -. [Q9NR82-2]
DR   RefSeq; NP_001153602.1; NM_001160130.1. [Q9NR82-2]
DR   RefSeq; NP_001153604.1; NM_001160132.1. [Q9NR82-3]
DR   RefSeq; NP_001153605.1; NM_001160133.1. [Q9NR82-6]
DR   RefSeq; NP_001153606.1; NM_001160134.1. [Q9NR82-5]
DR   RefSeq; NP_062816.2; NM_019842.3. [Q9NR82-1]
DR   UniGene; Hs.445324; -.
DR   ProteinModelPortal; Q9NR82; -.
DR   BioGrid; 121149; 6.
DR   STRING; 9606.ENSP00000345055; -.
DR   BindingDB; Q9NR82; -.
DR   ChEMBL; CHEMBL2925; -.
DR   DrugBank; DB04953; Ezogabine.
DR   GuidetoPHARMACOLOGY; 564; -.
DR   iPTMnet; Q9NR82; -.
DR   PhosphoSitePlus; Q9NR82; -.
DR   BioMuta; KCNQ5; -.
DR   DMDM; 122065285; -.
DR   PaxDb; Q9NR82; -.
DR   PeptideAtlas; Q9NR82; -.
DR   PRIDE; Q9NR82; -.
DR   Ensembl; ENST00000342056; ENSP00000345055; ENSG00000185760. [Q9NR82-6]
DR   Ensembl; ENST00000370392; ENSP00000359419; ENSG00000185760. [Q9NR82-4]
DR   Ensembl; ENST00000370398; ENSP00000359425; ENSG00000185760. [Q9NR82-1]
DR   Ensembl; ENST00000628967; ENSP00000486187; ENSG00000185760. [Q9NR82-5]
DR   Ensembl; ENST00000629977; ENSP00000485743; ENSG00000185760. [Q9NR82-2]
DR   GeneID; 56479; -.
DR   KEGG; hsa:56479; -.
DR   UCSC; uc003pgj.5; human. [Q9NR82-1]
DR   CTD; 56479; -.
DR   DisGeNET; 56479; -.
DR   GeneCards; KCNQ5; -.
DR   HGNC; HGNC:6299; KCNQ5.
DR   HPA; HPA016655; -.
DR   MIM; 607357; gene.
DR   neXtProt; NX_Q9NR82; -.
DR   OpenTargets; ENSG00000185760; -.
DR   PharmGKB; PA30077; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; Q9NR82; -.
DR   KO; K04930; -.
DR   OMA; RMYTSRK; -.
DR   PhylomeDB; Q9NR82; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNQ5; human.
DR   GeneWiki; KCNQ5; -.
DR   GenomeRNAi; 56479; -.
DR   PRO; PR:Q9NR82; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000185760; -.
DR   CleanEx; HS_KCNQ5; -.
DR   ExpressionAtlas; Q9NR82; baseline and differential.
DR   Genevisible; Q9NR82; HS.
DR   GO; GO:0030118; C:clathrin coat; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0006461; P:protein complex assembly; NAS:ProtInc.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    932       Potassium voltage-gated channel subfamily
FT                                KQT member 5.
FT                                /FTId=PRO_0000054040.
FT   TRANSMEM    126    146       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    157    177       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    230    252       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    267    287       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    299    319       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    326    346       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       311    316       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      88     88       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK45}.
FT   MOD_RES     447    447       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK45}.
FT   MOD_RES     831    831       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     407    416       KKEQGEASSS -> N (in isoform 2).
FT                                {ECO:0000303|PubMed:10816588,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001014.
FT   VAR_SEQ     407    416       KKEQGEASSS -> NKFCSNKQKLFRMYTSRKQS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:10816588}.
FT                                /FTId=VSP_001015.
FT   VAR_SEQ     408    416       KEQGEASSS -> QNQQGESQSC (in isoform 7).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_056730.
FT   VAR_SEQ     416    525       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045487.
FT   VAR_SEQ     416    427       SQKLSFKERVRM -> RFVISLLLHVCL (in isoform
FT                                4). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022318.
FT   VAR_SEQ     416    416       S -> SKFCSNKQKLFRMYTSRKQS (in isoform 6).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_056731.
FT   VAR_SEQ     428    932       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022319.
FT   VARIANT     191    191       W -> G (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035772.
FT   VARIANT     244    244       R -> C (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035773.
FT   CONFLICT     92     93       KP -> SR (in Ref. 1; AAF91335).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       R -> Q (in Ref. 4; BAG61495).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       Y -> H (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    727    727       A -> V (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    799    799       T -> P (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    857    857       S -> R (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    909    909       R -> Q (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
SQ   SEQUENCE   932 AA;  102179 MW;  CB41C243FD2B00FC CRC64;
     MPRHHAGGEE GGAAGLWVKS GAAAAAAGGG RLGSGMKDVE SGRGRVLLNS AAARGDGLLL
     LGTRAATLGG GGGGLRESRR GKQGARMSLL GKPLSYTSSQ SCRRNVKYRR VQNYLYNVLE
     RPRGWAFIYH AFVFLLVFGC LILSVFSTIP EHTKLASSCL LILEFVMIVV FGLEFIIRIW
     SAGCCCRYRG WQGRLRFARK PFCVIDTIVL IASIAVVSAK TQGNIFATSA LRSLRFLQIL
     RMVRMDRRGG TWKLLGSVVY AHSKELITAW YIGFLVLIFS SFLVYLVEKD ANKEFSTYAD
     ALWWGTITLT TIGYGDKTPL TWLGRLLSAG FALLGISFFA LPAGILGSGF ALKVQEQHRQ
     KHFEKRRNPA ANLIQCVWRS YAADEKSVSI ATWKPHLKAL HTCSPTKKEQ GEASSSQKLS
     FKERVRMASP RGQSIKSRQA SVGDRRSPST DITAEGSPTK VQKSWSFNDR TRFRPSLRLK
     SSQPKPVIDA DTALGTDDVY DEKGCQCDVS VEDLTPPLKT VIRAIRIMKF HVAKRKFKET
     LRPYDVKDVI EQYSAGHLDM LCRIKSLQTR VDQILGKGQI TSDKKSREKI TAEHETTDDL
     SMLGRVVKVE KQVQSIESKL DCLLDIYQQV LRKGSASALA LASFQIPPFE CEQTSDYQSP
     VDSKDLSGSA QNSGCLSRST SANISRGLQF ILTPNEFSAQ TFYALSPTMH SQATQVPISQ
     SDGSAVAATN TIANQINTAP KPAAPTTLQI PPPLPAIKHL PRPETLHPNP AGLQESISDV
     TTCLVASKEN VQVAQSNLTK DRSMRKSFDM GGETLLSVCP MVPKDLGKSL SVQNLIRSTE
     ELNIQLSGSE SSGSRGSQDF YPKWRESKLF ITDEEVGPEE TETDTFDAAP QPAREAAFAS
     DSLRTGRSRS SQSICKAGES TDALSLPHVK LK
//
ID   KCNV1_HUMAN             Reviewed;         500 AA.
AC   Q6PIU1; Q9UHJ4;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   15-FEB-2017, entry version 118.
DE   RecName: Full=Potassium voltage-gated channel subfamily V member 1;
DE   AltName: Full=Neuronal potassium channel alpha subunit HNKA;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv8.1;
GN   Name=KCNV1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH KCNB1; KCNB2; KCNC4 AND KCND1.
RX   PubMed=8670833;
RA   Hugnot J.-P., Salinas M., Lesage F., Guillemare E., de Weille J.,
RA   Heurteaux C., Mattei M.-G., Lazdunski M.;
RT   "Kv8.1, a new neuronal potassium channel subunit with specific
RT   inhibitory properties towards Shab and Shaw channels.";
RL   EMBO J. 15:3322-3331(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=12383276; DOI=10.1046/j.1528-1157.43.s.9.7.x;
RA   Sano A., Mikami M., Nakamura M., Ueno S., Tanabe H., Kaneko S.;
RT   "Positional candidate approach for the gene responsible for benign
RT   adult familial myoclonic epilepsy.";
RL   Epilepsia 43:26-31(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Xia J.-H., Zheng D., Tang X.-X., Yu K.-P., Tan S.;
RT   "Molecular cloning of human neuronal potassium channel alpha subunit
RT   (HNKA).";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-22.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNB1 AND KCNB2.
RX   PubMed=9079713; DOI=10.1074/jbc.272.13.8774;
RA   Salinas M., de Weille J., Guillemare E., Lazdunski M., Hugnot J.-P.;
RT   "Modes of regulation of shab K+ channel activity by the Kv8.1
RT   subunit.";
RL   J. Biol. Chem. 272:8774-8780(1997).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Modulates KCNB1 and KCNB2 channel activity by
CC       shifting the threshold for inactivation to more negative values
CC       and by slowing the rate of inactivation. Can down-regulate the
CC       channel activity of KCNB1, KCNB2, KCNC4 and KCND1, possibly by
CC       trapping them in intracellular membranes.
CC       {ECO:0000269|PubMed:8670833, ECO:0000269|PubMed:9079713}.
CC   -!- SUBUNIT: Heteromultimer with KCNB1 and KCNB2. Interacts with KCNC4
CC       and KCND1. {ECO:0000269|PubMed:8670833,
CC       ECO:0000269|PubMed:9079713}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8670833,
CC       ECO:0000269|PubMed:9079713}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8670833, ECO:0000269|PubMed:9079713}. Note=Has
CC       to be associated with another potassium channel subunit to get
CC       inserted in the plasma membrane. Remains intracellular in the
CC       absence of KCNB2.
CC   -!- TISSUE SPECIFICITY: Detected in brain.
CC       {ECO:0000269|PubMed:12383276}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. V
CC       (TC 1.A.1.2) subfamily. Kv8.1/KCNV1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB032013; BAA92316.1; -; Genomic_DNA.
DR   EMBL; AF167082; AAD48031.2; -; mRNA.
DR   EMBL; BC028739; AAH28739.1; -; mRNA.
DR   CCDS; CCDS6314.1; -.
DR   RefSeq; NP_055194.1; NM_014379.3.
DR   UniGene; Hs.13285; -.
DR   ProteinModelPortal; Q6PIU1; -.
DR   BioGrid; 117954; 2.
DR   IntAct; Q6PIU1; 1.
DR   STRING; 9606.ENSP00000297404; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   PhosphoSitePlus; Q6PIU1; -.
DR   BioMuta; KCNV1; -.
DR   DMDM; 160013825; -.
DR   PaxDb; Q6PIU1; -.
DR   PeptideAtlas; Q6PIU1; -.
DR   PRIDE; Q6PIU1; -.
DR   DNASU; 27012; -.
DR   Ensembl; ENST00000297404; ENSP00000297404; ENSG00000164794.
DR   Ensembl; ENST00000524391; ENSP00000435954; ENSG00000164794.
DR   GeneID; 27012; -.
DR   KEGG; hsa:27012; -.
DR   UCSC; uc003ynr.5; human.
DR   CTD; 27012; -.
DR   DisGeNET; 27012; -.
DR   GeneCards; KCNV1; -.
DR   HGNC; HGNC:18861; KCNV1.
DR   MIM; 608164; gene.
DR   neXtProt; NX_Q6PIU1; -.
DR   OpenTargets; ENSG00000164794; -.
DR   PharmGKB; PA38721; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q6PIU1; -.
DR   KO; K04934; -.
DR   OMA; GMTIAQC; -.
DR   OrthoDB; EOG090705C6; -.
DR   PhylomeDB; Q6PIU1; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNV1; -.
DR   GenomeRNAi; 27012; -.
DR   PRO; PR:Q6PIU1; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164794; -.
DR   CleanEx; HS_KCNV1; -.
DR   Genevisible; Q6PIU1; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc.
DR   GO; GO:0015459; F:potassium channel regulator activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003970; K_chnl_volt-dep_Kv8.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF186; PTHR11537:SF186; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01493; KV8CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    500       Potassium voltage-gated channel subfamily
FT                                V member 1.
FT                                /FTId=PRO_0000308350.
FT   TOPO_DOM      1    210       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    211    231       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    232    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    260    276       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    277    297       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    298    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    331       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    332    345       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    346    366       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    407    427       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    428    500       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       392    397       Selectivity filter. {ECO:0000250}.
FT   VARIANT      22     22       D -> G (in dbSNP:rs17852611).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_036804.
SQ   SEQUENCE   500 AA;  56304 MW;  C229E21ABC869C73 CRC64;
     MPSSGRALLD SPLDSGSLTS LDSSVFCSEG EGEPLALGDC FTVNVGGSRF VLSQQALSCF
     PHTRLGKLAV VVASYRRPGA LAAVPSPLEL CDDANPVDNE YFFDRSSQAF RYVLHYYRTG
     RLHVMEQLCA LSFLQEIQYW GIDELSIDSC CRDRYFRRKE LSETLDFKKD TEDQESQHES
     EQDFSQGPCP TVRQKLWNIL EKPGSSTAAR IFGVISIIFV VVSIINMALM SAELSWLDLQ
     LLEILEYVCI SWFTGEFVLR FLCVRDRCRF LRKVPNIIDL LAILPFYITL LVESLSGSQT
     TQELENVGRI VQVLRLLRAL RMLKLGRHST GLRSLGMTIT QCYEEVGLLL LFLSVGISIF
     STVEYFAEQS IPDTTFTSVP CAWWWATTSM TTVGYGDIRP DTTTGKIVAF MCILSGILVL
     ALPIAIINDR FSACYFTLKL KEAAVRQREA LKKLTKNIAT DSYISVNLRD VYARSIMEML
     RLKGRERAST RSSGGDDFWF
//
ID   KCNV2_HUMAN             Reviewed;         545 AA.
AC   Q8TDN2; Q5T6X0;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-FEB-2017, entry version 133.
DE   RecName: Full=Potassium voltage-gated channel subfamily V member 2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv8.2;
GN   Name=KCNV2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANTS RCD3B GLN-126; CYS-188; TRP-256; VAL-259; 339-ASP--VAL-341
RP   DEL AND ASP-459, AND VARIANT VAL-533.
RX   PubMed=16909397; DOI=10.1086/507568;
RA   Wu H., Cowing J.A., Michaelides M., Wilkie S.E., Jeffery G.,
RA   Jenkins S.A., Mester V., Bird A.C., Robson A.G., Holder G.E.,
RA   Moore A.T., Hunt D.M., Webster A.R.;
RT   "Mutations in the gene KCNV2 encoding a voltage-gated potassium
RT   channel subunit cause 'cone dystrophy with supernormal rod
RT   electroretinogram' in humans.";
RL   Am. J. Hum. Genet. 79:574-579(2006).
CC   -!- FUNCTION: Potassium channel subunit. Modulates channel activity by
CC       shifting the threshold and the half-maximal activation to more
CC       negative values.
CC   -!- SUBUNIT: Heteromultimer with KCNB1, KCNC1 and KCNF1. Does not form
CC       homomultimers. {ECO:0000269|PubMed:12060745}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Has to be associated with KCNB1 or possibly another partner
CC       to get inserted in the plasma membrane. Remains intracellular in
CC       the absence of KCNB1.
CC   -!- TISSUE SPECIFICITY: Detected in lung, liver, kidney, pancreas,
CC       spleen, thymus, prostate, testis, ovary and colon.
CC       {ECO:0000269|PubMed:12060745}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DISEASE: Cone dystrophy retinal 3B (RCD3B) [MIM:610356]: A rare
CC       form of cone dystrophy associated with supernormal rod responses.
CC       The disorder is characterized by reduced visual acuity,
CC       photoaversion, night blindness, and abnormal color vision. At an
CC       early age, the retina shows subtle depigmentation at the macula
CC       and, later, more obvious areas of atrophy.
CC       {ECO:0000269|PubMed:16909397}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. V
CC       (TC 1.A.1.2) subfamily. Kv8.2/KCNV2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF348983; AAL83910.1; -; mRNA.
DR   EMBL; AL354723; CAI15124.1; -; Genomic_DNA.
DR   EMBL; BC101352; AAI01353.1; -; mRNA.
DR   EMBL; BC101353; AAI01354.1; -; mRNA.
DR   CCDS; CCDS6447.1; -.
DR   RefSeq; NP_598004.1; NM_133497.3.
DR   UniGene; Hs.622675; -.
DR   UniGene; Hs.624689; -.
DR   UniGene; Hs.740173; -.
DR   ProteinModelPortal; Q8TDN2; -.
DR   BioGrid; 127982; 6.
DR   IntAct; Q8TDN2; 1.
DR   STRING; 9606.ENSP00000371514; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q8TDN2; -.
DR   PhosphoSitePlus; Q8TDN2; -.
DR   BioMuta; KCNV2; -.
DR   DMDM; 26006804; -.
DR   PaxDb; Q8TDN2; -.
DR   PeptideAtlas; Q8TDN2; -.
DR   PRIDE; Q8TDN2; -.
DR   Ensembl; ENST00000382082; ENSP00000371514; ENSG00000168263.
DR   GeneID; 169522; -.
DR   KEGG; hsa:169522; -.
DR   UCSC; uc003zho.3; human.
DR   CTD; 169522; -.
DR   DisGeNET; 169522; -.
DR   GeneCards; KCNV2; -.
DR   H-InvDB; HIX0035118; -.
DR   HGNC; HGNC:19698; KCNV2.
DR   HPA; HPA031131; -.
DR   MalaCards; KCNV2; -.
DR   MIM; 607604; gene.
DR   MIM; 610356; phenotype.
DR   neXtProt; NX_Q8TDN2; -.
DR   OpenTargets; ENSG00000168263; -.
DR   Orphanet; 209932; Cone dystrophy with supernormal rod response.
DR   PharmGKB; PA134992655; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG095321; -.
DR   InParanoid; Q8TDN2; -.
DR   KO; K04935; -.
DR   OMA; FQLIYNF; -.
DR   OrthoDB; EOG090B06J7; -.
DR   PhylomeDB; Q8TDN2; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNV2; -.
DR   GenomeRNAi; 169522; -.
DR   PRO; PR:Q8TDN2; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000168263; -.
DR   CleanEx; HS_KCNV2; -.
DR   Genevisible; Q8TDN2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Cone-rod dystrophy;
KW   Disease mutation; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    545       Potassium voltage-gated channel subfamily
FT                                V member 2.
FT                                /FTId=PRO_0000054094.
FT   TOPO_DOM      1    155       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    177    261       Extracellular. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    283    336       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    337    357       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    358    374       Extracellular. {ECO:0000255}.
FT   TRANSMEM    375    395       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    396    410       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    411    431       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    432    444       Extracellular. {ECO:0000255}.
FT   INTRAMEM    445    465       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    466    471       Extracellular. {ECO:0000255}.
FT   TRANSMEM    472    492       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    493    545       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       457    462       Selectivity filter. {ECO:0000250}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT     126    126       L -> Q (in RCD3B).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027632.
FT   VARIANT     188    188       W -> C (in RCD3B; dbSNP:rs772921412).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027633.
FT   VARIANT     256    256       S -> W (in RCD3B; dbSNP:rs104894116).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027634.
FT   VARIANT     259    259       A -> V (in RCD3B).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027635.
FT   VARIANT     339    341       Missing (in RCD3B).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027636.
FT   VARIANT     459    459       G -> D (in RCD3B; dbSNP:rs104894115).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027637.
FT   VARIANT     533    533       L -> V (in dbSNP:rs12352254).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027638.
SQ   SEQUENCE   545 AA;  62459 MW;  72D175B4C0C6B1DA CRC64;
     MLKQSERRRS WSYRPWNTTE NEGSQHRRSI CSLGARSGSQ ASIHGWTEGN YNYYIEEDED
     GEEEDQWKDD LAEEDQQAGE VTTAKPEGPS DPPALLSTLN VNVGGHSYQL DYCELAGFPK
     TRLGRLATST SRSRQLSLCD DYEEQTDEYF FDRDPAVFQL VYNFYLSGVL LVLDGLCPRR
     FLEELGYWGV RLKYTPRCCR ICFEERRDEL SERLKIQHEL RAQAQVEEAE ELFRDMRFYG
     PQRRRLWNLM EKPFSSVAAK AIGVASSTFV LVSVVALALN TVEEMQQHSG QGEGGPDLRP
     ILEHVEMLCM GFFTLEYLLR LASTPDLRRF ARSALNLVDL VAILPLYLQL LLECFTGEGH
     QRGQTVGSVG KVGQVLRVMR LMRIFRILKL ARHSTGLRAF GFTLRQCYQQ VGCLLLFIAM
     GIFTFSAAVY SVEHDVPSTN FTTIPHSWWW AAVSISTVGY GDMYPETHLG RFFAFLCIAF
     GIILNGMPIS ILYNKFSDYY SKLKAYEYTT IRRERGEVNF MQRARKKIAE CLLGSNPQLT
     PRQEN
//
ID   KCNS1_HUMAN             Reviewed;         526 AA.
AC   Q96KK3; A2RUL9; B7ZM31; O43652; Q6DJU6;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 2.
DT   15-FEB-2017, entry version 130.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 1;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.1;
GN   Name=KCNS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Lens epithelium;
RX   PubMed=10484328;
RA   Shepard A.R., Rae J.L.;
RT   "Electrically silent potassium channel subunits from human lens
RT   epithelium.";
RL   Am. J. Physiol. 277:C412-C424(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-489.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1 and KCNB2; modulates the delayed rectifier voltage-
CC       gated potassium channel activation and deactivation rates of KCNB1
CC       and KCNB2 (PubMed:10484328). {ECO:0000269|PubMed:10484328}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:10484328).
CC       Heterotetramer with KCNB2 (By similarity). Does not form
CC       homomultimers (PubMed:10484328). {ECO:0000250|UniProtKB:O35173,
CC       ECO:0000269|PubMed:10484328}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10484328};
CC       Multi-pass membrane protein {ECO:0000305}. Note=May not reach the
CC       plasma membrane but remain in an intracellular compartment in the
CC       absence of KCNB1 or KCNB2 (PubMed:10484328).
CC       {ECO:0000269|PubMed:10484328}.
CC   -!- TISSUE SPECIFICITY: Detected in all tissues tested with the
CC       exception of skeletal muscle. Highly expressed in adult and fetal
CC       brain, fetal kidney and lung, and adult prostate and testis
CC       (PubMed:10484328). {ECO:0000269|PubMed:10484328}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S
CC       (TC 1.A.1.2) subfamily. Kv9.1/KCNS1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043473; AAC13165.2; -; mRNA.
DR   EMBL; Z93016; CAB07507.2; -; Genomic_DNA.
DR   EMBL; BC075033; AAH75033.2; -; mRNA.
DR   EMBL; BC075034; AAH75034.2; -; mRNA.
DR   EMBL; BC132959; AAI32960.1; -; mRNA.
DR   EMBL; BC144234; AAI44235.1; -; mRNA.
DR   CCDS; CCDS13342.1; -.
DR   RefSeq; NP_001309728.1; NM_001322799.1.
DR   RefSeq; NP_002242.2; NM_002251.4.
DR   UniGene; Hs.117780; -.
DR   UniGene; Hs.563002; -.
DR   ProteinModelPortal; Q96KK3; -.
DR   STRING; 9606.ENSP00000307694; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.7; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q96KK3; -.
DR   PhosphoSitePlus; Q96KK3; -.
DR   BioMuta; KCNS1; -.
DR   DMDM; 24418474; -.
DR   PaxDb; Q96KK3; -.
DR   PRIDE; Q96KK3; -.
DR   Ensembl; ENST00000306117; ENSP00000307694; ENSG00000124134.
DR   Ensembl; ENST00000537075; ENSP00000445595; ENSG00000124134.
DR   GeneID; 3787; -.
DR   KEGG; hsa:3787; -.
DR   UCSC; uc002xnc.4; human.
DR   CTD; 3787; -.
DR   DisGeNET; 3787; -.
DR   GeneCards; KCNS1; -.
DR   HGNC; HGNC:6300; KCNS1.
DR   MIM; 602905; gene.
DR   neXtProt; NX_Q96KK3; -.
DR   OpenTargets; ENSG00000124134; -.
DR   PharmGKB; PA30078; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q96KK3; -.
DR   KO; K04931; -.
DR   OMA; WLTLENP; -.
DR   OrthoDB; EOG090705FC; -.
DR   PhylomeDB; Q96KK3; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNS1; -.
DR   GenomeRNAi; 3787; -.
DR   PRO; PR:Q96KK3; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124134; -.
DR   CleanEx; HS_KCNS1; -.
DR   ExpressionAtlas; Q96KK3; baseline and differential.
DR   Genevisible; Q96KK3; HS.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    526       Potassium voltage-gated channel subfamily
FT                                S member 1.
FT                                /FTId=PRO_0000054081.
FT   TOPO_DOM      1    217       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    218    239       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    240    270       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    271    293       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    294    304       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    305    322       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    323    337       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    338    358       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    359    373       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    374    395       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    396    408       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    409    420       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    421    428       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    429    435       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    436    464       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    465    526       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       421    426       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS    250    259       Poly-Ala.
FT   VARIANT     489    489       I -> V (in dbSNP:rs734784).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_020052.
FT   VARIANT     508    508       Q -> R (in dbSNP:rs7264544).
FT                                /FTId=VAR_053867.
SQ   SEQUENCE   526 AA;  58372 MW;  00F0E415E3A68C91 CRC64;
     MLMLLVRGTH YENLRSKVVL PTPLGGRSTE TFVSEFPGPD TGIRWRRSDE ALRVNVGGVR
     RQLSARALAR FPGTRLGRLQ AAASEEQARR LCDDYDEAAR EFYFDRHPGF FLSLLHFYRT
     GHLHVLDELC VFAFGQEADY WGLGENALAA CCRARYLERR LTQPHAWDED SDTPSSVDPC
     PDEISDVQRE LARYGAARCG RLRRRLWLTM ENPGYSLPSK LFSCVSISVV LASIAAMCIH
     SLPEYQAREA AAAVAAVAAG RSPEGVRDDP VLRRLEYFCI AWFSFEVSSR LLLAPSTRNF
     FCHPLNLIDI VSVLPFYLTL LAGVALGDQG GKEFGHLGKV VQVFRLMRIF RVLKLARHST
     GLRSLGATLK HSYREVGILL LYLAVGVSVF SGVAYTAEKE EDVGFNTIPA CWWWGTVSMT
     TVGYGDVVPV TVAGKLAASG CILGGILVVA LPITIIFNKF SHFYRRQKAL EAAVRNSNHQ
     EFEDLLSSID GVSEASLETS RETSQEGQSA DLESQAPSEP PHPQMY
//
ID   KCNS2_HUMAN             Reviewed;         477 AA.
AC   Q9ULS6; A8KAN1;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2002, sequence version 2.
DT   15-FEB-2017, entry version 136.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 2;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.2;
GN   Name=KCNS2; Synonyms=KIAA1144;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1 and KCNB2; modulates the delayed rectifier voltage-
CC       gated potassium channel activation and deactivation rates of KCNB1
CC       and KCNB2. {ECO:0000250|UniProtKB:O35174}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 and KCNB2. Does not form
CC       homomultimers. {ECO:0000250|UniProtKB:O35174}.
CC   -!- INTERACTION:
CC       Q969F0:FATE1; NbExp=5; IntAct=EBI-10323864, EBI-743099;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:O35174}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O35174}. Note=May not reach the plasma
CC       membrane but remain in an intracellular compartment in the absence
CC       of KCNB1 or KCNB2. {ECO:0000250|UniProtKB:O35174}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S
CC       (TC 1.A.1.2) subfamily. Kv9.2/KCNS2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86458.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB032970; BAA86458.1; ALT_INIT; mRNA.
DR   EMBL; AK293096; BAF85785.1; -; mRNA.
DR   EMBL; CH471060; EAW91780.1; -; Genomic_DNA.
DR   EMBL; BC027932; AAH27932.1; -; mRNA.
DR   EMBL; BC034778; AAH34778.1; -; mRNA.
DR   CCDS; CCDS6279.1; -.
DR   RefSeq; NP_065748.1; NM_020697.3.
DR   UniGene; Hs.388045; -.
DR   ProteinModelPortal; Q9ULS6; -.
DR   BioGrid; 109989; 1.
DR   IntAct; Q9ULS6; 3.
DR   STRING; 9606.ENSP00000287042; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.16; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9ULS6; -.
DR   PhosphoSitePlus; Q9ULS6; -.
DR   BioMuta; KCNS2; -.
DR   DMDM; 24418481; -.
DR   PaxDb; Q9ULS6; -.
DR   PeptideAtlas; Q9ULS6; -.
DR   PRIDE; Q9ULS6; -.
DR   DNASU; 3788; -.
DR   Ensembl; ENST00000287042; ENSP00000287042; ENSG00000156486.
DR   Ensembl; ENST00000521839; ENSP00000430712; ENSG00000156486.
DR   GeneID; 3788; -.
DR   KEGG; hsa:3788; -.
DR   UCSC; uc003yin.4; human.
DR   CTD; 3788; -.
DR   GeneCards; KCNS2; -.
DR   HGNC; HGNC:6301; KCNS2.
DR   HPA; HPA051417; -.
DR   MIM; 602906; gene.
DR   neXtProt; NX_Q9ULS6; -.
DR   OpenTargets; ENSG00000156486; -.
DR   PharmGKB; PA30079; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q9ULS6; -.
DR   KO; K04932; -.
DR   OMA; AQREFYF; -.
DR   OrthoDB; EOG090705A4; -.
DR   PhylomeDB; Q9ULS6; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNS2; -.
DR   GenomeRNAi; 3788; -.
DR   PRO; PR:Q9ULS6; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000156486; -.
DR   CleanEx; HS_KCNS2; -.
DR   Genevisible; Q9ULS6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:Ensembl.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    477       Potassium voltage-gated channel subfamily
FT                                S member 2.
FT                                /FTId=PRO_0000054084.
FT   TOPO_DOM      1    184       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    185    206       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    207    225       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    226    248       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    249    259       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    260    280       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    281    290       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    291    311       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    312    326       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    327    348       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    349    361       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    362    373       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    374    381       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    382    388       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    389    417       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    418    477       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       374    379       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
SQ   SEQUENCE   477 AA;  54237 MW;  F231AD99EC02EB46 CRC64;
     MTGQSLWDVS EANVEDGEIR INVGGFKRRL RSHTLLRFPE TRLGRLLLCH SREAILELCD
     DYDDVQREFY FDRNPELFPY VLHFYHTGKL HVMAELCVFS FSQEIEYWGI NEFFIDSCCS
     YSYHGRKVEP EQEKWDEQSD QESTTSSFDE ILAFYNDASK FDGQPLGNFR RQLWLALDNP
     GYSVLSRVFS ILSILVVMGS IITMCLNSLP DFQIPDSQGN PGEDPRFEIV EHFGIAWFTF
     ELVARFAVAP DFLKFFKNAL NLIDLMSIVP FYITLVVNLV VESTPTLANL GRVAQVLRLM
     RIFRILKLAR HSTGLRSLGA TLKYSYKEVG LLLLYLSVGI SIFSVVAYTI EKEENEGLAT
     IPACWWWATV SMTTVGYGDV VPGTTAGKLT ASACILAGIL VVVLPITLIF NKFSHFYRRQ
     KQLESAMRSC DFGDGMKEVP SVNLRDYYAH KVKSLMASLT NMSRSSPSEL SLNDSLR
//
ID   KCNS3_HUMAN             Reviewed;         491 AA.
AC   Q9BQ31; D6W520; O43651; Q4ZFY1; Q96B56;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   15-FEB-2017, entry version 136.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 3;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.3;
GN   Name=KCNS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND VARIANT ALA-450.
RC   TISSUE=Lens epithelium;
RX   PubMed=10484328;
RA   Shepard A.R., Rae J.L.;
RT   "Electrically silent potassium channel subunits from human lens
RT   epithelium.";
RL   Am. J. Physiol. 277:C412-C424(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-450.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-225 AND
RP   ALA-450.
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=22943705; DOI=10.3109/01443615.2012.709288;
RA   Fyfe G.K., Panicker S., Jones R.L., Wareing M.;
RT   "Expression of an electrically silent voltage-gated potassium channel
RT   in the human placenta.";
RL   J. Obstet. Gynaecol. 32:624-629(2012).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1; modulates the delayed rectifier voltage-gated
CC       potassium channel activation and deactivation rates of KCNB1
CC       (PubMed:10484328). Heterotetrameric channel activity formed with
CC       KCNB1 show increased current amplitude with the threshold for
CC       action potential activation shifted towards more negative values
CC       in hypoxic-treated pulmonary artery smooth muscle cells (By
CC       similarity). {ECO:0000250|UniProtKB:O88759,
CC       ECO:0000269|PubMed:10484328}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:10484328). Does not
CC       form homomultimers (PubMed:10484328).
CC       {ECO:0000269|PubMed:10484328}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10484328};
CC       Multi-pass membrane protein {ECO:0000305}. Note=May not reach the
CC       plasma membrane but remain in an intracellular compartment in the
CC       absence of KCNB1 (PubMed:10484328). {ECO:0000269|PubMed:10484328}.
CC   -!- TISSUE SPECIFICITY: Detected in whole normal term placental and
CC       placental chorionic plate arteries and veins. Detected in
CC       syncytiotrophoblast and in blood vessel endothelium within
CC       intermediate villi and chorionic plate (at protein level)
CC       (PubMed:22943705). Detected in most tissues, but not in peripheral
CC       blood lymphocytes. The highest levels of expression are in lung
CC       (PubMed:10484328). {ECO:0000269|PubMed:10484328,
CC       ECO:0000269|PubMed:22943705}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S
CC       (TC 1.A.1.2) subfamily. Kv9.3/KCNS3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043472; AAC13164.1; -; mRNA.
DR   EMBL; AK314451; BAG37059.1; -; mRNA.
DR   EMBL; AC093731; AAX88969.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00861.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00862.1; -; Genomic_DNA.
DR   EMBL; BC004148; AAH04148.1; -; mRNA.
DR   EMBL; BC004987; AAH04987.1; -; mRNA.
DR   EMBL; BC015947; AAH15947.1; -; mRNA.
DR   CCDS; CCDS1692.1; -.
DR   RefSeq; NP_001269357.1; NM_001282428.1.
DR   RefSeq; NP_002243.3; NM_002252.4.
DR   RefSeq; XP_011531127.1; XM_011532825.1.
DR   RefSeq; XP_016859548.1; XM_017004059.1.
DR   UniGene; Hs.414489; -.
DR   ProteinModelPortal; Q9BQ31; -.
DR   SMR; Q9BQ31; -.
DR   BioGrid; 109991; 34.
DR   IntAct; Q9BQ31; 1.
DR   STRING; 9606.ENSP00000305824; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.15; the voltage-gated ion channel (vic) superfamily.
DR   BioMuta; KCNS3; -.
DR   DMDM; 311033434; -.
DR   PaxDb; Q9BQ31; -.
DR   PRIDE; Q9BQ31; -.
DR   DNASU; 3790; -.
DR   Ensembl; ENST00000304101; ENSP00000305824; ENSG00000170745.
DR   Ensembl; ENST00000403915; ENSP00000385968; ENSG00000170745.
DR   GeneID; 3790; -.
DR   KEGG; hsa:3790; -.
DR   UCSC; uc002rcv.4; human.
DR   CTD; 3790; -.
DR   DisGeNET; 3790; -.
DR   GeneCards; KCNS3; -.
DR   H-InvDB; HIX0001848; -.
DR   HGNC; HGNC:6302; KCNS3.
DR   HPA; HPA014864; -.
DR   MIM; 603888; gene.
DR   neXtProt; NX_Q9BQ31; -.
DR   OpenTargets; ENSG00000170745; -.
DR   PharmGKB; PA30080; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q9BQ31; -.
DR   KO; K04933; -.
DR   OMA; FTWVENV; -.
DR   OrthoDB; EOG0907057U; -.
DR   PhylomeDB; Q9BQ31; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   GeneWiki; KCNS3; -.
DR   GenomeRNAi; 3790; -.
DR   PRO; PR:Q9BQ31; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170745; -.
DR   CleanEx; HS_KCNS3; -.
DR   ExpressionAtlas; Q9BQ31; baseline and differential.
DR   Genevisible; Q9BQ31; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0015459; F:potassium channel regulator activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR027359; Channel_four-helix_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    491       Potassium voltage-gated channel subfamily
FT                                S member 3.
FT                                /FTId=PRO_0000054087.
FT   TOPO_DOM      1    182       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    183    204       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    205    220       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    221    243       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    244    254       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    255    275       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    276    285       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    286    306       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    307    321       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    322    343       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    344    357       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    358    369       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    370    377       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    378    384       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    385    413       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    414    491       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       370    375       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   VARIANT     225    225       V -> L (in dbSNP:rs17856097).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_036986.
FT   VARIANT     450    450       T -> A (in dbSNP:rs4832524).
FT                                {ECO:0000269|PubMed:10484328,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014200.
FT   CONFLICT     27     27       S -> Y (in Ref. 3; AAH15947).
FT                                {ECO:0000305}.
SQ   SEQUENCE   491 AA;  56001 MW;  FFE02CA3DCA50185 CRC64;
     MVFGEFFHRP GQDEELVNLN VGGFKQSVDQ STLLRFPHTR LGKLLTCHSE EAILELCDDY
     SVADKEYYFD RNPSLFRYVL NFYYTGKLHV MEELCVFSFC QEIEYWGINE LFIDSCCSNR
     YQERKEENHE KDWDQKSHDV STDSSFEESS LFEKELEKFD TLRFGQLRKK IWIRMENPAY
     CLSAKLIAIS SLSVVLASIV AMCVHSMSEF QNEDGEVDDP VLEGVEIACI AWFTGELAVR
     LAAAPCQKKF WKNPLNIIDF VSIIPFYATL AVDTKEEESE DIENMGKVVQ ILRLMRIFRI
     LKLARHSVGL RSLGATLRHS YHEVGLLLLF LSVGISIFSV LIYSVEKDDH TSSLTSIPIC
     WWWATISMTT VGYGDTHPVT LAGKLIASTC IICGILVVAL PITIIFNKFS KYYQKQKDID
     VDQCSEDAPE KCHELPYFNI RDIYAQRMHT FITSLSSVGI VVSDPDSTDA SSIEDNEDIC
     NTTSLENCTA K
//
ID   KCNH1_HUMAN             Reviewed;         989 AA.
AC   O95259; B1AQ26; O76035; Q14CL3;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   15-FEB-2017, entry version 166.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 1;
DE   AltName: Full=Ether-a-go-go potassium channel 1 {ECO:0000303|PubMed:27325704};
DE            Short=EAG channel 1 {ECO:0000303|PubMed:23881642, ECO:0000303|PubMed:27325704};
DE            Short=h-eag;
DE            Short=hEAG1 {ECO:0000303|PubMed:23881642, ECO:0000303|PubMed:27325704};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.1;
GN   Name=KCNH1;
GN   Synonyms=EAG {ECO:0000303|PubMed:10523298},
GN   EAG1 {ECO:0000303|PubMed:23881642, ECO:0000303|PubMed:27325704};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Myoblast;
RX   PubMed=9738473; DOI=10.1016/S0014-5793(98)00973-9;
RA   Occhiodoro T., Bernheim L., Liu J.-H., Bijlenga P., Sinnreich M.,
RA   Bader C.R., Fischer-Lougheed J.;
RT   "Cloning of a human ether-a-go-go potassium channel expressed in
RT   myoblasts at the onset of fusion.";
RL   FEBS Lett. 434:177-182(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=10523298; DOI=10.1093/emboj/18.20.5540;
RA   Pardo L.A., del Camino D., Sanchez A., Alves F., Brueggemann A.,
RA   Beckh S., Stuehmer W.;
RT   "Oncogenic potential of EAG K(+) channels.";
RL   EMBO J. 18:5540-5547(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, CALMODULIN-BINDING DOMAIN, AND ENZYME
RP   REGULATION.
RX   PubMed=10880439; DOI=10.1093/emboj/19.13.3263;
RA   Schoenherr R., Lober K., Heinemann S.H.;
RT   "Inhibition of human ether a go-go potassium channels by
RT   Ca(2+)/calmodulin.";
RL   EMBO J. 19:3263-3271(2000).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNH5.
RX   PubMed=11943152; DOI=10.1016/S0014-5793(02)02365-7;
RA   Schoenherr R., Gessner G., Loeber K., Heinemann S.H.;
RT   "Functional distinction of human EAG1 and EAG2 potassium channels.";
RL   FEBS Lett. 514:204-208(2002).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21559285; DOI=10.1371/journal.pone.0019257;
RA   Chen Y., Sanchez A., Rubio M.E., Kohl T., Pardo L.A., Stuhmer W.;
RT   "Functional K(v)10.1 channels localize to the inner nuclear
RT   membrane.";
RL   PLoS ONE 6:E19257-E19257(2011).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22841712; DOI=10.1016/j.febslet.2012.07.055;
RA   Ninkovic M., Mitkovski M., Kohl T., Stuhmer W., Pardo L.A.;
RT   "Physical and functional interaction of KV10.1 with Rabaptin-5 impacts
RT   ion channel trafficking.";
RL   FEBS Lett. 586:3077-3084(2012).
RN   [10]
RP   INTERACTION WITH CTTN.
RX   PubMed=23144454; DOI=10.1074/jbc.M112.372540;
RA   Herrmann S., Ninkovic M., Kohl T., Lorinczi E., Pardo L.A.;
RT   "Cortactin controls surface expression of the voltage-gated potassium
RT   channel K(V)10.1.";
RL   J. Biol. Chem. 287:44151-44163(2012).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 699-TYR--LEU-701.
RX   PubMed=22732247; DOI=10.1016/j.jmb.2012.06.025;
RA   Marques-Carvalho M.J., Sahoo N., Muskett F.W., Vieira-Pires R.S.,
RA   Gabant G., Cadene M., Schonherr R., Morais-Cabral J.H.;
RT   "Structural, biochemical, and functional characterization of the
RT   cyclic nucleotide binding homology domain from the mouse EAG1
RT   potassium channel.";
RL   J. Mol. Biol. 423:34-46(2012).
RN   [12]
RP   FUNCTION.
RX   PubMed=23881642; DOI=10.1002/jcp.24435;
RA   Zhang Y.Y., Yue J., Che H., Sun H.Y., Tse H.F., Li G.R.;
RT   "BKCa and hEag1 channels regulate cell proliferation and
RT   differentiation in human bone marrow-derived mesenchymal stem cells.";
RL   J. Cell. Physiol. 229:202-212(2014).
RN   [13]
RP   PHOSPHORYLATION.
RX   PubMed=24587194; DOI=10.1371/journal.pone.0090024;
RA   Schlichter L.C., Jiang J., Wang J., Newell E.W., Tsui F.W., Lam D.;
RT   "Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine
RT   phosphatase via an ITIM region in the cyclic nucleotide binding
RT   domain.";
RL   PLoS ONE 9:E90024-E90024(2014).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25556795; DOI=10.1113/jphysiol.2014.281600;
RA   Mortensen L.S., Schmidt H., Farsi Z., Barrantes-Freer A., Rubio M.E.,
RA   Ufartes R., Eilers J., Sakaba T., Stuehmer W., Pardo L.A.;
RT   "KV 10.1 opposes activity-dependent increase in Ca2+ influx into the
RT   presynaptic terminal of the parallel fibre-Purkinje cell synapse.";
RL   J. Physiol. (Lond.) 593:181-196(2015).
RN   [15]
RP   INVOLVEMENT IN TMBTS, VARIANTS TMBTS ASN-217; PHE-489; VAL-494 AND
RP   ARG-503, AND CHARACTERIZATION OF VARIANTS TMBTS ASN-217; PHE-489;
RP   VAL-494 AND ARG-503.
RX   PubMed=25420144; DOI=10.1038/ng.3153;
RA   Simons C., Rash L.D., Crawford J., Ma L., Cristofori-Armstrong B.,
RA   Miller D., Ru K., Baillie G.J., Alanay Y., Jacquinet A., Debray F.G.,
RA   Verloes A., Shen J., Yesil G., Guler S., Yuksel A., Cleary J.G.,
RA   Grimmond S.M., McGaughran J., King G.F., Gabbett M.T., Taft R.J.;
RT   "Mutations in the voltage-gated potassium channel gene KCNH1 cause
RT   Temple-Baraitser syndrome and epilepsy.";
RL   Nat. Genet. 47:73-77(2015).
RN   [16]
RP   INVOLVEMENT IN ZLS1, VARIANTS ZLS1 TYR-352; ARG-375; VAL-379; LEU-383;
RP   VAL-494 AND ARG-496, AND CHARACTERIZATION OF VARIANTS ZLS1 TYR-352;
RP   ARG-375; VAL-379; LEU-383; VAL-494 AND ARG-496.
RX   PubMed=25915598; DOI=10.1038/ng.3282;
RA   Kortuem F., Caputo V., Bauer C.K., Stella L., Ciolfi A., Alawi M.,
RA   Bocchinfuso G., Flex E., Paolacci S., Dentici M.L., Grammatico P.,
RA   Korenke G.C., Leuzzi V., Mowat D., Nair L.D., Nguyen T.T., Thierry P.,
RA   White S.M., Dallapiccola B., Pizzuti A., Campeau P.M., Tartaglia M.,
RA   Kutsche K.;
RT   "Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome.";
RL   Nat. Genet. 47:661-667(2015).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND DOMAIN.
RX   PubMed=27325704; DOI=10.1074/jbc.M116.733576;
RA   Loerinczi E., Helliwell M., Finch A., Stansfeld P.J., Davies N.W.,
RA   Mahaut-Smith M., Muskett F.W., Mitcheson J.S.;
RT   "Calmodulin regulates human ether a go-go 1 (hEAG1) potassium channels
RT   through interactions of the Eag domain with the cyclic nucleotide
RT   binding homology domain.";
RL   J. Biol. Chem. 291:17907-17918(2016).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=27005320; DOI=10.1038/srep23417;
RA   Han B., He K., Cai C., Tang Y., Yang L., Heinemann S.H., Hoshi T.,
RA   Hou S.;
RT   "Human EAG channels are directly modulated by PIP2 as revealed by
RT   electrophysiological and optical interference investigations.";
RL   Sci. Rep. 6:23417-23417(2016).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, INTERACTION WITH
RP   CALM, AND MUTAGENESIS OF VAL-737 AND LEU-740.
RX   PubMed=27618660; DOI=10.1016/j.str.2016.07.020;
RA   Marques-Carvalho M.J., Oppermann J., Munoz E., Fernandes A.S.,
RA   Gabant G., Cadene M., Heinemann S.H., Schoenherr R.,
RA   Morais-Cabral J.H.;
RT   "Molecular insights into the mechanism of calmodulin inhibition of the
RT   EAG1 potassium channel.";
RL   Structure 24:1742-1754(2016).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1-146.
RA   Xue T., Juan S., Xiaohong Q.;
RT   "Crystal structure of PAS domain from the hEAG potassium channel.";
RL   Submitted (APR-2016) to the PDB data bank.
CC   -!- FUNCTION: Pore-forming (alpha) subunit of a voltage-gated delayed
CC       rectifier potassium channel (PubMed:9738473, PubMed:11943152,
CC       PubMed:10880439, PubMed:22732247, PubMed:25556795,
CC       PubMed:27325704, PubMed:27005320, PubMed:27618660). Channel
CC       properties are modulated by subunit assembly (PubMed:11943152).
CC       Mediates IK(NI) current in myoblasts (PubMed:9738473). Involved in
CC       the regulation of cell proliferation and differentiation, in
CC       particular adipogenic and osteogenic differentiation in bone
CC       marrow-derived mesenchymal stem cells (MSCs) (PubMed:23881642).
CC       {ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:11943152,
CC       ECO:0000269|PubMed:22732247, ECO:0000269|PubMed:23881642,
CC       ECO:0000269|PubMed:25556795, ECO:0000269|PubMed:27005320,
CC       ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660,
CC       ECO:0000269|PubMed:9738473}.
CC   -!- ENZYME REGULATION: Channel activity is inhibited by interaction
CC       with Ca(2+)-bound calmodulin (PubMed:10880439, PubMed:27325704,
CC       PubMed:27005320, PubMed:27618660). Interaction of a single pore-
CC       forming alpha subunit with a calmodulin chain is sufficient to
CC       promote channel closure (PubMed:10880439). Channel activity is not
CC       regulated by cyclic nucleotides (By similarity). Channel activity
CC       is inhibited by binding intracellular phosphatidylinositol-3,5-
CC       bisphosphate and phosphatidylinositol-4,5-bisphosphate (PIP2), but
CC       is not inhibited by phosphatidylinositol 4-phosphate
CC       (PubMed:27005320). {ECO:0000250|UniProtKB:Q60603,
CC       ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:27005320,
CC       ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH5/EAG2 (PubMed:11943152). Interacts with ALG10B (By
CC       similarity). Interacts with RABEP1 (By similarity). Interacts (via
CC       C-terminus) with CTTN (PubMed:23144454). Interacts (via C-terminal
CC       cytoplasmic region) with Ca(2+)-bound calmodulin (PubMed:10880439,
CC       PubMed:27325704, PubMed:27618660). {ECO:0000250|UniProtKB:Q63472,
CC       ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:11943152,
CC       ECO:0000269|PubMed:23144454, ECO:0000269|PubMed:27325704,
CC       ECO:0000269|PubMed:27618660}.
CC   -!- INTERACTION:
CC       P62158:CALM3; NbExp=8; IntAct=EBI-9836801, EBI-397435;
CC       Q7L8L6:FASTKD5; NbExp=3; IntAct=EBI-2909270, EBI-747570;
CC       P02638:S100B (xeno); NbExp=3; IntAct=EBI-2909270, EBI-458452;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-2909270, EBI-727004;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-2909270, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10880439,
CC       ECO:0000269|PubMed:11943152, ECO:0000269|PubMed:21559285,
CC       ECO:0000269|PubMed:22732247, ECO:0000269|PubMed:22841712,
CC       ECO:0000269|PubMed:25556795, ECO:0000269|PubMed:27005320,
CC       ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660,
CC       ECO:0000269|PubMed:9738473}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21559285}. Nucleus inner membrane
CC       {ECO:0000269|PubMed:21559285}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21559285}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q63472}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63472}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:Q63472}.
CC       Perikaryon {ECO:0000250|UniProtKB:Q63472}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000250|UniProtKB:Q63472}. Early endosome membrane
CC       {ECO:0000269|PubMed:22841712}. Note=Perinuclear KCNH1 is located
CC       to NPC-free islands.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2; Synonyms=hEAGB;
CC         IsoId=O95259-1; Sequence=Displayed;
CC       Name=1; Synonyms=hEAG;
CC         IsoId=O95259-2; Sequence=VSP_000964;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and in myoblasts at
CC       the onset of fusion, but not in other tissues. Detected in HeLa
CC       (cervical carcinoma), SH-SY5Y (neuroblastoma) and MCF-7
CC       (epithelial tumor) cells, but not in normal epithelial cells.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:Q63472}.
CC   -!- DOMAIN: The C-terminal region interacts with the cyclic
CC       nucleotide-binding domain and contributes to regulate channel
CC       gating. {ECO:0000250|UniProtKB:Q60603}.
CC   -!- DOMAIN: The PAS and PAC domain interact with the cyclic
CC       nucleotide-binding domain and contribute to the regulation of
CC       channel gating (PubMed:27325704). Calmodulin binding clamps
CC       together the PAS and PAC domain with the cyclic nucleotide-binding
CC       domain from a neighboring subunit and causes a conformation change
CC       that leads to channel closure. {ECO:0000250|UniProtKB:Q63472,
CC       ECO:0000269|PubMed:27325704}.
CC   -!- DOMAIN: The cyclic nucleotide-binding domain lacks residues that
CC       are essential for nucleotide-binding and cannot bind cyclic
CC       nucleotides. Instead, residues from the C-terminal domain (the so-
CC       called intrinsic ligand) bind in the cavity that would be expected
CC       to bind cyclic nucleotides. Interaction with the C-terminal region
CC       hinders interaction with CALM and reduces the affinity for CALM.
CC       {ECO:0000250|UniProtKB:Q60603}.
CC   -!- PTM: Channel activity is regulated via tyrosine
CC       phosphorylation/dephosphorylation by SRC and PTPN6
CC       (PubMed:24587194). {ECO:0000269|PubMed:24587194}.
CC   -!- DISEASE: Temple-Baraitser syndrome (TMBTS) [MIM:611816]: A
CC       developmental disorder characterized by intellectual disability,
CC       epilepsy, hypoplasia or aplasia of the thumb and great toe nails,
CC       and broadening and/or elongation of the thumbs and halluces, which
CC       have a tubular aspect. Some patients show facial dysmorphism.
CC       {ECO:0000269|PubMed:25420144}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]: A
CC       disorder characterized by gingival fibromatosis, dysplastic or
CC       absent nails, finger abnormalities, hepatosplenomegaly, and
CC       abnormalities of the cartilage of the nose and/or ears.
CC       {ECO:0000269|PubMed:25915598}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv10.1/KCNH1 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/KCNH1ID41048ch1q32.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ001366; CAA04700.1; -; mRNA.
DR   EMBL; AF078741; AAC68668.1; -; mRNA.
DR   EMBL; AF078742; AAC68669.1; -; mRNA.
DR   EMBL; AL590132; CAH71752.1; -; Genomic_DNA.
DR   EMBL; AC092017; CAH71752.1; JOINED; Genomic_DNA.
DR   EMBL; AC096636; CAH71752.1; JOINED; Genomic_DNA.
DR   EMBL; AC099755; CAH71752.1; JOINED; Genomic_DNA.
DR   EMBL; AL590132; CAH71753.1; -; Genomic_DNA.
DR   EMBL; AC092017; CAH71753.1; JOINED; Genomic_DNA.
DR   EMBL; AC096636; CAH71753.1; JOINED; Genomic_DNA.
DR   EMBL; AC099755; CAH71753.1; JOINED; Genomic_DNA.
DR   EMBL; CH471100; EAW93424.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93425.1; -; Genomic_DNA.
DR   EMBL; BC113709; AAI13710.1; -; mRNA.
DR   EMBL; BC143599; AAI43600.1; -; mRNA.
DR   CCDS; CCDS1496.1; -. [O95259-1]
DR   CCDS; CCDS31015.1; -. [O95259-2]
DR   RefSeq; NP_002229.1; NM_002238.3. [O95259-2]
DR   RefSeq; NP_758872.1; NM_172362.2. [O95259-1]
DR   UniGene; Hs.553187; -.
DR   PDB; 5J7E; X-ray; 1.90 A; A/B/C/D/E/F=1-146.
DR   PDBsum; 5J7E; -.
DR   ProteinModelPortal; O95259; -.
DR   SMR; O95259; -.
DR   BioGrid; 109958; 7.
DR   IntAct; O95259; 10.
DR   MINT; MINT-138319; -.
DR   STRING; 9606.ENSP00000271751; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 570; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   iPTMnet; O95259; -.
DR   PhosphoSitePlus; O95259; -.
DR   BioMuta; KCNH1; -.
DR   MaxQB; O95259; -.
DR   PaxDb; O95259; -.
DR   PeptideAtlas; O95259; -.
DR   PRIDE; O95259; -.
DR   Ensembl; ENST00000271751; ENSP00000271751; ENSG00000143473. [O95259-1]
DR   Ensembl; ENST00000367007; ENSP00000355974; ENSG00000143473. [O95259-2]
DR   GeneID; 3756; -.
DR   KEGG; hsa:3756; -.
DR   UCSC; uc001hib.3; human. [O95259-1]
DR   CTD; 3756; -.
DR   DisGeNET; 3756; -.
DR   GeneCards; KCNH1; -.
DR   HGNC; HGNC:6250; KCNH1.
DR   HPA; HPA014551; -.
DR   HPA; HPA019445; -.
DR   MalaCards; KCNH1; -.
DR   MIM; 135500; phenotype.
DR   MIM; 603305; gene.
DR   MIM; 611816; phenotype.
DR   neXtProt; NX_O95259; -.
DR   OpenTargets; ENSG00000143473; -.
DR   PharmGKB; PA30037; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG101348; -.
DR   InParanoid; O95259; -.
DR   KO; K04904; -.
DR   OMA; IRTESWL; -.
DR   OrthoDB; EOG090B01ED; -.
DR   PhylomeDB; O95259; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH1; -.
DR   GenomeRNAi; 3756; -.
DR   PRO; PR:O95259; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143473; -.
DR   CleanEx; HS_KCNH1; -.
DR   Genevisible; O95259; HS.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005637; C:nuclear inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:1902936; F:phosphatidylinositol bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB.
DR   GO; GO:0007520; P:myoblast fusion; TAS:ProtInc.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0001964; P:startle response; IEA:Ensembl.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003949; K_chnl_volt-dep_EAG.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01464; EAGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calmodulin-binding; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome; Disease mutation;
KW   Endosome; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Lipid-binding; Membrane; Mental retardation; Nucleus; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    989       Potassium voltage-gated channel subfamily
FT                                H member 1.
FT                                /FTId=PRO_0000053994.
FT   TOPO_DOM      1    220       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    221    241       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    242    248       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    249    269       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    270    290       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    291    309       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    310    345       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    346    368       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    369    377       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    378    399       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    400    448       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   INTRAMEM    449    470       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    471    477       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    478    498       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    499    989       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   DOMAIN       14     94       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   REGION      151    162       Required for phosphatidylinositol
FT                                bisphosphate binding.
FT                                {ECO:0000269|PubMed:27005320}.
FT   REGION      673    770       Calmodulin-binding.
FT                                {ECO:0000269|PubMed:10880439}.
FT   REGION      699    701       Interaction with cyclic nucleotide-
FT                                binding pocket.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   REGION      924    964       CAD (involved in subunit assembly).
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   MOTIF       463    468       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   MOD_RES     974    974       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   MOD_RES     978    978       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   MOD_RES     981    981       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   CARBOHYD    415    415       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    433    433       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     318    344       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:10523298,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000964.
FT   VARIANT     217    217       K -> N (in TMBTS; gain-of-function
FT                                mutation resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation compared to wild-
FT                                type; dbSNP:rs727502822).
FT                                {ECO:0000269|PubMed:25420144}.
FT                                /FTId=VAR_072612.
FT   VARIANT     352    352       S -> Y (in ZLS1; gain-of-function effect;
FT                                accelerated channel activation and slower
FT                                deactivation; associated in cis with L-
FT                                383; dbSNP:rs730882172).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073957.
FT   VARIANT     375    375       G -> R (in ZLS1; gain-of-function effect;
FT                                accelerated channel activation and slower
FT                                deactivation; dbSNP:rs730882174).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073958.
FT   VARIANT     379    379       L -> V (in ZLS1; dbSNP:rs730882176).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073959.
FT   VARIANT     383    383       V -> L (in ZLS1; gain-of-function effect;
FT                                accelerated channel activation and slower
FT                                deactivation; associated in cis with Y-
FT                                352; dbSNP:rs730882173).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073960.
FT   VARIANT     489    489       L -> F (in TMBTS; gain-of-function
FT                                mutation resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation compared to wild-
FT                                type). {ECO:0000269|PubMed:25420144}.
FT                                /FTId=VAR_072613.
FT   VARIANT     494    494       I -> V (in TMBTS and ZLS1; gain-of-
FT                                function effect; resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation; dbSNP:rs727502819).
FT                                {ECO:0000269|PubMed:25420144,
FT                                ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_072614.
FT   VARIANT     496    496       G -> R (in ZLS1; gain-of-function effect;
FT                                increased conductance at negative
FT                                potentials; dbSNP:rs730882175).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073961.
FT   VARIANT     503    503       Q -> R (in TMBTS; gain-of-function
FT                                mutation resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation compared to wild-
FT                                type; dbSNP:rs727502821).
FT                                {ECO:0000269|PubMed:25420144}.
FT                                /FTId=VAR_072615.
FT   MUTAGEN     699    701       YNL->ANA: Shifts the voltage-dependence
FT                                of channel gating and decreases the rate
FT                                of channel opening.
FT                                {ECO:0000269|PubMed:22732247}.
FT   MUTAGEN     737    737       V->S: Abolishes inhibition of channel
FT                                activity by elevated cytoplasmic Ca(2+).
FT                                {ECO:0000269|PubMed:27618660}.
FT   MUTAGEN     740    740       L->S: Abolishes inhibition of channel
FT                                activity by elevated cytoplasmic Ca(2+).
FT                                {ECO:0000269|PubMed:27618660}.
FT   STRAND       29     34       {ECO:0000244|PDB:5J7E}.
FT   STRAND       41     45       {ECO:0000244|PDB:5J7E}.
FT   HELIX        47     53       {ECO:0000244|PDB:5J7E}.
FT   HELIX        57     59       {ECO:0000244|PDB:5J7E}.
FT   TURN         60     62       {ECO:0000244|PDB:5J7E}.
FT   HELIX        68     70       {ECO:0000244|PDB:5J7E}.
FT   HELIX        77     88       {ECO:0000244|PDB:5J7E}.
FT   STRAND       93    100       {ECO:0000244|PDB:5J7E}.
FT   STRAND      106    117       {ECO:0000244|PDB:5J7E}.
FT   STRAND      123    132       {ECO:0000244|PDB:5J7E}.
SQ   SEQUENCE   989 AA;  111423 MW;  CAA8CB251300C7E5 CRC64;
     MTMAGGRRGL VAPQNTFLEN IVRRSNDTNF VLGNAQIVDW PIVYSNDGFC KLSGYHRAEV
     MQKSSTCSFM YGELTDKDTI EKVRQTFENY EMNSFEILMY KKNRTPVWFF VKIAPIRNEQ
     DKVVLFLCTF SDITAFKQPI EDDSCKGWGK FARLTRALTS SRGVLQQLAP SVQKGENVHK
     HSRLAEVLQL GSDILPQYKQ EAPKTPPHII LHYCVFKTTW DWIILILTFY TAILVPYNVS
     FKTRQNNVAW LVVDSIVDVI FLVDIVLNFH TTFVGPAGEV ISDPKLIRMN YLKTWFVIDL
     LSCLPYDVIN AFENVDEVSA FMGDPGKIGF ADQIPPPLEG RESQGISSLF SSLKVVRLLR
     LGRVARKLDH YIEYGAAVLV LLVCVFGLAA HWMACIWYSI GDYEIFDEDT KTIRNNSWLY
     QLAMDIGTPY QFNGSGSGKW EGGPSKNSVY ISSLYFTMTS LTSVGFGNIA PSTDIEKIFA
     VAIMMIGSLL YATIFGNVTT IFQQMYANTN RYHEMLNSVR DFLKLYQVPK GLSERVMDYI
     VSTWSMSRGI DTEKVLQICP KDMRADICVH LNRKVFKEHP AFRLASDGCL RALAMEFQTV
     HCAPGDLIYH AGESVDSLCF VVSGSLEVIQ DDEVVAILGK GDVFGDVFWK EATLAQSCAN
     VRALTYCDLH VIKRDALQKV LEFYTAFSHS FSRNLILTYN LRKRIVFRKI SDVKREEEER
     MKRKNEAPLI LPPDHPVRRL FQRFRQQKEA RLAAERGGRD LDDLDVEKGN VLTEHASANH
     SLVKASVVTV RESPATPVSF QAASTSGVPD HAKLQAPGSE CLGPKGGGGD CAKRKSWARF
     KDACGKSEDW NKVSKAESME TLPERTKASG EATLKKTDSC DSGITKSDLR LDNVGEARSP
     QDRSPILAEV KHSFYPIPEQ TLQATVLEVR HELKEDIKAL NAKMTNIEKQ LSEILRILTS
     RRSSQSPQEL FEISRPQSPE SERDIFGAS
//
ID   KCNH5_HUMAN             Reviewed;         988 AA.
AC   Q8NCM2; C9JP98;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 3.
DT   15-FEB-2017, entry version 148.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 5;
DE   AltName: Full=Ether-a-go-go potassium channel 2;
DE            Short=hEAG2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.2;
GN   Name=KCNH5; Synonyms=EAG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-745.
RC   TISSUE=Brain;
RX   PubMed=11943152; DOI=10.1016/S0014-5793(02)02365-7;
RA   Schoenherr R., Gessner G., Loeber K., Heinemann S.H.;
RT   "Functional distinction of human EAG1 and EAG2 potassium channels.";
RL   FEBS Lett. 514:204-208(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT THR-745.
RC   TISSUE=Fetal brain;
RX   PubMed=12135768; DOI=10.1016/S0014-5793(02)03055-7;
RA   Ju M., Wray D.;
RT   "Molecular identification and characterisation of the human eag2
RT   potassium channel.";
RL   FEBS Lett. 524:204-210(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-745.
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-785, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=18655026; DOI=10.1002/pmic.200700887;
RA   Tan F., Lu L., Cai Y., Wang J., Xie Y., Wang L., Gong Y., Xu B.-E.,
RA   Wu J., Luo Y., Qiang B., Yuan J., Sun X., Peng X.;
RT   "Proteomic analysis of ubiquitinated proteins in normal hepatocyte
RT   cell line Chang liver cells.";
RL   Proteomics 8:2885-2896(2008).
RN   [8]
RP   VARIANT HIS-327.
RX   PubMed=23647072; DOI=10.1111/epi.12201;
RA   Veeramah K.R., Johnstone L., Karafet T.M., Wolf D., Sprissler R.,
RA   Salogiannis J., Barth-Maron A., Greenberg M.E., Stuhlmann T.,
RA   Weinert S., Jentsch T.J., Pazzi M., Restifo L.L., Talwar D.,
RA   Erickson R.P., Hammer M.F.;
RT   "Exome sequencing reveals new causal mutations in children with
RT   epileptic encephalopathies.";
RL   Epilepsia 54:1270-1281(2013).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits a non-inactivating outward rectifying current.
CC       Channel properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH1/EAG (Probable). {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q8NCM2-1; Sequence=Displayed;
CC       Name=2; Synonyms=2b;
CC         IsoId=Q8NCM2-2; Sequence=VSP_000973, VSP_000974;
CC       Name=3;
CC         IsoId=Q8NCM2-3; Sequence=VSP_000972, VSP_000975, VSP_000976;
CC   -!- TISSUE SPECIFICITY: Detected in brain, skeletal muscle, heart,
CC       placenta, lung and liver, and at low levels in kidney.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv10.2/KCNH5 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11016.1; Type=Erroneous termination; Positions=436; Note=Translated as Gly.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF418206; AAM28435.1; -; mRNA.
DR   EMBL; AF472412; AAM49565.1; -; mRNA.
DR   EMBL; AF493798; AAM49574.1; -; mRNA.
DR   EMBL; AK074484; BAC11016.1; ALT_SEQ; mRNA.
DR   EMBL; AL109985; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL132666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137191; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355101; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80819.1; -; Genomic_DNA.
DR   EMBL; BC073979; AAH73979.1; -; mRNA.
DR   CCDS; CCDS45122.1; -. [Q8NCM2-2]
DR   CCDS; CCDS9756.1; -. [Q8NCM2-1]
DR   RefSeq; NP_647479.2; NM_139318.4. [Q8NCM2-1]
DR   RefSeq; NP_758963.1; NM_172375.2. [Q8NCM2-2]
DR   UniGene; Hs.27043; -.
DR   ProteinModelPortal; Q8NCM2; -.
DR   SMR; Q8NCM2; -.
DR   STRING; 9606.ENSP00000321427; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 571; -.
DR   iPTMnet; Q8NCM2; -.
DR   PhosphoSitePlus; Q8NCM2; -.
DR   BioMuta; KCNH5; -.
DR   DMDM; 334302891; -.
DR   EPD; Q8NCM2; -.
DR   PaxDb; Q8NCM2; -.
DR   PeptideAtlas; Q8NCM2; -.
DR   PRIDE; Q8NCM2; -.
DR   Ensembl; ENST00000322893; ENSP00000321427; ENSG00000140015. [Q8NCM2-1]
DR   Ensembl; ENST00000394968; ENSP00000378419; ENSG00000140015. [Q8NCM2-3]
DR   Ensembl; ENST00000420622; ENSP00000395439; ENSG00000140015. [Q8NCM2-2]
DR   GeneID; 27133; -.
DR   KEGG; hsa:27133; -.
DR   UCSC; uc001xfx.5; human. [Q8NCM2-1]
DR   CTD; 27133; -.
DR   DisGeNET; 27133; -.
DR   GeneCards; KCNH5; -.
DR   HGNC; HGNC:6254; KCNH5.
DR   HPA; HPA030487; -.
DR   MIM; 605716; gene.
DR   neXtProt; NX_Q8NCM2; -.
DR   OpenTargets; ENSG00000140015; -.
DR   PharmGKB; PA30040; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG101348; -.
DR   InParanoid; Q8NCM2; -.
DR   KO; K04908; -.
DR   OMA; NKAEVVH; -.
DR   OrthoDB; EOG090B01ED; -.
DR   PhylomeDB; Q8NCM2; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH5; -.
DR   GenomeRNAi; 27133; -.
DR   PRO; PR:Q8NCM2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000140015; -.
DR   CleanEx; HS_KCNH5; -.
DR   Genevisible; Q8NCM2; HS.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IDA:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003949; K_chnl_volt-dep_EAG.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01464; EAGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Isopeptide bond; Membrane;
KW   Phosphoprotein; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN         1    988       Potassium voltage-gated channel subfamily
FT                                H member 5.
FT                                /FTId=PRO_0000054010.
FT   TOPO_DOM      1    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    239    243       Extracellular. {ECO:0000255}.
FT   TRANSMEM    244    264       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    265    291       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    313    319       Extracellular. {ECO:0000255}.
FT   TRANSMEM    320    340       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    341    346       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    347    367       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    368    419       Extracellular. {ECO:0000255}.
FT   INTRAMEM    420    440       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    441    446       Extracellular. {ECO:0000255}.
FT   TRANSMEM    447    467       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    468    988       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       12     90       PAS.
FT   DOMAIN       91    143       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     550    667       cNMP.
FT   REGION      704    715       Calmodulin-binding. {ECO:0000255}.
FT   REGION      909    948       CAD (involved in subunit assembly).
FT                                {ECO:0000250}.
FT   MOTIF       432    437       Selectivity filter. {ECO:0000250}.
FT   MOD_RES     883    883       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q920E3}.
FT   CARBOHYD    403    403       N-linked (GlcNAc...). {ECO:0000255}.
FT   CROSSLNK    785    785       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:18655026}.
FT   VAR_SEQ       1     58       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000972.
FT   VAR_SEQ     608    611       GKGD -> DHLS (in isoform 2).
FT                                {ECO:0000303|PubMed:12135768}.
FT                                /FTId=VSP_000973.
FT   VAR_SEQ     612    988       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12135768}.
FT                                /FTId=VSP_000974.
FT   VAR_SEQ     674    682       IIFRKISDV -> GWFSMANAL (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000975.
FT   VAR_SEQ     683    988       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000976.
FT   VARIANT     327    327       R -> H (found in a child with sporadic
FT                                epilepsy; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23647072}.
FT                                /FTId=VAR_077834.
FT   VARIANT     745    745       A -> T (in dbSNP:rs4902176).
FT                                {ECO:0000269|PubMed:11943152,
FT                                ECO:0000269|PubMed:12135768,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_065162.
SQ   SEQUENCE   988 AA;  111877 MW;  A58E4CE0A32C83BC CRC64;
     MPGGKRGLVA PQNTFLENIV RRSSESSFLL GNAQIVDWPV VYSNDGFCKL SGYHRADVMQ
     KSSTCSFMYG ELTDKKTIEK VRQTFDNYES NCFEVLLYKK NRTPVWFYMQ IAPIRNEHEK
     VVLFLCTFKD ITLFKQPIED DSTKGWTKFA RLTRALTNSR SVLQQLTPMN KTEVVHKHSR
     LAEVLQLGSD ILPQYKQEAP KTPPHIILHY CAFKTTWDWV ILILTFYTAI MVPYNVSFKT
     KQNNIAWLVL DSVVDVIFLV DIVLNFHTTF VGPGGEVISD PKLIRMNYLK TWFVIDLLSC
     LPYDIINAFE NVDEGISSLF SSLKVVRLLR LGRVARKLDH YLEYGAAVLV LLVCVFGLVA
     HWLACIWYSI GDYEVIDEVT NTIQIDSWLY QLALSIGTPY RYNTSAGIWE GGPSKDSLYV
     SSLYFTMTSL TTIGFGNIAP TTDVEKMFSV AMMMVGSLLY ATIFGNVTTI FQQMYANTNR
     YHEMLNNVRD FLKLYQVPKG LSERVMDYIV STWSMSKGID TEKVLSICPK DMRADICVHL
     NRKVFNEHPA FRLASDGCLR ALAVEFQTIH CAPGDLIYHA GESVDALCFV VSGSLEVIQD
     DEVVAILGKG DVFGDIFWKE TTLAHACANV RALTYCDLHI IKREALLKVL DFYTAFANSF
     SRNLTLTCNL RKRIIFRKIS DVKKEEEERL RQKNEVTLSI PVDHPVRKLF QKFKQQKELR
     NQGSTQGDPE RNQLQVESRS LQNGASITGT SVVTVSQITP IQTSLAYVKT SESLKQNNRD
     AMELKPNGGA DQKCLKVNSP IRMKNGNGKG WLRLKNNMGA HEEKKEDWNN VTKAESMGLL
     SEDPKSSDSE NSVTKNPLRK TDSCDSGITK SDLRLDKAGE ARSPLEHSPI QADAKHPFYP
     IPEQALQTTL QEVKHELKED IQLLSCRMTA LEKQVAEILK ILSEKSVPQA SSPKSQMPLQ
     VPPQIPCQDI FSVSRPESPE SDKDEIHF
//
ID   KCNH2_HUMAN             Reviewed;        1159 AA.
AC   Q12809; A5H1P7; C4PFH9; D3DX04; O75418; O75680; Q708S9; Q9BT72;
AC   Q9BUT7; Q9H3P0;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-FEB-2017, entry version 193.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 2;
DE   AltName: Full=Eag homolog;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 1;
DE            Short=ERG-1;
DE            Short=Eag-related protein 1;
DE            Short=Ether-a-go-go-related protein 1;
DE            Short=H-ERG;
DE            Short=hERG-1;
DE            Short=hERG1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.1;
GN   Name=KCNH2; Synonyms=ERG, ERG1, HERG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Hippocampus;
RX   PubMed=8159766; DOI=10.1073/pnas.91.8.3438;
RA   Warmke J.W., Ganetzky B.;
RT   "A family of potassium channel genes related to eag in Drosophila and
RT   mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3438-3442(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A), AND VARIANT LQT2
RP   CYS-534.
RX   PubMed=9600240; DOI=10.1007/s004390050717;
RA   Itoh T., Tanaka T., Nagai R., Kamiya T., Sawayama T., Nakayama T.,
RA   Tomoike H., Sakurada H., Yazaki Y., Nakamura Y.;
RT   "Genomic organization and mutational analysis of HERG, a gene
RT   responsible for familial long QT syndrome.";
RL   Hum. Genet. 102:435-439(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A-USO).
RC   TISSUE=Heart;
RX   PubMed=11374908; DOI=10.1006/geno.2001.6527;
RA   Soejima H., Kawamoto S., Akai J., Miyoshi O., Arai Y., Morohka T.,
RA   Matsuo S., Niikawa N., Kimura A., Okubo K., Mukai T.;
RT   "Isolation of novel heart-specific genes using the BodyMap database.";
RL   Genomics 74:115-120(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RA   Downie D., Chapman C.G., Punia P., Rice S., Bahmani F., Murdock P.,
RA   Pearson N., Randall A.D., Meadows H.J.;
RT   "Potent inhibition of HERG K+ channels by the neuroprotective agent
RT   Sipatrigine.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=12431979; DOI=10.1074/jbc.M210789200;
RA   Crociani O., Guasti L., Balzi M., Becchetti A., Wanke E., Olivotto M.,
RA   Wymore R.S., Arcangeli A.;
RT   "Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor
RT   cells.";
RL   J. Biol. Chem. 278:2947-2955(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B-USO), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18559421; DOI=10.1128/MCB.00304-08;
RA   Guasti L., Crociani O., Redaelli E., Pillozzi S., Polvani S.,
RA   Masselli M., Mello T., Galli A., Amedei A., Wymore R.S., Wanke E.,
RA   Arcangeli A.;
RT   "Identification of a posttranslational mechanism for the regulation of
RT   hERG1 K+ channel expression and hERG1 current density in tumor
RT   cells.";
RL   Mol. Cell. Biol. 28:5043-5060(2008).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3.1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=19412172; DOI=10.1038/nm.1962;
RA   Huffaker S.J., Chen J., Nicodemus K.K., Sambataro F., Yang F.,
RA   Mattay V., Lipska B.K., Hyde T.M., Song J., Rujescu D., Giegling I.,
RA   Mayilyan K., Proust M.J., Soghoyan A., Caforio G., Callicott J.H.,
RA   Bertolino A., Meyer-Lindenberg A., Chang J., Ji Y., Egan M.F.,
RA   Goldberg T.E., Kleinman J.E., Lu B., Weinberger D.R.;
RT   "A primate-specific, brain isoform of KCNH2 affects cortical
RT   physiology, cognition, neuronal repolarization and risk of
RT   schizophrenia.";
RL   Nat. Medicines 15:509-518(2009).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-376 (ISOFORM B).
RC   TISSUE=Heart;
RX   PubMed=9351462; DOI=10.1161/01.RES.81.5.870;
RA   London B., Trudeau M.C., Newton K.P., Beyer A.K., Copeland N.G.,
RA   Gilbert D.J., Jenkins N.A., Satler C.A., Robertson G.A.;
RT   "Two isoforms of the mouse ether-a-go-go-related gene coassemble to
RT   form channels with properties similar to the rapidly activating
RT   component of the cardiac delayed rectifier K+ current.";
RL   Circ. Res. 81:870-878(1997).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-376 (ISOFORM B).
RC   TISSUE=Heart atrium;
RX   PubMed=9351446; DOI=10.1161/01.RES.81.5.719;
RA   Lees-Miller J.P., Kondo C., Wang L., Duff H.J.;
RT   "Electrophysiological characterization of an alternatively processed
RT   ERG K+ channel in mouse and human hearts.";
RL   Circ. Res. 81:719-726(1997).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 27-1159 (ISOFORM A), AND VARIANT
RP   GLY-ALA-GLY-189 INS.
RX   PubMed=10790218;
RX   DOI=10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU18>3.3.CO;2-K;
RA   Paulussen A., Yang P., Pangalos M., Verhasselt P., Marrannes R.,
RA   Verfaille C., Vandenberk I., Crabbe R., Konings F., Luyten W.,
RA   Armstrong M.;
RT   "Analysis of the human KCNH2(HERG) gene: identification and
RT   characterization of a novel mutation Y667X associated with long QT
RT   syndrome and a non-pathological 9 bp insertion.";
RL   Hum. Mutat. 15:483-483(2000).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 59-800 (ISOFORM 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 716-1159 (ISOFORMS A/B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 795-888 (ISOFORM A-USO).
RC   TISSUE=Heart ventricle;
RX   PubMed=9765245; DOI=10.1074/jbc.273.42.27231;
RA   Kupershmidt S., Snyders D.J., Raes A., Roden D.M.;
RT   "A K+ channel splice variant common in human heart lacks a C-terminal
RT   domain required for expression of rapidly activating delayed rectifier
RT   current.";
RL   J. Biol. Chem. 273:27231-27235(1998).
RN   [16]
RP   MUTAGENESIS OF ASN-598; ASN-629 AND SER-631, AND GLYCOSYLATION AT
RP   ASN-598.
RX   PubMed=12063277; DOI=10.1152/ajpheart.00008.2002;
RA   Gong Q., Anderson C.L., January C.T., Zhou Z.;
RT   "Role of glycosylation in cell surface expression and stability of
RT   HERG potassium channels.";
RL   Am. J. Physiol. 283:H77-H84(2002).
RN   [17]
RP   MUTAGENESIS OF SER-283; SER-890; THR-895 AND SER-1137, AND
RP   PHOSPHORYLATION.
RX   PubMed=10837251; DOI=10.1016/S0960-9822(00)00516-9;
RA   Cui J., Melman Y., Palma E., Fishman G.I., McDonald T.V.;
RT   "Cyclic AMP regulates the HERG K(+) channel by dual pathways.";
RL   Curr. Biol. 10:671-674(2000).
RN   [18]
RP   INTERACTION WITH KCNE1.
RX   PubMed=9230439; DOI=10.1038/40882;
RA   McDonald T.V., Yu Z., Ming Z., Palma E., Meyers M.B., Wang K.-W.,
RA   Goldstein S.A.N., Fishman G.I.;
RT   "A minK-HERG complex regulates the cardiac potassium current I(Kr).";
RL   Nature 388:289-292(1997).
RN   [19]
RP   INTERACTION WITH KCNE2.
RX   PubMed=10219239; DOI=10.1016/S0092-8674(00)80728-X;
RA   Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H.,
RA   Timothy K.W., Keating M.T., Goldstein S.A.N.;
RT   "MiRP1 forms IKr potassium channels with HERG and is associated with
RT   cardiac arrhythmia.";
RL   Cell 97:175-187(1999).
RN   [20]
RP   INTERACTION WITH CANX, AND CHARACTERIZATION OF VARIANT LQT2 ASP-470.
RX   PubMed=16361248; DOI=10.1074/jbc.M511765200;
RA   Gong Q., Jones M.A., Zhou Z.;
RT   "Mechanisms of pharmacological rescue of trafficking-defective hERG
RT   mutant channels in human long QT syndrome.";
RL   J. Biol. Chem. 281:4069-4074(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-320; SER-871
RP   AND SER-1137, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   INTERACTION WITH RNF207, AND INDUCTION BY RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.M114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac
RT   excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-135, AND MUTAGENESIS OF
RP   PHE-29 AND TYR-43.
RX   PubMed=9845367; DOI=10.1016/S0092-8674(00)81635-9;
RA   Morais Cabral J.H., Lee A., Cohen S.L., Chait B.T., Li M.,
RA   Mackinnon R.;
RT   "Crystal structure and functional analysis of the HERG potassium
RT   channel N-terminus: a eukaryotic PAS domain.";
RL   Cell 95:649-655(1998).
RN   [25]
RP   VARIANTS LQT2 ASP-470; VAL-561 AND SER-628.
RX   PubMed=7889573; DOI=10.1016/0092-8674(95)90358-5;
RA   Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D.,
RA   Keating M.T.;
RT   "A molecular basis for cardiac arrhythmia: HERG mutations cause long
RT   QT syndrome.";
RL   Cell 80:795-803(1995).
RN   [26]
RP   VARIANT LQT2 MET-822.
RX   PubMed=8914737;
RX   DOI=10.1002/(SICI)1096-8628(19961002)65:1<27::AID-AJMG4>3.3.CO;2-J;
RA   Satler C.A., Walsh E.P., Vesely M.R., Plummer M.H., Ginsburg G.S.,
RA   Jacob H.J.;
RT   "Novel missense mutation in the cyclic nucleotide-binding domain of
RT   HERG causes long QT syndrome.";
RL   Am. J. Med. Genet. 65:27-35(1996).
RN   [27]
RP   VARIANT LQT2 ARG-593.
RX   PubMed=8635257; DOI=10.1161/01.CIR.93.10.1791;
RA   Benson D.W., MacRae C.A., Vesely M.R., Walsh E.P., Seidman J.G.,
RA   Seidman C.E., Satler C.A.;
RT   "Missense mutation in the pore region of HERG causes familial long QT
RT   syndrome.";
RL   Circulation 93:1791-1795(1996).
RN   [28]
RP   VARIANT LQT2 THR-561.
RX   PubMed=8877771; DOI=10.1006/jmcc.1996.0151;
RA   Dausse E., Berthet M., Denjoy I., Andre-Fouet X., Cruaud C.,
RA   Bennaceur M., Faure S., Coumel P., Schwartz K., Guicheney P.;
RT   "A mutation in HERG associated with notched T waves in long QT
RT   syndrome.";
RL   J. Mol. Cell. Cardiol. 28:1609-1615(1996).
RN   [29]
RP   VARIANTS LQT2 ILE-474; HIS-611; VAL-614 AND LEU-630.
RX   PubMed=9024139; DOI=10.1161/01.CIR.95.3.565;
RA   Tanaka T., Nagai R., Tomoike H., Takata S., Yano K., Yabuta K.,
RA   Haneda N., Nakano O., Shibata A., Sawayama T., Kasai H., Yazaki Y.,
RA   Nakamura Y.;
RT   "Four novel KVLQT1 and four novel HERG mutations in familial long-QT
RT   syndrome.";
RL   Circulation 95:565-567(1997).
RN   [30]
RP   VARIANTS LQT2 CYS-572; ASP-588; VAL-614 AND ALA-630.
RX   PubMed=9693036; DOI=10.1006/geno.1998.5361;
RA   Splawski I., Shen J., Timothy K.W., Vincent G.M., Lehmann M.H.,
RA   Keating M.T.;
RT   "Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and
RT   KCNE1.";
RL   Genomics 51:86-97(1998).
RN   [31]
RP   VARIANTS LQT2 LEU-612; VAL-614; ASP-629; SER-629 AND SER-633.
RX   PubMed=9544837; DOI=10.1007/s004390050690;
RA   Satler C.A., Vesely M.R., Duggal P., Ginsburg G.S., Beggs A.H.;
RT   "Multiple different missense mutations in the pore region of HERG in
RT   patients with long QT syndrome.";
RL   Hum. Genet. 102:265-272(1998).
RN   [32]
RP   VARIANT LQT2 SER-601.
RX   PubMed=9452080;
RA   Akimoto K., Furutani M., Imamura S., Furutani Y., Kasanuki H.,
RA   Takao A., Momma K., Matsuoka R.;
RT   "Novel missense mutation (G601S) of HERG in a Japanese long QT
RT   syndrome family.";
RL   Hum. Mutat. Suppl. 1:S184-S186(1998).
RN   [33]
RP   VARIANT LQT2 LEU-818.
RX   PubMed=10086971; DOI=10.1161/01.CIR.99.11.1464;
RA   Berthet M., Denjoy I., Donger C., Demay L., Hammoude H., Klug D.,
RA   Schulze-Bahr E., Richard P., Funke H., Schwartz K., Coumel P.,
RA   Hainque B., Guicheney P.;
RT   "C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-
RT   associated mutation in cardiac event occurrence.";
RL   Circulation 99:1464-1470(1999).
RN   [34]
RP   VARIANTS LQT2 PRO-558; CYS-582; SER-604; MET-613 AND LEU-640.
RX   PubMed=10220144;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.0.CO;2-V;
RA   Jongbloed R.J.E., Wilde A.A.M., Geelen J.L.M.C., Doevendans P.,
RA   Schaap C., van Langen I., van Tintelen J.P., Cobben J.M.,
RA   Beaufort-Krol G.C.M., Geraedts J.P.M., Smeets H.J.M.;
RT   "Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.";
RL   Hum. Mutat. 13:301-310(1999).
RN   [35]
RP   VARIANTS LQT2 LEU-29; THR-33; ARG-53; GLN-56; GLY-66; ARG-70; PRO-78
RP   AND ARG-86.
RX   PubMed=10187793; DOI=10.1074/jbc.274.15.10113;
RA   Chen J., Zou A., Splawski I., Keating M.T., Sanguinetti M.C.;
RT   "Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS)
RT   domain of HERG potassium channels accelerate channel deactivation.";
RL   J. Biol. Chem. 274:10113-10118(1999).
RN   [36]
RP   VARIANT LQT2 LYS-629.
RX   PubMed=10517660; DOI=10.1111/j.1540-8167.1999.tb00304.x;
RA   Yoshida H., Horie M., Otani H., Takano M., Tsuji K., Kubota T.,
RA   Fukunami M., Sasayama S.;
RT   "Characterization of a novel missense mutation in the pore of HERG in
RT   a patient with long QT syndrome.";
RL   J. Cardiovasc. Electrophysiol. 10:1262-1270(1999).
RN   [37]
RP   VARIANT LQT2 ARG-572.
RX   PubMed=10735633; DOI=10.1034/j.1399-0004.2000.570206.x;
RA   Larsen L.A., Svendsen I.H., Jensen A.M., Kanters J.K., Andersen P.S.,
RA   Moeller M., Soerensen S.A., Sandoee E., Jacobsen J.R., Vuust J.,
RA   Christiansen M.;
RT   "Long QT syndrome with a high mortality rate caused by a novel G572R
RT   missense mutation in KCNH2.";
RL   Clin. Genet. 57:125-130(2000).
RN   [38]
RP   VARIANTS LQT2, AND REVIEW ON VARIANTS.
RX   PubMed=10973849; DOI=10.1161/01.CIR.102.10.1178;
RA   Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S.G.,
RA   Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M.,
RA   Keating M.T.;
RT   "Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A,
RT   KCNE1, and KCNE2.";
RL   Circulation 102:1178-1185(2000).
RN   [39]
RP   VARIANTS LQT2 TRP-176; LEU-451; HIS-569; SER-584; SER-601 AND MET-613,
RP   AND VARIANT THR-897.
RX   PubMed=10862094;
RX   DOI=10.1002/1098-1004(200006)15:6<580::AID-HUMU16>3.3.CO;2-S;
RA   Laitinen P., Fodstad H., Piippo K., Swan H., Toivonen L.,
RA   Viitasalo M., Kaprio J., Kontula K.;
RT   "Survey of the coding region of the HERG gene in long QT syndrome
RT   reveals six novel mutations and an amino acid polymorphism with
RT   possible phenotypic effects.";
RL   Hum. Mutat. 15:580-581(2000).
RN   [40]
RP   CHARACTERIZATION OF VARIANT LQT2 VAL-561.
RX   PubMed=10753933; DOI=10.1074/jbc.275.15.11241;
RA   Kagan A., Yu Z., Fishman G.I., McDonald T.V.;
RT   "The dominant negative LQT2 mutation A561V reduces wild-type HERG
RT   expression.";
RL   J. Biol. Chem. 275:11241-11248(2000).
RN   [41]
RP   VARIANT LQT2 THR-490.
RX   PubMed=11170080;
RX   DOI=10.1002/1096-8628(20010201)98:4<348::AID-AJMG1109>3.0.CO;2-A;
RA   Yoshida H., Horie M., Otani H., Kawashima T., Onishi Y., Sasayama S.;
RT   "Bradycardia-induced long QT syndrome caused by a de novo missense
RT   mutation in the S2-S3 inner loop of HERG.";
RL   Am. J. Med. Genet. 98:348-352(2001).
RN   [42]
RP   VARIANT LQT2 LYS-637.
RX   PubMed=12062363; DOI=10.1016/S0008-6363(02)00240-7;
RA   Hayashi K., Shimizu M., Ino H., Yamaguchi M., Mabuchi H., Hoshi N.,
RA   Higashida H.;
RT   "Characterization of a novel missense mutation E637K in the pore-S6
RT   loop of HERG in a patient with long QT syndrome.";
RL   Cardiovasc. Res. 54:67-76(2002).
RN   [43]
RP   VARIANTS TRP-784 AND THR-897, AND CHARACTERIZATION OF VARIANT TRP-784.
RX   PubMed=11997281; DOI=10.1161/01.CIR.0000014448.19052.4C;
RA   Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C.,
RA   Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T.,
RA   Norris K., George A.L. Jr., Roden D.M.;
RT   "Allelic variants in long-QT disease genes in patients with drug-
RT   associated torsades de pointes.";
RL   Circulation 105:1943-1948(2002).
RN   [44]
RP   VARIANTS LQT2 PRO-413; ASP-444 AND HIS-559.
RX   PubMed=12442276; DOI=10.1002/humu.9085;
RA   Liu W., Yang J., Hu D., Kang C., Li C., Zhang S., Li P., Chen Z.,
RA   Qin X., Ying K., Li Y., Li Y., Li Z., Cheng X., Li L., Qi Y., Chen S.,
RA   Wang Q.;
RT   "KCNQ1 and KCNH2 mutations associated with long QT syndrome in a
RT   Chinese population.";
RL   Hum. Mutat. 20:475-476(2002).
RN   [45]
RP   VARIANT LQT2 PRO-65.
RX   PubMed=12354768; DOI=10.1074/jbc.M206569200;
RA   Paulussen A., Raes A., Matthijs G., Snyders D.J., Cohen N.,
RA   Aerssens J.;
RT   "A novel mutation (T65P) in the PAS domain of the human potassium
RT   channel HERG results in the long QT syndrome by trafficking
RT   deficiency.";
RL   J. Biol. Chem. 277:48610-48616(2002).
RN   [46]
RP   VARIANT LQT2 GLN-752.
RX   PubMed=12621127; DOI=10.1203/01.PDR.0000059750.17002.B6;
RA   Johnson W.H. Jr., Yang P., Yang T., Lau Y.R., Mostella B.A.,
RA   Wolff D.J., Roden D.M., Benson D.W.;
RT   "Clinical, genetic, and biophysical characterization of a homozygous
RT   HERG mutation causing severe neonatal long QT syndrome.";
RL   Pediatr. Res. 53:744-748(2003).
RN   [47]
RP   VARIANT SQT1 LYS-588.
RX   PubMed=14676148; DOI=10.1161/01.CIR.0000109482.92774.3A;
RA   Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M.,
RA   Menendez T.M., Brugada J., Pollevick G.D., Wolpert C., Burashnikov E.,
RA   Matsuo K., Wu Y.S., Guerchicoff A., Bianchi F., Giustetto C.,
RA   Schimpf R., Brugada P., Antzelevitch C.;
RT   "Sudden death associated with short-QT syndrome linked to mutations in
RT   HERG.";
RL   Circulation 109:30-35(2004).
RN   [48]
RP   VARIANT LQT2 ILE-861.
RX   PubMed=15051636; DOI=10.1161/01.CIR.0000125524.34234.13;
RA   Westenskow P., Splawski I., Timothy K.W., Keating M.T.,
RA   Sanguinetti M.C.;
RT   "Compound mutations: a common cause of severe long-QT syndrome.";
RL   Circulation 109:1834-1841(2004).
RN   [49]
RP   VARIANTS LQT2 ILE-26; LEU-29; SER-31; ARG-53; LEU-55; PRO-65; ARG-70;
RP   PRO-78; VAL-85; GLN-100; SER-238; TRP-306; LEU-320; CYS-328; CYS-420;
RP   MET-421; THR-422; SER-427; TYR-456; TYR-475 DEL; CYS-534; SER-552;
RP   THR-561; VAL-561; PRO-562; LEU-571; SER-572; CYS-582; SER-584;
RP   ASP-588; ARG-596; SER-604; MET-613; VAL-614; PHE-622; ILE-623;
RP   SER-628; VAL-628; ALA-630; SER-633; ILE-635; VAL-640; PHE-641;
RP   671-ALA--THR-675 DEL; LEU-721; TYR-774; TRP-784; ASP-788; CYS-805;
RP   ARG-820; MET-822; GLY-837; HIS-887; VAL-913; ARG-925; ILE-983; ILE-996
RP   AND ASP-1036.
RX   PubMed=15840476; DOI=10.1016/j.hrthm.2005.01.020;
RA   Tester D.J., Will M.L., Haglund C.M., Ackerman M.J.;
RT   "Compendium of cardiac channel mutations in 541 consecutive unrelated
RT   patients referred for long QT syndrome genetic testing.";
RL   Heart Rhythm 2:507-517(2005).
RN   [50]
RP   VARIANTS LQT2 CYS-43; TYR-49; ALA-58; ASP-58; GLY-58; LEU-68; ARG-71;
RP   MET-74; SER-251; SER-410; HIS-426; HIS-427; LEU-428; TYR-460; HIS-501;
RP   LEU-534; SER-566; ARG-568; VAL-571; ASP-572; LEU-582; HIS-609;
RP   PHE-615; ARG-621; ALA-626; ASP-637; PHE-644; CYS-656; LEU-660;
RP   PRO-696; TRP-800; PRO-818; HIS-861; LEU-968 AND TYR-1153.
RX   PubMed=16414944; DOI=10.1001/jama.294.23.2975;
RA   Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E.,
RA   Nastoli J., Bottelli G., Cerrone M., Leonardi S.;
RT   "Genetic testing in the long QT syndrome: development and validation
RT   of an efficient approach to genotyping in clinical practice.";
RL   JAMA 294:2975-2980(2005).
RN   [51]
RP   VARIANT SQT1 LYS-588.
RX   PubMed=15828882; DOI=10.1046/j.1540-8167.2005.40621.x;
RA   Hong K., Bjerregaard P., Gussak I., Brugada R.;
RT   "Short QT syndrome and atrial fibrillation caused by mutation in
RT   KCNH2.";
RL   J. Cardiovasc. Electrophysiol. 16:394-396(2005).
RN   [52]
RP   VARIANTS LQT2 GLY-100; HIS-427; ASN-525; PRO-528; CYS-696 AND CYS-948.
RX   PubMed=16922724; DOI=10.1111/j.1399-0004.2006.00671.x;
RA   Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P.,
RA   Kugener B., Fayol L., Gonzalez Armengod C., Oddou B., Chanavat V.,
RA   Froidefond E., Perraudin R., Rousson R., Rodriguez-Lafrasse C.;
RT   "Spectrum of pathogenic mutations and associated polymorphisms in a
RT   cohort of 44 unrelated patients with long QT syndrome.";
RL   Clin. Genet. 70:214-227(2006).
RN   [53]
RP   VARIANTS LQT2 ALA-16; GLY-20; LEU-29; THR-30; THR-32; PHE-41; TYR-45;
RP   ASP-53; HIS-54; PRO-57; TRP-64; ARG-70; ASN-70; 72-PRO--ALA-80 DELINS
RP   ARG-PRO-VAL; GLN-72; LEU-72; ARG-74; MET-74; PRO-74; VAL-85; PRO-86;
RP   GLY-94; GLN-100; TRP-100; ALA-102; TYR-106; ARG-108; SER-114; CYS-125;
RP   LEU-141; ALA-149; HIS-164; VAL-218; GLY-242; ASN-259; ASP-277;
RP   THR-291; LEU-301; CYS-312; SER-314; ASN-323; CYS-328; ARG-402;
RP   MET-421; CYS-427; LEU-431; LEU-440; LEU-451; TYR-466; ASN-473;
RP   CYS-475; ILE-476; THR-490; CYS-493; SER-493; ASN-501; TRP-531;
RP   CYS-534; LEU-534; SER-552; GLU-558; THR-561; VAL-561; ARG-562;
RP   THR-565; ASP-572; SER-572; VAL-572; CYS-582; ARG-584; SER-584;
RP   CYS-585; LYS-593; ASP-594; HIS-596; LEU-596; CYS-597; ARG-599;
RP   CYS-601; SER-601; SER-604; LEU-605; SER-605; GLY-609; MET-613;
RP   VAL-614; CYS-616; ASP-626; SER-628; ILE-629; SER-629; ILE-634;
RP   ASP-635; LYS-635; ASP-637; ASN-638; LYS-638 DEL; LEU-644; PHE-644;
RP   ILE-645; SER-648; ARG-657; LEU-660; THR-662; PRO-678; TYR-687;
RP   PRO-693; VAL-711; PHE-728; VAL-749; ASN-757; TYR-767; ALA-770;
RP   TYR-774; LYS-788; 791-ARG--LEU-799 DEL; TRP-791; GLU-806; MET-822;
RP   TRP-823; TYR-837; SER-846; CYS-885; CYS-894; LEU-894; ARG-903;
RP   LEU-906; VAL-913; GLN-920; TRP-920; GLN-922; ALA-924; GLU-924;
RP   ASN-937; GLN-1005; HIS-1007; TRP-1033; MET-1038; PRO-1049; VAL-1066;
RP   CYS-1078; LEU-1093 AND VAL-1115.
RX   PubMed=19716085; DOI=10.1016/j.hrthm.2009.05.021;
RA   Kapplinger J.D., Tester D.J., Salisbury B.A., Carr J.L.,
RA   Harris-Kerr C., Pollevick G.D., Wilde A.A., Ackerman M.J.;
RT   "Spectrum and prevalence of mutations from the first 2,500 consecutive
RT   unrelated patients referred for the FAMILION long QT syndrome genetic
RT   test.";
RL   Heart Rhythm 6:1297-1303(2009).
RN   [54]
RP   VARIANT LQT2 PRO-744, AND CHARACTERIZATION OF VARIANT LQT2 PRO-744.
RX   PubMed=22314138; DOI=10.1016/j.bbrc.2012.01.118;
RA   Aidery P., Kisselbach J., Gaspar H., Baldea I., Schweizer P.A.,
RA   Becker R., Katus H.A., Thomas D.;
RT   "Identification and functional characterization of the novel human
RT   ether-a-go-go-related gene (hERG) R744P mutant associated with
RT   hereditary long QT syndrome 2.";
RL   Biochem. Biophys. Res. Commun. 418:830-835(2012).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated inwardly
CC       rectifying potassium channel. Channel properties are modulated by
CC       cAMP and subunit assembly. Mediates the rapidly activating
CC       component of the delayed rectifying potassium current in heart
CC       (IKr). Isoforms USO have no channel activity by themself, but
CC       modulates channel characteristics by forming heterotetramers with
CC       other isoforms which are retained intracellularly and undergo
CC       ubiquitin-dependent degradation. {ECO:0000269|PubMed:18559421}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH6/ERG2 and KCNH7/ERG3 (By similarity). Interacts with ALG10B
CC       (By similarity). Heteromultimer with KCNE1 and KCNE2
CC       (PubMed:9230439, PubMed:10219239). Interacts with CANX
CC       (PubMed:16361248). The core-glycosylated, but not the fully
CC       glycosylated form interacts with RNF207 (PubMed:25281747).
CC       {ECO:0000250|UniProtKB:O08962, ECO:0000269|PubMed:10219239,
CC       ECO:0000269|PubMed:16361248, ECO:0000269|PubMed:25281747,
CC       ECO:0000269|PubMed:9230439}.
CC   -!- INTERACTION:
CC       Self; NbExp=6; IntAct=EBI-720643, EBI-720643;
CC       Q03135:CAV1; NbExp=5; IntAct=EBI-720643, EBI-603614;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18559421,
CC       ECO:0000269|PubMed:19412172}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18559421, ECO:0000269|PubMed:19412172}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=A;
CC         IsoId=Q12809-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q12809-2; Sequence=VSP_000965;
CC       Name=4;
CC         IsoId=Q12809-4; Sequence=VSP_000966;
CC         Note=No experimental confirmation available.;
CC       Name=A-USO;
CC         IsoId=Q12809-5; Sequence=VSP_047880, VSP_047881;
CC         Note=Twice more abundant than isoform 1 in heart.;
CC       Name=B-USO;
CC         IsoId=Q12809-6; Sequence=VSP_047878, VSP_047879, VSP_047880,
CC                                  VSP_047881;
CC       Name=3.1;
CC         IsoId=Q12809-7; Sequence=VSP_047877;
CC         Note=Primate-specific. Lacks a domain that is crucial for slow
CC         channel deactivation.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and brain. Isoforms
CC       USO are frequently overexpressed in cancer cells.
CC       {ECO:0000269|PubMed:18559421}.
CC   -!- INDUCTION: Up-regulated by RNF207 (at protein level).
CC       {ECO:0000269|PubMed:25281747}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Phosphorylated on serine and threonine residues.
CC       Phosphorylation by PKA inhibits ion conduction.
CC       {ECO:0000269|PubMed:10837251}.
CC   -!- DISEASE: Long QT syndrome 2 (LQT2) [MIM:613688]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy. Deafness
CC       is often associated with long QT syndrome type 2.
CC       {ECO:0000269|PubMed:10086971, ECO:0000269|PubMed:10187793,
CC       ECO:0000269|PubMed:10220144, ECO:0000269|PubMed:10517660,
CC       ECO:0000269|PubMed:10735633, ECO:0000269|PubMed:10753933,
CC       ECO:0000269|PubMed:10862094, ECO:0000269|PubMed:10973849,
CC       ECO:0000269|PubMed:11170080, ECO:0000269|PubMed:12062363,
CC       ECO:0000269|PubMed:12354768, ECO:0000269|PubMed:12442276,
CC       ECO:0000269|PubMed:12621127, ECO:0000269|PubMed:15051636,
CC       ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16361248,
CC       ECO:0000269|PubMed:16414944, ECO:0000269|PubMed:16922724,
CC       ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:22314138,
CC       ECO:0000269|PubMed:7889573, ECO:0000269|PubMed:8635257,
CC       ECO:0000269|PubMed:8877771, ECO:0000269|PubMed:8914737,
CC       ECO:0000269|PubMed:9024139, ECO:0000269|PubMed:9452080,
CC       ECO:0000269|PubMed:9544837, ECO:0000269|PubMed:9600240,
CC       ECO:0000269|PubMed:9693036}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Short QT syndrome 1 (SQT1) [MIM:609620]: A heart disorder
CC       characterized by idiopathic persistently and uniformly short QT
CC       interval on ECG in the absence of structural heart disease in
CC       affected individuals. It causes syncope and sudden death.
CC       {ECO:0000269|PubMed:14676148, ECO:0000269|PubMed:15828882}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv11.1/KCNH2 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA09232.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ether-a-go-go potassium
CC       channels entry;
CC       URL="https://en.wikipedia.org/wiki/Ether-a-go-go_potassium_channels";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U04270; AAA62473.1; -; mRNA.
DR   EMBL; AB009071; BAA37096.1; -; Genomic_DNA.
DR   EMBL; AB044806; BAB19682.1; -; mRNA.
DR   EMBL; AF363636; AAL37559.1; -; mRNA.
DR   EMBL; AJ512214; CAD54447.1; -; mRNA.
DR   EMBL; AJ609614; CAE82156.1; -; mRNA.
DR   EMBL; FJ938021; ACR24650.1; -; mRNA.
DR   EMBL; DQ784808; ABQ01243.1; -; Genomic_DNA.
DR   EMBL; AC006343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471173; EAW54072.1; -; Genomic_DNA.
DR   EMBL; AJ010538; CAA09232.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ010539; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010540; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010541; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010542; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010543; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010544; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010545; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010546; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010547; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010548; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010549; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010550; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010551; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; CH471173; EAW54075.1; -; Genomic_DNA.
DR   EMBL; BC001914; AAH01914.2; -; mRNA.
DR   EMBL; BC004311; AAH04311.2; -; mRNA.
DR   EMBL; AF052728; AAC69709.1; -; mRNA.
DR   CCDS; CCDS5910.1; -. [Q12809-1]
DR   CCDS; CCDS5911.1; -. [Q12809-2]
DR   PIR; I38465; I38465.
DR   RefSeq; NP_000229.1; NM_000238.3. [Q12809-1]
DR   RefSeq; NP_001191727.1; NM_001204798.1. [Q12809-6]
DR   RefSeq; NP_742053.1; NM_172056.2. [Q12809-5]
DR   RefSeq; NP_742054.1; NM_172057.2. [Q12809-2]
DR   UniGene; Hs.647099; -.
DR   PDB; 1BYW; X-ray; 2.60 A; A=26-135.
DR   PDB; 1UJL; NMR; -; A=570-611.
DR   PDB; 2L0W; NMR; -; A=1-135.
DR   PDB; 2L1M; NMR; -; A=1-135.
DR   PDB; 2L4R; NMR; -; A=1-135.
DR   PDB; 2LE7; NMR; -; A=532-551.
DR   PDB; 2N7G; NMR; -; A=734-864.
DR   PDB; 4HP9; X-ray; 2.12 A; A=10-135.
DR   PDB; 4HQA; X-ray; 1.96 A; A=1-135.
DR   PDBsum; 1BYW; -.
DR   PDBsum; 1UJL; -.
DR   PDBsum; 2L0W; -.
DR   PDBsum; 2L1M; -.
DR   PDBsum; 2L4R; -.
DR   PDBsum; 2LE7; -.
DR   PDBsum; 2N7G; -.
DR   PDBsum; 4HP9; -.
DR   PDBsum; 4HQA; -.
DR   ProteinModelPortal; Q12809; -.
DR   SMR; Q12809; -.
DR   BioGrid; 109959; 21.
DR   DIP; DIP-48929N; -.
DR   IntAct; Q12809; 7.
DR   MINT; MINT-1427435; -.
DR   STRING; 9606.ENSP00000262186; -.
DR   BindingDB; Q12809; -.
DR   ChEMBL; CHEMBL240; -.
DR   DrugBank; DB00346; Alfuzosin.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00276; Amsacrine.
DR   DrugBank; DB00637; Astemizole.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00537; Ciprofloxacin.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB00204; Dofetilide.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00199; Erythromycin.
DR   DrugBank; DB01218; Halofantrine.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB06144; Sertindole.
DR   DrugBank; DB00489; Sotalol.
DR   DrugBank; DB01162; Terazosin.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00661; Verapamil.
DR   GuidetoPHARMACOLOGY; 572; -.
DR   TCDB; 1.A.1.20.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q12809; -.
DR   PhosphoSitePlus; Q12809; -.
DR   BioMuta; KCNH2; -.
DR   DMDM; 7531135; -.
DR   PaxDb; Q12809; -.
DR   PeptideAtlas; Q12809; -.
DR   PRIDE; Q12809; -.
DR   DNASU; 3757; -.
DR   Ensembl; ENST00000262186; ENSP00000262186; ENSG00000055118. [Q12809-1]
DR   Ensembl; ENST00000330883; ENSP00000328531; ENSG00000055118. [Q12809-2]
DR   GeneID; 3757; -.
DR   KEGG; hsa:3757; -.
DR   UCSC; uc003wib.4; human. [Q12809-1]
DR   CTD; 3757; -.
DR   DisGeNET; 3757; -.
DR   GeneCards; KCNH2; -.
DR   GeneReviews; KCNH2; -.
DR   HGNC; HGNC:6251; KCNH2.
DR   MalaCards; KCNH2; -.
DR   MIM; 152427; gene.
DR   MIM; 609620; phenotype.
DR   MIM; 613688; phenotype.
DR   neXtProt; NX_Q12809; -.
DR   OpenTargets; ENSG00000055118; -.
DR   Orphanet; 51083; Familial short QT syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA212; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000207541; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q12809; -.
DR   KO; K04905; -.
DR   OMA; FMAFEEL; -.
DR   OrthoDB; EOG093705SE; -.
DR   PhylomeDB; Q12809; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   SignaLink; Q12809; -.
DR   SIGNOR; Q12809; -.
DR   ChiTaRS; KCNH2; human.
DR   EvolutionaryTrace; Q12809; -.
DR   GeneWiki; HERG; -.
DR   GenomeRNAi; 3757; -.
DR   PRO; PR:Q12809; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000055118; -.
DR   CleanEx; HS_ERG; -.
DR   CleanEx; HS_KCNH2; -.
DR   ExpressionAtlas; Q12809; baseline and differential.
DR   Genevisible; Q12809; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IMP:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; IC:BHF-UCL.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IDA:BHF-UCL.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1902303; P:negative regulation of potassium ion export; IDA:BHF-UCL.
DR   GO; GO:1901380; P:negative regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0055075; P:potassium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0003064; P:regulation of heart rate by hormone; TAS:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Deafness; Disease mutation; Glycoprotein; Ion channel; Ion transport;
KW   Long QT syndrome; Membrane; Methylation; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Short QT syndrome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1159       Potassium voltage-gated channel subfamily
FT                                H member 2.
FT                                /FTId=PRO_0000053999.
FT   TOPO_DOM      1    403       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    404    424       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    425    450       Extracellular. {ECO:0000255}.
FT   TRANSMEM    451    471       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    472    495       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    496    516       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    517    520       Extracellular. {ECO:0000255}.
FT   TRANSMEM    521    541       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    542    547       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    548    568       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    569    611       Extracellular. {ECO:0000255}.
FT   INTRAMEM    612    632       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    633    638       Extracellular. {ECO:0000255}.
FT   TRANSMEM    639    659       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    660   1159       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       92    144       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     742    842       cNMP.
FT   MOTIF       624    629       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS    297    300       Poly-Pro.
FT   MOD_RES     179    179       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ER47}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     351    351       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08962}.
FT   MOD_RES     871    871       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     874    874       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     890    890       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54852}.
FT   MOD_RES    1014   1014       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES    1137   1137       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    598    598       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:12063277}.
FT   VAR_SEQ       1    376       MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAV
FT                                IYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQI
FT                                AQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVI
FT                                MFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFR
FT                                LKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAP
FT                                SSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPG
FT                                QLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADD
FT                                IEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYR
FT                                TISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHN
FT                                VTEKVTQ -> MAAPAGKASRTGALRPRAQKGRVRRAVRIS
FT                                SLVAQE (in isoform B).
FT                                {ECO:0000303|PubMed:12431979,
FT                                ECO:0000303|PubMed:9351446,
FT                                ECO:0000303|PubMed:9351462}.
FT                                /FTId=VSP_000965.
FT   VAR_SEQ       1    102       MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAV
FT                                IYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQI
FT                                AQALLGAEERKVEIAFYRKD -> MSSHSA (in
FT                                isoform 3.1).
FT                                {ECO:0000303|PubMed:19412172}.
FT                                /FTId=VSP_047877.
FT   VAR_SEQ       1     36       MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARV -> M
FT                                AAPAGKASRTGALRPRAQKGRVRRAVRISSLVAQE (in
FT                                isoform B-USO).
FT                                {ECO:0000303|PubMed:18559421}.
FT                                /FTId=VSP_047878.
FT   VAR_SEQ      37    376       Missing (in isoform B-USO).
FT                                {ECO:0000303|PubMed:18559421}.
FT                                /FTId=VSP_047879.
FT   VAR_SEQ     139    195       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000966.
FT   VAR_SEQ     801    888       KNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEV
FT                                LDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFS
FT                                RQRKRK -> MGWGAGTGLEMPSAASRGASLLNMQSLGLWT
FT                                WDCLQGHWAPLIHLNSGPPSGAMERSPTWGEAAELWGSHIL
FT                                LPFRIRHKQTLFASLK (in isoform A-USO and
FT                                isoform B-USO).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:18559421,
FT                                ECO:0000303|PubMed:9765245}.
FT                                /FTId=VSP_047880.
FT   VAR_SEQ     889   1159       Missing (in isoform A-USO and isoform B-
FT                                USO). {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:18559421,
FT                                ECO:0000303|PubMed:9765245}.
FT                                /FTId=VSP_047881.
FT   VARIANT      16     16       D -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472825).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074765.
FT   VARIANT      20     20       R -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473486).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074766.
FT   VARIANT      26     26       S -> I (in LQT2; dbSNP:rs199472827).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068249.
FT   VARIANT      29     29       F -> L (in LQT2; dbSNP:rs199472830).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008907.
FT   VARIANT      30     30       I -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472832).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074767.
FT   VARIANT      31     31       I -> S (in LQT2; dbSNP:rs199472833).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068250.
FT   VARIANT      32     32       A -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472834).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074768.
FT   VARIANT      33     33       N -> T (in LQT2; dbSNP:rs199473487).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008908.
FT   VARIANT      41     41       V -> F (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472835).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074769.
FT   VARIANT      43     43       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472836).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074770.
FT   VARIANT      45     45       N -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472839).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074771.
FT   VARIANT      47     47       G -> V (in LQT2; dbSNP:rs199473490).
FT                                /FTId=VAR_009909.
FT   VARIANT      49     49       C -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472840).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074772.
FT   VARIANT      53     53       G -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473491).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074773.
FT   VARIANT      53     53       G -> R (in LQT2; dbSNP:rs199472842).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_008909.
FT   VARIANT      54     54       Y -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472843).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074774.
FT   VARIANT      55     55       S -> L (in LQT2; dbSNP:rs199472844).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068251.
FT   VARIANT      56     56       R -> Q (in LQT2; dbSNP:rs199472845).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008910.
FT   VARIANT      57     57       A -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472846).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074775.
FT   VARIANT      58     58       E -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472847).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074776.
FT   VARIANT      58     58       E -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473492).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074777.
FT   VARIANT      58     58       E -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472847).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074778.
FT   VARIANT      64     64       C -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473414).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074779.
FT   VARIANT      65     65       T -> P (in LQT2; dbSNP:rs28933095).
FT                                {ECO:0000269|PubMed:12354768,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_014371.
FT   VARIANT      66     66       C -> G (in LQT2; dbSNP:rs199473416).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008911.
FT   VARIANT      68     68       F -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473417).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074780.
FT   VARIANT      70     70       H -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473418).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074781.
FT   VARIANT      70     70       H -> R (in LQT2; dbSNP:rs199473419).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008912.
FT   VARIANT      71     71       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473420).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074782.
FT   VARIANT      72     80       PRTQRRAAA -> RPV (in LQT2; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074783.
FT   VARIANT      72     72       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473421).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074784.
FT   VARIANT      72     72       P -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473421).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009910.
FT   VARIANT      74     74       T -> M (in LQT2; dbSNP:rs199473422).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074785.
FT   VARIANT      74     74       T -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473666).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074786.
FT   VARIANT      74     74       T -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473422).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074787.
FT   VARIANT      78     78       A -> P (in LQT2; dbSNP:rs199472848).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_008913.
FT   VARIANT      85     85       A -> V (in LQT2; dbSNP:rs199473494).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068252.
FT   VARIANT      86     86       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472851).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074788.
FT   VARIANT      86     86       L -> R (in LQT2; dbSNP:rs199472851).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008914.
FT   VARIANT      94     94       V -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472852).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074789.
FT   VARIANT     100    100       R -> G (in LQT2; digenic; the patient
FT                                also carries mutation N-1819 on SCN5A;
FT                                dbSNP:rs121912515).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036669.
FT   VARIANT     100    100       R -> Q (in LQT2; dbSNP:rs199472855).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068253.
FT   VARIANT     100    100       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs121912515).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074790.
FT   VARIANT     102    102       D -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472857).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074791.
FT   VARIANT     106    106       F -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472858).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074792.
FT   VARIANT     108    108       C -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472859).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074793.
FT   VARIANT     114    114       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472861).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074794.
FT   VARIANT     125    125       F -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473499).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074795.
FT   VARIANT     141    141       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472864).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074796.
FT   VARIANT     149    149       G -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472865).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074797.
FT   VARIANT     164    164       R -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472866).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074798.
FT   VARIANT     176    176       R -> W (in LQT2; dbSNP:rs36210422).
FT                                {ECO:0000269|PubMed:10862094}.
FT                                /FTId=VAR_008915.
FT   VARIANT     181    181       R -> Q (in dbSNP:rs41308954).
FT                                /FTId=VAR_036670.
FT   VARIANT     189    189       G -> GGAG. {ECO:0000269|PubMed:10790218}.
FT                                /FTId=VAR_014372.
FT   VARIANT     218    218       M -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472869).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074799.
FT   VARIANT     238    238       G -> S (in LQT2; dbSNP:rs199473501).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068254.
FT   VARIANT     242    242       R -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472872).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074800.
FT   VARIANT     251    251       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472873).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074801.
FT   VARIANT     259    259       D -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472876).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074802.
FT   VARIANT     277    277       A -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472878).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074803.
FT   VARIANT     291    291       M -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472881).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074804.
FT   VARIANT     301    301       R -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472883).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074805.
FT   VARIANT     306    306       G -> W (in LQT2; dbSNP:rs199472884).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068255.
FT   VARIANT     312    312       R -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472885).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009911.
FT   VARIANT     314    314       G -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473504).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074806.
FT   VARIANT     320    320       S -> L (in LQT2; dbSNP:rs199472886).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068256.
FT   VARIANT     323    323       D -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472887).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074807.
FT   VARIANT     328    328       R -> C (in LQT2; dbSNP:rs199473505).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068257.
FT   VARIANT     347    347       P -> S (in LQT2; dbSNP:rs138776684).
FT                                /FTId=VAR_009912.
FT   VARIANT     402    402       H -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473506).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074808.
FT   VARIANT     410    410       W -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472892).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074809.
FT   VARIANT     413    413       L -> P (in LQT2; dbSNP:rs199472893).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074684.
FT   VARIANT     420    420       Y -> C (in LQT2; dbSNP:rs199473507).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068258.
FT   VARIANT     421    421       T -> M (in LQT2; dbSNP:rs199472894).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068259.
FT   VARIANT     422    422       A -> T (in LQT2; dbSNP:rs199472895).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068260.
FT   VARIANT     426    426       P -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472896).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074810.
FT   VARIANT     427    427       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472897).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074811.
FT   VARIANT     427    427       Y -> H (in LQT2; dbSNP:rs199472898).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_074812.
FT   VARIANT     427    427       Y -> S (in LQT2; dbSNP:rs199472897).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068261.
FT   VARIANT     428    428       S -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472899).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074813.
FT   VARIANT     431    431       F -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472900).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074814.
FT   VARIANT     436    436       T -> M (in LQT2; dbSNP:rs199472901).
FT                                /FTId=VAR_008916.
FT   VARIANT     440    440       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473509).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074815.
FT   VARIANT     444    444       E -> D (in LQT2; dbSNP:rs9770044).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074685.
FT   VARIANT     451    451       P -> L (in LQT2; dbSNP:rs199472902).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_014373.
FT   VARIANT     456    456       D -> Y (in LQT2; dbSNP:rs199473510).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068262.
FT   VARIANT     460    460       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472903).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074816.
FT   VARIANT     466    466       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473511).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074817.
FT   VARIANT     470    470       N -> D (in LQT2; aberrant protein folding
FT                                increases the association of mutant KCNH2
FT                                with CANX and results in defective
FT                                protein trafficking; dbSNP:rs121912505).
FT                                {ECO:0000269|PubMed:16361248,
FT                                ECO:0000269|PubMed:7889573}.
FT                                /FTId=VAR_008578.
FT   VARIANT     473    473       T -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472905).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074818.
FT   VARIANT     474    474       T -> I (in LQT2; dbSNP:rs199472906).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_008917.
FT   VARIANT     475    475       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472907).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074819.
FT   VARIANT     475    475       Missing (in LQT2).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068263.
FT   VARIANT     476    476       V -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472908).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074820.
FT   VARIANT     490    490       A -> T (in LQT2; bradycardia-induced;
FT                                dbSNP:rs28928905).
FT                                {ECO:0000269|PubMed:11170080,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_036671.
FT   VARIANT     493    493       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472911).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074821.
FT   VARIANT     493    493       Y -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472911).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074822.
FT   VARIANT     500    508       Missing (in LQT2).
FT                                /FTId=VAR_009178.
FT   VARIANT     501    501       D -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472912).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074823.
FT   VARIANT     501    501       D -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472912).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074824.
FT   VARIANT     525    525       K -> N (in LQT2; located on the same
FT                                allele as Pro-528; dbSNP:rs199472913).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036672.
FT   VARIANT     528    528       R -> P (in LQT2; located on the same
FT                                allele as Asn-525; dbSNP:rs199472914).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036673.
FT   VARIANT     531    531       R -> Q (in LQT2; dbSNP:rs199473515).
FT                                /FTId=VAR_009913.
FT   VARIANT     531    531       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472915).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074825.
FT   VARIANT     534    534       R -> C (in LQT2; dbSNP:rs199472916).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9600240}.
FT                                /FTId=VAR_008579.
FT   VARIANT     534    534       R -> L (in LQT2; dbSNP:rs199473516).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074826.
FT   VARIANT     552    552       L -> S (in LQT2; dbSNP:rs199472918).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008918.
FT   VARIANT     558    558       A -> E (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472919).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074827.
FT   VARIANT     558    558       A -> P (in LQT2; dbSNP:rs121912516).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008919.
FT   VARIANT     559    559       L -> H (in LQT2; dbSNP:rs199472920).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074686.
FT   VARIANT     561    561       A -> T (in LQT2; dbSNP:rs199472921).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8877771}.
FT                                /FTId=VAR_014374.
FT   VARIANT     561    561       A -> V (in LQT2; the mutation reduces
FT                                wild-type channel expression;
FT                                dbSNP:rs121912504).
FT                                {ECO:0000269|PubMed:10753933,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:7889573}.
FT                                /FTId=VAR_008580.
FT   VARIANT     562    562       H -> P (in LQT2; dbSNP:rs199472922).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068264.
FT   VARIANT     562    562       H -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472922).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074828.
FT   VARIANT     564    564       L -> P (in LQT2; dbSNP:rs199472924).
FT                                /FTId=VAR_008920.
FT   VARIANT     565    565       A -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473518).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074829.
FT   VARIANT     566    566       C -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472925).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074830.
FT   VARIANT     568    568       W -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472927).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074831.
FT   VARIANT     569    569       Y -> H (in LQT2; dbSNP:rs199473520).
FT                                {ECO:0000269|PubMed:10862094}.
FT                                /FTId=VAR_008921.
FT   VARIANT     571    571       I -> L (in LQT2; dbSNP:rs199472928).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068265.
FT   VARIANT     571    571       I -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472928).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074832.
FT   VARIANT     572    572       G -> C (in LQT2; dbSNP:rs9333649).
FT                                {ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008923.
FT   VARIANT     572    572       G -> D (in LQT2; dbSNP:rs199473423).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074833.
FT   VARIANT     572    572       G -> R (in LQT2; severe form;
FT                                dbSNP:rs9333649).
FT                                {ECO:0000269|PubMed:10735633}.
FT                                /FTId=VAR_008922.
FT   VARIANT     572    572       G -> S (in LQT2; dbSNP:rs9333649).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068266.
FT   VARIANT     572    572       G -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473423).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074834.
FT   VARIANT     582    582       R -> C (in LQT2; dbSNP:rs121912508).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008581.
FT   VARIANT     582    582       R -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473426).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074835.
FT   VARIANT     584    584       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473428).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074836.
FT   VARIANT     584    584       G -> S (in LQT2; dbSNP:rs199473428).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008924.
FT   VARIANT     585    585       W -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473430).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009914.
FT   VARIANT     588    588       N -> D (in LQT2; dbSNP:rs199473431).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008925.
FT   VARIANT     588    588       N -> K (in SQT1; dbSNP:rs104894021).
FT                                {ECO:0000269|PubMed:14676148,
FT                                ECO:0000269|PubMed:15828882}.
FT                                /FTId=VAR_023840.
FT   VARIANT     593    593       I -> K (in LQT2; unknown pathological
FT                                significance; dbSNP:rs28928904).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074837.
FT   VARIANT     593    593       I -> R (in LQT2; dbSNP:rs28928904).
FT                                {ECO:0000269|PubMed:8635257}.
FT                                /FTId=VAR_008582.
FT   VARIANT     593    593       I -> T (in LQT2; dbSNP:rs28928904).
FT                                /FTId=VAR_009915.
FT   VARIANT     594    594       G -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472931).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074838.
FT   VARIANT     596    596       P -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472933).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074839.
FT   VARIANT     596    596       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472933).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074840.
FT   VARIANT     596    596       P -> R (in LQT2; dbSNP:rs199472933).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068267.
FT   VARIANT     597    597       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472934).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074841.
FT   VARIANT     599    599       S -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472935).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074842.
FT   VARIANT     601    601       G -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472936).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074843.
FT   VARIANT     601    601       G -> S (in LQT2; dbSNP:rs199472936).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9452080}.
FT                                /FTId=VAR_008926.
FT   VARIANT     604    604       G -> S (in LQT2; dbSNP:rs199473522).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008927.
FT   VARIANT     605    605       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472938).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074844.
FT   VARIANT     605    605       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472939).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074845.
FT   VARIANT     609    609       D -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472940).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074846.
FT   VARIANT     609    609       D -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472941).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074847.
FT   VARIANT     609    609       D -> N (in LQT2; dbSNP:rs199472941).
FT                                /FTId=VAR_009916.
FT   VARIANT     611    611       Y -> H (in LQT2; dbSNP:rs199472942).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_008928.
FT   VARIANT     612    612       V -> L (in LQT2; dbSNP:rs199472943).
FT                                {ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_008929.
FT   VARIANT     613    613       T -> M (in LQT2; dbSNP:rs199473524).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008930.
FT   VARIANT     614    614       A -> V (in LQT2; dbSNP:rs199472944).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9024139,
FT                                ECO:0000269|PubMed:9544837,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008931.
FT   VARIANT     615    615       L -> F (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472945).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074848.
FT   VARIANT     615    615       L -> V (in LQT2; dbSNP:rs199472945).
FT                                /FTId=VAR_014375.
FT   VARIANT     616    616       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472946).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074849.
FT   VARIANT     621    621       S -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472949).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074850.
FT   VARIANT     622    622       L -> F (in LQT2; dbSNP:rs199473525).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068268.
FT   VARIANT     623    623       T -> I (in LQT2; dbSNP:rs199472950).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068269.
FT   VARIANT     626    626       G -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472952).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074851.
FT   VARIANT     626    626       G -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472952).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074852.
FT   VARIANT     626    626       G -> S (in LQT2; dbSNP:rs199472953).
FT                                /FTId=VAR_014376.
FT   VARIANT     627    627       F -> L (in LQT2; dbSNP:rs199473039).
FT                                /FTId=VAR_014377.
FT   VARIANT     628    628       G -> S (in LQT2; dbSNP:rs121912507).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:7889573}.
FT                                /FTId=VAR_008583.
FT   VARIANT     628    628       G -> V (in LQT2; dbSNP:rs199472955).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068270.
FT   VARIANT     629    629       N -> D (in LQT2; dbSNP:rs199472956).
FT                                {ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_008932.
FT   VARIANT     629    629       N -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472957).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074853.
FT   VARIANT     629    629       N -> K (in LQT2; dbSNP:rs41307295).
FT                                {ECO:0000269|PubMed:10517660}.
FT                                /FTId=VAR_008933.
FT   VARIANT     629    629       N -> S (in LQT2; dbSNP:rs199472957).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_009179.
FT   VARIANT     630    630       V -> A (in LQT2; dbSNP:rs199473526).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008935.
FT   VARIANT     630    630       V -> L (in LQT2; dbSNP:rs199472958).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_008934.
FT   VARIANT     632    632       P -> S (in LQT2; dbSNP:rs199473527).
FT                                /FTId=VAR_014378.
FT   VARIANT     633    633       N -> S (in LQT2; dbSNP:rs199472961).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_008936.
FT   VARIANT     634    634       T -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472962).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074854.
FT   VARIANT     635    635       N -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472963).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074855.
FT   VARIANT     635    635       N -> I (in LQT2; dbSNP:rs199472964).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068271.
FT   VARIANT     635    635       N -> K (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472965).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074856.
FT   VARIANT     637    637       E -> D (in LQT2; dbSNP:rs199472966).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074857.
FT   VARIANT     637    637       E -> K (in LQT2; dbSNP:rs199472968).
FT                                {ECO:0000269|PubMed:12062363}.
FT                                /FTId=VAR_014379.
FT   VARIANT     638    638       K -> E (in LQT2; dbSNP:rs199473528).
FT                                /FTId=VAR_014380.
FT   VARIANT     638    638       K -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472969).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074858.
FT   VARIANT     638    638       Missing (in LQT2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_014381.
FT   VARIANT     640    640       F -> L (in LQT2; dbSNP:rs199472970).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008937.
FT   VARIANT     640    640       F -> V (in LQT2; dbSNP:rs199473529).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068272.
FT   VARIANT     641    641       S -> F (in LQT2; dbSNP:rs199472971).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068273.
FT   VARIANT     644    644       V -> F (in LQT2; dbSNP:rs199472972).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074859.
FT   VARIANT     644    644       V -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472972).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074860.
FT   VARIANT     645    645       M -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472973).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074861.
FT   VARIANT     645    645       M -> L (in LQT2; dbSNP:rs199472974).
FT                                /FTId=VAR_014382.
FT   VARIANT     648    648       G -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472975).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074862.
FT   VARIANT     656    656       F -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472977).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074863.
FT   VARIANT     657    657       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472978).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074864.
FT   VARIANT     660    660       S -> L (in LQT2; dbSNP:rs199472979).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074865.
FT   VARIANT     662    662       I -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472980).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074866.
FT   VARIANT     671    675       Missing (in LQT2).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068274.
FT   VARIANT     678    678       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472981).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074867.
FT   VARIANT     687    687       H -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472982).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074868.
FT   VARIANT     693    693       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472983).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074869.
FT   VARIANT     696    696       R -> C (in LQT2; dbSNP:rs199472984).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036674.
FT   VARIANT     696    696       R -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473531).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074870.
FT   VARIANT     711    711       I -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473532).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074871.
FT   VARIANT     721    721       P -> L (in LQT2; dbSNP:rs199472986).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068275.
FT   VARIANT     728    728       I -> F (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473533).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074872.
FT   VARIANT     744    744       R -> P (in LQT2; impairs channel
FT                                function; exhibits reduced activating
FT                                currents compared to wild-type; cell
FT                                surface trafficking is not impaired; does
FT                                not exert dominant-negative effects on
FT                                wild-type channel; the half-maximal
FT                                activation voltage is not significantly
FT                                affected by the mutation).
FT                                {ECO:0000269|PubMed:22314138}.
FT                                /FTId=VAR_068276.
FT   VARIANT     749    749       G -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472989).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074873.
FT   VARIANT     752    752       R -> Q (in LQT2; dbSNP:rs121912512).
FT                                {ECO:0000269|PubMed:12621127}.
FT                                /FTId=VAR_036675.
FT   VARIANT     752    752       R -> W (in LQT2; dbSNP:rs199472990).
FT                                /FTId=VAR_014383.
FT   VARIANT     757    757       K -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472992).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074874.
FT   VARIANT     767    767       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472993).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074875.
FT   VARIANT     770    770       V -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472994).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074876.
FT   VARIANT     774    774       D -> Y (in LQT2; dbSNP:rs199472995).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068277.
FT   VARIANT     784    784       R -> W (predisposes to LQT2 and torsades
FT                                de pointes while taking the drug
FT                                amiodarone; in vitro studies confirmed a
FT                                significant reduction in potassium
FT                                currents; the ECG abnormalities reversed
FT                                on drug withdrawal; dbSNP:rs12720441).
FT                                {ECO:0000269|PubMed:11997281,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_036676.
FT   VARIANT     788    788       E -> D (in LQT2; dbSNP:rs199473535).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068278.
FT   VARIANT     788    788       E -> K (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472997).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074877.
FT   VARIANT     791    799       Missing (in LQT2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074878.
FT   VARIANT     791    791       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs138498207).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074879.
FT   VARIANT     800    800       G -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472998).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074880.
FT   VARIANT     805    805       F -> C (in LQT2; dbSNP:rs199472999).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_014384.
FT   VARIANT     805    805       F -> S (in LQT2; dbSNP:rs199472999).
FT                                /FTId=VAR_014385.
FT   VARIANT     806    806       G -> E (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473000).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074881.
FT   VARIANT     818    818       S -> L (in LQT2; dbSNP:rs121912510).
FT                                {ECO:0000269|PubMed:10086971}.
FT                                /FTId=VAR_008938.
FT   VARIANT     818    818       S -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473537).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074882.
FT   VARIANT     820    820       G -> R (in LQT2; dbSNP:rs199473001).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068279.
FT   VARIANT     822    822       V -> M (in LQT2; dbSNP:rs121912506).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8914737}.
FT                                /FTId=VAR_008584.
FT   VARIANT     823    823       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473538).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_014386.
FT   VARIANT     837    837       D -> G (in LQT2; dbSNP:rs199473004).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068280.
FT   VARIANT     837    837       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473005).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074883.
FT   VARIANT     846    846       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473006).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074884.
FT   VARIANT     861    861       N -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473007).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074885.
FT   VARIANT     861    861       N -> I (in LQT2; dbSNP:rs121912513).
FT                                {ECO:0000269|PubMed:15051636}.
FT                                /FTId=VAR_014387.
FT   VARIANT     885    885       R -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs143512106).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074886.
FT   VARIANT     887    887       R -> H (in LQT2; dbSNP:rs199473432).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068281.
FT   VARIANT     894    894       R -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473433).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074887.
FT   VARIANT     894    894       R -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473668).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074888.
FT   VARIANT     897    897       K -> T (in dbSNP:rs1805123).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:11997281}.
FT                                /FTId=VAR_014388.
FT   VARIANT     903    903       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473669).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074889.
FT   VARIANT     906    906       S -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473435).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074890.
FT   VARIANT     913    913       A -> V (in LQT2; dbSNP:rs77331749).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068282.
FT   VARIANT     917    917       P -> L (in LQT2; dbSNP:rs76420733).
FT                                /FTId=VAR_014389.
FT   VARIANT     920    920       R -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473670).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074891.
FT   VARIANT     920    920       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473438).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074892.
FT   VARIANT     922    922       R -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473439).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074893.
FT   VARIANT     922    922       R -> W (in LQT2; dbSNP:rs199473440).
FT                                /FTId=VAR_014390.
FT   VARIANT     924    924       G -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473009).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074894.
FT   VARIANT     924    924       G -> E (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473009).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074895.
FT   VARIANT     925    925       G -> R (in LQT2; dbSNP:rs199473010).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068283.
FT   VARIANT     937    937       S -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473540).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074896.
FT   VARIANT     948    948       R -> C (in LQT2; dbSNP:rs121912514).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036677.
FT   VARIANT     968    968       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473017).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074897.
FT   VARIANT     983    983       T -> I (in LQT2; dbSNP:rs149955375).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068284.
FT   VARIANT     996    996       N -> I (in LQT2; dbSNP:rs199473018).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068285.
FT   VARIANT    1005   1005       R -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473019).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074898.
FT   VARIANT    1007   1007       R -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473542).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074899.
FT   VARIANT    1016   1016       P -> L (in dbSNP:rs41313074).
FT                                /FTId=VAR_036679.
FT   VARIANT    1016   1016       P -> S (in dbSNP:rs41307280).
FT                                /FTId=VAR_036678.
FT   VARIANT    1020   1020       P -> S (in dbSNP:rs41307274).
FT                                /FTId=VAR_036680.
FT   VARIANT    1026   1026       P -> L (in dbSNP:rs41307271).
FT                                /FTId=VAR_036681.
FT   VARIANT    1033   1033       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473021).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074900.
FT   VARIANT    1036   1036       G -> D (in LQT2; dbSNP:rs199473022).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068286.
FT   VARIANT    1038   1038       V -> M (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473544).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074901.
FT   VARIANT    1049   1049       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473026).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074902.
FT   VARIANT    1055   1055       R -> Q (in dbSNP:rs41307270).
FT                                /FTId=VAR_036682.
FT   VARIANT    1066   1066       L -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473027).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074903.
FT   VARIANT    1078   1078       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473029).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074904.
FT   VARIANT    1093   1093       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473545).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074905.
FT   VARIANT    1115   1115       M -> V (in LQT2; dbSNP:rs199473546).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074906.
FT   VARIANT    1153   1153       H -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473035).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074907.
FT   MUTAGEN      29     29       F->A: Slows down deactivation.
FT                                {ECO:0000269|PubMed:9845367}.
FT   MUTAGEN      43     43       Y->A: Slows down deactivation.
FT                                {ECO:0000269|PubMed:9845367}.
FT   MUTAGEN     283    283       S->A: Abolishes phosphorylation; when
FT                                associated with A-890; A-895 and A-1137.
FT                                {ECO:0000269|PubMed:10837251}.
FT   MUTAGEN     598    598       N->Q: No effect on cell surface
FT                                expression, but changes inactivation
FT                                kinetics; when associated with A-631.
FT                                {ECO:0000269|PubMed:12063277}.
FT   MUTAGEN     629    629       N->Q: Abolishes cell surface expression;
FT                                has no effect on N-glycosylation.
FT                                {ECO:0000269|PubMed:12063277}.
FT   MUTAGEN     631    631       S->A: No effect on cell surface
FT                                expression, but changes inactivation
FT                                kinetics; when associated with Q-598.
FT                                {ECO:0000269|PubMed:12063277}.
FT   MUTAGEN     890    890       S->A: Abolishes phosphorylation; when
FT                                associated with A-283; A-895 and A-1137.
FT                                {ECO:0000269|PubMed:10837251}.
FT   MUTAGEN     895    895       T->A: Abolishes phosphorylation; when
FT                                associated with A-283; A-890 and A-1137.
FT                                {ECO:0000269|PubMed:10837251}.
FT   MUTAGEN    1137   1137       S->A: Abolishes phosphorylation; when
FT                                associated with A-283; A-890 and A-895.
FT                                {ECO:0000269|PubMed:10837251}.
FT   HELIX        15     19       {ECO:0000244|PDB:4HP9}.
FT   TURN         23     26       {ECO:0000244|PDB:2L0W}.
FT   STRAND       29     33       {ECO:0000244|PDB:4HQA}.
FT   STRAND       36     38       {ECO:0000244|PDB:1BYW}.
FT   STRAND       40     44       {ECO:0000244|PDB:4HQA}.
FT   HELIX        46     52       {ECO:0000244|PDB:4HQA}.
FT   HELIX        56     59       {ECO:0000244|PDB:4HQA}.
FT   HELIX        67     69       {ECO:0000244|PDB:4HQA}.
FT   HELIX        76     87       {ECO:0000244|PDB:4HQA}.
FT   STRAND       88     90       {ECO:0000244|PDB:4HP9}.
FT   STRAND       92     99       {ECO:0000244|PDB:4HQA}.
FT   STRAND      105    116       {ECO:0000244|PDB:4HQA}.
FT   STRAND      118    120       {ECO:0000244|PDB:4HQA}.
FT   STRAND      122    134       {ECO:0000244|PDB:4HQA}.
FT   TURN        538    540       {ECO:0000244|PDB:2LE7}.
FT   HELIX       542    549       {ECO:0000244|PDB:2LE7}.
FT   STRAND      577    580       {ECO:0000244|PDB:1UJL}.
FT   HELIX       586    593       {ECO:0000244|PDB:1UJL}.
FT   HELIX       605    610       {ECO:0000244|PDB:1UJL}.
FT   HELIX       735    739       {ECO:0000244|PDB:2N7G}.
FT   STRAND      743    745       {ECO:0000244|PDB:2N7G}.
FT   TURN        748    750       {ECO:0000244|PDB:2N7G}.
FT   HELIX       751    757       {ECO:0000244|PDB:2N7G}.
FT   STRAND      759    763       {ECO:0000244|PDB:2N7G}.
FT   STRAND      768    770       {ECO:0000244|PDB:2N7G}.
FT   STRAND      778    785       {ECO:0000244|PDB:2N7G}.
FT   STRAND      787    795       {ECO:0000244|PDB:2N7G}.
FT   TURN        809    811       {ECO:0000244|PDB:2N7G}.
FT   STRAND      819    824       {ECO:0000244|PDB:2N7G}.
FT   STRAND      826    834       {ECO:0000244|PDB:2N7G}.
FT   HELIX       835    844       {ECO:0000244|PDB:2N7G}.
FT   HELIX       846    855       {ECO:0000244|PDB:2N7G}.
FT   STRAND      859    861       {ECO:0000244|PDB:2N7G}.
SQ   SEQUENCE   1159 AA;  126655 MW;  D03BD4F657641FBA CRC64;
     MPVRRGHVAP QNTFLDTIIR KFEGQSRKFI IANARVENCA VIYCNDGFCE LCGYSRAEVM
     QRPCTCDFLH GPRTQRRAAA QIAQALLGAE ERKVEIAFYR KDGSCFLCLV DVVPVKNEDG
     AVIMFILNFE VVMEKDMVGS PAHDTNHRGP PTSWLAPGRA KTFRLKLPAL LALTARESSV
     RSGGAGGAGA PGAVVVDVDL TPAAPSSESL ALDEVTAMDN HVAGLGPAEE RRALVGPGSP
     PRSAPGQLPS PRAHSLNPDA SGSSCSLART RSRESCASVR RASSADDIEA MRAGVLPPPP
     RHASTGAMHP LRSGLLNSTS DSDLVRYRTI SKIPQITLNF VDLKGDPFLA SPTSDREIIA
     PKIKERTHNV TEKVTQVLSL GADVLPEYKL QAPRIHRWTI LHYSPFKAVW DWLILLLVIY
     TAVFTPYSAA FLLKETEEGP PATECGYACQ PLAVVDLIVD IMFIVDILIN FRTTYVNANE
     EVVSHPGRIA VHYFKGWFLI DMVAAIPFDL LIFGSGSEEL IGLLKTARLL RLVRVARKLD
     RYSEYGAAVL FLLMCTFALI AHWLACIWYA IGNMEQPHMD SRIGWLHNLG DQIGKPYNSS
     GLGGPSIKDK YVTALYFTFS SLTSVGFGNV SPNTNSEKIF SICVMLIGSL MYASIFGNVS
     AIIQRLYSGT ARYHTQMLRV REFIRFHQIP NPLRQRLEEY FQHAWSYTNG IDMNAVLKGF
     PECLQADICL HLNRSLLQHC KPFRGATKGC LRALAMKFKT THAPPGDTLV HAGDLLTALY
     FISRGSIEIL RGDVVVAILG KNDIFGEPLN LYARPGKSNG DVRALTYCDL HKIHRDDLLE
     VLDMYPEFSD HFWSSLEITF NLRDTNMIPG SPGSTELEGG FSRQRKRKLS FRRRTDKDTE
     QPGEVSALGP GRAGAGPSSR GRPGGPWGES PSSGPSSPES SEDEGPGRSS SPLRLVPFSS
     PRPPGEPPGG EPLMEDCEKS SDTCNPLSGA FSGVSNIFSF WGDSRGRQYQ ELPRCPAPTP
     SLLNIPLSSP GRRPRGDVES RLDALQRQLN RLETRLSADM ATVLQLLQRQ MTLVPPAYSA
     VTTPGPGPTS TSPLLPVSPL PTLTLDSLSQ VSQFMACEEL PPGAPELPQE GPTRRLSLPG
     QLGALTSQPL HRHGSDPGS
//
ID   KCNH6_HUMAN             Reviewed;         994 AA.
AC   Q9H252; Q9BRD7;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-FEB-2017, entry version 152.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 6;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 2;
DE            Short=ERG-2;
DE            Short=Eag-related protein 2;
DE            Short=Ether-a-go-go-related protein 2;
DE            Short=hERG-2;
DE            Short=hERG2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.2;
GN   Name=KCNH6; Synonyms=ERG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Titus S.A., Ganetzky B.S.;
RT   "Human Eag-related gene member 2 (Herg2) potassium channel.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   MET-925.
RC   TISSUE=Amygdala, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12634931; DOI=10.1007/s00424-002-0980-0;
RA   Bauer C.K., Wulfsen I., Schaefer R., Glassmeier G., Wimmers S.,
RA   Flitsch J., Luedecke D.K., Schwarz J.R.;
RT   "HERG K(+) currents in human prolactin-secreting adenoma cells.";
RL   Pflugers Arch. 445:589-600(2003).
RN   [5]
RP   GLYCOSYLATION AT ASN-449.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits a slowly activating, rectifying current (By
CC       similarity). Channel properties may be modulated by cAMP and
CC       subunit assembly. {ECO:0000250}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimers with
CC       KCNH2/ERG1 and KCNH7/ERG3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q9H252-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H252-2; Sequence=VSP_000977, VSP_000978;
CC       Name=3;
CC         IsoId=Q9H252-3; Sequence=VSP_000979, VSP_000980;
CC   -!- TISSUE SPECIFICITY: Expressed in prolactin-secreting adenomas.
CC       {ECO:0000269|PubMed:12634931}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv11.2/KCNH6 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF311913; AAG40871.1; -; mRNA.
DR   EMBL; AK090969; BAC03559.1; -; mRNA.
DR   EMBL; AK091877; BAC03764.1; -; mRNA.
DR   EMBL; BC006334; AAH06334.1; -; mRNA.
DR   CCDS; CCDS11638.1; -. [Q9H252-1]
DR   CCDS; CCDS11639.1; -. [Q9H252-2]
DR   RefSeq; NP_001265848.1; NM_001278919.1.
DR   RefSeq; NP_001265849.1; NM_001278920.1.
DR   RefSeq; NP_110406.1; NM_030779.3. [Q9H252-1]
DR   RefSeq; NP_775115.1; NM_173092.2. [Q9H252-2]
DR   RefSeq; XP_011523612.1; XM_011525310.2. [Q9H252-2]
DR   RefSeq; XP_016880664.1; XM_017025175.1. [Q9H252-1]
DR   UniGene; Hs.591177; -.
DR   ProteinModelPortal; Q9H252; -.
DR   SMR; Q9H252; -.
DR   STRING; 9606.ENSP00000463533; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB01162; Terazosin.
DR   GuidetoPHARMACOLOGY; 573; -.
DR   iPTMnet; Q9H252; -.
DR   PhosphoSitePlus; Q9H252; -.
DR   BioMuta; KCNH6; -.
DR   DMDM; 26006810; -.
DR   PaxDb; Q9H252; -.
DR   PeptideAtlas; Q9H252; -.
DR   PRIDE; Q9H252; -.
DR   DNASU; 81033; -.
DR   Ensembl; ENST00000456941; ENSP00000396900; ENSG00000173826. [Q9H252-2]
DR   Ensembl; ENST00000580652; ENSP00000464672; ENSG00000173826. [Q9H252-3]
DR   Ensembl; ENST00000581784; ENSP00000463830; ENSG00000173826. [Q9H252-2]
DR   Ensembl; ENST00000583023; ENSP00000463533; ENSG00000173826. [Q9H252-1]
DR   GeneID; 81033; -.
DR   KEGG; hsa:81033; -.
DR   UCSC; uc002jax.2; human. [Q9H252-1]
DR   CTD; 81033; -.
DR   DisGeNET; 81033; -.
DR   GeneCards; KCNH6; -.
DR   HGNC; HGNC:18862; KCNH6.
DR   MIM; 608168; gene.
DR   neXtProt; NX_Q9H252; -.
DR   OpenTargets; ENSG00000173826; -.
DR   PharmGKB; PA38722; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230793; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q9H252; -.
DR   KO; K04909; -.
DR   OMA; VSHPRRI; -.
DR   OrthoDB; EOG093705SE; -.
DR   PhylomeDB; Q9H252; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH6; -.
DR   GenomeRNAi; 81033; -.
DR   PRO; PR:Q9H252; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173826; -.
DR   CleanEx; HS_KCNH6; -.
DR   ExpressionAtlas; Q9H252; baseline and differential.
DR   Genevisible; Q9H252; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR030172; KCNH6.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF579; PTHR10217:SF579; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    994       Potassium voltage-gated channel subfamily
FT                                H member 6.
FT                                /FTId=PRO_0000054013.
FT   TOPO_DOM      1    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    283    298       Extracellular. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    320    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    362    370       Extracellular. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    392    398       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    399    419       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    420    463       Extracellular. {ECO:0000255}.
FT   INTRAMEM    464    484       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    485    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    512    994       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS.
FT   DOMAIN       92    144       PAC.
FT   NP_BIND     594    711       cNMP.
FT   MOTIF       476    481       Selectivity filter. {ECO:0000250}.
FT   CARBOHYD    449    449       N-linked (GlcNAc...) (complex).
FT                                {ECO:0000269|PubMed:19139490}.
FT   VAR_SEQ     419    472       WYAIGNVERPYLEHKIGWLDSLGVQLGKRYNGSDPASGPSV
FT                                QDKYVTALYFTFS -> C (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000977.
FT   VAR_SEQ     501    502       SL -> CE (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000979.
FT   VAR_SEQ     503    994       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000980.
FT   VAR_SEQ     745    780       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000978.
FT   VARIANT     165    165       G -> R (in dbSNP:rs35399062).
FT                                /FTId=VAR_053857.
FT   VARIANT     925    925       T -> M (in dbSNP:rs35819807).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_053858.
FT   CONFLICT    963    963       F -> L (in Ref. 2; BAC03764).
FT                                {ECO:0000305}.
SQ   SEQUENCE   994 AA;  109925 MW;  BE9ECB349A798576 CRC64;
     MPVRRGHVAP QNTYLDTIIR KFEGQSRKFL IANAQMENCA IIYCNDGFCE LFGYSRVEVM
     QQPCTCDFLT GPNTPSSAVS RLAQALLGAE ECKVDILYYR KDASSFRCLV DVVPVKNEDG
     AVIMFILNFE DLAQLLAKCS SRSLSQRLLS QSFLGSEGSH GRPGGPGPGT GRGKYRTISQ
     IPQFTLNFVE FNLEKHRSSS TTEIEIIAPH KVVERTQNVT EKVTQVLSLG ADVLPEYKLQ
     APRIHRWTIL HYSPFKAVWD WLILLLVIYT AVFTPYSAAF LLSDQDESRR GACSYTCSPL
     TVVDLIVDIM FVVDIVINFR TTYVNTNDEV VSHPRRIAVH YFKGWFLIDM VAAIPFDLLI
     FRTGSDETTT LIGLLKTARL LRLVRVARKL DRYSEYGAAV LFLLMCTFAL IAHWLACIWY
     AIGNVERPYL EHKIGWLDSL GVQLGKRYNG SDPASGPSVQ DKYVTALYFT FSSLTSVGFG
     NVSPNTNSEK VFSICVMLIG SLMYASIFGN VSAIIQRLYS GTARYHTQML RVKEFIRFHQ
     IPNPLRQRLE EYFQHAWSYT NGIDMNAVLK GFPECLQADI CLHLHRALLQ HCPAFSGAGK
     GCLRALAVKF KTTHAPPGDT LVHLGDVLST LYFISRGSIE ILRDDVVVAI LGKNDIFGEP
     VSLHAQPGKS SADVRALTYC DLHKIQRADL LEVLDMYPAF AESFWSKLEV TFNLRDAAGG
     LHSSPRQAPG SQDHQGFFLS DNQSGSPHEL GPQFPSKGYS LLGPGSQNSM GAGPCAPGHP
     DAAPPLSISD ASGLWPELLQ EMPPRHSPQS PQEDPDCWPL KLGSRLEQLQ AQMNRLESRV
     SSDLSRILQL LQKPMPQGHA SYILEAPASN DLALVPIASE TTSPGPRLPQ GFLPPAQTPS
     YGDLDDCSPK HRNSSPRMPH LAVATDKTLA PSSEQEQPEG LWPPLASPLH PLEVQGLICG
     PCFSSLPEHL GSVPKQLDFQ RHGSDPGFAG SWGH
//
ID   KCNH7_HUMAN             Reviewed;        1196 AA.
AC   Q9NS40; Q53QU4; Q53TB7; Q53TP9; Q8IV15;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   15-FEB-2017, entry version 151.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 7;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 3;
DE            Short=ERG-3;
DE            Short=Eag-related protein 3;
DE            Short=Ether-a-go-go-related protein 3;
DE            Short=hERG-3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.3;
GN   Name=KCNH7; Synonyms=ERG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Ganetzky B., Titus S.A.;
RT   "Polynucleotides encoding herg-3 potassium channel.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12634931; DOI=10.1007/s00424-002-0980-0;
RA   Bauer C.K., Wulfsen I., Schaefer R., Glassmeier G., Wimmers S.,
RA   Flitsch J., Luedecke D.K., Schwarz J.R.;
RT   "HERG K(+) currents in human prolactin-secreting adenoma cells.";
RL   Pflugers Arch. 445:589-600(2003).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Channel properties may be modulated by cAMP and subunit
CC       assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH2/ERG1 and KCNH6/ERG2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NS40-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NS40-2; Sequence=VSP_037116, VSP_037117, VSP_037118;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in prolactin-secreting adenomas.
CC       {ECO:0000269|PubMed:12634931}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv11.3/KCNH7 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD01946.1; Type=Frameshift; Positions=792, 795; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF032897; AAD01946.1; ALT_FRAME; mRNA.
DR   EMBL; AC010876; AAX93139.1; -; Genomic_DNA.
DR   EMBL; AC007740; AAX93153.1; -; Genomic_DNA.
DR   EMBL; AC104822; AAY24106.1; -; Genomic_DNA.
DR   EMBL; BC035815; AAH35815.1; -; mRNA.
DR   CCDS; CCDS2219.1; -. [Q9NS40-1]
DR   CCDS; CCDS2220.1; -. [Q9NS40-2]
DR   RefSeq; NP_150375.2; NM_033272.3. [Q9NS40-1]
DR   RefSeq; NP_775185.1; NM_173162.2. [Q9NS40-2]
DR   UniGene; Hs.657413; -.
DR   ProteinModelPortal; Q9NS40; -.
DR   SMR; Q9NS40; -.
DR   BioGrid; 124667; 1.
DR   IntAct; Q9NS40; 1.
DR   STRING; 9606.ENSP00000331727; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB01162; Terazosin.
DR   iPTMnet; Q9NS40; -.
DR   PhosphoSitePlus; Q9NS40; -.
DR   BioMuta; KCNH7; -.
DR   DMDM; 229462892; -.
DR   EPD; Q9NS40; -.
DR   PaxDb; Q9NS40; -.
DR   PeptideAtlas; Q9NS40; -.
DR   PRIDE; Q9NS40; -.
DR   Ensembl; ENST00000328032; ENSP00000333781; ENSG00000184611. [Q9NS40-2]
DR   Ensembl; ENST00000332142; ENSP00000331727; ENSG00000184611. [Q9NS40-1]
DR   GeneID; 90134; -.
DR   KEGG; hsa:90134; -.
DR   UCSC; uc002uch.3; human. [Q9NS40-1]
DR   CTD; 90134; -.
DR   DisGeNET; 90134; -.
DR   GeneCards; KCNH7; -.
DR   HGNC; HGNC:18863; KCNH7.
DR   HPA; HPA018039; -.
DR   MalaCards; KCNH7; -.
DR   MIM; 608169; gene.
DR   neXtProt; NX_Q9NS40; -.
DR   OpenTargets; ENSG00000184611; -.
DR   PharmGKB; PA38723; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230793; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q9NS40; -.
DR   KO; K04910; -.
DR   OMA; QMTTDIQ; -.
DR   OrthoDB; EOG093705SE; -.
DR   PhylomeDB; Q9NS40; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNH7; human.
DR   GeneWiki; KCNH7; -.
DR   GenomeRNAi; 90134; -.
DR   PRO; PR:Q9NS40; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000184611; -.
DR   CleanEx; HS_KCNH7; -.
DR   ExpressionAtlas; Q9NS40; baseline and differential.
DR   Genevisible; Q9NS40; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1196       Potassium voltage-gated channel subfamily
FT                                H member 7.
FT                                /FTId=PRO_0000054015.
FT   TOPO_DOM      1    412       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    413    433       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    434    449       Extracellular. {ECO:0000255}.
FT   TRANSMEM    450    470       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    471    494       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    495    515       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    516    521       Extracellular. {ECO:0000255}.
FT   TRANSMEM    522    542       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    543    549       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    550    570       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    571    614       Extracellular. {ECO:0000255}.
FT   INTRAMEM    615    635       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    636    641       Extracellular. {ECO:0000255}.
FT   TRANSMEM    642    662       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    663   1196       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS.
FT   DOMAIN       92    144       PAC.
FT   NP_BIND     745    862       cNMP.
FT   MOTIF       627    632       Selectivity filter. {ECO:0000250}.
FT   MOD_RES     174    174       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ER47}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ER47}.
FT   MOD_RES     274    274       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     319    319       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54852}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08962}.
FT   MOD_RES     877    877       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q12809}.
FT   MOD_RES     896    896       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54852}.
FT   MOD_RES     899    899       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54852}.
FT   MOD_RES    1170   1170       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q12809}.
FT   CARBOHYD    600    600       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     298    304       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037116.
FT   VAR_SEQ     720    739       LKGFPECLQADICLHLNQTL -> CMSVFQNESAAGIIVIA
FT                                KME (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037117.
FT   VAR_SEQ     740   1196       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037118.
FT   VARIANT     958    958       G -> A (in dbSNP:rs6757850).
FT                                /FTId=VAR_057767.
FT   CONFLICT    555    555       L -> S (in Ref. 1; AAD01946).
FT                                {ECO:0000305}.
FT   CONFLICT    562    562       I -> N (in Ref. 1; AAD01946).
FT                                {ECO:0000305}.
FT   CONFLICT    767    768       PP -> LQ (in Ref. 1; AAD01946).
FT                                {ECO:0000305}.
FT   CONFLICT    797    797       I -> M (in Ref. 1; AAD01946).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1196 AA;  135000 MW;  A22D046D02C2A759 CRC64;
     MPVRRGHVAP QNTFLGTIIR KFEGQNKKFI IANARVQNCA IIYCNDGFCE MTGFSRPDVM
     QKPCTCDFLH GPETKRHDIA QIAQALLGSE ERKVEVTYYH KNGSTFICNT HIIPVKNQEG
     VAMMFIINFE YVTDNENAAT PERVNPILPI KTVNRKFFGF KFPGLRVLTY RKQSLPQEDP
     DVVVIDSSKH SDDSVAMKHF KSPTKESCSP SEADDTKALI QPSKCSPLVN ISGPLDHSSP
     KRQWDRLYPD MLQSSSQLSH SRSRESLCSI RRASSVHDIE GFGVHPKNIF RDRHASEDNG
     RNVKGPFNHI KSSLLGSTSD SNLNKYSTIN KIPQLTLNFS EVKTEKKNSS PPSSDKTIIA
     PKVKDRTHNV TEKVTQVLSL GADVLPEYKL QTPRINKFTI LHYSPFKAVW DWLILLLVIY
     TAIFTPYSAA FLLNDREEQK RRECGYSCSP LNVVDLIVDI MFIIDILINF RTTYVNQNEE
     VVSDPAKIAI HYFKGWFLID MVAAIPFDLL IFGSGSDETT TLIGLLKTAR LLRLVRVARK
     LDRYSEYGAA VLMLLMCIFA LIAHWLACIW YAIGNVERPY LTDKIGWLDS LGQQIGKRYN
     DSDSSSGPSI KDKYVTALYF TFSSLTSVGF GNVSPNTNSE KIFSICVMLI GSLMYASIFG
     NVSAIIQRLY SGTARYHMQM LRVKEFIRFH QIPNPLRQRL EEYFQHAWTY TNGIDMNMVL
     KGFPECLQAD ICLHLNQTLL QNCKAFRGAS KGCLRALAMK FKTTHAPPGD TLVHCGDVLT
     ALYFLSRGSI EILKDDIVVA ILGKNDIFGE MVHLYAKPGK SNADVRALTY CDLHKIQRED
     LLEVLDMYPE FSDHFLTNLE LTFNLRHESA KADLLRSQSM NDSEGDNCKL RRRKLSFESE
     GEKENSTNDP EDSADTIRHY QSSKRHFEEK KSRSSSFISS IDDEQKPLFS GIVDSSPGIG
     KASGLDFEET VPTSGRMHID KRSHSCKDIT DMRSWERENA HPQPEDSSPS ALQRAAWGIS
     ETESDLTYGE VEQRLDLLQE QLNRLESQMT TDIQTILQLL QKQTTVVPPA YSMVTAGSEY
     QRPIIQLMRT SQPEASIKTD RSFSPSSQCP EFLDLEKSKL KSKESLSSGV HLNTASEDNL
     TSLLKQDSDL SLELHLRQRK TYVHPIRHPS LPDSSLSTVG IVGLHRHVSD PGLPGK
//
ID   KCNH8_HUMAN             Reviewed;        1107 AA.
AC   Q96L42; B7Z2I7; Q59GQ6;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   15-FEB-2017, entry version 145.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 8;
DE   AltName: Full=ELK1;
DE            Short=hElk1;
DE   AltName: Full=Ether-a-go-go-like potassium channel 3;
DE            Short=ELK channel 3;
DE            Short=ELK3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv12.1;
GN   Name=KCNH8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-893.
RC   TISSUE=Brain;
RX   PubMed=11897058; DOI=10.1089/108705702753520369;
RA   Baxter D.F., Kirk M., Garcia A.F., Raimondi A., Holmqvist M.H.,
RA   Flint K.K., Bojanic D., DiStefano P.S., Curtis R., Xie Y.;
RT   "A novel membrane potential-sensitive fluorescent dye improves cell-
RT   based assays for ion channels.";
RL   J. Biomol. Screen. 7:79-85(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 525-1107 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=12890647; DOI=10.1152/ajpcell.00179.2003;
RA   Zou A., Lin Z., Humble M., Creech C.D., Wagoner P.K., Krafte D.,
RA   Jegla T.J., Wickenden A.D.;
RT   "Distribution and functional properties of human KCNH8 (Elk1)
RT   potassium channels.";
RL   Am. J. Physiol. 285:C1356-C1366(2003).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits a slowly activating, outward rectifying current.
CC       Channel properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96L42-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96L42-2; Sequence=VSP_057036, VSP_057037, VSP_057038,
CC                                  VSP_057039;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Primarily expressed in the nervous system.
CC       {ECO:0000269|PubMed:12890647}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv12.1/KCNH8 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY053503; AAL15429.1; -; mRNA.
DR   EMBL; AK294759; BAH11873.1; -; mRNA.
DR   EMBL; AC015542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC061958; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099538; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116098; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB209053; BAD92290.1; -; mRNA.
DR   CCDS; CCDS2632.1; -. [Q96L42-1]
DR   RefSeq; NP_653234.2; NM_144633.2. [Q96L42-1]
DR   UniGene; Hs.475656; -.
DR   ProteinModelPortal; Q96L42; -.
DR   SMR; Q96L42; -.
DR   STRING; 9606.ENSP00000328813; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 575; -.
DR   iPTMnet; Q96L42; -.
DR   PhosphoSitePlus; Q96L42; -.
DR   BioMuta; KCNH8; -.
DR   DMDM; 229462927; -.
DR   EPD; Q96L42; -.
DR   PaxDb; Q96L42; -.
DR   PeptideAtlas; Q96L42; -.
DR   PRIDE; Q96L42; -.
DR   DNASU; 131096; -.
DR   Ensembl; ENST00000328405; ENSP00000328813; ENSG00000183960. [Q96L42-1]
DR   GeneID; 131096; -.
DR   KEGG; hsa:131096; -.
DR   UCSC; uc003cbk.2; human. [Q96L42-1]
DR   CTD; 131096; -.
DR   DisGeNET; 131096; -.
DR   GeneCards; KCNH8; -.
DR   H-InvDB; HIX0030767; -.
DR   HGNC; HGNC:18864; KCNH8.
DR   MIM; 608260; gene.
DR   neXtProt; NX_Q96L42; -.
DR   OpenTargets; ENSG00000183960; -.
DR   PharmGKB; PA38724; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q96L42; -.
DR   KO; K04911; -.
DR   OMA; NGSSFWC; -.
DR   OrthoDB; EOG090B01MM; -.
DR   PhylomeDB; Q96L42; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNH8; human.
DR   GeneWiki; KCNH8; -.
DR   GenomeRNAi; 131096; -.
DR   PRO; PR:Q96L42; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000183960; -.
DR   CleanEx; HS_KCNH8; -.
DR   ExpressionAtlas; Q96L42; baseline and differential.
DR   Genevisible; Q96L42; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003950; K_chnl_volt-dep_ELK.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01465; ELKCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1107       Potassium voltage-gated channel subfamily
FT                                H member 8.
FT                                /FTId=PRO_0000054018.
FT   TOPO_DOM      1    225       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    226    246       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    247    255       Extracellular. {ECO:0000255}.
FT   TRANSMEM    256    276       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    277    298       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    320    327       Extracellular. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    349    357       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    358    378       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    379    419       Extracellular. {ECO:0000255}.
FT   INTRAMEM    420    440       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    441    448       Extracellular. {ECO:0000255}.
FT   TRANSMEM    449    469       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    470   1107       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       18     90       PAS.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     551    668       cNMP.
FT   MOTIF       434    439       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS    711    723       Poly-Glu.
FT   COMPBIAS    951   1064       Ser-rich.
FT   CARBOHYD    320    320       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ       1    359       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057036.
FT   VAR_SEQ     459    459       A -> VSQFQVCPRPSWIICWFRNHFGFILLMTT (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057037.
FT   VAR_SEQ     515    516       WS -> CF (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057038.
FT   VAR_SEQ     517   1107       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057039.
FT   VARIANT     893    893       Q -> R (in dbSNP:rs33915638).
FT                                {ECO:0000269|PubMed:11897058}.
FT                                /FTId=VAR_055098.
FT   VARIANT     984    984       E -> Q (in dbSNP:rs35160416).
FT                                /FTId=VAR_055099.
FT   CONFLICT    525    525       E -> Q (in Ref. 4; BAD92290).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1107 AA;  123804 MW;  F0E5DEC9A7877869 CRC64;
     MPVMKGLLAP QNTFLDTIAT RFDGTHSNFI LANAQVAKGF PIVYCSDGFC ELAGFARTEV
     MQKSCSCKFL FGVETNEQLM LQIEKSLEEK TEFKGEIMFY KKNGSPFWCL LDIVPIKNEK
     GDVVLFLASF KDITDTKVKI TPEDKKEDKV KGRSRAGTHF DSARRRSRAV LYHISGHLQR
     REKNKLKINN NVFVDKPAFP EYKVSDAKKS KFILLHFSTF KAGWDWLILL ATFYVAVTVP
     YNVCFIGNDD LSTTRSTTVS DIAVEILFII DIILNFRTTY VSKSGQVIFE ARSICIHYVT
     TWFIIDLIAA LPFDLLYAFN VTVVSLVHLL KTVRLLRLLR LLQKLDRYSQ HSTIVLTLLM
     SMFALLAHWM ACIWYVIGKM EREDNSLLKW EVGWLHELGK RLESPYYGNN TLGGPSIRSA
     YIAALYFTLS SLTSVGFGNV SANTDAEKIF SICTMLIGAL MHALVFGNVT AIIQRMYSRW
     SLYHTRTKDL KDFIRVHHLP QQLKQRMLEY FQTTWSVNNG IDSNELLKDF PDELRSDITM
     HLNKEILQLS LFECASRGCL RSLSLHIKTS FCAPGEYLLR QGDALQAIYF VCSGSMEVLK
     DSMVLAILGK GDLIGANLSI KDQVIKTNAD VKALTYCDLQ CIILKGLFEV LDLYPEYAHK
     FVEDIQHDLT YNLREGHESD VISRLSNKSM VSQSEPKGNG NINKRLPSIV EDEEEEEEGE
     EEEAVSLSPI CTRGSSSRNK KVGSNKAYLG LSLKQLASGT VPFHSPIRVS RSNSPKTKQE
     IDPPNHNKRK EKNLKLQLST LNNAGPPDLS PRIVDGIEDG NSSEESQTFD FGSERIRSEP
     RISPPLGDPE IGAAVLFIKA EETKQQINKL NSEVTTLTQE VSQLGKDMRN VIQLLENVLS
     PQQPSRFCSL HSTSVCPSRE SLQTRTSWSA HQPCLHLQTG GAAYTQAQLC SSNITSDIWS
     VDPSSVGSSP QRTGAHEQNP ADSELYHSPS LDYSPSHYQV VQEGHLQFLR CISPHSDSTL
     TPLQSISATL SSSVCSSSET SLHLVLPSRS EEGSFSQGTV SSFSLENLPG SWNQEGMASA
     STKPLENLPL EVVTSTAEVK DNKAINV
//
ID   KCNH3_HUMAN             Reviewed;        1083 AA.
AC   Q9ULD8; Q9UQ06;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2002, sequence version 2.
DT   15-FEB-2017, entry version 151.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 3;
DE   AltName: Full=Brain-specific eag-like channel 1;
DE            Short=BEC1;
DE   AltName: Full=Ether-a-go-go-like potassium channel 2;
DE            Short=ELK channel 2;
DE            Short=ELK2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv12.2;
GN   Name=KCNH3; Synonyms=KIAA1282;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10455180; DOI=10.1074/jbc.274.35.25018;
RA   Miyake A., Mochizuki S., Yokoi H., Kohda M., Furuichi K.;
RT   "New ether-a-go-go K+ channel family members localized in human
RT   telencephalon.";
RL   J. Biol. Chem. 274:25018-25025(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits an outward current with fast inactivation.
CC       Channel properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits.
CC   -!- INTERACTION:
CC       P04578:env (xeno); NbExp=3; IntAct=EBI-8079227, EBI-6163496;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected only in brain, in particular in the
CC       telencephalon. Detected in the cerebral cortex, occipital pole,
CC       frontal and temporal lobe, putamen, amygdala, hippocampus and
CC       caudate nucleus.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv12.2/KCNH3 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86596.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB022696; BAA83590.1; -; mRNA.
DR   EMBL; AB033108; BAA86596.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8786.1; -.
DR   RefSeq; NP_001300959.1; NM_001314030.1.
DR   RefSeq; NP_036416.1; NM_012284.2.
DR   UniGene; Hs.64064; -.
DR   ProteinModelPortal; Q9ULD8; -.
DR   SMR; Q9ULD8; -.
DR   IntAct; Q9ULD8; 1.
DR   MINT; MINT-7968644; -.
DR   STRING; 9606.ENSP00000257981; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 576; -.
DR   TCDB; 1.A.1.20.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9ULD8; -.
DR   PhosphoSitePlus; Q9ULD8; -.
DR   BioMuta; KCNH3; -.
DR   DMDM; 26006814; -.
DR   PaxDb; Q9ULD8; -.
DR   PRIDE; Q9ULD8; -.
DR   Ensembl; ENST00000257981; ENSP00000257981; ENSG00000135519.
DR   GeneID; 23416; -.
DR   KEGG; hsa:23416; -.
DR   UCSC; uc001ruh.2; human.
DR   CTD; 23416; -.
DR   DisGeNET; 23416; -.
DR   GeneCards; KCNH3; -.
DR   HGNC; HGNC:6252; KCNH3.
DR   HPA; HPA051088; -.
DR   MIM; 604527; gene.
DR   neXtProt; NX_Q9ULD8; -.
DR   OpenTargets; ENSG00000135519; -.
DR   PharmGKB; PA30038; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q9ULD8; -.
DR   KO; K04906; -.
DR   OMA; PLMAPWP; -.
DR   OrthoDB; EOG090B01MM; -.
DR   PhylomeDB; Q9ULD8; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH3; -.
DR   GenomeRNAi; 23416; -.
DR   PRO; PR:Q9ULD8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135519; -.
DR   CleanEx; HS_KCNH3; -.
DR   Genevisible; Q9ULD8; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003950; K_chnl_volt-dep_ELK.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01465; ELKCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1083       Potassium voltage-gated channel subfamily
FT                                H member 3.
FT                                /FTId=PRO_0000054005.
FT   TOPO_DOM      1    228       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    229    249       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    250    259       Extracellular. {ECO:0000255}.
FT   TRANSMEM    260    280       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    281    302       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    324    331       Extracellular. {ECO:0000255}.
FT   TRANSMEM    332    352       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    353    361       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    383    453       Extracellular. {ECO:0000255}.
FT   INTRAMEM    454    474       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    475    479       Extracellular. {ECO:0000255}.
FT   TRANSMEM    480    500       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    501   1083       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       18     90       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     582    697       cNMP.
FT   MOTIF       465    470       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS    951   1057       Pro-rich.
FT   CARBOHYD    421    421       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    436    436       N-linked (GlcNAc...). {ECO:0000255}.
SQ   SEQUENCE   1083 AA;  117129 MW;  EF35C8968D7418CC CRC64;
     MPAMRGLLAP QNTFLDTIAT RFDGTHSNFV LGNAQVAGLF PVVYCSDGFC DLTGFSRAEV
     MQRGCACSFL YGPDTSELVR QQIRKALDEH KEFKAELILY RKSGLPFWCL LDVIPIKNEK
     GEVALFLVSH KDISETKNRG GPDRWKETGG GRRRYGRARS KGFNANRRRS RAVLYHLSGH
     LQKQPKGKHK LNKGVFGEKP NLPEYKVAAI RKSPFILLHC GALRATWDGF ILLATLYVAV
     TVPYSVCVST AREPSAARGP PSVCDLAVEV LFILDIVLNF RTTFVSKSGQ VVFAPKSICL
     HYVTTWFLLD VIAALPFDLL HAFKVNVYFG AHLLKTVRLL RLLRLLPRLD RYSQYSAVVL
     TLLMAVFALL AHWVACVWFY IGQREIESSE SELPEIGWLQ ELARRLETPY YLVGRRPAGG
     NSSGQSDNCS SSSEANGTGL ELLGGPSLRS AYITSLYFAL SSLTSVGFGN VSANTDTEKI
     FSICTMLIGA LMHAVVFGNV TAIIQRMYAR RFLYHSRTRD LRDYIRIHRI PKPLKQRMLE
     YFQATWAVNN GIDTTELLQS LPDELRADIA MHLHKEVLQL PLFEAASRGC LRALSLALRP
     AFCTPGEYLI HQGDALQALY FVCSGSMEVL KGGTVLAILG KGDLIGCELP RREQVVKANA
     DVKGLTYCVL QCLQLAGLHD SLALYPEFAP RFSRGLRGEL SYNLGAGGGS AEVDTSSLSG
     DNTLMSTLEE KETDGEQGPT VSPAPADEPS SPLLSPGCTS SSSAAKLLSP RRTAPRPRLG
     GRGRPGRAGA LKAEAGPSAP PRALEGLRLP PMPWNVPPDL SPRVVDGIED GCGSDQPKFS
     FRVGQSGPEC SSSPSPGPES GLLTVPHGPS EARNTDTLDK LRQAVTELSE QVLQMREGLQ
     SLRQAVQLVL APHREGPCPR ASGEGPCPAS TSGLLQPLCV DTGASSYCLQ PPAGSVLSGT
     WPHPRPGPPP LMAPWPWGPP ASQSSPWPRA TAFWTSTSDS EPPASGDLCS EPSTPASPPP
     SEEGARTGPA EPVSQAEATS TGEPPPGSGG LALPWDPHSL EMVLIGCHGS GTVQWTQEEG
     TGV
//
ID   KCNH4_HUMAN             Reviewed;        1017 AA.
AC   Q9UQ05;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-FEB-2017, entry version 152.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 4;
DE   AltName: Full=Brain-specific eag-like channel 2;
DE            Short=BEC2;
DE   AltName: Full=Ether-a-go-go-like potassium channel 1;
DE            Short=ELK channel 1;
DE            Short=ELK1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv12.3;
GN   Name=KCNH4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10455180; DOI=10.1074/jbc.274.35.25018;
RA   Miyake A., Mochizuki S., Yokoi H., Kohda M., Furuichi K.;
RT   "New ether-a-go-go K+ channel family members localized in human
RT   telencephalon.";
RL   J. Biol. Chem. 274:25018-25025(1999).
RN   [2]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-797.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits an outward current, but shows no inactivation.
CC       Channel properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected only in brain, in particular in the
CC       telencephalon. Detected in putamen and caudate nucleus, and at
CC       lower levels in cerebral cortex, occipital and hippocampus.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag)
CC       (TC 1.A.1.20) subfamily. Kv12.3/KCNH4 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB022698; BAA83592.1; -; mRNA.
DR   CCDS; CCDS11420.1; -.
DR   RefSeq; NP_036417.1; NM_012285.2.
DR   RefSeq; XP_016879889.1; XM_017024400.1.
DR   UniGene; Hs.304081; -.
DR   ProteinModelPortal; Q9UQ05; -.
DR   SMR; Q9UQ05; -.
DR   STRING; 9606.ENSP00000264661; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q9UQ05; -.
DR   PhosphoSitePlus; Q9UQ05; -.
DR   BioMuta; KCNH4; -.
DR   DMDM; 26006815; -.
DR   EPD; Q9UQ05; -.
DR   PaxDb; Q9UQ05; -.
DR   PRIDE; Q9UQ05; -.
DR   DNASU; 23415; -.
DR   Ensembl; ENST00000264661; ENSP00000264661; ENSG00000089558.
DR   Ensembl; ENST00000607371; ENSP00000475564; ENSG00000089558.
DR   GeneID; 23415; -.
DR   KEGG; hsa:23415; -.
DR   UCSC; uc002hzb.3; human.
DR   CTD; 23415; -.
DR   DisGeNET; 23415; -.
DR   GeneCards; KCNH4; -.
DR   HGNC; HGNC:6253; KCNH4.
DR   MIM; 604528; gene.
DR   neXtProt; NX_Q9UQ05; -.
DR   OpenTargets; ENSG00000089558; -.
DR   PharmGKB; PA30039; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00760000118772; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q9UQ05; -.
DR   KO; K04907; -.
DR   OMA; VPKAVWD; -.
DR   OrthoDB; EOG090B01MM; -.
DR   PhylomeDB; Q9UQ05; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH4; -.
DR   GenomeRNAi; 23415; -.
DR   PRO; PR:Q9UQ05; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000089558; -.
DR   CleanEx; HS_KCNH4; -.
DR   Genevisible; Q9UQ05; HS.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003950; K_chnl_volt-dep_ELK.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01465; ELKCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1017       Potassium voltage-gated channel subfamily
FT                                H member 4.
FT                                /FTId=PRO_0000054008.
FT   TOPO_DOM      1    228       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    229    249       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    250    259       Extracellular. {ECO:0000255}.
FT   TRANSMEM    260    280       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    281    302       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    324    332       Extracellular. {ECO:0000255}.
FT   TRANSMEM    333    353       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    354    361       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    383    427       Extracellular. {ECO:0000255}.
FT   INTRAMEM    428    448       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    449    482       Extracellular. {ECO:0000255}.
FT   TRANSMEM    483    503       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    504   1017       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       14     90       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     556    671       cNMP.
FT   MOTIF       439    444       Selectivity filter. {ECO:0000250}.
FT   CARBOHYD    326    326       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    473    473       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT     797    797       G -> R (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035771.
SQ   SEQUENCE   1017 AA;  111693 MW;  4B480DFC75816A38 CRC64;
     MPVMKGLLAP QNTFLDTIAT RFDGTHSNFL LANAQGTRGF PIVYCSDGFC ELTGYGRTEV
     MQKTCSCRFL YGPETSEPAL QRLHKALEGH QEHRAEICFY RKDGSAFWCL LDMMPIKNEM
     GEVVLFLFSF KDITQSGSPG LGPQGGRGDS NHENSLGRRG ATWKFRSARR RSRTVLHRLT
     GHFGRRGQGG MKANNNVFEP KPSVPEYKVA SVGGSRCLLL HYSVSKAIWD GLILLATFYV
     AVTVPYNVCF SGDDDTPITS RHTLVSDIAV EMLFILDIIL NFRTTYVSQS GQVISAPRSI
     GLHYLATWFF IDLIAALPFD LLYIFNITVT SLVHLLKTVR LLRLLRLLQK LERYSQCSAV
     VLTLLMSVFA LLAHWMACIW YVIGRREMEA NDPLLWDIGW LHELGKRLEV PYVNGSVGGP
     SRRSAYIAAL YFTLSSLTSV GFGNVCANTD AEKIFSICTM LIGALMHAVV FGNVTAIIQR
     MYSRRSLYHS RMKDLKDFIR VHRLPRPLKQ RMLEYFQTTW AVNSGIDANE LLRDFPDELR
     ADIAMHLNRE ILQLPLFGAA SRGCLRALSL HIKTSFCAPG EYLLRRGDAL QAHYYVCSGS
     LEVLRDNMVL AILGKGDLIG ADIPEPGQEP GLGADPNFVL KTSADVKALT YCGLQQLSSR
     GLAEVLRLYP EYGAAFRAGL PRDLTFNLRQ GSDTSGLSRF SRSPRLSQPR SESLGSSSDK
     TLPSITEAES GAEPGGGPRP RRPLLLPNLS PARPRGSLVS LLGEELPPFS ALVSSPSLSP
     SLSPALAGQG HSASPHGPPR CSAAWKPPQL LIPPLGTFGP PDLSPRIVDG IEDSGSTAEA
     PSFRFSRRPE LPRPRSQAPP TGTRPSPELA SEAEEVKEKV CRLNQEISRL NQEVSQLSRE
     LRHIMGLLQA RLGPPGHPAG SAWTPDPPCP QLRPPCLSPC ASRPPPSLQD TTLAEVHCPA
     SVGTMETGTA LLDLRPSILP PYPSEPDPLG PSPVPEASPP TPSLLRHSFQ SRSDTFH
//
